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This thesis concerns strain-release driven stereoselective addition reactions to 
cyclopropenes leading to the synthesis of medium-sized 8-membered 1,5-dioxocane ring 
structures, optically active cyclopropylboronates, and densely functionalized cyclopropane 
scaffolds via the addition of highly reactive carbon nucleophiles. This thesis is separated into 
three chapters detailing the background, development, optimization, scope, and limitations of 
each developed methodology. 
Chapter one describes a strain-release driven nucleophilic (4+4) cyclodimerization of 
cyclopropenes providing a fused three ring system possessing a medium-sized eight member ring 
core. The process is believed to proceed via a face-selective nucleophilic attack of an alkoxide on 
the strained double bond of cyclopropene followed by highly diastereoselective nucleophilic ring 
closure. Additionally, a newly developed expedited and cost saving method of accessing prochiral 
cyclopropenes possessing an unsubstituted double bond via Rh(II)-catalyzed [2+1] cycloaddition 
is detailed. 
Chapter two describes the directed rhodium(I)-catalyzed asymmetric hydroboration of 
cyclopropenes bearing ester and amide functions as directing groups. Hydroboration of esters 
provided variable results sensitive to the identity of the substituent on the opposing face of 
cyclopropene. The utilization of a much more Lewis basic amide function as a highly efficient 
directing group along with the development of a new class of prochiral cyclopropenyl amides is 
detailed. 
Chapter three describes the directed copper(I)-catalyzed ring retentive addition of Grignard 
reagents across the stained double bond of cyclopropenes. The high degree of conformational 
and configurational stability of the intermediate cyclopropyl Grignard reagent allowed for highly 
diastereoselective trapping with a variety of electrophiles, providing the possibility of 
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Chapter 1. Strain-Release Driven (4+4) Cyclodimerization of Cyclopropenes 
1.1 Introduction 
Medium-sized rings are considered to be those between 7 and 11 members. These structures 
are widely found in various natural products,[1] pharmaceuticals,[1] and materials science.[2] 
Despite their well-known biological and industrial applications, methods for direct cyclization 
are quite rare. Nucleophilic closure of medium-sized rings is considerably more challenging than 
assembly of five-, six-, and twelve-membered and even larger analogs. This is due to an increase 
in ring strain (enthalpic barrier) and a significant loss in conformational freedom (entropic 
barrier) accompanying such cycizations. The inherent strain energy of cycloalkanes (Figure 
1a)[3] rapidly decreases from a maximum with cyclopropane to essentially none with 
cyclohexane, mostly due to a relaxation of bond angle distortion. However, the strain of rings then 
increases between seven and eleven members and can be attributed to the development of 
transannular strain. In many cases, the rate of intramolecular head-to-tail cyclization forming 
medium-sized rings becomes considerably slower than the undesired intermolecular 
polymerization reaction (Figure 1b).[4] 
 
Figure 1. Strain energies of cycloalkanes and relative rates of intra- to intermolecular cyclization. 

















































Strain Energies of Cycloalkanes
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 To achieve acceptable reaction efficiency, substrate activation is typically required to 
overcome the two inhibitory barriers (enthalpic and entropic) opposing medium-sized ring 
synthesis. Two of the oldest and most widely used methods were developed by Yamaguchi[5] and 
Mitsunobu,[6] in which either a carboxylic acid or alcohol terminus are activated by conversion to 
the corresponding intermediate mixed anhydride or oxyphosphonium ion respectively (Scheme 
1a).  
More recently, Rousseau[7] has shown that a variety of electrophilic iodine reagents 
sufficiently activate olefins toward macroiodolactonizations (Scheme 1b). In a classic example 
by Corey and Nicolaou,[8] double activation of a substrate was achieved by converting a carboxylic 
acid into a strategically designed thioester, which could then efficiently perform intramolecular 
deprotonation of the alcohol, simultaneously activating both termini toward cyclization (Scheme 
1c). 
 We envisioned our own mode of double activation toward the synthesis of medium-sized 
rings utilizing cyclopropenemethanol derivatives. Simple deprotonation would activate the 
alcohol while the inherent ring strain of cyclopropene would facilitate efficient nucleophilic ring 




Scheme 1.  







Scheme 2.  
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1.2 Synthesis of Cyclopropenes 
1.2.1 Introduction 
To begin thorough evaluation of nucleophilic (4+4) cyclodimerization of cyclopropenes, it 
was quickly found that development of a protocol providing expedited access to 1-arylcycloprop-
2-ene carboxylates possessing an unsubstituted double bond was necessary. Such structures are 
typically accessed via metal-catalyzed cycloadditions of carbenoids generated from diazoesters 
1, to various acetylenes 2 to provide ‘internal’ and ‘terminal’ cyclopropenes (3a and 3b 
respectively), which have applications as strained chiral building blocks (Scheme 3).[9]  
 
Scheme 3.  
Scheme 4.  
1 2 3 
4 
5 6 
3a: R2, R3 = alkyl, aryl 
3b: R2 = alkyl, aryl; R3 = H 
3c: R2 = R3 = H 
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However, prochiral cyclopropenes 3c with an unsubstituted double bond, are often 
underutilized due to limited availability. Classical routes toward 3,3-disubstituted cyclopropenes 
include a photoinduced isomerization of vinylcarbenes 4[10] and 1,2-dehydrohalogenation of 2-
bromocyclopropylcarboxylate salts 5,[11] followed by esterification of intermediate cyclopropene 
carboxylate 6 (Scheme 4). 
Direct Rh(II)-catalyzed cyclopropenation of acetylene gas has also been reported,[12] but has 
seen only limited application due to the inherent difficulties of handling gaseous reagents. 
Gevorgyan[13] first reported the preparation of 1-phenylcycloprop-2-enecarboxylate via 
cyclopropenation of trimethylsilylacetylene with phenyldiazoacetate followed by removal of 
TMS. However, to access the necessary starting materials to evaluate the (4+4) nucleophilic 
cyclodimerization of cyclopropenes, a more general, scalable, and efficient protocol was required. 
1.2.2 Results and Discussion 
 The use of bis(trimethylsilyl)acetylene 8 and trimethylsilylacetylene 11 as a substitute for 
acetylene gas in copper-catalyzed cyclopropenations[14] of diazomalonates 7 has been known for 
some time (Scheme 5a). To access the desired 3,3-disubstituted cyclopropenes (Scheme 3, R1 ≠ 
CO2R), a Rh(II)-catalyzed transformation was chosen due to their precedent[15] as catalysts for 
cyclopropenation of phenyldiazoacetates 10 and trimethylsilylacetylene 11 (Scheme 5b). 
However, this reaction proved to be very sluggish and only provided acceptable yields when a 
dilute solution of phenyldiazoacetate dissolved in TMS-acetylene was added to solvent quantities 
of neat TMS-acetylene and Rh(II)-catalyst by slow (<0.25 mL/h) syringe pump addition. 
It was found that the large excess of TMS-acetylene could almost completely be recovered by 
direct distillation from the reaction mixture following reaction completion. The high volatility of 
TMS-acetylene, when compared to bis(trimethylsilyl)acetylene, allowed for efficient recovery 
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and reuse in subsequent reactions which was critical to the scalability of this protocol because 






The most straightforward synthesis of diazoesters 1 utilizes sulfonylazides 14a to transfer a 
diazo function to activated methylene species 13 under basic conditions (Scheme 6). A result of 
this process is the generation of stoichiometric quantities of sulfonylamine 15a which, due to 
solubility and polarity issues, cause considerable complications with efficient purification. 
Davies[16] has reported the use of 4-acetamidobenzenesulfonylazide 14b as an easily 
separable, although considerably more expensive, diazo transfer reagent. Due to the quantities 
of starting material envisioned to complete our investigation of (4+4) cyclodimerization of 
cyclopropenes, we sought a robust preparative protocol providing 12 utilizing the inexpensive 
and readily accessible p-tolyl substituted diazo transfer reagent 14a. 
  
7 8 9 
10 11 12 
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Scheme 6.  
 
The synthesis of cyclopropenes 12 by Rh(II)-catalyzed cycloaddition, requiring the use of 
TMS-acetylene both as a reagent and a solvent, strictly limits the array of diazoesters able to 
undergo this transformation to those which are stable, non-polar, and display a high degree of 
solubility in TMS-acetylene. Initial studies were conducted using methylphenylacetate 16a and 
tosylazide 14a in the presence of DBU (Scheme 7). After sufficient optimization, it was found 
that careful washing of the product with saturated aqueous ammonium chloride and quick 
vacuum filtration through silica gel using hexanes could provide roughly purified diazoester 17a, 
which showed approximately 80% assay by NMR analysis. This extremely expedited purification 
protocol, while completely removing the tosylamine byproduct, still gave a diazoester product 
possessing considerable insoluble impurities.  
Interestingly, it was found that these impurities could easily be removed by dissolving the 
crude product in TMS-acetylene and withdrawing the supernatant solution into a syringe 
through a cotton wrapped needle. This syringe could then directly be used to deliver diazoester 
17a by syringe pump addition to refluxing solution of Rh(II) acetate in TMS-acetylene. These 
extremely expedited purification conditions provided cyclopropene 18a in equivalent yield (78% 
vs 80%) to established procedures using diazoesters in fully and laboriously purified form 
(Scheme 7).[17] 
 
13 14a: R2 = Me 
14b: R2 = NHAc 
1 15a: R2 = Me 
15b: R2 = NHAc 
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Scheme 7.  
 
The developed protocol (Method A) which provided an expedited and efficient path to 
previously difficult to obtain substrates 18, was then applied to a variety of diazoarylacetates 16 
which proved to be sufficiently soluble in TMS-acetylene (Table 1). It was found that chlorinated 
and brominated diazoarylacetates exhibited decreased solubility and thus required higher 
dilution in TMS-acetylene for efficient syringe pump addition. Furthermore, fluorinated 
substrates were generally more soluble and in most cases good yields were obtained (Table 1). 
For diazo compounds which were found to be poorly soluble in TMS-acetylene, an alternative 
method (Method B) was developed which relies on very slow continuous extraction to deliver 
diazoacetates to the reaction. In method B, the crude solid diazoesters 17f and 17g were placed 
into a piece of filter paper which had been rolled into cone and then set within a typical addition 
funnel. The addition funnel was then topped with a water cooled reflux condenser and then 
placed on top of a round bottom flask containing Rh2(OAc)4 in refluxing TMS-acetylene (Figure 
2). 
  








74% 71% 49% 68% 
 
43% 64% 74% 59% 
72% 46% 71% 52% 
16 17 18 
18b 18c 18d 18e 
18h 18i 18j 18k 
18l 18m 18n 18o 
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Figure 2. Schematic of continuous extraction apparatus. 
 
In this setup, a dilute solution of diazoester is slowly washed into the lower flask by 
condensing vapors of TMS-acetylene. This process allows for slow and steady dropwise delivery 
of diazoester into the reaction flask and offered far superior efficiency when compared to a 
typical Soxhlet apparatus, in which periodic syphoning of large volumes of relatively 
concentrated diazoester are added. This newly developed protocol was employed to synthesize 
cyclopropenes 18f and 18g in good yield (Scheme 8). 
 
Scheme 8.  
73% 
71% 
16f 17f 18f 
16g 17g 18g 
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All TMS-protected cyclopropenes 18 could efficiently be desilylated by aqueous potassium 
carbonate while preserving the strained double bond and ester function to provide prochiral 
cyclopropenes 19 (Table 2). 
 
Table 2. Desilylation of protected cyclopropenes. 
 
18 19 
82% 84% 81% 80% 
79% 96% 89% 78% 




19a 19b 19c 19d 
19h 19g 19f 19e 
19i 19j 19k 19l 
19o 19n 19m 
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1.3 Optimization of (4+4) Cyclodimerization of Deprotected Cyclopropenes 
Initial attempts to achieve the desired (4+4) cyclodimerization reaction involved exposure of 
cyclopropene 20a to conditions previously developed for addition of various alkoxide 
nucleophiles to cyclopropenes.[18] Exposure of 20a to t-BuOK in THF at 55 °C for six hours 
resulted in the selective formation of the eight membered homodimerization product 21a in 70% 
yield as a single diastereomer (Table 3, entry 1)! Interestingly, no detectable evidence of the 
tert-butoxide addition product was observable by crude NMR analysis. 
Replacement of t-BuOK with freshly powdered KOH under the same reaction conditions 
improved the reaction yield to as high as 74% while maintaining the exclusive 
diastereoselectivity (Table 3, entry 2). Concentrating the reaction drastically shortened reaction 
times and reactions performed in THF resulted in no observable cyclodimerization product most 
likely due to an increased propensity toward intermolecular polymerization (entries 5-8). 
Further dilution of the reaction had little effect on the transformation and only resulted in a 
substantial increase in reaction time (entries 9, 10). It was also found that polar aprotic well 
coordinating solvents resulted in substantial deterioration in diastereoselectivity (entries 3, 4, 
7, 8, 11-14). Diethyl ether and toluene provided high selectivity but rather disappointing yields 
(entries 15-18). Reactions performed in dichloromethane, carbon tetrachloride, and 1,4-






























1 t-BuOK (2.5) THF (0.085) 6 70 99:1 
2 KOH (2.5) THF (0.085) 6 74 99:1 
3 t-BuOK (2.5) DMSO (0.085) 6 75 85:15 
4 KOH (2.5) DMSO (0.085) 6 32 83:17 
5 KOH (2.5) THF (0.225) <2 0 - 
6 t-BuOK (2.5) THF (0.225) <2 0 - 
7 KOH (2.5) DMSO (0.225) <2 57 81:19 
8 t-BuOK (2.5) DMSO (0.225) <2 71 82:18 
9 KOH (2.5) THF (0.028) <18 72 99:1 
10 t-BuOK (2.5) THF (0.028) <18 71 98:2 
11 KOH (2.5) DMF (0.085) 6 36 89:11 
12 t-BuOK (2.5) DMF (0.085) 6 57 95:5 
13 KOH (2.5) DMA (0.085) 6 36 91:9 
14 t-BuOK (2.5) DMA (0.085) 6 68 90:10 
15 KOH (2.5) Et2O (0.085) 6 60 99:1 
16 t-BuOK (2.5) Et2O (0.085) 6 58 98:2 
17 KOH (2.5) PhMe (0.085) 6 28 99:1 
18 t-BuOK (2.5) PhMe (0.085) 6 43 98:2 
19 KOH (2.5) CH2Cl2 (0.085) 6 0 - 
20 t-BuOK (2.5) CH2Cl2 (0.085) 6 0 - 
21 KOH (2.5) CCl4 (0.085) 6 0 - 
22 t-BuOK (2.5) CCl4 (0.085) 6 0 - 
23 KOH (2.5) 1,4-dioxane (0.085) 6 0 - 
24 t-BuOK (2.5) 1,4-dioxane (0.085) 6 0 - 
20a 21a 22a 
[a] NMR yields using dibromomethane as standard. Test reactions were 
performed in 6.3 mg (43 µmol) scale (based on 20a) at 55°C with 18-C-6 (0.25 
equiv.). [b] Determined by GC analyses of crude reaction mixtures. 
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1.4 (4+4) Cyclodimerization of Deprotected Cyclopropenes 
With optimized conditions established, the preparative scale reaction was evaluated across 
several substrates. In addition to 21a, the 4-fluoro- 21b, 2,4-difluoro- 21c, 2-chloro-4-fluoro- 
21d, and 2-bromo-4-fluoro- 21e analogs were obtained in good yields (Table 4). 
 
Table 4. (4+4) cyclodimerization of deprotected cyclopropenes. 
 
 
1.5 Optimization of Starting Material Synthesis 
During the synthesis of starting materials to fully evaluate the scope of nucleophilic (4+4) 
cyclodimerization, it was found that cyclopropenes 18 could be efficiently desilylated with 
21a 21b 21c 
21d 21e 
66%, 
dr = >98:2 
63%, 
dr = >98:2 
59%, 
dr = 94:6 
75%, 
dr = >98:2 
63%, 
dr = >98:2 
20 21 22 
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potassium carbonate in a biphasic mixture of water and THF (Scheme 2). However, subsequent 
attempts to selectively reduce the ester function in the presence of the unprotected strained 
double bond proved quite challenging. Significant optimization involving the extremely slow 
addition of DIBAL-H to cyclopropenes 19 at -78 °C eventually provided acceptable yields of 
cyclopropenemethanols 20a-e (Table 5). In an attempt to obtain structures 20a-e in a more 
efficient and milder sequence, it was found that the order of desilylation/reduction could be 
swapped (Scheme 9).  
 

















While it was found that reaction conditions were required to be held at -78 °C to achieve 
conversion of 18 to 23, the presence of the TMS protecting group during reduction provided 
improved yields in most cases (Table 6). However, this slight increase in efficiency was 
squandered by the subsequent deprotection step which typically did not provide yields above 
50%, most likely due to prolonged exposure of a hydroxyl group to the strained electrophilic 
























1.6 Optimization of One-Pot Desilylative (4+4) Cyclodimerization 
To overcome the synthetic bottleneck observed while attempting to access structures 20, a 
one-pot desilylative/nucleophilic addition process providing 1,5-dioxocane 21a directly from 
18 23 
87% 75% 80% 53% 
62% 53% 83% 64% 
95% 90% 77% 63% 
74% 81% 57% 
23a 23b 23c 23d 
23e 23f 23g 23h 
23i 23j 23k 23l 
23o 23n 23m 
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cyclopropene 23a was evaluated under the previously optimized reaction conditions for 
cyclization of cyclopropenes 20 (Scheme 10). Interestingly, the reaction did proceed to provide 




Subsequent optimization of the new direct route toward 1,5-dioxocanes 21 found that any 
lowering of reaction temperature below 55 °C resulted in sharp declines in chemical yield (Table 
7, entries 1, 2). Furthermore, increasing temperature to 65 °C offered a substantial gain in 
efficiency while further increasing the temperature to just 75 °C once again sharply decreased 
yield and even began to erode diastereoselectivity (entries 4, 5). Due to the process now 
requiring base, not only deprotonate the alcohol but also remove the TMS protecting group, 
increasing the base loading to five equivalents further increased yield to 77% (entries 6-8). As 
was observed in optimization with 20a, reactions conducted with KOH and t-BuOK in a variety 
of other solvents offered reduced efficiencies and selectivities (entries 10-21). In all cases, the 
one-pot transformation proved to be somewhat slower, requiring reaction times of 24 hours and 




dr = 98:2 
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Table 7. Optimization of one-pot desilylative (4+4) cyclodimerization.  









1 KOH (2.5) THF 35 24 0 - 
2 KOH (2.5) THF 45 24 21 98:2 
3 KOH (2.5) THF 55 24 56 98:2 
4 KOH (2.5) THF 65 24 68 98:2 
5 KOH (2.5) THF 75 24 49 97:3 
6 KOH (1.5) THF 65 24 45 98:2 
7 KOH (5.0) THF 65 24 77 98:2 
8 KOH (7.5) THF 65 24 75 98:2 
9 t-BuOK (5.0) THF 65 24 70 99:1 
10 KOH (5.0) DMSO 65 24 45 86:14 
11 t-BuOK (5.0) DMSO 65 24 67 87:13 
12 KOH (5.0) DMF 65 24 29[b] 94:6 
13 t-BuOK (5.0) DMF 65 24 29[b] 91:9 
14 KOH (5.0) DMF 65 72 34[b] 93:7 
15 t-BuOK (5.0) DMF 65 72 21[b] 92:8 
16 KOH (5.0) DMA 65 72 54 93:7 
17 t-BuOK (5.0) DMA 65 72 48 92:8 
18 KOH (5.0) Et2O 65 24 59 99:1 
19 t-BuOK (5.0) Et2O 65 24 61 99:1 
20 KOH (5.0) PhMe 65 72 71 98:2 





1.7 One-Pot Desilylative (4+4) Cyclodimerization 
With optimized conditions for a one-pot desilylative nucleophilic (4+4) cyclodimerization 
reaction in hand, the scope was evaluated across fifteen other protected cyclopropenes 23 
possessing different aryl substitution (Table 8).  
 
23a 21a 22a 
[a] NMR yields using dibromomethane as standard [b] Incomplete conversion: 
GC analysis showed presence of unreacted starting material 23a. Test 



























dr = >98:2 
23 21 22 
64% 
dr = 98:2 
21a 21b 21c 21d 
21h 21g 21f 21e 
21i 21j 21k 21l 
21o 21n 21m 
59% 
dr = >98:2 
62% 
dr = 92:8 
63% 
dr = >98:2 
55% 
dr = >98:2 
78% 
dr = >98:2 
69% 
dr = >98:2 
62% 
dr = >98:2 
57% 
dr = 88:12 
83% 
dr = >98:2 
67% 
dr = >98:2 
32% 
dr = 98:2 
70% 
dr = >98:2 
65% 
dr = >98:2 
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Dioxocanes 21a through 21e in Table 8 allow for direct comparison of the one-pot 
desilylation/cyclization method to the stepwise protocol evaluated in Table 4. In all cases, the 
efficiency of nucleophilic (4+4) cyclodimerization remained essentially the same while avoiding 
the losses of material experienced in Scheme 9. All products were obtained as essentially a single 
diastereomer except for substrates possessing two fluorine substituents 21c and 21j, in which 
cis-configured dioxocanes 22c and 22j were observed in measurable quantities (Table 8). 
1.8 Proposesd Mechanism and Discussion of Diastereoselectivity 
The stereochemical outcomes of the tricyclic products produced in Table 8 were confirmed 
by X-ray analysis of 4-methyl substituted dioxocane 21g (Figure 3), in which a trans-
configuration is clearly seen with aryl substituents being placed on opposite faces of the 8-
member-heterocycle. 
 














 The high degree of trans-diastereoselectivity is believed to be rationalized by Scheme 11. 
The proposed mechanism begins with intermolecular nucleophilic attack of one alkoxide moiety 
on the less sterically hindered face of cyclopropene, possibly being assisted via coordination of 
the incoming nucleophile to a potassium cation, to establish cis-linear dimer 24. From here, a 
subsequent 8-exo-trig strain-release driven nucleophilic addition occurs to produce trans-cyclic 
dimer 21 selectively, possibly once again aided by coordination of the alkoxide to potassium 
(Scheme 11).  
 
Scheme 11 














The origin of diastereoselectivity during the intramolecular cyclization event is not precisely 
known, however, the formation of a more favorable transition state via participation of a 
potassium cation is believed to occur due to the deterioration of diastereoselectivity observed in 
reactions performed in polar cation coordinating solvents such as DMSO, DMA, and DMF (Tables 
3 and 7). 
 A portion of the lost material balance can be accounted for by the formation of trans-linear 
dimer 25 which cannot undergo intramolecular cyclization due to the alkoxide moiety being 
oriented away from the site of ring closure. This species instead undergoes intermolecular 
nucleophilic attack to form various oligomers and polymers. At the optimized reaction 
concentration of 0.085 M, the intermolecular polymerization process occurs much slower than 
intramolecular cyclization, and by reduction of reaction temperature to 45 °C and careful 
monitoring of reaction progress it was possible to isolate and characterize 25a in 9% yield 
(Scheme 12). The inability of the trans-linear dimer to undergo intramolecular cyclization was 
confirmed by subjecting 25a to optimized conditions, from which, no evidence of the intended 











In conclusion, a strain-release driven nucleophilic (4+4) cyclodimerization of cyclopropenes 
to provide a fused three ring system possessing a medium-sized eight member ring core was 
successfully developed. The process proceeds via face-selective nucleophilic attack of an alkoxide 
species on the strained double bond of cyclopropene followed by highly diastereoselective 
nucleophilic ring closure to provide interesting 1,5-dioxocane structures. The development of 
this process also resulted in an expedited and cost saving method of accessing prochiral 
cyclopropenes possessing an unsubstituted double bond via Rh(II)-catalyzed [2+1] cycloaddition 





1.10.1 General Information 
NMR spectra were recorded on a Bruker Avance DPX-400 instrument, equipped with a 
quadruple-band gradient probe (H/C/P/F QNP) or a Bruker Avance DRX-500 with a dual 
carbon/proton cryoprobe (CPDUL). 13C NMR spectra were registered with broadband 
decoupling. The (+) and (-) designations represent positive and negative intensities of signals in 
13C DEPT-135 experiments. IR spectra were recorded on a Shimadzu FT-IR 8400S instrument. 
HRMS was carried out on LCT Premier (Micromass Technologies) instrument; ESI TOF detection 
techniques were used. GC analyses were performed on a Shimadzu GC-2010 gas chromatograph 
with FID detector and equipped with an AOC-20i auto-injector and an AOC-20S auto-sampler tray 
(150 vials); 30 m 0.25 mm 0.25 mm capillary column, SHR5XLB, polydimethylsiloxane; 5% Ph 
was employed. Helium (99.96%), additionally purified by passing consecutively through a CRS 
oxygen/moisture/hydrocarbon trap (#202839) and VICI oxygen/moisture trap (P100-1), was 
used as a carrier gas. Hydrogen gas was used as FID fuel; zero-grade air and zero-grade nitrogen 
were used as an oxidant and make-up gas, respectively, for the FID. All these gases were purified 
by passing through CRS #202839 traps. The following GC parameters were used for all analyses: 
carrier gas flow rate 2.5 mL/min; oven temperature program: 50 °C (2 min) – 20 °C/min – 230 
°C (6 min), injector temperature 275 °C. HPLC analyses were performed on a Rainin Dynamax 
SD-200 equipped with Alltech Econosphere Si 5U column (L 150 mm ID 4.6 mm) or a 250 mm x 
4.6 mm Chiracel OD-H column and Rainin Dynamax Absorbance detector UV-C set at 254 nm or 
Agilent Technologies 1220 Infinity system equipped with either Diacel Chirapak IC, Diacel 
Chirapak IE, or Diacel Chirapak IB. Glassware employed in moisture-free syntheses was flame-
dried in vacuum prior to use. A combination of glove box and standard Schlenk technique was 
used to handle moisture sensitive materials. Column chromatography was carried out on silica 
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gel (Sorbent Technologies, 40-63 µm). Pre-coated silica gel plates (Sorbent Technologies Silica 
XG 200 µm) were used for TLC analyses. Anhydrous diethyl ether and THF were obtained by 
passing degassed commercially available HPLC-grade inhibitor-free solvents consecutively 
through two columns filled with activated alumina and stored over molecular sieves under 
nitrogen. Other anhydrous solvents were obtained according to standard procedures. Water was 
purified by dual stage deionization followed by dual stage reverse osmosis. Powdered potassium 
hydroxide was obtained by grinding commercially available pelleted reagent employing 
conventional electric-powered blade coffee-grinder housed inside a nitrogen-filled glove box. All 




methyl 2-(2-fluorophenyl)acetate (16p) 
(Typical Esterification Procedure) 2-(2-fluorophenyl)acetic acid (9.69 g, 
62.9 mmol, 1.0 equiv.) and amberlyst-15 exchange resin (100 mg) were combined in freshly 
distilled methanol (100 mL) and refluxed overnight with stirring. The solution was then filtered 
and concentrated under vacuum. The remaining solution was then added to cold water and 
extracted with ethyl acetate (3 x 30 mL). Combined organic layers were then washed successively 
with potassium carbonate and brine, dried with magnesium sulfate, and concentrated. If 
necessary, the product was then purified by column chromatography using a 3:1 hexane:ethyl 
acetate mobile phase to provide the titled compound as a colorless oil in 73% yield (7.75 g, 46.1 
mmol); 1H NMR (400 MHz, CDCl3): δ 7.33 – 7.21 (m, 2H), 7.16–7.00 (m, 2H), 3.71 (s, 3H), 3.68 (s, 
2H); 13C (126 MHz, CDCl3): δ 171.2, 161.1 (d, J = 246.5 Hz), 131.5 (d, J = 4.0 Hz, +), 129.2 (d, J = 8.1 
Hz, +), 124.2 (d, J = 3.7 Hz, +), 121.4 (d, J = 15.9 Hz), 115.5 (d, J = 21.6 Hz, +), 52.3 (+), 34.4 (d, J = 
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3.3 Hz, -); FTIR (KBr, cm-1): 3032, 3001, 2955, 1744, 1620, 1587, 1495, 1458, 1435, 1418, 1344, 
1285, 1258, 1234, 1209, 1163, 1100, 1013, 945, 930, 860, 835, 806, 758, 739, 685, 631; HRMS 
(TOF ES): Found 169.0668, calculated for C9H10FO2 (M+H) 169.0665 (1.8 ppm). 
 
methyl 2-(2-chloro-6-fluorophenyl)acetate (16h) 
Titled compound was obtained via typical esterification procedure using 2-
(2-chloro-6-fluorophenyl)acetic acid (20.0 g, 106.1 mmol, 1.0 equiv.), as a 
clear liquid in 73% yield (15.6 mg, 76.8 mmol); 1H NMR (400 MHz, CDCl3): δ 7.22 – 7.14 (m, 2H), 
7.02 – 6.94 (m, 1H), 3.82 (s, 2H), 3.69 (s, 3H); 13C (126 MHz, CDCl3): δ 170.0, 161.5 (d, J = 248.8 
Hz), 135.7 (d, J = 5.3 Hz), 129.1 (d, J = 9.5 Hz, +), 125.1 (d, J = 3.5 Hz, +), 121.0 (d, J = 18.6 Hz), 
113.9 (d, J = 22.7 Hz, +), 52.2 (+), 31.7 (-); FTIR (KBr, cm-1): 3001, 2953, 1747, 1609, 1580, 1466, 
1454, 1435, 1416, 1340, 1292, 1248, 1221, 1171, 1138, 1065, 1014, 1003, 953, 897, 858, 827, 
781, 746, 681, 660; HRMS (TOF ES): Found 203.0279, calculated for C9H9ClFO2 (M+H) 203.0275 
(2.0 ppm). 
 
methyl 2-(2-chloro-4,5-difluorophenyl)acetate (16o) 
Titled compound was obtained via typical esterification procedure using 
2-(2-chloro-4,5-difluorophenyl)acetic acid (7.04 g, 34.1 mmol, 1.0 equiv.), 
as a pale yellow liquid in 80% yield (6.02 g, 27.3 mmol); 1H NMR (400 MHz, CDCl3): δ 7.23 (dd, J 
= 9.9, 7.2 Hz, 1H), 7.15 (dd, J = 10.5, 8.2 Hz, 1H), 3.72 (s, 3H), 3.71 (s, 2H); 13C (126 MHz, CDCl3): δ 
170.3, 149.3 (dd, J = 251.7, 13.6 Hz), 148.9 (dd, J = 248.9, 12.5 Hz), 129.2 (dd, J = 7.9, 3.7 Hz), 129.0 
(dd, J = 5.9, 4.1 Hz), 119.8 (d, J = 19.0 Hz, +), 118.5 (d, J = 20.3 Hz, +), 52.4 (+), 38.1 (+); FTIR (KBr, 
cm-1): 3057, 3003, 2957, 1747, 1732, 1607, 1504, 1437, 1421, 1402, 1340, 1302, 1263, 1198, 
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1165, 1151, 1018, 991, 939, 903, 876, 856, 822, 766, 721, 652; HRMS (TOF ES): Found 221.0183, 
calculated for C9H8ClF2O2 (M+H) 221.0181 (0.9 ppm). 
 
methyl 2-(4-fluoro-2-methylphenyl)acetate (16q) 
Titled compound was obtained via typical esterification procedure using 
2-(4-fluoro-2-methylphenyl)acetic acid (10.7 g, 63.6 mmol, 1.0 equiv.), as a clear oil in 81% yield 
(9.38 g, 51.5 mmol); 1H NMR (400 MHz, CDCl3): δ 7.15 (dd, J = 8.4, 5.8 Hz, 1H), 6.92 – 6.82 (m, 2H), 
3.69 (s, 3H), 3.60 (s, 2H), 2.30 (s, 3H); 13C NMR (126 MHz, CDCl3): δ 171.8, 162.0 (d, J = 245.1 Hz), 
139.2 (d, J = 7.8 Hz), 131.6 (d, J = 8.2 Hz, +), 128.5 (d, J = 3.1 Hz), 117.0 (d, J = 21.3 Hz, +), 112.8 
(d, J = 21.0 Hz, +), 52.0 (+), 38.2 (-), 19.7 (+); FTIR (KBr, cm-1): 2995, 2953, 2928, 1730, 1610, 
1591, 1501, 1435, 1381, 1339, 1313, 1256, 1211, 1161, 1095, 1005, 962, 924, 891, 864, 822, 793, 
735, 723, 683, 617; HRMS (TOF ES): Found 182.0744, calculated for C10H11FO2 (M+) 182.0743 
(0.5 ppm). 
 




(Typical Cyclopropenation Procedure A) methyl 2-(4-
fluorophenyl)acetate (16b) (5.0 g, 29.7 mmol, 1.0 equiv.) and tosyl azide (6.15 g, 31.2 mmol, 1.05 
equiv.) were stirred in acetonitrile (75 mL) at 0 °C. 1,8-Diazabicyclo[5.4.0]undec-7-ene (DBU) 
(5.45 g, 35.6 mmol, 1.2 equiv.) was then added drop wise to the stirring solution via an addition 
funnel. Upon complete addition, the reaction was allowed to warm to room temperature and was 
stirred overnight. Solvent was then evaporated and the reaction was partitioned between 
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saturated ammonium chloride and methylene chloride. The aqueous phase was then extracted 
with methylene chloride (3 x 30 mL). Combined organic phases were then washed with brine, 
dried with magnesium sulfate, filtered, and concentrated. The recovered material was then 
immediately filtered through a short pad of Silica gel using a 9:1 mixture of hexane and ethyl 
acetate. methyl 2-diazo-2-(4-fluorophenyl)acetate was obtained as an orange oil in 62% crude 
yield (3.6 g, 18.5 mmol). methyl 2-diazo-2-(4-fluorophenyl)acetate (3.60 g, 18.5 mmol, 1.0 equiv.) 
was then dissolved in a minimum amount of trimethylsilylacetylene (~4.0 mL) and added via 
syringe pump over 18 hours to a stirring and refluxing suspension of rhodium(II) acetate dimer 
catalyst (3.7 mg, 8.30 μmol, 0.09 mol%) in trimethylsilylacetylene (26 mL, 185 mmol, 10.0 
equiv.). After complete addition, the reaction was monitored by gas chromatography until 
complete consumption of the starting material was observed. Once this was achieved, the reflux 
condenser was replaced with distillation head and most of the trimethylsilylacetylene was 
recovered by distillation at ambient pressure. Residual solvent was then removed under vacuum. 
The reaction was then purified by column chromatography using a 3:1 hexanes:methylene 
chloride mobile phase. The titled compound was obtained as an amber oil in 74% yield (3.64 g, 
13.8 mmol); 1H NMR (400 MHz, CDCl3): δ 7.23 (s, 1H), 7.06-7.01 (m, 2H), 6.79-6.73 (m, 2H), 3.47 
(s, 3H), 0.00 (s, 9H); 13C (126 MHz, CDCl3): δ 176.0, 161.3 (d, J = 244.4 Hz), 138.3 (d, J = 3.2 Hz), 
130.0 (d, J = 7.9 Hz, 2C, +), 120.3, 115.5 (+), 114.8 (d, J = 21.3 Hz, 2C, +), 52.0 (+), 30.7, -1.4 (3C, 
+); FTIR (KBr, cm-1): 3119, 3042, 2993, 2955, 2901, 1732, 1703, 1603, 1510, 1435, 1286, 1252, 
1223, 1157, 1034, 1014, 897, 847, 820, 760, 710; HRMS (TOF ES): Found 301.1036, calculated 






Compound was obtained via typical cyclopropenation procedure A using 
methyl 2-(2,4-difluorophenyl)acetate (16c) (6.83 g, 36.7 mmol, 1.0 equiv.), tosyl azide (7.60 g, 
38.5 mmol, 1.05 equiv.), acetonitrile (105 mL), and DBU (6.70 g, 44.0 mmol, 1.20 equiv.). methyl 
2-diazo-2-(2,4-difluorophenyl)acetate was obtained as a orange liquid in 83% yield (6.49 g, 30.59 
mmol). methyl 2-diazo-2-(2,4-difluorophenyl)acetate (6.49 g, 30.6 mmol, 1.0 equiv.) was then 
dissolved in a minimum amount of trimethylsilylacetylene (~7.5 mL) and added to a refluxing 
suspension of rhodium(II) acetate dimer catalyst (6.08 mg, 13.8 μmol, 0.09 mol%) in 
trimethylsilylacetylene (43.5 mL, 306 mmol, 10.0 equiv.). The titled compound was obtained as 
a brown oil in 71% yield (6.1 g, 21.6 mmol); 1H NMR (400 MHz, CDCl3): δ 7.50 (s, 1H), 7.08-7.01 
(m, 1H), 6.83 – 6.71 (m, 2H), 3.64 (s, 3H), 0.21 (s, 9H); 13C (126 MHz, CDCl3): δ 175.7, 162.0 (dd, J 
= 246.3, 8.8 Hz), 161.9 (dd, J = 246.3, 9.5 Hz), 131.0 (dd, J = 9.6, 5.9 Hz, +), 126.4 (dd, J = 16.0, 3.9 
Hz), 121.4, 115.9 (+), 111.0 (dd, J = 21.1, 3.7 Hz, +), 103.8 (t, J = 25.7 Hz, +), 52.3 (+), 26.7, -1.6 (3C, 
+); FTIR (KBr, cm-1): 3124, 3078, 2995, 2957, 2903, 1736, 1730, 1701, 1612, 1601, 1502, 1425, 
1290, 1269, 1252, 1227, 1211, 1163, 1138, 1111, 1090, 1030, 1013, 964, 845, 785, 760, 712, 615; 






Compound was obtained via typical cyclopropenation procedure A using 
methyl 2-(2-chloro-4-fluorophenyl)acetate (16d) (5.0 g, 24.7 mmol, 1.0 equiv.), tosyl azide (5.11 
g, 25.9 mmol, 1.05 equiv.), acetonitrile (70.9 mL), and DBU (4.51 g, 29.6 mmol, 1.2 equiv.). methyl 
2-(2-chloro-4-fluorophenyl)-2-diazoacetate was obtained as an orange liquid in 88% yield (4.96 
g, 21.7 mmol). methyl 2-(2-chloro-4-fluorophenyl)-2-diazoacetate (4.96 g, 21.7 mmol, 1.0 equiv.) 
was then dissolved in a minimum amount of trimethylsilylacetylene (~5.0 mL) and added to a 
refluxing suspension of rhodium(II) acetate dimer catalyst (4.30 mg, 9.76 μmol, 0.09 mol%) in 
trimethylsilylacetylene (31.0 mL, 217 mmol, 10.0 equiv.). The titled compound was obtained as 
a brown oil in 49% yield (3.2 g, 10.7 mmol); 1H NMR (400 MHz, CDCl3): δ 7.57 (s, 1H), 7.12 – 7.06 
(m, 2H), 6.91 (td, J = 8.3, 2.6 Hz, 1H), 3.64 (s, 3H), 0.25 (s, 9H); 13C (126 MHz, CDCl3): δ 175.5, 
161.4 (d, J = 248.4 Hz), 137.1 (d, J = 3.6 Hz), 135.9 (d, J = 10.4 Hz), 131.4 (d, J = 8.8 Hz, +), 121.9, 
117.8 (+), 116.8 (d, J = 24.6 Hz, +), 114.1 (d, J = 21.0 Hz, +), 52.4 (+), 31.0, -1.3 (3C, +); FTIR (KBr, 
cm-1): 3123, 3072, 2955, 2901, 2847, 1929, 1753, 1730, 1693, 1599, 1587, 1487, 1435, 1393, 
1319, 1281, 1254, 1221, 1051, 1009, 916, 891, 847, 710, 604; HRMS (TOF ES): Found 299.0672, 




Compound was obtained via typical cyclopropenation procedure A using 
methyl 2-(2-bromo-4-fluorophenyl)acetate (16e) (15.3 g, 61.9 mmol, 1.0 equiv.), tosyl azide 
(12.8 g, 65.0 mmol, 1.05 equiv.), acetonitrile (178 mL), and DBU (11.3 g, 74.3 mmol, 1.20 equiv.). 
methyl 2-(2-bromo-4-fluorophenyl)-2-diazoacetate was obtained as a orange liquid in 71% yield 
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(12.0 g, 44.1 mmol). methyl 2-(2-bromo-4-fluorophenyl)-2-diazoacetate (12.0 g, 43.9 mmol, 1.0 
equiv.) was then dissolved in a minimum amount of trimethylsilylacetylene (~11.0 mL) and 
added to a refluxing suspension of rhodium(II) acetate dimer catalyst (8.70 mg, 19.8 μmol, 0.09 
mol%) in trimethylsilylacetylene (62.6 mL, 439.4 mmol, 10.0 equiv.). The titled compound was 
obtained as a brown oil in 68% yield (10.2 g, 29.7 mmol); 1H NMR (400 MHz, CDCl3): δ 7.61 (s, 
1H), 7.27 (dd, J = 2.5, 1.25 Hz, 1H) 7.09 (dd, J = 8.5, 6.0 Hz, 1H), 6.96 (td, J = 8.3, 2.7 Hz, 1H), 3.64 
(s, 3H), 0.27 (s, 9H); 13C (126 MHz, CDCl3): δ 175.4, 161.2 (d, J = 249.7 Hz), 138.8 (d, J = 3.5 Hz), 
131.5 (d, J = 8.5 Hz, +), 125.6 (d, J = 9.6 Hz), 121.9, 120.0 (d, J = 24.3 Hz, +), 118.6 (+), 114.7 (d, J = 
20.9 Hz, +), 52.4 (+), 33.2, -1.2 (3C, +); FTIR (KBr, cm-1): 3123, 3069, 2953, 2901, 2841, 1730, 
1697, 1597, 1580, 1485, 1433, 1416, 1385, 1279, 1252, 1219, 1105, 1041, 1009, 968, 897, 847, 
781, 760, 712, 673, 638, 604; HRMS (TOF ES): Found 343.0168, calculated for C14H17BrFO2Si 




(Typical Cyclopropenation Procedure B)  
methyl 2-(naphthalen-1-yl)acetate (16f) (22.0 g, 110.0 mmol, 1.0 equiv.) and tosyl azide (22.8 g, 
115.6 mmol, 1.05 equiv.) were stirred in acetonitrile  (250 mL) at 0 °C. 1,8-
Diazabicyclo[5.4.0]undec-7-ene (DBU) (20.1 g, 132.1 mmol, 1.2 equiv.) was then added drop wise 
to the stirring solution via an addition funnel. Upon complete addition, the reaction was allowed 
to warm to room temperature and was stirred overnight. Solvent was then evaporated and the 
reaction was partitioned between saturated ammonium chloride and methylene chloride. The 
aqueous phase was then extracted with methylene chloride (3 x 30 mL). Combined organic 
phases were then washed with brine, dried with magnesium sulfate, filtered, and concentrated. 
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The recovered material was then immediately filtered through a short pad of Silica gel using a 
9:1 mixture of hexane and ethyl acetate. methyl 2-diazo-2-(naphthalen-1-yl)acetate was obtained 
as an red solid in 65% crude yield (16.2 g, 72.0 mmol). An apparatus was then assembled 
consisting of a round bottom flask topped with an addition funnel and a small water cooled 
condenser. methyl 2-diazo-2-(naphthalen-1-yl)acetate (4.65 g, 20.5 mmol, 1.0 equiv.), as a solid, 
was then rolled into a conical piece of filter paper and placed within the addition funnel. The 
round bottom flask, containing rhodium(II) acetate dimer catalyst (4.0 mg, 9.2 μmol, 0.09 mol%) 
in trimethylsilylacetylene (29.0 mL, 205 mmol, 10.0 equiv.) was then placed in an oil bath and 
heated until reflux was achieved at a rate in which condensation occurred just within the addition 
funnel. This state of reflux was maintained until GC analysis showed complete conversion of the 
starting material, then the addition funnel was replaced with a distillation head and excess 
trimethylsilylacetylene was distilled under ambient pressure. The reaction was then purified by 
column chromatography using a 3:1 hexanes:methylene chloride mobile phase. The titled 
compound was obtained as a brown oil in 73% yield (2.16 g, 7.29 mmol); 1H NMR (400 MHz, 
CDCl3): δ 8.13 – 8.08 (m, 1H), 7.89-7.84 (m, 1H), 7.81 (s, 1H), 7.78-7.74 (m, 1H), 7.57 – 7.39 (m, 
3H), 7.34-7.29 (m, 1H), 3.60 (s, 3H), 0.27 (s, 9H); 13C (126 MHz, CDCl3): δ 177.0 139.8, 133.9, 
132.6, 128.8 (+), 127.6 (+), 126.2 (+), 125.9 (+), 125.8 (+), 125.7 (+), 124.8 (+), 121.9, 119.6 (+), 
52.4 (+), 30.8, -1.1 (3C, +); FTIR (KBr, cm-1): 3119, 3059, 3043, 3011, 2953, 2899, 1927, 1730, 
1697, 1595, 1508, 1433, 1394, 1340, 1283, 1250, 1221, 1177, 1144, 1121, 1080, 1049, 1020, 
1001, 951, 893, 843, 802, 777, 762, 735, 708, 667, 642, 631; HRMS (TOF ES): Found 296.1233, 






Compound was obtained via typical cyclopropenation procedure B using 
methyl 2-(p-tolyl)acetate (16g) (9.3 g, 56.6 mmol, 1.0 equiv.), tosyl azide (11.7 g, 59.5 mmol, 1.05 
equiv.), acetonitrile (162 mL), and DBU (10.3 g, 67.9 mmol, 1.20 equiv.). methyl 2-diazo-2-(p-
tolyl)acetate was obtained as a red solid in 47% crude yield (5.06 g, 26.6 mmol). Subsequent 
operations were performed with methyl 2-diazo-2-(p-tolyl)acetate (2.0 g, 10.5 mmol, 1.0 equiv.), 
rhodium(II) acetate dimer (2.10 mg, 4.73 μmol, 0.09 mol%) and trimethylsilylacetylene (15.0 mL, 
105 mmol, 10.0 equiv.). The titled compound was obtained as a brown oil in 71% yield (1.93 g, 
7.41 mmol); 1H NMR (400 MHz, CDCl3): δ 7.45 (s, 1H), 7.16 (d, J = 8.3 Hz, 2H), 7.09 (d, J = 7.9 Hz, 
2H), 3.68 (s, 3H), 2.32 (s, 3H), 0.21 (s, 9H); 13C (126 MHz, CDCl3): δ 176.4, 139.5, 135.7, 128.8 (2C, 
+), 128.3 (2C, +), 120.1, 116.2, 52.0 (+), 31.2 (+), 21.2 (+), -1.3 (3C, +); FTIR (KBr, cm-1): 3117, 
3022, 2993, 2953, 2922, 2901, 2870, 1730, 1703, 1605, 1514, 1433, 1412, 1379, 1327, 1288, 
1250, 1219, 1207, 1182, 1117, 1095, 1036, 1016, 970, 897, 845, 768, 719, 708, 635; HRMS (TOF 




Compound was obtained via typical cyclopropenation procedure A using 
methyl 2-(2-chloro-6-fluorophenyl)acetate (16h) (6.51 g, 32.1 mmol, 1.0 equiv.), tosyl azide 
(6.65 g, 33.7 mmol, 1.05 equiv.), acetonitrile (93 mL), and DBU (5.87 g, 38.6 mmol, 1.20 equiv.). 
methyl 2-(2-chloro-6-fluorophenyl)-2-diazoacetate was obtained as a yellow liquid in 48% yield 
(3.55 g, 15.53 mmol). methyl 2-(2-chloro-6-fluorophenyl)-2-diazoacetate (2.7 g, 11.8 mmol, 1.0 
equiv.) was then dissolved in a minimum amount of trimethylsilylacetylene (~2.5 mL) and added 
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to a refluxing suspension of rhodium(II) acetate dimer catalyst (2.3 mg, 5.30 μmol, 0.09 mol%) 
in trimethylsilylacetylene (16.8 mL, 118 mmol, 10.0 equiv.). The titled compound was obtained 
as a brown oil in 43% yield (1.50 g, 5.02 mmol); 1H NMR (400 MHz, CDCl3): δ 7.54 (d, J = 2.3 Hz, 
1H), 7.19 – 7.09 (m, 2H), 7.00 – 6.89 (m, 1H), 3.64 (s, 3H), 0.23 (s, 9H); 13C (126 MHz, CDCl3): δ 
175.3, 162.5 (d, J = 248.0 Hz), 136.3 (d, J = 5.3 Hz), 129.0 (d, J = 17.6 Hz), 128.7 (d, J = 9.8 Hz, +), 
125.3 (d, J = 3.4 Hz, +), 119.4 (d, J = 2.1 Hz), 117.8 (d, J = 3.3 Hz, +), 114.2 (d, J = 23.1 Hz, +), 52.4 
(+), 25.9 (d, J = 2.0 Hz), -1.5 (3C, +); FTIR (KBr, cm-1): 2955, 2903, 1734, 1705, 1607, 1572, 1447, 
1435, 1418, 1252, 1242, 1217, 1177, 1146, 1030, 1011, 885, 845, 795, 781, 760, 721, 636; HRMS 




Compound was obtained via typical cyclopropenation procedure A using 
methyl 2-(2-chlorophenyl)acetate (16i) (5.89 g, 31.9 mmol, 1.0 equiv.), tosyl azide (6.80 g, 33.5 
mmol, 1.05 equiv.), acetonitrile (92 mL), and DBU (5.82 g, 38.3 mmol, 1.2 equiv.). methyl 2-(2-
chlorophenyl)-2-diazoacetate was obtained as a orange liquid in 83% yield (5.55 g, 26.4 mmol). 
methyl 2-(2-chlorophenyl)-2-diazoacetate (5.55 g, 26.4 mmol, 1.0 equiv.) was then dissolved in 
a minimum amount of trimethylsilylacetylene (~5.0 mL) and added to a refluxing suspension of 
rhodium(II) acetate dimer catalyst (5.2 mg, 11.9 μmol, 0.09 mol%) in trimethylsilylacetylene 
(37.5 mL, 263 mmol, 10.0 equiv.). The titled compound was obtained as a brown oil in 64% yield 
(4.75 g, 16.9 mmol); 1H NMR (400 MHz, CDCl3): δ 7.61 (s, 1H), 7.33 (dd, J = 7.6, 1.6 Hz, 1H), 7.22 
– 7.11 (m, 3H), 3.64 (s, 3H), 0.27 (s, 9H); 13C (126 MHz, CDCl3): δ 175.6, 140.9, 135.2, 130.3 (+), 
129.4 (+), 128.1 (+), 126.9 (+), 121.8, 118.0 (+), 52.2 (+), 31.5, -1.3 (3C, +); FTIR (KBr, cm-1): 3123, 
3061, 3020, 2953, 2901, 2841, 2405, 2253, 1950, 1736, 1591, 1433, 1414, 1209, 1059, 1038, 
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1024, 1011, 893, 847, 750, 735, 717, 700, 642; HRMS (TOF ES): Found 287.0846, calculated for 




Compound was obtained via typical cyclopropenation procedure A using 
methyl 2-(2,3-difluorophenyl)acetate (16j) (6.4 g, 34.38 mmol, 1.0 equiv.), tosyl azide (7.12 g, 
36.1 mmol, 1.05 equiv.), acetonitrile (99 mL), and DBU (6.28 g, 41.25 mmol, 1.20 equiv.). methyl 
2-diazo-2-(2,3-difluorophenyl)acetate was obtained as a orange liquid in 77% yield (5.60 g, 26.4 
mmol). methyl 2-diazo-2-(2,3-difluorophenyl)acetate (5.60 g, 26.4 mmol, 1.0 equiv.) was then 
dissolved in a minimum amount of trimethylsilylacetylene (~5.0 mL) and added to a refluxing 
suspension of rhodium(II) acetate dimer catalyst (5.30 mg, 11.9 μmol, 0.09 mol%) in 
trimethylsilylacetylene (37.6 mL, 264 mmol, 10.0 equiv.). The titled compound was obtained as 
a brown oil in 74% yield (5.55 g, 19.7 mmol); 1H NMR (400 MHz, CDCl3): δ 7.50 (s, 1H), 7.04 – 
6.92 (m, 2H), 6.86-6.81 (m, 1H), 3.63 (s, 3H), 0.22 (s, 9H); 13C (126 MHz, CDCl3): δ 175.3, 150.5 
(dd, J=247.7, 13.1 Hz), 149.8 (dd, J= 247.2, 12.4 Hz) 132.8 (d, J = 12.4 Hz), 124.9 (t, J = 3.1 Hz, +), 
123.8 (dd, J = 7.0, 4.6 Hz, +), 121.1, 115.8 (+), 115.7 (d, J = 17.3 Hz, +), 52.3 (d, J = 1.7 Hz, +), 27.0 
(t, J = 2.4 Hz), -1.7 (3C, +); FTIR (KBr, cm-1): 3124, 3036, 2957, 2903, 2843, 1730, 1703, 1624, 
1591, 1479, 1435, 1302, 1288, 1252, 1229, 1215, 1163, 1051, 993, 874, 845, 818, 789, 762, 725, 







Compound was obtained via typical cyclopropenation procedure A using 
methyl 2-(3-bromophenyl)acetate (16k) (2.75 g, 12.0 mmol, 1.0 equiv.), tosyl azide (2.48 g, 12.6 
mol, 1.05 equiv.), acetonitrile (35 mL), and DBU (2.19 g, 14.4 mmol, 1.20 equiv.). methyl 2-(3-
bromophenyl)-2-diazoacetate was obtained as a orange liquid in 65% yield (2.0 g, 7.84 mmol). 
methyl 2-(3-bromophenyl)-2-diazoacetate (2.0 g, 7.84 mmol, 1.0 equiv.) was then dissolved in a 
minimum amount of trimethylsilylacetylene (~2.5 mL) and added to a refluxing suspension of 
rhodium(II) acetate dimer catalyst (1.56 mg, 3.5 μmol, 0.09 mol%) in trimethylsilylacetylene 
(11.2 mL, 78.4 mmol, 10.0 equiv.). The titled compound was obtained as a brown oil in 59% yield 
(1.5 g, 4.61 mmol); 1H NMR (400 MHz, CDCl3): δ 7.41-7.39 (m, 1H), 7.39 (s, 1H), 7.31-7.28 (m, 1H), 
7.24-7.21 (m, 1H), 7.13 (t, J = 7.8 Hz, 1H), 3.67 (s, 3H), 0.20 (s, 9H); 13C (126 MHz, CDCl3): δ 175.4, 
145.0, 131.4 (+), 129.5 (+), 129.1 (+), 127.1 (+), 122.1, 119.6, 115.2 (+), 52.1 (+), 31.0, -1.4 (3C, 
+); FTIR (KBr, cm-1): 3121, 3063, 2953, 2899, 2841, 1732, 1705, 1593, 1562, 1474, 1435, 1416, 
1283, 1252, 1209, 1107, 1072, 1036, 1014, 997, 974, 845, 781, 760, 723, 694, 633; HRMS (TOF 




Compound was obtained via typical cyclopropenation procedure A using 
methyl 2-(4-bromophenyl)acetate (16l) (2.70 g, 11.8 mmol, 1.0 equiv.), tosyl azide (2.44 g, 12.4 
mmol, 1.05 equiv.), acetonitrile (34.0 mL), and DBU (2.15 g, 14.1 mmol, 1.20 equiv.). methyl 2-(4-
bromophenyl)-2-diazoacetate was obtained as a orange liquid in 89% yield (2.67 g, 10.5 mmol). 
methyl 2-(4-bromophenyl)-2-diazoacetate (2.67 g, 10.5 mmol, 1.0 equiv.) was then dissolved in 
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a minimum amount of trimethylsilylacetylene (~2.5 mL) and added to a refluxing suspension of 
rhodium(II) acetate dimer catalyst (2.08 mg, 4.71 μmol, 0.09 mol%) in trimethylsilylacetylene 
(14.9 mL, 105 mmol, 10.0 equiv.). The titled compound was obtained as a brown oil in 72% yield 
(2.45 g, 7.53 mmol); 1H NMR (400 MHz, CDCl3): δ 7.40 (s, 1H), 7.38 (d, J = 5.5 Hz, 2H), 7.15 (d, J = 
8.5 Hz, 2H), 3.66 (s, 3H), 0.19 (s, 9H); 13C (126 MHz, CDCl3): δ 175.7, 141.7, 131.0 (2C, +), 130.2 
(2C, +), 120.0, 119.9, 115.1 (+), 52.1 (+), 30.9, -1.4 (3C, +); FTIR (KBr, cm-1): 3121, 3080, 3063, 
3024, 2953, 2899, 2841, 1730, 1703, 1589, 1487, 1433, 1394, 1288, 1252, 1209, 1111, 1072, 
1032, 1009, 897, 845, 789, 760, 721, 679, 636; HRMS (TOF ES): Found 342.0536, calculated for 




Compound was obtained via typical cyclopropenation procedure A using 
methyl 2-(2,4-dichlorophenyl)acetate (16m) (8.75 g, 39.9 mmol, 1.0 equiv.), tosyl azide (8.27 g, 
41.9 mmol, 1.05 equiv.), acetonitrile (115 mL), and DBU (7.30 g, 47.9 mmol, 1.20 equiv.). methyl 
2-diazo-2-(2,4-dichlorophenyl)acetate was obtained as an orange liquid in 79% yield (7.69 g, 
31.38 mmol). methyl 2-diazo-2-(2,4-dichlorophenyl)acetate (7.69 g, 31.4 mmol, 1.0 equiv.) was 
then dissolved in a minimum amount of trimethylsilylacetylene (~7.5 mL) and added to a 
refluxing suspension of rhodium(II) acetate dimer catalyst (6.20 mg, 14.1 μmol, 0.09 mol%) in 
trimethylsilylacetylene (44.7 mL, 314 mmol, 10.0 equiv.). The titled compound was obtained as 
a brown oil in 46% yield (4.5 g, 14.3 mmol); 1H NMR (400 MHz, CDCl3): δ 7.57 (s, 1H), 7.35 (d, J = 
2.1 Hz, 1H), 7.17 (dd, J = 8.2, 2.1 Hz, 1H), 7.05 (d, J = 8.2 Hz, 1H), 3.64 (s, 3H), 0.25 (s, 9H); 13C (126 
MHz, CDCl3): δ 175.3, 139.8, 136.0, 133.1, 131.3 (+), 129.3 (+), 127.3 (+), 121.9, 117.6 (+), 52.4 
(+), 31.1, -1.3 (3C, +); FTIR (KBr, cm-1): 3123, 2953, 2901, 1736, 1701, 1587, 1556, 1472, 1433, 
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1377, 1283, 1250, 1217, 1101, 1059, 1024, 1011, 966, 897, 847, 812, 766, 710, 636; HRMS (TOF 




Compound was obtained via typical cyclopropenation procedure A using methyl 2-(3-
(trifluoromethyl)phenyl)acetate (16n) (3.70 g, 17.0 mmol, 1.0 equiv.), tosyl azide (3.51 g, 17.8 
mmol, 1.05 equiv.), acetonitrile (49.0 mL), and DBU (3.10 g, 20.4 mmol, 1.20 equiv.). methyl 2-
diazo-2-(3-(trifluoromethyl)phenyl)acetate was obtained as a orange liquid in 95% yield (3.95 g, 
16.18 mmol). methyl 2-diazo-2-(3-(trifluoromethyl)phenyl)acetate (3.95 g, 16.2 mmol, 1.0 
equiv.) was then dissolved in a minimum amount of trimethylsilylacetylene (~3.5 mL) and added 
to a refluxing suspension of rhodium(II) acetate dimer catalyst (3.20 mg, 7.28 μmol, 0.09 mol%) 
in trimethylsilylacetylene (23.0 mL, 162 mmol, 10.0 equiv.). The titled compound was obtained 
as a brown oil in 64% yield (3.25 g, 10.3 mmol); 1H NMR (400 MHz, CDCl3): δ 7.55 – 7.43 (m, 3H), 
7.42 (s, 1H), 7.41 – 7.35 (m, 1H), 3.68 (s, 3H), 0.20 (s, 9H); 13C (126 MHz, CDCl3): δ 175.4, 143.7, 
132.0 (d, J = 1.4 Hz, +), 130.3 (q, J = 31.9 Hz), 128.4 (+), 125.1 (d, J = 3.8 Hz, +), 124.4 (q, J = 272.3), 
122.9 (d, J = 3.8 Hz, +), 119.5, 115.2 (+), 52.1 (+), 31.1, -1.5 (3C, +); FTIR (KBr, cm-1): 2957, 1734, 
1705, 1491, 1437, 1333, 1275, 1254, 1207, 1165, 1124, 1074, 1038, 845, 802, 762, 702. HRMS 




Compound was obtained via typical cyclopropenation procedure A using 
methyl 2-(2-chloro-4,5-difluorophenyl)acetate (16o) (10.0 g, 45.3 mmol, 1.0 equiv.), tosyl azide 
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(9.39 g, 47.6 mmol, 1.05 equiv.), acetonitrile (130 mL), and DBU (8.28 g, 54.4 mmol, 1.20 equiv.). 
methyl 2-(2-chloro-4,5-difluorophenyl)-2-diazoacetate was obtained as a orange oil in 92% yield 
(10.3 g, 41.6 mmol). methyl 2-(2-chloro-4,5-difluorophenyl)-2-diazoacetate (10.3 g, 41.6 mmol, 
1.0 equiv.) was then dissolved in a minimum amount of trimethylsilylacetylene (~11.0 mL) and 
added to a refluxing suspension of rhodium(II) acetate dimer catalyst (8.27 mg, 18.7 μmol, 0.09 
mol%) in trimethylsilylacetylene (59.2 mL, 416 mmol, 10.0 equiv.). The titled compound was 
obtained as a brown oil in 52% yield (6.9 g, 21.8 mmol); 1H NMR (400 MHz, CDCl3): δ 7.54 (s, 1H), 
7.17 (dd, J = 9.9, 7.2 Hz, 1H), 6.92 (dd, J = 10.6, 8.2 Hz, 1H), 3.65 (s, 3H), 0.25 (d, J = 0.6 Hz, 9H); 
13C (126 MHz, CDCl3): δ 175.0, 149.1 (dd, J = 247.5, 3.7 Hz), 149.0 (dd, J = 248.8, 4.8 Hz), 138.1 (t, 
J = 4.5 Hz), 129.9 (dd, J = 7.9, 3.4 Hz), 121.9, 118.8 (d, J = 18.1 Hz, +), 118.5 (d, J = 20.2 Hz, +), 117.4 
(+), 52.4 (+), 31.1, -1.3 (3C, +); FTIR (KBr, cm-1): 3123, 3051, 2955, 2903, 2843, 2359, 1732, 1703, 
1601, 1495, 1460, 1435, 1396, 1308, 1252, 1219, 1200, 1165, 1105, 1057, 997, 966, 910, 878, 
847, 804, 768, 712, 660, 633, 619; HRMS (TOF ES): Found 339.0397, calculated for 




Compound was obtained via typical cyclopropenation procedure A using 
methyl 2-(4-fluoro-2-methylphenyl)acetate (16q) (2.38 g, 29.5 mmol, 1.0 equiv.), tosyl azide 
(6.11 g, 31.0 mmol, 1.05 equiv.), acetonitrile (84 mL), and DBU (5.39 g, 35.4 mmol, 1.20 equiv.). 
methyl 2-diazo-2-(4-fluoro-2-methylphenyl)acetate was obtained as a orange oil in 86% yield 
(5.3 g, 25.5 mmol). methyl 2-diazo-2-(4-fluoro-2-methylphenyl)acetate (2.0 g, 9.60 mmol, 1.0 
equiv.) was then dissolved in a minimum amount of trimethylsilylacetylene (~2.5 mL) and added 
to a refluxing suspension of rhodium(II) acetate dimer catalyst (1.9 mg, 4.3 μmol, 0.09 mol%) in 
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trimethylsilylacetylene (13.7 mL, 96.0 mmol, 10.0 equiv.). The titled compound was obtained as 
a yellow oil in 35% yield (0.94 g, 3.38 mmol); 1H NMR (400 MHz, CDCl3): δ 7.62 (s, 1H), 7.01 (dd, 
J = 8.4, 5.9 Hz, 1H), 6.88 – 6.76 (m, 2H), 3.64 (s, 3H), 2.33 (s, 3H), 0.27 (s, 9H); 13C (126 MHz, 
CDCl3): δ 176.4, 161.6 (d, J = 244.3 Hz), 139.9 (d, J = 7.9 Hz), 137.2 (d, J = 3.2 Hz), 130.4 (d, J = 8.4 
Hz, +), 121.6, 119.5 (+), 116.8 (d, J = 21.0 Hz, +), 112.7 7(d, J = 21.0 Hz, +), 52.3 (+), 30.7, 19.7 (d, 
J = 1.7 Hz, +), -1.2 (3C, +); FTIR (KBr, cm-1): 3119, 2955, 2928, 2901, 2091, 1730, 1697, 1614, 
1587, 1495, 1435, 1412, 1377, 1269, 1252, 1229, 1151, 1109, 1090, 1030, 1011, 972, 953, 928, 
885, 845, 781, 760, 729, 710, 640, 604; HRMS (TOF ES): Found 301.1036, calculated for 
C15H19FO2SiNa (M+Na) 301.1036 (0.0 ppm). 
 
1.10.4 Cyclopropene Desilylation 
 
methyl 1-(4-fluorophenyl)cycloprop-2-enecarboxylate (19b) 
(Typical Desilylation Procedure) methyl 1-(4-fluorophenyl)-2-
(trimethylsilyl)cycloprop-2-enecarboxylate (18b) (1.06 mg, 4.0 mmol, 1.0 equiv.) was dissolved 
in THF (6.50 mL) at 0 °C and 10% aqueous potassium carbonate (2.21 g, 16.0 mmol, 4.0 equiv.) 
was added drop wise. Upon complete addition, the reaction was allowed to warm to room 
temperature and stirred until gas chromatography showed complete conversion of starting 
material. Ether (20 mL) and brine (25 mL) were added to the solution and the aqueous layer was 
extracted (3 x 10 mL). The combined organic layers were then washed with brine (20 mL), dried 
with magnesium sulfate, filtered, and concentrated. The product was then purified by column 
chromatography using 6:1 Hexane:ethyl acetate as the mobile phase to provide the titled 
compound as a very pale yellow oil in 84% yield (648 mg, 3.36 mmol); 1H NMR (400 MHz, CDCl3): 
δ 7.25 – 7.20 (m, 2H), 7.20 (s, 2H), 7.03 – 6.95 (m, 2H), 3.70 (s, 3H); 13C (126 MHz, CDCl3): δ 175.5, 
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161.7 (d, J = 245.2 Hz), 137.4 (d, J = 3.2 Hz), 130.0 (d, J = 8.1 Hz, 2C, +), 115.1 (d, J = 21.4 Hz, 2C, 
+), 107.8 (2C, +), 52.5 (+), 30.1; FTIR (KBr, cm-1): 3159, 3117, 3042, 2999, 2953, 1720, 1659, 1603, 
1510, 1435, 1292, 1267, 1225, 1161, 1109, 1095, 1030, 1005, 899, 870, 831, 818, 777, 744, 625; 
HRMS (TOF ES): Found 215.0485, calculated for C11H9O2FNa (M+Na) 215.0484 (0.5 ppm). 
 
methyl 1-(2,4-difluorophenyl)cycloprop-2-enecarboxylate (19c) 
Compound was obtained via typical desilylation procedure using methyl 
1-(2,4-difluorophenyl)-2-(trimethylsilyl)cycloprop-2-enecarboxylate 
(18c) (1.13 g, 4.0 mmol, 1.0 equiv.) dissolved in THF (6.50 mL) and potassium carbonate (2.21 g, 
16.0 mmol, 4.0 equiv.). The titled compound was obtained as a pale yellow oil in 86% yield (723 
mg, 3.44 mmol); 1H NMR (400 MHz, CDCl3): δ 7.27 (s, 2H), 7.10 (td, J = 8.5, 6.4 Hz, 1H), 6.85 – 6.72 
(m, 2H), 3.67 (s, 3H); 13C (126 MHz, CDCl3): δ 175.1, 162.2 (dd, J = 247.8, 11.9 Hz), 161.8 (dd, J = 
249.0, 12.0 Hz), 130.9 (dd, J = 9.6, 5.8 Hz, +), 125.4 (dd, J = 15.9, 3.9 Hz), 111.2 (dd, J = 21.1, 3.8 
Hz, +), 108.0 (d, J = 1.5 Hz, 2C, +), 104.0 (t, J = 25.5 Hz, +), 52.7 (+), 25.9 (d, J = 1.4 Hz); FTIR (KBr, 
cm-1): 3165, 3123, 2955, 1720, 1664, 1612, 1599, 1501, 1423, 1292, 1269, 1244, 1213, 1140, 
1092, 1026, 1007, 968, 939, 878, 851, 785, 748, 628, 613; HRMS (TOF ES): Found 209.0413, 




Compound was obtained via typical desilylation procedure using methyl 
1-(2-bromo-4-fluorophenyl)-2-(trimethylsilyl)cycloprop-2-enecarboxylate (18d) (1.19 g, 4.0 
mmol, 1.0 equiv.) dissolved in THF (6.50 mL) and potassium carbonate (2.21 g, 16.0 mmol, 4.0 
equiv.). The titled compound was obtained as a pale yellow oil in 80% yield (729 mg, 3.22 mmol); 
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1H NMR (400 MHz, CDCl3): δ 7.31 (s, 2H), 7.16 (dd, J = 8.5, 6.0 Hz, 1H), 7.09 (dd, J = 8.5, 2.6 Hz, 
1H), 6.93 (td, J = 8.3, 2.6 Hz, 1H), 3.67 (s, 3H); 13C (126 MHz, CDCl3): δ 175.1, 161.7 (d, J = 248.9 
Hz), 136.2 (d, J = 3.7 Hz), 135.8 (d, J = 10.4 Hz), 131.2 (d, J = 9.0 Hz, +), 116.9 (d, J = 24.8 Hz, +), 
114.3 (d, J = 21.2 Hz, +), 108.6 (2C, +), 52.7 (+), 29.7; FTIR (KBr, cm-1): 3163, 3124, 3105, 2952, 
1735, 1718, 1701, 1572, 1431, 1389, 1283, 1221, 1115, 1051, 1005, 953, 920, 889, 820, 781, 746, 





Compound was obtained via typical desilylation procedure using methyl 
1-(2-chloro-4-fluorophenyl)-2-(trimethylsilyl)cycloprop-2-enecarboxylate (18e) (1.37 g, 4.0 
mmol, 1.0 equiv.) dissolved in THF (6.50 mL) and potassium carbonate (2.21 g, 16.0 mmol, 4.0 
equiv.). The titled compound was obtained as a pale yellow oil in 79% yield (861 mg, 3.18 mmol); 
1H NMR (400 MHz, CDCl3): δ 7.32 (s, 2H), 7.27 (dd, J = 8.3, 2.6 Hz, 1H), 7.16 (dd, J = 8.5, 5.9 Hz, 
1H), 6.98 (ddd, J = 8.5, 8.1, 2.6 Hz, 1H), 3.67 (s, 3H); 13C (126 MHz, CDCl3): δ 175.0, 161.5 (d, J = 
250.1 Hz), 138.0 (d, J = 3.4 Hz), 131.3 (d, J = 8.6 Hz, +), 125.3 (d, J = 9.6 Hz), 120.0 (d, J = 24.4 Hz, 
+), 114.9 (d, J = 21.1 Hz, +), 108.8 (2C, +), 52.8 (+), 31.8; FTIR (KBr, cm-1): 3161, 3121, 2951, 1736, 
1718, 1655, 1597, 1578, 1483, 1433, 1383, 1283, 1259, 1236, 1003, 910, 878, 866, 820, 781, 746, 
671, 627; HRMS (TOF ES): Found 269.9691, calculated for C11H8O2FBr (M+) 269.9692 (0.4 ppm). 
 
methyl 1-(naphthalen-1-yl)cycloprop-2-enecarboxylate (19f) 




(1.19 g, 4.0 mmol, 1.0 equiv.) dissolved in THF (6.50 mL) and potassium carbonate (2.21 g, 16.0 
mmol, 4.0 equiv.). The titled compound was obtained as a yellow solid in 96% yield (865 mg, 3.86 
mmol); mp: 71.4-72.8 °C; 1H NMR (400 MHz, CDCl3): 8.09 (d, J = 8.4 Hz, 1H), 7.90 (d, J = 7.5 Hz, 
1H), 7.80 (d, J = 8.2 Hz, 1H), 7.60 – 7.50 (m, 2H), 7.50 (s, 2H), 7.49 – 7.42 (m, 1H), 7.40 – 7.33 (m, 
1H), 3.63 (s, 3H); 13C (126 MHz, CDCl3): 176.5, 138.9, 133.8, 132.2, 128.8 (+), 127.9 (+), 126.2 (+), 
125.9 (+), 125.8 (+, 2C), 124.3 (+), 109.3 (+, 2C), 52.6 (+), 29.4; FTIR (KBr, cm-1): 3155, 3113, 
3061, 3043, 3003, 2951, 1718, 1657, 1595, 1508, 1433, 1394, 1286, 1252, 1229, 1180, 1080, 
1051, 991, 804, 781, 762, 762, 741, 640, 603; HRMS (TOF ES): Found 233.0755, Calculated for 
C15H11O2 (M-H) 223.0759 (1.8 ppm). 
 
methyl 1-(p-tolyl)cycloprop-2-enecarboxylate (19g) 
Compound was obtained via typical desilylation procedure using methyl 
1-(p-tolyl)-2-(trimethylsilyl)cycloprop-2-enecarboxylate (18g) (1.04 g, 4.0 mmol, 1.0 equiv.) 
dissolved in THF (6.50 mL) and potassium carbonate (2.21 g, 16.0 mmol, 4.0 equiv.). The titled 
compound was obtained as a pale yellow oil in 89% yield (673 mg, 3.58 mmol); 1H NMR (400 
MHz, CDCl3): 7.23 (s, 2H), 7.18 (d, J = 8.2, 2H), 7.13 (d, J = 8.4 Hz, 2H) 3.71 (s, 3H), 2.34 (s, 3H); 13C 
(126 MHz, CDCl3): 175.8, 138.6, 136.3, 129.0 (2C, +), 128.2 (2C, +), 107.9 (2C, +), 52.4 (+), 30.4, 
21.2 (+); FTIR (KBr, cm-1): 3155, 3111, 3047, 3022, 2995, 2951, 2922, 2843, 2359, 2332, 1907, 
1720, 1659, 1514, 1433, 1288, 1225, 1209, 1184, 1113, 1034, 1005, 814, 770, 743, 625; HRMS 
(TOF ES): Found 211.0741, Calculated for C12H12O2Na (M+Na) 211.0735 (2.8 ppm). 
 
methyl 1-(2-chlorophenyl)cycloprop-2-enecarboxylate (19i) 
Compound was obtained via typical desilylation procedure using methyl 1-(2-
chlorophenyl)-2-(trimethylsilyl)cycloprop-2-enecarboxylate (18i) (1.04 g, 
45 
 
4.0 mmol, 1.0 equiv.) dissolved in THF (6.50 mL) and potassium carbonate (2.21 g, 16.0 mmol, 
4.0 equiv.). The titled compound was obtained as a pale yellow oil in 67% yield (557 mg, 2.67 
mmol); 1H NMR (400 MHz, CDCl3): 7.37 – 7.33 (m, 1H), 7.33 (s, 2H), 7.25 – 7.16 (m, 3H), 3.67 (s, 
3H); 13C (126 MHz, CDCl3): 175.3, 140.1, 135.1, 130.1 (+), 129.4 (+), 128.5 (+), 127.1 (+), 108.6 
(2C, +), 52.6 (+), 30.3; FTIR (KBr, cm-1): 3157, 3117, 3059, 3018, 2951, 2359, 2341, 1718, 1655, 
1474, 1433, 1290, 1248, 1221, 1130, 1115, 1061, 1038, 1022, 1005, 901, 878, 793, 758, 746, 733, 
706, 650, 608; HRMS (TOF ES): Found 215.0450, Calculated for C11H9ClO2Li (M+Li) 215.0451 (0.5 
ppm). 
 
methyl 1-(2,3-difluorophenyl)cycloprop-2-enecarboxylate (19j) 
Compound was obtained via typical desilylation procedure using methyl 
1-(2,3-difluorophenyl)-2-(trimethylsilyl)cycloprop-2-enecarboxylate (18j) (1.12 g, 4.0 mmol, 
1.0 equiv.) dissolved in THF (6.50 mL) and potassium carbonate (2.21 mg, 16.0 mmol, 4.0 equiv.). 
The titled compound was obtained as a pale yellow oil in 81% yield (677 mg, 3.22 mmol); 1H NMR 
(400 MHz, CDCl3): 7.28 (s, 2H), 7.09 – 6.96 (m, 2H), 6.92 – 6.86 (m, 1H), 3.68 (s, 3H); 13C (126 
MHz, CDCl3): 174.8, 150.6 (dd, J = 248.0, 12.9 Hz), 149.8 (dd, J = 247.8, 12.6 Hz), 131.7 (d, J = 12.5 
Hz), 124.8 (t, J = 3.1 Hz, +), 124.0 (dd, J = 7.0, 4.6 Hz, +), 116.2 (d, J = 17.3 Hz, +), 107.7 (d, J = 1.5 
Hz, 2C, +), 52.7 (+), 27.0 – 25.2 (m); FTIR (KBr, cm-1): 3165, 3121, 3038, 3001, 2955, 2361, 1720, 
1663, 1624, 1591, 1477, 1437, 1304, 1265, 1240, 1217, 1167, 1132, 1053, 976, 881, 866, 854, 
816, 791, 762, 746, 721, 631; HRMS (TOF ES): Found 210.0491, Calculated for C11H8F2O2 (M+) 




methyl 1-(3-bromophenyl)cycloprop-2-enecarboxylate (19k) 
Compound was obtained via typical desilylation procedure using methyl 
methyl 1-(3-bromophenyl)-2-(trimethylsilyl)cycloprop-2-enecarboxylate (18k) (510 mg, 1.57 
mmol, 1.0 equiv.) dissolved in THF (2.55 mL) and potassium carbonate (866 mg, 6.27 mmol, 4.0 
equiv.). The titled compound was obtained as a pale yellow oil in 86% yield (344 mg, 1.36 mmol); 
1H NMR (400 MHz, CDCl3): 7.42 – 7.39 (m, 1H), 7.37 – 7.33 (m, 1H), 7.24 – 7.20 (m, 1H), 7.19 (s, 
2H), 7.19 – 7.13 (m, 1H), 3.70 (s, 3H); 13C (126 MHz, CDCl3): 174.9, 143.9, 131.5 (+), 129.8 (+), 
129.8 (+), 127.1 (+), 122.3, 107.4 (2C, +), 52.5 (+), 30.3; FTIR (KBr, cm-1): 3157, 3117, 3061, 2997, 
2951, 2361, 1718, 1661, 1593, 1560, 1475, 1433, 1414, 1283, 1265, 1221, 1111, 1072, 1032, 
1011, 997, 916, 883, 783, 743, 710, 689, 650, 604; HRMS (TOF ES): Found 274.9686, Calculated 
for C11H9BrO2Na (M+Na) 274.9684 (0.7 ppm). 
 
methyl 1-(4-bromophenyl)cycloprop-2-enecarboxylate (19l) 
Compound was obtained via typical desilylation procedure using methyl 
1-(4-bromophenyl)-2-(trimethylsilyl)cycloprop-2-enecarboxylate (18l) 
(1.30 g, 4.0 mmol, 1.0 equiv.) dissolved in THF (6.50 mL) and potassium carbonate (2.21 g, 16.0 
mmol, 4.0 equiv.). The titled compound was obtained as a pale yellow oil in 91% yield (917 mg, 
3.62 mmol); 1H NMR (400 MHz, CDCl3): 7.42 (d, J = 8.5 Hz, 2H), 7.19 (s, 2H), 7.15 (d, J = 8.4 Hz, 
2H), 3.70 (s, 3H); 13C (126 MHz, CDCl3): 175.1, 140.6, 131.3 (2C, +), 130.1 (2C, +), 120.6, 107.5 
(2C, +), 52.5 (+), 30.2; FTIR (KBr, cm-1): 3157, 3117, 3026, 2997, 2951, 2361, 1718, 1711, 1649, 
1483, 1433, 1394, 1288, 1217, 1113, 1070, 1030, 1009, 897, 868, 820, 787, 743, 717, 692, 609; 




methyl 1-(2,4-dichlorophenyl)cycloprop-2-enecarboxylate (19m) 
Compound was obtained via typical desilylation procedure using methyl 
1-(2,4-dichlorophenyl)-2-(trimethylsilyl)cycloprop-2-enecarboxylate 
(18m) (1.26 g, 4.0 mmol, 1.0 equiv.) dissolved in THF (6.50 mL) and potassium carbonate (2.21 
g, 16.0 mmol, 4.0 equiv.). The titled compound was obtained as a pale yellow oil in 71% yield 
(693 mg, 2.85 mmol); 1H NMR (400 MHz, CDCl3): 7.35 (d, J = 2.2 Hz, 1H), 7.30 (s, 2H), 7.19 (dd, J 
= 8.2, 2.1 Hz, 1H), 7.12 (d, J = 8.2 Hz, 1H), 3.66 (s, 3H); 13C (126 MHz, CDCl3): 174.8, 138.8, 135.8, 
133.5, 131.1 (+), 129.3 (+), 127.4 (+), 108.4 (2C, +), 52.7 (+), 29.7; FTIR (KBr, cm-1): 3161, 3119, 
2997, 2951, 2361, 1720, 1663, 1587, 1556, 1474, 1434, 1377, 1296, 1286, 1244, 1229, 1119, 
1103, 1061, 1020, 1005, 903, 879, 868, 810, 770, 748, 673, 617; HRMS (TOF ES): Found 264.9804, 




Compound was obtained via typical desilylation procedure using methyl 1-(3-
(trifluoromethyl)phenyl)-2-(trimethylsilyl)cycloprop-2-enecarboxylate (18n) (1.26 g, 4.0 mmol, 
1.0 equiv.) dissolved in THF (6.50 mL) and potassium carbonate (2.21 g, 16.0 mmol, 4.0 equiv.). 
The titled compound was obtained as a pale yellow oil in 93% yield (902 mg, 3.72 mmol); 1H NMR 
(400 MHz, CDCl3): 7.53 – 7.46 (m, 3H), 7.45 – 7.38 (m, 1H), 7.23 (d, J = 0.6 Hz, 2H), 3.71 (d, J = 0.6 
Hz, 3H); 13C (126 MHz, CDCl3): 174.9, 142.5, 131.9 (d, J = 1.3 Hz, +), 130.6 (q, J = 32.0 Hz), 128.6 
(+), 125.2 (q, J = 3.9 Hz, +), 124.3 (q, J = 272.3 Hz), 123.5 (q, J = 3.8 Hz, +), 107.4 (2C, +), 52.5 (+), 
30.4; FTIR (KBr, cm-1): 3163, 3121, 3003, 2955, 2361, 1718, 1664, 1491, 1439, 1333, 1292, 1277, 
1259, 1213, 1163, 1122, 1097, 1072, 1036, 1014, 918, 903, 802, 764, 743, 702, 687, 644, 604; 






Compound was obtained via typical desilylation procedure using methyl 
1-(2-chloro-4,5-difluorophenyl)-2-(trimethylsilyl)cycloprop-2-enecarboxylate (18o) (1.27 g, 
4.0 mmol, 1.0 equiv.) dissolved in THF (6.50 mL) and potassium carbonate (2.21 g, 16.0 mmol, 
4.0 equiv.). The titled compound was obtained as a pale yellow oil in 69% yield (678 mg, 2.77 
mmol); 1H NMR (400 MHz, CDCl3): 7.29 (s, 2H), 7.19 (dd, J = 9.9, 7.2 Hz, 1H), 7.0 (dd, J = 10.3, 8.2 
Hz, 1H), 3.67 (s, 3H); 13C (126 MHz, CDCl3): 174.5, 149.4 (dd, J = 251.4, 13.6 Hz), 149.2 (dd, J = 
249.3, 12.6 Hz), 137.1 (t, J = 4.6 Hz), 129.8 (dd, J = 7.9, 3.5 Hz), 118.7 (d, J = 18.2 Hz, +), 118.6 (d, 
J = 20.2 Hz, +), 108.3 (2C, +), 52.8 (+), 29.8; FTIR (KBr, cm-1): 3163, 3121, 3051, 2955, 2361, 
1728, 1661, 1603, 1497, 1437, 1398, 1310, 1258, 1225, 1200, 1173, 1113, 1055, 987, 889, 854, 
802, 770, 748, 669, 658, 629, 608; HRMS (TOF ES): Found 243.0017, Calculated for C11H6ClF2O2 




1.10.5 Reduction of TMS-Protected Cyclopropenes 
 
(1-phenyl-2-(trimethylsilyl)cycloprop-2-en-1-yl)methanol (23a) 
(Typical Ester Reduction Procedure) An oven dried two neck flask was 
charged with methyl 1-phenyl-2-(trimethylsilyl)cycloprop-2-enecarboxylate 
(18a) (1.0 g, 4.06 mmol, 1.0 equiv.) and diethyl ether (10 mL) under a nitrogen atmosphere. The 
mixture was cooled to -78 °C and DIBAL-H (1.21 g, 1.52 mL, 8.52 mmol, 2.10 equiv.) was then 
added very slowly dropwise via syringe. Upon complete addition, the reaction was stirred for one 
hour while maintaining -78 °C. The mixture was then allowed to warm to room temperature, 
stirred for one hour, and then saturated aqueous ammonium chloride was added dropwise until 
the solution became a gel. A 10% aqueous solution of HCl solution was then added very slowly 
until just the moment when the gel dissolves. Ether (10 mL) was added to the solution and the 
aqueous layer was extracted (3 x 10 mL). Combined organic layers were washed with saturated 
sodium bicarbonate, brine, dried with magnesium sulfate, filtered, and concentrated. The 
recovered product was then purified by column chromatography using 6:1 hexane:ethyl acetate 
mobile phase to provide the titled compound as a white solid in 87% yield (771 mg, 3.53 mmol); 
mp: 37.2 - 37.8 °C; 1H NMR (400 MHz, CDCl3): δ 7.70 (s, 1H), 7.31 – 7.26 (m, 2H), 7.22 – 7.12 (m, 
3H), 4.17 (d, J = 11.0 Hz, 1H), 3.99 (d, J = 11.0 Hz, 1H), 1.36 (s, 1H), 0.18 (s, 9H); 13C (126 MHz, 
CDCl3): δ 146.9, 128.1 (2C, +), 126.1 (2C, +), 125.3 (+), 124.0, 123.5 (+), 68.9 (-), 30.1, -0.9 (3C, +); 
FTIR (KBr, cm-1): 3389, 3057, 3022, 2957, 2897, 2870, 1693, 1599, 1495, 1445, 1408, 1250, 1065, 
1013, 989, 866, 843, 756, 727, 698; HRMS (TOF ES): Found 217.1050, calculated for C13H17OSi 






Compound was obtained via typical ester reduction procedure using 
methyl 1-(4-fluorophenyl)-2-(trimethylsilyl)cycloprop-2-enecarboxylate (18b) (397 mg, 1.5 
mmol, 1.0 equiv.), diethyl ether (4.0 mL), and DIBAL-H (448 mg, 562 μL, 3.15 mmol, 2.10 equiv.). 
The titled compound was obtained as a pale yellow solid in 75% yield (267 mg, 1.13 mmol); mp: 
40.8 – 41.4 °C 1H NMR (400 MHz, CDCl3): δ 7.70 (s, 1H), 7.13 (dd, J = 8.9, 5.3 Hz, 2H), 6.95 (t, J = 
8.8 Hz, 2H), 4.13 (d, J = 11.5 Hz, 1H), 3.94 (d, J = 11.6 Hz, 1H), 1.35 (s, 1H), 0.16 (s, 9H); 13C (126 
MHz, CDCl3): δ 161.0 (d, J = 243.2 Hz), 142.6 (d, J = 3.1 Hz), 127.6 (d, J = 7.7 Hz, 2C, +), 124.6, 123.6 
(+), 114.8 (d, J = 21.3 Hz, 2C, +), 69.2 (-), 29.6, -1.0 (3C, +); FTIR (KBr, cm-1): 3396, 3377, 3367, 
2959, 2899, 2872, 2361, 1691, 1603, 1508, 1410, 1250, 1229, 1159, 1059, 1013, 989, 868, 843, 
814, 760, 727, 717; HRMS (TOF ES): Found 243.1200, calculated for C13H17FOSiLi (M+Li) 




Compound was obtained via typical ester reduction procedure using 
methyl 1-(2,4-difluorophenyl)-2-(trimethylsilyl)cycloprop-2-enecarboxylate (18c) (424 mg, 
1.50 mmol, 1.0 equiv.), diethyl ether (4.0 mL), and DIBAL-H (448 mg, 562 μL, 3.15 mmol, 2.10 
equiv.). The titled compound was obtained as a white solid in 80% yield (305 mg, 1.20 mmol); 
mp: 57.7 – 58.8 °C; 1H NMR (400 MHz, CDCl3): δ 8.02 (s, 1H), 7.07 (td, J = 8.4, 6.4 Hz, 1H), 6.81 – 
6.69 (m, 2H), 3.96 (d, J = 11.0 Hz, 1H), 3.67 (d, J = 11.2 Hz, 1H), 1.24 (s, 1H), 0.19 (s, 9H); 13C (126 
MHz, CDCl3): δ 161.8 (dd, J = 247.2, 11.8 Hz), 161.5 (dd, J = 246.7, 12.0 Hz), 131.1 (dd, J = 9.5, 7.0 
Hz, +), 129.0 (dd, J = 16.3, 3.7 Hz), 129.0, 127.0 (+), 111.2 (dd, J = 20.8, 3.6 Hz, +), 103.9 (dd, J = 
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27.0, 25.1 Hz, +), 69.8 (d, J = 3.1 Hz, -), 27.5, -1.3 (3C, +); FTIR (KBr, cm-1): 3259, 3244, 2957, 2872, 
1693, 1609, 1601, 1502, 1464, 1418, 1269, 1250, 1136, 1099, 1053, 1022, 966, 881, 843, 818, 
760, 741, 731, 717, 700, 615; HRMS (TOF ES): Found 254.0943, calculated for C13H16F2OSi (M+) 




Compound was obtained via typical ester reduction procedure using 
methyl 1-(2-chloro-4-fluorophenyl)-2-(trimethylsilyl)cycloprop-2-enecarboxylate (18d) (448 
mg, 1.5 mmol, 1.0 equiv.), diethyl ether (4.0 mL), and DIBAL-H (448 mg, 562 μL, 3.15 mmol, 2.1 
equiv.). The titled compound was obtained as a white solid in 53% yield (214 mg, 0.790 mmol); 
mp: 61.7 – 63.2 °C; 1H NMR (400 MHz, CDCl3): δ 8.13 (s, 1H), 7.20 (dd, J = 8.5, 6.2 Hz, 1H), 7.06 
(dd, J = 8.6, 2.6 Hz, 1H), 6.90 (td, J = 8.3, 2.6 Hz, 1H), 3.90 (d, J = 11.2 Hz, 1H), 3.71 (d, J = 11.2 Hz, 
1H), 1.09 (s, 1H), 0.24 (s, 9H); 13C (126 MHz, CDCl3): δ 161.3 (d, J = 248.0 Hz), 139.6 (d, J = 3.6 Hz), 
135.0 (d, J = 10.3 Hz), 132.2 (d, J = 8.7 Hz, +), 129.4, 129.1 (+), 117.0 (d, J = 24.5 Hz, +), 114.3 (d, J 
= 20.7 Hz, +), 69.1 (-), 31.3, -1.0 (3C, +); FTIR (KBr, cm-1): 3398, 3379, 3360, 3342, 2959, 2899, 
2870, 1680, 1599, 1580, 1485, 1408, 1389, 1250, 1223, 1192, 1068, 1036, 1014, 995, 939, 876, 
843, 820, 760, 741, 717; HRMS (TOF ES): Found 270.0643, calculated for C13H16ClFOSi (M+) 




Compound was obtained via typical ester reduction procedure using 
methyl 1-(2-bromo-4-fluorophenyl)-2-(trimethylsilyl)cycloprop-2-enecarboxylate (18e) (515 
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mg, 1.50 mmol, 1.0 equiv.), diethyl ether (4.0 mL), and DIBAL-H (448 mg, 562 μL, 3.15 mmol, 2.10 
equiv.). The titled compound was obtained as a pale yellow solid in 62% yield (292 mg, 0.926 
mmol); mp: 51.6 – 52.8 °C; 1H NMR (400 MHz, CDCl3): δ 8.15 (s, 1H), 7.26 – 7.19 (m, 2H), 6.95 (td, 
J = 8.3, 2.6 Hz, 1H), 3.85 (d, J = 11.2 Hz, 1H), 3.74 (d, J = 11.2 Hz, 1H), 1.13 (s, 1H), 0.26 (s, 9H); 13C 
(126 MHz, CDCl3): δ 161.1 (d, J = 249.1 Hz), 141.2 (d, J = 3.6 Hz), 132.5 (d, J = 8.4 Hz, +), 129.7 (+), 
129.3, 124.4 (d, J = 9.5 Hz), 120.1 (d, J = 24.1 Hz, +), 114.8 (d, J = 20.7 Hz, +), 68.9 (-), 33.2, -0.9 
(3C, +); FTIR (KBr, cm-1): 3394, 3381, 3366, 2959, 2899, 2868, 1682, 1595, 1580, 1479, 1410, 
1383, 1250, 1221, 1196, 1065, 1032, 1014, 993, 889, 860, 843, 820, 760, 739, 717; HRMS (TOF 




Compound was obtained via typical ester reduction procedure using 
methyl 1-(naphthalen-1-yl)-2-(trimethylsilyl)cycloprop-2-enecarboxylate (18f) (445 mg, 1.50 
mmol, 1.0 equiv.), diethyl ether (4.0 mL), and DIBAL-H (448 mg, 562 μL, 3.15 mmol, 2.1 equiv.). 
The titled compound was obtained as a light brown oil in 53% yield (213 mg, 0.794 mmol); 1H 
NMR (400 MHz, CDCl3): δ 8.38 – 8.35 (m, 2H), 7.88 – 7.85 (m, 1H), 7.76 – 7.71 (m, 1H), 7.59 – 7.41 
(m, 3H), 7.40 (s, 1H), 3.96 (d, J = 11.6 Hz, 1H), 3.89 (d, J = 11.1 Hz, 1H), 1.39 (s, 1H), 0.28 (s, 9H); 
13C (126 MHz, CDCl3): δ 142.5, 134.2, 131.9, 130.9 (+), 129.9, 128.9 (+), 127.3 (+), 126.6 (+), 125.9 
(+), 125.8 (+), 125.7 (+), 125.0 (+), 69.9 (-), 31.3, -0.8 (3C, +); FTIR (KBr, cm-1): 3441, 3423, 3406, 
3389, 3344, 3059, 3045, 2955, 2899, 2864, 2361, 1732, 1680, 1593, 1508, 1393, 1250, 1020, 887, 






Compound was obtained via typical ester reduction procedure using 
methyl 1-(p-tolyl)-2-(trimethylsilyl)cycloprop-2-enecarboxylate (18g) 
(391 mg, 1.50 mmol, 1.0 equiv.), diethyl ether (4.0 mL), and DIBAL-H (448 mg, 562 μL, 3.15 mmol, 
2.1 equiv.). The titled compound was obtained as a pale yellow solid in 83% yield (288 mg, 1.24 
mmol); mp: 53.2-54.0 °C; 1H NMR (400 MHz, CDCl3): δ 7.70 (s, 1H), 7.13 – 7.04 (m, 4H), 4.13 (dd, 
J = 11.0, 5.1 Hz, 1H), 3.97 (dd, J = 11.4, 5.1 Hz, 1H), 2.31 (s, 3H), 1.15 (s, 1H), 0.18 (s, 9H); 13C (126 
MHz, CDCl3): δ 143.8, 134.8, 128.9 (2C, +), 126.1 (2C, +), 124.2, 124.0 (+), 68.9 (-), 29.9, 21.0 (+), 
-0.9 (3C, +); FTIR (KBr, cm-1): 3398, 3385, 3022, 2993, 2957, 2920, 2899, 2868, 2361, 1690, 1512, 
1466, 1408, 1250, 1061, 1018, 993, 868, 843, 760, 725. HRMS (TOF ES): Found 232.1283, 




Compound was obtained via typical ester reduction procedure using methyl 
1-(2-chloro-6-fluorophenyl)-2-(trimethylsilyl)cycloprop-2-enecarboxylate (18h) (448 mg, 1.50 
mmol, 1.0 equiv.), diethyl ether (4.0 mL), and DIBAL-H (448 mg, 562 μL, 3.15 mmol, 2.1 equiv.). 
The titled compound was obtained as a white solid in 64% yield (259 mg, 0.957 mmol); mp: 64.1 
– 65.0 °C; 1H NMR (400 MHz, CDCl3): δ 8.13 (s, 1H), 7.20 (dd, J = 8.5, 6.2 Hz, 1H), 7.06 (dd, J = 8.6, 
2.6 Hz, 1H), 6.90 (td, J = 8.3, 2.6 Hz, 1H), 3.90 (d, J = 11.2 Hz, 1H), 3.71 (d, J = 11.2 Hz, 1H), 1.08 (s, 
1H), 0.24 (s, 9H); 13C (126 MHz, CDCl3): δ 161.3 (d, J = 248.0 Hz), 139.6 (d, J = 3.6 Hz), 135.0 (d, J 
= 10.3 Hz), 132.2 (d, J = 8.8 Hz, +), 129.4, 129.2 (+), 117.0 (d, J = 24.4 Hz, +), 114.3 (d, J = 20.8 Hz, 
+), 69.1 (-), 31.3, -1.0 (2C, +); FTIR (KBr, cm-1): 3369, 3360, 2959, 1682, 1601, 1580, 1485, 1250, 
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1225, 1068, 1034, 1014, 993, 937, 876, 843, 820, 760, 741, 717; HRMS (TOF ES): Found 271.0724, 




Compound was obtained via typical ester reduction procedure using methyl 
1-(2-chlorophenyl)-2-(trimethylsilyl)cycloprop-2-enecarboxylate (18i) (421 mg, 1.5 mmol, 1.0 
equiv.), diethyl ether (4.0 mL), and DIBAL-H (448 mg, 562 μL, 3.15 mmol, 2.10 equiv.). The titled 
compound was obtained as a pale yellow solid in 63% yield (240 mg, 0.947 mmol); mp: 61.8 – 
63.3 °C; 1H NMR (400 MHz, CDCl3): δ 8.16 (s, 1H), 7.33 – 7.29 (m, 1H), 7.25 – 7.22 (m, 1H), 7.20 – 
7.11 (m, 2H), 3.94 (d, J = 11.2 Hz, 1H), 3.74 (d, J = 11.1 Hz, 1H), 1.09 (s, 1H), 0.24 (s, 9H); 13C (126 
MHz, CDCl3): δ 143.5, 134.4, 131.3 (+), 129.9 (+), 129.4 (+), 129.4, 128.0 (+), 127.1 (+), 69.1 (-), 
32.0, -1.0 (3C, +); FTIR (KBr, cm-1): 3389, 2957, 2899, 2870, 1682, 1468, 1431, 1250, 1074, 1038, 
1014, 993, 885, 841, 744, 735, 719; HRMS (TOF ES): Found 259.0898, calculated for C13H17ClOSiLi 




Compound was obtained via typical ester reduction procedure using 
methyl 1-(2,3-difluorophenyl)-2-(trimethylsilyl)cycloprop-2-enecarboxylate (18j) (424 mg, 
1.50 mmol, 1.0 equiv.), diethyl ether (4.0 mL), and DIBAL-H (448 mg, 562 μL, 3.15 mmol, 2.10 
equiv.). The titled compound was obtained as a white solid in 77% yield (292 mg, 1.15 mmol); 
mp: 64.3-64.8 °C; 1H NMR (400 MHz, CDCl3): δ 8.01 (s, 1H), 7.02 – 6.92 (m, 2H), 6.89 – 6.83 (m, 
1H), 4.00 (dd, J = 11.2, 5.8 Hz, 1H), 3.72 (dd, J = 11.2, 5.4 Hz, 1H), 1.19 (t, J = 6.0 Hz, 1H), 0.20 (s, 
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9H); 13C (126 MHz, CDCl3): δ 150.8 (dd, J = 247.8, 13.7 Hz), 149.9 (dd, J = 246.0, 12.5 Hz), 135.7 
(d, J = 12.4 Hz), 128.5, 126.6 (+), 125.0 (t, J = 3.6 Hz, +), 124.0 (dd, J = 7.1, 4.4 Hz, +), 115.1 (d, J = 
17.3 Hz, +), 69.7 (d, J = 3.1 Hz, -), 27.9 (d, J = 2.7 Hz), -1.3 (3C, +); FTIR (KBr, cm-1): 3240, 3124, 
2959, 2876, 1697, 1620, 1585, 1474, 1456, 1435, 1250, 1211, 1063, 1032, 903, 864, 841, 814, 





Compound was obtained via typical ester reduction procedure using 
methyl 1-(3-bromophenyl)-2-(trimethylsilyl)cycloprop-2-enecarboxylate (18k) (488 mg, 1.50 
mmol, 1.0 equiv.), diethyl ether (4.0 mL), and DIBAL-H (448 mg, 562 μL, 3.15 mmol, 2.10 equiv.). 
The titled compound was obtained as a white solid in 90% yield (400 mg, 1.35 mmol); mp: 58.5 
– 59.7 °C; 1H NMR (400 MHz, CDCl3): δ 7.65 (s, 1H), 7.30 (d, J = 1.1 Hz, 1H), 7.28 – 7.23 (m, 1H), 
7.13 (d, J = 5.0 Hz, 2H), 4.12 (d, J = 10.8 Hz, 1H), 3.93 (d, J = 11.1 Hz, 1H), 1.26 (s, 1H), 0.18 (s, 9H); 
13C (126 MHz, CDCl3): δ 149.8, 129.6 (+), 129.3 (+), 128.2 (+), 124.8 (+), 123.7, 122.7 (+), 122.6, 
68.9 (-), 29.8, -0.9 (3C, +); FTIR (KBr, cm-1): 3296, 3283, 3119, 2959, 2935, 2897, 2878, 1693, 
1591, 1562, 1472, 1462, 1416, 1410, 1250, 1076, 1055, 1015, 995, 872, 843, 787, 758, 725, 702; 




Compound was obtained via typical ester reduction procedure using 
methyl 1-(4-bromophenyl)-2-(trimethylsilyl)cycloprop-2-enecarboxylate (18l) (488 mg, 1.50 
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mmol, 1.0 equiv.), diethyl ether (4.0 mL), and DIBAL-H (448 mg, 562 μL, 3.15 mmol, 2.10 equiv.). 
The titled compound was obtained as a white solid in 95% yield (423 mg, 1.14 mmol); mp: 58.5 
– 58.9 °C; 1H NMR (400 MHz, CDCl3): δ 7.65 (s, 1H), 7.37 (d, J = 8.6 Hz, 2H), 7.05 (d, J = 8.6 Hz, 2H), 
4.12 (d, J = 11.1 Hz, 1H), 3.92 (d, J = 11.1 Hz, 1H), 1.26 (s, 1H), 0.16 (s, 9H); 13C (126 MHz, CDCl3): 
δ 146.2, 131.0 (2C, +), 127.9 (2C, +), 123.9, 122.8 (+), 119.0, 69.0 (-), 29.7, -0.9 (3C, +); FTIR (KBr, 
cm-1): 3371, 3356, 2957, 2897, 2872, 1693, 1487, 1406, 1394, 1250, 1076, 1055, 1007, 989, 868, 





Compound was obtained via typical ester reduction procedure using 
methyl 1-(2,4-dichlorophenyl)-2-(trimethylsilyl)cycloprop-2-enecarboxylate (18m) (473 mg, 
1.50 mmol, 1.0 equiv.), diethyl ether (4.0 mL), and DIBAL-H (448 mg, 562 μL, 3.15 mmol, 2.10 
equiv.). The titled compound was obtained as a pale yellow solid in 74% yield (319 mg, 1.11 
mmol); mp: 60.3 – 61.4 °C; 1H NMR (400 MHz, CDCl3): δ 8.11 (s, 1H), 7.35 – 7.30 (m, 1H), 7.16 – 
7.15 (m, 2H), 3.91 (d, J = 11.2 Hz, 1H), 3.70 (d, J = 11.2 Hz, 1H), 1.13 (s, 1H), 0.24 (s, 9H); 13C (126 
MHz, CDCl3): δ 142.2, 135.1, 132.8, 132.2 (+), 129.6 (+), 129.3, 128.8 (+), 127.4 (+), 69.0 (-), 31.4, 
-1.0 (3C, +); FTIR (KBr, cm-1): 3363, 2957, 2899, 2870, 1682, 1585, 1553, 1470, 1410, 1375, 1250, 
1101, 1074, 1036, 1014, 993, 932, 887, 843, 822, 800, 760, 741, 719, 702; HRMS (TOF ES): Found 






Compound was obtained via typical ester reduction procedure using 
methyl 1-(3-(trifluoromethyl)phenyl)-2-(trimethylsilyl)cycloprop-2-enecarboxylate (18n) (472 
mg, 1.50 mmol, 1.0 equiv.), diethyl ether (4.0 mL), and DIBAL-H (448 mg, 562 μL, 3.15 mmol, 2.10 
equiv.). The titled compound was obtained as a white solid in 81% yield (349 mg, 1.22 mmol); 
mp: 53.8 – 54.3 °C; 1H NMR (400 MHz, CDCl3): δ 7.67 (s, 1H), 7.59 – 7.33 (m, 4H), 4.17 (d, J = 11.2 
Hz, 1H), 3.99 (d, J = 11.2 Hz, 1H), 1.25 (s, 1H), 0.18 (s, 9H); 13C (126 MHz, CDCl3): δ 148.3, 130.4 
(q, J = 31.8 Hz), 129.5 (d, J = 1.4 Hz, +), 128.5 (+), 124.5 (q, J = 272.3 Hz) 123.6, 122.9 (q, J = 3.8 
Hz, +), 122.7 (+), 121.9 (q, J = 3.8 Hz, +), 69.1 (-), 29.9, -1.0 (3C, +); FTIR (KBr, cm-1): 3360, 2961, 
2901, 2874, 1697, 1612, 1591, 1435, 1331, 1252, 1163, 1124, 1097, 1078, 1063, 1014, 868, 843, 





Compound was obtained via typical ester reduction procedure using 
methyl 1-(2-chloro-4,5-difluorophenyl)-2-(trimethylsilyl)cycloprop-2-enecarboxylate (18o) 
(475 mg, 1.5 mmol, 1.0 equiv.), diethyl ether (4.0 mL), and DIBAL-H (448 mg, 562 μL, 3.15 mmol, 
2.10 equiv.). The titled compound was obtained as a pale yellow solid in 57% yield (245 mg, 0.848 
mmol); mp: 98.4 – 99.8 °C; 1H NMR (400 MHz, CDCl3): δ 8.08 (s, 1H), 7.15 (dd, J = 10.0, 7.3 Hz, 
1H), 7.03 (dd, J = 10.7, 8.4 Hz, 1H), 3.90 (d, J = 11.2 Hz, 1H), 3.70 (d, J = 11.2 Hz, 1H), 1.10 (s, 1H), 
0.24 (s, 9H); 13C (126 MHz, CDCl3): δ 149.2 (dd, J = 249.2, 12.4 Hz), 148.9 (dd, J = 250.3, 13.7 Hz), 
140.7, 129.3, 128.8 (dd, J = 7.9, 3.3 Hz), 128.5 (+), 119.4 (d, J = 17.6 Hz, +), 118.7 (d, J = 20.0 Hz, 
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+), 69.0 (-), 31.5, -1.0 (3C, +); FTIR (KBr, cm-1): 3240, 2962, 2880, 1688, 1599, 1497, 1462, 1387, 
1302, 1275, 1252, 1171, 1080, 1020, 878, 841, 798, 760, 739, 719, 700, 679, 633; HRMS (TOF 
ES): Found 289.0627, calculated for C13H16ClF2OSi (M+H) 289.0627 (0.0 ppm). 
 
1.10.6 Reduction of Deprotected Cyclopropenes 
 
(1-(4-fluorophenyl)cycloprop-2-en-1-yl)methanol (20b) 
Compound was obtained via typical ester reduction procedure using 
methyl 1-(4-fluorophenyl)cycloprop-2-enecarboxylate (19b) (182 mg, 0.947 mmol, 1.0 equiv.), 
diethyl ether (2.5 mL), and DIBAL-H (283 mg, 355 μL, 1.99 mmol, 2.10 equiv.). The titled 
compound was obtained as a pale yellow oil in 79% yield (123 mg, 0.748 mmol); 1H NMR (400 
MHz, CDCl3): δ 7.35 (s, 2H), 7.22 – 7.15 (m, 2H), 7.02 – 6.94 (m, 2H), 4.04 (s, 2H), 1.45 (s, 1H); 13C 
(126 MHz, CDCl3): δ 161.4 (d, J = 244.2 Hz), 141.5 (d, J = 3.1 Hz), 128.0 (d, J = 7.8 Hz, 2C, +), 115.0 
(d, J = 21.0 Hz, 2C, +), 113.5 (2C, +), 68.3 (-), 28.8; FTIR (KBr, cm-1): 3423, 3404, 3387, 3364, 3346, 
2926, 2876, 1641, 1601, 1502, 1474, 1406, 1225, 1159, 1099, 1067, 1011, 997, 968, 839, 818, 
669, 611; HRMS (TOF ES): Found 171.0798, calculated for C10H9OFLi (M+Li) 171.0797 (0.6 ppm). 
 
(1-(2,4-difluorophenyl)cycloprop-2-en-1-yl)methanol (20c) 
Compound was obtained via typical ester reduction procedure using 
methyl 1-(2,4-difluorophenyl)cycloprop-2-enecarboxylate (19c) (139 
mg, 0.660 mmol, 1.0 equiv.), diethyl ether (1.75 mL), and DIBAL-H (197 mg, 247 μL, 1.39 mmol, 
2.10 equiv.). The titled compound was obtained as a pale yellow solid in 79% yield (94.5 mg, 
0.519 mmol); mp: 59.5 – 61.2 °C; 1H NMR (400 MHz, CDCl3): δ 7.57 (s, 2H), 7.17 – 7.09 (m, 1H), 
6.83 – 6.70 (m, 2H), 3.84 (s, 2H), 1.32 (s, 1H); 13C (126 MHz, CDCl3): δ 161.8 (d, J = 247.4 Hz), 
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161.7 (d, J = 247.5 Hz),131.0 (dd, J = 9.6, 6.8 Hz, +), 128.2 (dd, J = 16.2, 3.8 Hz), 116.2 (d, J = 1.7 
Hz, 2C, +), 111.3 (dd, J = 21.0, 3.7 Hz, +), 104.1 (dd, J = 26.6, 25.0 Hz, +), 68.7 (d, J = 2.5 Hz, -), 
26.4; FTIR (KBr, cm-1): 3259, 3246, 3142, 3105, 2935, 2878, 1637, 1609, 1595, 1501, 1462, 
1425, 1294, 1267, 1138, 1103, 1051, 1024, 1001, 984, 964, 851, 812, 729, 669, 623, 611; HRMS 
(TOF ES): Found 181.0468, calculated for C10H7OF2 (M-H) 181.0465 (1.7 ppm). 
 
(1-(2-chloro-4-fluorophenyl)cycloprop-2-en-1-yl)methanol (20d) 
Compound was obtained via typical ester reduction procedure using 
methyl 1-(2-chloro-4-fluorophenyl)cycloprop-2-enecarboxylate (19d) 
(113 mg, 0.496 mmol, 1.0 equiv.), diethyl ether (1.5 mL), and DIBAL-H (148 mg, 186 μL, 1.04 
mmol, 2.10 equiv.). The titled compound was obtained as a pale yellow oil in 91% yield (89.4 mg, 
0.450 mmol); 1H NMR (400 MHz, CDCl3): δ 7.62 (s, 2H), 7.23 (dd, J = 8.5, 6.2 Hz, 1H), 7.06 (dd, J = 
8.6, 2.6 Hz, 1H), 6.91 (td, J = 8.3, 2.6 Hz, 1H), 3.80 (s, 2H), 1.36 (s, 1H); 13C (126 MHz, CDCl3): δ 
161.4 (d, J = 248.4 Hz), 138.8 (d, J = 3.6 Hz), 134.9 (d, J = 10.4 Hz), 131.8 (d, J = 8.7 Hz, +), 117.0 
(d, J = 24.5 Hz, +), 116.9 (2C, +), 114.4 (d, J = 20.7 Hz, +), 68.0 (-), 29.7; FTIR (KBr, cm-1): 3358, 
3111, 2926, 2870, 2361, 1637, 1597, 1578, 1483, 1389, 1258, 1223, 1217, 1198, 1180, 1070, 
1043, 1011, 968, 928, 891, 858, 818, 687, 669, 611; HRMS (TOF ES): Found 205.0417, calculated 
for C10H8OFClLi (M+Li) 205.0408 (4.4 ppm). 
 
(1-(2-bromo-4-fluorophenyl)cycloprop-2-en-1-yl)methanol (20e) 
Compound was obtained via typical ester reduction procedure using 
methyl 1-(2-bromo-4-fluorophenyl)cycloprop-2-enecarboxylate (19e) 
(128 mg, 0.472 mmol, 1.0 equiv.), diethyl ether (1.5 mL), and DIBAL-H (141 mg, 177 μL, 0.992 
mmol, 2.10 equiv.). The titled compound was obtained as a clear oil in 74% yield (85.0 mg, 0.350 
60 
 
mmol); 1H NMR (400 MHz, CDCl3): δ 7.63 (s, 2H), 7.27 – 7.21 (m, 2H), 6.96 (td, J = 8.3, 2.6 Hz, 1H), 
3.81 (s, 2H), 1.40 (s, 1H); 13C (126 MHz, CDCl3): δ 161.3 (d, J = 249.4 Hz), 140.4 (d, J = 3.5 Hz), 
132.1 (d, J = 8.3 Hz, +), 124.1 (d, J = 9.6 Hz), 120.1 (d, J = 24.4 Hz, +), 117.0 (2C, +), 115.0 (d, J = 
20.8 Hz, +), 67.7 (-), 31.5; FTIR (KBr, cm-1): 3321, 2934, 2862, 1637, 1597, 1572, 1477, 1383, 
1290, 1256, 1209, 1192, 1178, 1067, 1034, 1011, 968, 922, 858, 818, 729, 708, 663, 608; HRMS 
(TOF ES): Found 264.9641, calculated for C10H8OFBrNa (M+Na) 264.9640 (0.4 ppm). 
 




(Typical Cyclization Procedure) (1-phenylcycloprop-2-en-1-
yl)methanol (20a) (73.1 mg, 0.50 mmol, 1.0 equiv.), 18-C-6 (30.0 mg, 
0.113 mmol, 0.225 equiv.), potassium hydroxide (70.2 mg, 1.25 mmol, 2.50 equiv.) and THF (6.0 
mL) were placed in an oven dried Wheaton vial (5 mL) equipped with spin vane and mininert 
valve and stirred overnight at 55 °C. The reaction was then dried with magnesium sulfate, filtered, 
and concentrated. The product was then purified by column chromatography using a 9:1 
hexane:ethyl acetate mobile phase to provide the titled compound as a white solid in 66% yield 
(19.3 mg, 0.066 mmol.); dr: >98:2; GC (Rt, min): 11.47 (main), 11.34 (minor); mp: 186.6 – 187.4 
°C; 1H NMR (400 MHz, CDCl3): δ 7.35 – 7.27 (m, 8H), 7.25 – 7.19 (m, 2H), 4.71 (d, J = 12.1 Hz, 2H), 
3.73 (dd, J = 6.6, 3.6 Hz, 2H), 3.67 (d, J = 12.1 Hz, 2H), 1.31 – 1.22 (m, 4H); 13C (126 MHz, CDCl3): 
δ 142.7 (2C), 128.5 (4C, +), 127.4 (4C, +), 126.4 (2C, +), 76.9 (2C, -), 66.3 (2C, +), 33.3 (2C), 21.7 
(2C, -); FTIR (KBr, cm-1): 3084, 3055, 3022, 2986, 2959, 2934, 2876, 1601, 1495, 1454, 1360, 
61 
 
1310, 1269, 1258, 1165, 1070, 1049, 1024, 976, 916, 835, 820, 741, 692; HRMS (TOF ES): Found 




Compound was obtained via typical cyclization procedure using (1-(4-
fluorophenyl)cycloprop-2-en-1-yl)methanol (20b) (82.2 mg, 0.50 
mmol, 1.0 equiv.), 18-C-6 (30.0 mg, 0.113 mmol, 0.225 equiv.), 
potassium hydroxide (70.2 mg, 1.25 mmol, 2.50 equiv.) and THF (6.0 mL). The titled compound 
was obtained as a white solid in 63% yield (20.7 mg, 0.063 mmol.); dr: 98:2; GC (Rt, min): 11.30; 
mp: 209.1 – 210.4 °C; 1H NMR (400 MHz, CDCl3): δ 7.28 – 7.23 (m, 4H), 7.03 – 6.95 (m, 4H), 4.62 
(d, J = 12.0 Hz, 2H), 3.66 (dd, J = 8.01, 3.91 Hz, 2H), 3.63 (d, J = 12.0 Hz, 2H), 1.30 – 1.18 (m, 4H); 
13C (126 MHz, CDCl3): δ 161.6 (d, J = 244.8 Hz, 2C), 138.3 (d, J = 3.1 Hz, 2C), 129.3 (d, J = 7.8 Hz, 
4C, +), 115.3 (d, J = 21.3 Hz, 4C, +), 77.2 (2C, -), 66.0 (2C, +), 33.0 (2C), 21.4 (2C, -); FTIR (KBr, cm-
1): 2947, 2912, 2889, 2862, 2357, 2339, 2330, 1595, 1512, 1504, 1487, 1454, 1232, 1217, 1161, 
1074, 1036, 926, 841, 812, 729; HRMS (TOF ES): Found 327.12, calculated for C20H17F2O2 (M-H) 




Compound was obtained via typical cyclization procedure using (1-
(2,4-difluorophenyl)cycloprop-2-en-1-yl)methanol (20c) (91.0 mg, 
0.50 mmol, 1.0 equiv.), 18-C-6 (30.0 mg, 0.113 mmol, 0.225 equiv.), 
potassium hydroxide (70.2 mg, 1.25 mmol, 2.50 equiv.) and THF (6.0 mL). The titled compound 
62 
 
was obtained as a white solid in 59% yield (21.5 mg, 0.059 mmol.); dr: 94-6; GC (Rt, min): 10.71 
(main), 10.77 (minor); mp: 205 – 208.2 °C; 1H NMR (400 MHz, CDCl3): δ 7.34 – 7.26 (m, 2H), 6.86 
– 6.72 (m, 4H), 4.52 (d, J = 12.0 Hz, 2H), 3.82 (d, J = 12.1 Hz, 2H), 3.78 (dd, J = 6.8, 3.5 Hz, 2H), 1.29 
(dd, J = 6.4, 3.5 Hz, 2H), 1.08 (t, J = 6.6 Hz, 2H); 13C (126 MHz, CDCl3): δ 162.3 (dd, J = 250.6, 12.4 
Hz, 2C), 162.1 (dd, J = 247.7, 11.7 Hz, 2C), 133.0 (dd, J = 9.7, 5.8 Hz, 2C, +), 125.2 (dd, J = 13.5, 3.8 
Hz, 2C), 111.4 (dd, J = 20.9, 3.6 Hz, 2C, +), 104.3 (t, J = 25.6 Hz, 2C, +), 77.3 (2C, -), 63.8 (d, J = 1.5 
Hz, 2C, +), 29.5 (2C), 20.8 (2C, -); FTIR (KBr, cm-1): 3063, 2986, 2953, 2874, 2359, 2339, 1614, 
1595, 1504, 1462, 1423, 1362, 1312, 1263, 1231, 1163, 1140, 1097, 1078, 1045, 1034, 966, 851, 





Compound was obtained via typical cyclization procedure using (1-
(2-chloro-4-fluorophenyl)cycloprop-2-en-1-yl)methanol (20d) 
(99.3 mg, 0.50 mmol, 1.0 equiv.), 18-C-6 (30.0 mg, 0.113 mmol, 
0.225 equiv.), potassium hydroxide (70.2 mg, 1.25 mmol, 2.50 equiv.) and THF (6.0 mL). The 
titled compound was obtained as a white solid in 75% yield (29.8 mg, 0.075 mmol.); dr: 98:2; GC 
(Rt, min): 13.08; mp: 234.7 – 236.4 °C; 1H NMR (400 MHz, CDCl3): δ 7.38 (dd, J = 8.6, 6.1 Hz, 2H), 
7.10 (dd, J = 8.5, 2.6 Hz, 2H), 6.95 (td, J = 8.3, 2.7 Hz, 2H), 4.67 (d, J = 12.0 Hz, 2H), 3.78 (dd, J = 6.9, 
3.4 Hz, 2H), 3.71 (d, J = 12.1 Hz, 2H), 1.38 (dd, J = 6.8, 3.5 Hz, 2H), 1.09 (t, J = 6.8 Hz, 2H); 13C (126 
MHz, CDCl3): δ 161.7 (d, J = 249.3 Hz, 2C), 136.4 (d, J = 10.4 Hz, 2C), 134.7 (d, J = 3.6 Hz. 2C), 133.7 
(d, J = 8.7 Hz, 2C, +), 117.4 (d, J = 24.7 Hz, 2C, +), 114.1 (d, J = 21.0 Hz, 2C, +), 76.8 (2C, -), 64.9 (2C, 
+), 33.2 (2C), 22.0 (2C, -); FTIR (KBr, cm-1): 3074, 2976, 2957, 2934, 2874, 2359, 2341, 2330, 
63 
 
1601, 1574, 1487, 1458, 1392, 1354, 1304, 1258, 1202, 1161, 1080, 1057, 1028, 982, 897, 856, 





Compound was obtained via typical cyclization procedure using (1-
(2-bromo-4-fluorophenyl)cycloprop-2-en-1-yl)methanol (20e) 
(121.5 mg, 0.50 mmol, 1.0 equiv.), 18-C-6 (30.0 mg, 0.113 mmol, 
0.225 equiv.), potassium hydroxide (70.2 mg, 1.25 mmol, 2.50 equiv.) and THF (6.0 mL). The 
titled compound was obtained as a white solid in 63% yield (30.5 mg, 0.063 mmol.); dr: >98:2; 
mp: 221 – 223 °C (decomposed); 1H NMR (400 MHz, CDCl3): δ 7.38 (dd, J = 8.6, 6.0 Hz, 2H), 7.30 
(dd, J = 8.2, 2.6 Hz, 2H), 7.00 (td, J = 8.3, 2.7 Hz, 2H), 4.71 (d, J = 12.0 Hz, 2H), 3.77 (dd, J = 6.9, 3.4 
Hz, 2H), 3.67 (d, J = 12.1 Hz, 2H), 1.41 (dd, J = 6.8, 3.5 Hz, 2H), 1.11 (t, J = 6.9 Hz, 2H); 13C (126 
MHz, CDCl3): δ 161.6 (d, J = 250.3 Hz, 2C), 136.0 (d, J = 3.5 Hz, 2C), 133.9 (d, J = 8.6 Hz, 2C, +), 
125.9 (d, J = 9.6 Hz, 2C), 120.6 (d, J = 24.3 Hz, 2C, +), 114.6 (d, J = 20.9 Hz, 2C, +), 76.8 (2C, -), 65.3 
(2C, +), 35.0 (2C), 22.7 (2C, -); FTIR (KBr, cm-1): 3094, 3067, 2972, 2957, 2928, 2889, 2868, 2361, 
2345, 1597, 1582, 1487, 1458, 1356, 1306, 1259, 1204, 1163, 1078, 1053, 1024, 978, 881, 841, 









(Typical One-Pot Desilylative Cyclization Procedure)(1-phenyl-2-
(trimethylsilyl)cycloprop-2-en-1-yl)methanol (23a) (29.2 mg, 0.20 
mmol, 1.0 equiv.), 18-C-6 (12.0 mg, 0.045 mmol, 0.225 equiv.), potassium hydroxide (61.7 mg, 
1.10 mmol, 5.50 equiv.) and THF (2.20 mL) were placed in an oven dried Wheaton vial (5 mL) 
equipped with spin vane and mininert valve and stirred overnight at 65 °C. The reaction was then 
dried with magnesium sulfate, filtered, and concentrated. The product was then purified by 
column chromatography using a 9:1 hexane:ethyl acetate mobile phase to provide the titled 
compound as a white solid in 64% yield (18.8 mg, 0.064 mmol.); dr: 98:2; Physical and spectral 
properties of this compound were identical to those described above for the same material 




Compound was obtained via typical one-pot desilylative cyclization 
procedure using (1-(4-fluorophenyl)-2-(trimethylsilyl)cycloprop-2-
en-1-yl)methanol (23b) (47.3 mg, 0.2 mmol, 1.0 equiv.), 18-C-6 (12.0 
mg, 0.045 mmol, 0.225 equiv.), potassium hydroxide (61.7 mg, 1.10 mmol, 5.5 equiv.) and THF 
(2.20 mL). The titled compound was obtained as a white solid in 59% yield (19.3 mg, 0.059 
mmol.); dr: 98:2; Physical and spectral properties of this compound were identical to those 






Compound was obtained via typical one-pot desilylative cyclization 
procedure using (1-(2,4-difluorophenyl)-2-(trimethylsilyl)cycloprop-
2-en-1-yl)methanol (23c) (50.9 mg, 0.2 mmol, 1.0 equiv.), 18-C-6 
(12.0 mg, 0.045 mmol, 0.225 equiv.), potassium hydroxide (61.7 mg, 1.10 mmol, 5.50 equiv.) and 
THF (2.20 mL). The titled compound was obtained as a white solid in 62% yield (22.5 mg, 0.062 
mmol.); dr:79-21; Physical and spectral properties of this compound were identical to those 




Compound was obtained via typical one-pot desilylative cyclization 
procedure using (1-(2-chloro-4-fluorophenyl)-2-
(trimethylsilyl)cycloprop-2-en-1-yl)methanol (23d) (54.2 mg, 0.2 
mmol, 1.0 equiv.), 18-C-6 (12.0 mg, 0.045 mmol, 0.225 equiv.), potassium hydroxide (61.7 mg, 
1.10 mmol, 5.50 equiv.) and THF (2.20 mL). The titled compound was obtained as a white solid 
in 79% yield (31.4 mg, 0.079 mmol.); dr: >98:2; Physical and spectral properties of this 
compound were identical to those described above for the same material obtained in 4+4-






Compound was obtained via typical one-pot desilylative cyclization 
procedure using (1-(2-bromo-4-fluorophenyl)-2-
(trimethylsilyl)cycloprop-2-en-1-yl)methanol (23e) (63.1 mg, 0.20 
mmol, 1.0 equiv.), 18-C-6 (12.0 mg, 0.045 mmol, 0.225 equiv.), potassium hydroxide (61.7 mg, 
1.10 mmol, 5.50 equiv.) and THF (2.20 mL). The titled compound was obtained as a white solid 
in 63% yield (30.4 mg, 0.063 mmol.); dr: >98:2; Physical and spectral properties of this 
compound were identical to those described above for the same material obtained in 4+4-




Compound was obtained via typical one-pot desilylative 
cyclization procedure using (1-(naphthalen-1-yl)-2-
(trimethylsilyl)cycloprop-2-en-1-yl)methanol (23f) (52.9 mg, 0.20 mmol, 1.0 equiv.), 18-C-6 
(12.0 mg, 0.045 mmol, 0.225 equiv.), potassium hydroxide (61.7 mg, 1.10 mmol, 5.5 equiv.) and 
THF (2.2 mL). The titled compound was obtained as a white solid in 55% yield (21.4 mg, 0.055 
mmol.); dr: >98:2; mp: 253 – 256 °C (decomposed); 1H NMR (400 MHz, CDCl3): δ 8.20 (d, J = 8.2 
Hz, 2H), 7.89 (d, J = 7.3 Hz, 2H), 7.78 (d, J = 8.2 Hz, 2H), 7.64 (d, J = 5.8 Hz, 2H), 7.58 – 7.43 (m, 
6H), 4.83 (d, J = 11.6 Hz, 2H), 4.04 (d, J = 11.7 Hz, 2H), 3.95 (dd, J = 6.8, 3.2 Hz, 2H), 1.61 (dd, J = 
6.1, 3.2 Hz, 2H), 1.18 (t, J = 6.5 Hz, 2H); 13C (126 MHz, CDCl3): δ 137.4 (2C), 134.4 (2C), 132.0 (2C), 
129.2 (2C, +), 128.6 (2C, +), 128.0 (2C, +), 126.0 (2C, +), 125.7 (2C, +), 125.5 (2C, +), 124.0 (2C, +), 
77.6 (2C, -), 64.5 (2C, +), 33.1 (2C), 22.0 (2C, -); FTIR (KBr, cm-1): 3994, 3069, 3047, 2947, 2945, 
67 
 
2922, 2866, 1593, 1504, 1454, 1435, 1400, 1265, 1252, 1153, 1128, 1082, 1061, 1040, 1001, 968, 
864, 837, 800, 775, 733, 706, 621; HRMS (TOF ES): Found 391.1695, calculated for C28H23O2 (M-




Compound was obtained via typical one-pot desilylative cyclization 
procedure using (1-(p-tolyl)-2-(trimethylsilyl)cycloprop-2-en-1-
yl)methanol (23g) (46.5 mg, 0.20 mmol, 1.0 equiv.), 18-C-6 (12.0 mg, 
0.045 mmol, 0.225 equiv.), potassium hydroxide (61.7 mg, 1.10 mmol, 5.5 equiv.) and THF (2.20 
mL). The titled compound was obtained as a white solid in 78% yield (25.0 mg, 0.078 mmol.); dr: 
>98:2; GC (Rt, min): 12.77; mp: 170.2 – 172.8 °C; 1H NMR (400 MHz, CDCl3): δ 7.18 (d, J = 8.2 Hz, 
4H), 7.11 (d, J = 7.9 Hz, 4H), 4.66 (d, J = 12.0 Hz, 2H), 3.68 (dd, J = 6.6, 3.6 Hz, 2H), 3.64 (d, J = 12.0 
Hz, 2H), 2.32 (s, 6H), 1.29 – 1.16 (m, 4H); 13C (126 MHz, CDCl3): δ 139.8 (2C), 136.0 (2C), 129.2 
(4C, +), 127.3 (4C, +), 77.0 (2C, -), 66.2 (2C, +), 33.0 (2C), 21.6 (2C, -), 21.1 (2C, +); FTIR (KBr, cm-
1): 3088, 3049, 3013, 2982, 2943, 2922, 2872, 2361, 2332, 1518, 1458, 1447, 1360, 1265, 1161, 
1113, 1076, 1034, 1020, 978, 835, 787, 739; HRMS (TOF ES): Found 327.1936, calculated for 




Compound was obtained via typical one-pot desilylative cyclization 
procedure using (1-(2-chloro-6-fluorophenyl)-2-
(trimethylsilyl)cycloprop-2-en-1-yl)methanol (23h) (54.2 mg, 0.20 mmol, 1.0 equiv.), 18-C-6 
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(12.0 mg, 0.045 mmol, 0.225 equiv.), potassium hydroxide (61.7 mg, 1.10 mmol, 5.50 equiv.) and 
THF (2.20 mL). The titled compound was obtained as a white solid in 69% yield (27.3 mg, 0.069 
mmol.); dr: >98:2; GC (Rt, min): 13.11; mp: 237 - 240 °C; 1H NMR (400 MHz, CDCl3): δ 7.41 – 7.36 
(m, 2H), 7.13 – 7.08 (m, 2H), 6.98 – 6.92 (m, 2H), 4.67 (d, J = 12.0 Hz, 2H), 3.78 (dd, J = 6.8, 3.4 Hz, 
2H), 3.71 (d, J = 12.6 Hz, 2H), 1.39 (dd, J = 6.7, 3.4 Hz, 2H), 1.09 (t, J = 6.8 Hz, 2H); 13C (126 MHz, 
CDCl3): δ 161.7 (d, J = 249.3 Hz, 2C), 136.4 (d, J = 10.3 Hz, 2C), 134.7 (d, J = 3.4 Hz, 2C), 133.7 (d, J 
= 8.7 Hz, 2C, +), 117.4 (d, J = 24.6 Hz, 2C, +), 114.1 (d, J = 21.2 Hz, 2C, +), 76.8 (2C, -), 64.9 (2C, +), 
33.2 (2C), 22.0 (2C, -); FTIR (KBr, cm-1): 3074, 2976, 2957, 2935, 2874, 2359, 2332, 1601, 1574, 
1487, 1458, 1391, 1354, 1304, 1258, 1202, 1161, 1078, 1057, 1028, 982, 897, 856, 843, 820, 733, 




Compound was obtained via typical one-pot desilylative cyclization 
procedure using (1-(2-chlorophenyl)-2-(trimethylsilyl)cycloprop-2-
en-1-yl)methanol (23i) (50.6 mg, 0.20 mmol, 1.0 equiv.), 18-C-6 (12.0 mg, 0.045 mmol, 0.225 
equiv.), potassium hydroxide (61.7 mg, 1.10 mmol, 5.50 equiv.) and THF (2.20 mL). The titled 
compound was obtained as a white solid in 62% yield (22.4 mg, 0.062 mmol.); dr: >98:2; GC (Rt, 
min); mp: 233 - 236 °C; 1H NMR (400 MHz, CDCl3): δ 7.43 (dd, J = 7.4, 1.8 Hz, 2H), 7.35 (dd, J = 7.6, 
1.7 Hz, 2H), 7.25 – 7.15 (m, 4H), 4.73 (d, J = 12.0 Hz, 2H), 3.82 (dd, J = 6.8, 3.4 Hz, 2H), 3.77 (d, J = 
12.0 Hz, 2H), 1.40 (dd, J = 6.7, 3.5 Hz, 2H), 1.11 (t, J = 6.8 Hz, 2H); 13C (126 MHz, CDCl3): δ 138.7 
(2C), 135.7 (2C), 132.8 (2C, +), 130.1 (2C, +), 128.5 (2C, +), 126.9 (2C, +), 76.8 (2C, -), 64.9 (2C, +), 
33.9 (2C), 22.0 (2C, -); FTIR (KBr, cm-1): 3070, 3055, 2976, 2949, 2932, 2885, 2870, 2359, 1474, 
69 
 
1458, 1433, 1356, 1306, 1288, 1267, 1252, 1188, 1171, 1128, 1080, 1030, 976, 914, 839, 754, 




Compound was obtained via typical one-pot desilylative 
cyclization procedure using (1-(2,3-difluorophenyl)-2-
(trimethylsilyl)cycloprop-2-en-1-yl)methanol (23j) (50.9 mg, 0.20 mmol, 1.0 equiv.), 18-C-6 
(12.0 mg, 0.045 mmol, 0.225 equiv.), potassium hydroxide (61.7 mg, 1.10 mmol, 5.50 equiv.) and 
THF (2.20 mL). The titled compound was obtained as a white solid in 57% yield (20.9 mg, 0.057 
mmol.); dr: 84:16; GC (Rt, min): 11.22 (main), 11.14 (minor); mp: 211 – 214.8 °C; 1H NMR (400 
MHz, CDCl3): δ 7.14 – 6.96 (m, 6H), 4.56 (d, J = 12.1 Hz, 2H), 3.88 (d, J = 12.1 Hz, 2H), 3.84 (dd, J = 
6.8, 3.5 Hz, 2H), 1.34 (dd, J = 6.5, 3.5 Hz, 2H), 1.13 (t, J = 6.7 Hz, 2H); 13C (126 MHz, CDCl3): δ 150.9 
(dd, J = 248.2, 13.2 Hz, 2C), 150.5 (dd, J = 249.1, 12.5 Hz, 2C), 131.6 (d, J = 10.0 Hz, 2C), 126.8 (2C, 
+), 124.1 (dd, J = 7.1, 4.7 Hz, 2C, +), 116.1 (d, J = 17.2 Hz, 2C, +), 77.1 (2C, -), 63.6 (2C, +), 29.9 (d, J 
= 2.5 Hz, 2C), 20.9 (d, J = 2.2 Hz, 2C, -); FTIR (KBr, cm-1): 3088, 3045, 2976, 2928, 2868, 2363, 
1626, 1589, 1474, 1456, 1356, 1312, 1261, 1221, 1190, 1159, 1086, 1065, 1041, 987, 941, 928, 
895, 837, 798, 783, 725, 690; HRMS (TOF ES): Found 365.1161, calculated for C20H17F4O2 (M+H) 




Compound was obtained via typical one-pot desilylative 
cyclization procedure using (1-(3-bromophenyl)-2-
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(trimethylsilyl)cycloprop-2-en-1-yl)methanol (23k) (59.5 mg, 0.20 mmol, 1.0 equiv.), 18-C-6 
(12.0 mg, 0.045 mmol, 0.225 equiv.), potassium hydroxide (61.7 mg, 1.10 mmol, 5.50 equiv.) and 
THF (2.20 mL). The titled compound was obtained as a white solid in 83% yield (37.5 mg, 0.083 
mmol.); dr: >98:2; mp: 226 - 230 °C; 1H NMR (400 MHz, CDCl3): δ 7.39 (t, J = 1.8 Hz, 2H), 7.34 (dt, 
J = 7.6, 1.4 Hz, 2H), 7.23 – 7.14 (m, 4H), 4.66 (d, J = 12.1 Hz, 2H), 3.68 (dd, J = 6.4, 4.0 Hz, 2H), 3.60 
(d, J = 12.2 Hz, 2H), 1.33 – 1.23 (m, 4H); 13C (126 MHz, CDCl3): δ 145.0 (2C), 130.5 (2C, +), 130.1 
(2C, +), 129.6 (2C, +), 126.1 (2C, +), 122.7 (2C), 76.6 (2C, -), 66.2 (2C, +), 33.2 (2C), 21.9 (2C, -); 
FTIR (KBr, cm-1): 3078, 3063, 2959, 2956, 2359, 2341, 2332, 1724, 1591, 1560, 1477, 1458, 1433, 
1410, 1354, 1254, 1163, 1067, 1032, 835, 797, 771, 744, 735, 696, 669, 621; HRMS (TOF ES): 




Compound was obtained via typical one-pot desilylative cyclization 
procedure using (1-(4-bromophenyl)-2-(trimethylsilyl)cycloprop-
2-en-1-yl)methanol (23l) (59.5 mg, 0.20 mmol, 1.0 equiv.), 18-C-6 
(12.0 mg, 0.045 mmol, 0.225 equiv.), potassium hydroxide (61.7 mg, 1.10 mmol, 5.50 equiv.) and 
THF (2.20 mL). The titled compound was obtained as a white solid in 67% yield (30.2 mg, 0.067 
mmol.); dr: >98:2; mp: 231.3 - 234 °C; 1H NMR (400 MHz, CDCl3): δ 7.41 (d, J = 8.6 Hz, 4H), 7.14 
(d, J = 8.6 Hz, 4H), 4.64 (d, J = 12.1 Hz, 2H), 3.65 (dd, J = 6.5, 3.8 Hz, 2H), 3.59 (d, J = 12.2 Hz, 2H), 
1.30 – 1.19 (m, 4H); 13C (126 MHz, CDCl3): δ 141.6 (2C), 131.6 (4C, +), 129.2 (4C, +), 120.3 (2C), 
76.7 (2C, -), 66.2 (2C, +), 32.9 (2C), 21.8 (2C, -); FTIR (KBr, cm-1): 3086, 3059, 2978, 2922, 2864, 
1489, 1456, 1394, 1350, 1259, 1163, 1074, 1063, 1043, 1030, 1009, 978, 843, 818, 754, 714; 






Compound was obtained via typical one-pot desilylative cyclization 
procedure using (1-(2,4-dichlorophenyl)-2-
(trimethylsilyl)cycloprop-2-en-1-yl)methanol (23m) (57.5 mg, 0.20 
mmol, 1.0 equiv.), 18-C-6 (12.0 mg, 0.045 mmol, 0.225 equiv.), potassium hydroxide (61.7 mg, 
1.10 mmol, 5.50 equiv.) and THF (2.20 mL). The titled compound was obtained as a white solid 
in 65% yield (28.1 mg, 0.065 mmol.); dr: 96:4; mp: 250 – 252 °C (decomposed); 1H NMR (400 
MHz, CDCl3): δ 7.39 – 7.32 (m, 2H), 7.24 – 7.19 (m, 2H), 4.67 (d, J = 12.1 Hz, 2H), 3.77 (dd, J = 6.9, 
3.5 Hz, 2H), 3.70 (d, J = 12.1 Hz, 2H), 1.39 (dd, J = 6.8, 3.5 Hz, 2H), 1.09 (t, J = 6.9 Hz, 2H); 13C (126 
MHz, CDCl3): δ 137.3 (2C), 136.4 (2C), 133.8 (2C), 133.5 (2C, +), 129.9 (2C, +), 127.2 (2C, +), 76.6 
(2C, -), 64.8 (2C, +), 33.4 (2C), 22.0 (2C, -); FTIR (KBr, cm-1): 3078, 3059, 2972, 2950, 2928, 2872, 
1585, 1555, 1474, 1458, 1375, 1356, 1302, 1286, 1263, 1188, 1165, 1103, 1080, 1026, 976, 903, 
841, 798, 777, 727, 702; HRMS (TOF ES): Found 426.9818, calculated for C20H15Cl4O2 (M-H) 




Compound was obtained via typical one-pot desilylative 
cyclization procedure using (1-(3-
(trifluoromethyl)phenyl)-2-(trimethylsilyl)cycloprop-2-en-1-yl)methanol (23n) (57.3 mg, 0.20 
mmol, 1.0 equiv.), 18-C-6 (12.0 mg, 0.045 mmol, 0.225 equiv.), potassium hydroxide (61.7 mg, 
1.10 mmol, 5.50 equiv.) and THF (2.20 mL). The titled compound was obtained as a white solid 
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in 70% yield (30.1 mg, 0.070 mmol.); dr: >98:2; GC (Rt, min): 10.83; mp: 137.1 – 140.4 °C; 1H NMR 
(400 MHz, CDCl3): δ 7.54 – 7.39 (m, 8H), 4.71 (d, J = 12.2 Hz, 2H), 3.72 (dd, J = 6.6, 3.8 Hz, 2H), 
3.66 (d, J = 12.2 Hz, 2H), 1.41 – 1.28 (m, 4H); 13C (126 MHz, CDCl3): δ 155.8 (q, J = 31.2 Hz, 2C), 
143.6 (2C), 131.0 (2C, +), 129.0 (2C, +), 124.3 (q, J = 272.4 Hz, 2C), 124.1 (q, J = 3.9 Hz, 2C, +), 
123.3 (q, J = 3.8 Hz, 2C, +), 76.6 (2C, -), 66.3 (2C, +), 33.3 (2C), 21.9 (2C, -); FTIR (KBr, cm-1): 3084, 
3045, 2980, 2959, 2924, 2872, 2359, 1612, 1593, 1489, 1462, 1445, 1358, 1335, 1296, 1263, 
1163, 1119, 1074, 1049, 1038, 978, 841, 798, 735, 700, 662; HRMS (TOF ES): Found 428.1211, 




Compound was obtained via typical one-pot desilylative cyclization 
procedure using (1-(2-chloro-4,5-difluorophenyl)-2-
(trimethylsilyl)cycloprop-2-en-1-yl)methanol (23o) (57.8 mg, 0.20 
mmol, 1.0 equiv.), 18-C-6 (12.0 mg, 0.045 mmol, 0.225 equiv.), potassium hydroxide (61.7 mg, 
1.10 mmol, 5.50 equiv.) and THF (2.20 mL). The titled compound was obtained as a pale yellow 
solid in 32% yield (13.9 mg, 0.032 mmol.); dr: 98:2; GC (Rt, min): 12.57 (main), 12.64 (minor); 
mp: 239 – 242 °C (decomposition); 1H NMR (400MHz, CDCl3): δ 7.23 – 7.17 (m, 4H), 4.67 (d, J = 
12.2 Hz, 2H), 3.76 (dd, J = 6.9, 3.5 Hz, 2H), 3.65 (d, J = 12.2 Hz, 2H), 1.43 (dd, J = 6.9, 3.5 Hz, 2H), 
1.13 (t, J = 6.9 Hz, 2H); 13C (126 MHz, CDCl3): δ 149.4 (dd, J = 251.9, 13.6 Hz, 2C), 148.8 (dd, J = 
249.4, 12.6 Hz, 2C) 135.5 – 135.4 (m, 2C), 130.4 (dd, J = 7.9, 3.4 Hz, 2C), 121.1 (d, J = 17.9 Hz, 2C, 
+), 119.1 (d, J = 20.2 Hz, 2C, +), 76.6 (2C, -) 64.8 (2C, +), 33.5 (2C), 22.2 (2C, -); FTIR (KBr, cm-1): 
3065, 3051, 2972, 2959, 2926, 2870, 1736, 1599, 1495, 1460, 1410, 1315, 1267, 1244, 1180, 
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1148, 1121, 1078, 1059, 1040, 993, 922, 879, 839, 800, 739, 650, 625; HRMS (TOF ES): Found 
439.0471, calculated for C20H14Cl2F4O2Li (M+Li) 439.0467 (0.9 ppm). 
 
1.10.9  Isolation of linear dimer 
 
((1R*,2R*)-1-Phenyl-2-((1-phenylcycloprop-2-en-1-yl)methoxy)-
cyclopropyl)methanol (25a):  
An oven dried Wheaton vial (5 mL) equipped with spin vane and 
Mininert valve was charged with (1- phenylcycloprop-2-en-1-yl)methanol (50.0 mg, 0.342 mmol, 
1.00 equiv.), 18-crown-6 ether (20.0 mg, 0.076 mmol, 0.225 equiv.), powdered potassium 
hydroxide (48.0 mg, 0.855 mmol, 2.50 equiv) and THF (4.0 mL). The mixture was stirred for 
approximately one hour at 45 °C closely monitored by TLC. Retention factors of starting alcohol 
20a, intermediate 25a, and cyclic product 21a are 0.19, 0.31, and 0.59, respectively (eluent - 
hexane:EtOAc 3:1). When maximum concentration of the spot with Rf 0.31 (hexane:EtOAc 3:1) 
was observed, anhydrous magnesium sulfate was immediately added to the reaction mixture, 
which was then filtered, and concentrated. The intermediate 25a was isolated by preparative 
column chromatography eluting with a mixture of hexane and ethyl acetate (3:1) to afford a pale 
yellow oil in 9% yield (9.0 mg, 0.031 mmol); 1H NMR (500 MHz, CDCl3): δ 7.27 – 7.10 (m, 12H), 
4.02 (d, J = 10.3 Hz, 1H), 3.97 (d, J = 10.3 Hz, 1H), 3.94 (d, J = 11.6 Hz, 1H), 3.76 (d, J = 11.6 Hz, 1H), 
3.51 (dd, J = 6.5, 3.6 Hz, 1H), 1.73 (s, 1H), 1.09 (dd, J = 6.1, 3.6 Hz, 1H), 1.01 (t, J = 6.3 Hz, 1H); 13C 
NMR (126 MHz, CDCl3): δ 129.0, 128.8 (2C, +), 128.6 (2C, +), 128.5, 128.1 (2C, +), 126.7 (+), 126.3 
(2C, +), 125.8 (+), 112.9 (2C, +), 78.4 (+), 66.2 (-), 63.4 (-), 33.6, 17.2 (-), 11.4; FTIR (KBr, cm-1 ): 
3445, 3099, 3082, 3057, 3024, 2930, 2868, 1645, 1601, 1495, 1447, 1393, 1360, 1161, 1072, 
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1026, 918, 752, 698, 636, 569, 542; HRMS (TOF ES): Found 291.1384, calculated for C20H19O2 (M-




Chapter 2. Directed Rh(I)-Catalyzed Asymmetric Hydroboration of Cyclopropenes 
2.1 Introduction 
 Transition metal-catalyzed additions to cyclopropenes are intriguing transformations due to 
the ability of ligating the metal with asymmetric ligands, which when perform reactions on 3,3-
disubstituted cyclopropenes, provide the possibility of developing simultaneously 
diastereoselective and enantioselective reactions (Figure 4).  
 







Achieving a high degree of stereoselectivity relies on two independent factors. 
Diastereoselectivity or facial selectivity is determined by efficient interactions between 
substituents at C-3 of cyclopropene and the transition-metal catalyst. Enantioselectivity results 
from efficient site selectivity of the double bond as determined by the asymmetric environment 
established by chiral ligands attached to the catalyst. Successful incorporation of both forms of 
selectivity allow for the production of a single stereoisomeric product from prochiral starting 








 One motif we have become increasingly interested in are cyclopropylboronates due to their 
employment during the synthesis of a variety of natural products[19] and pharmaceuticals,[20] as 







In particular, cyclopropylboronates have been shown to participate in transition metal-
catalyzed cross-coupling reactions with a variety of electrophiles including acyl,[21] aryl,[22] 
vinyl,[23] and cyclopropyl[24] halides. Additionally, cyclopropylboronates are able to undergo ring 
retentive oxidation and subsequent functionalization.[25] Via homologation, the construction of a 
sp3 carbon-carbon bond is possible while preserving boron in the molecule and thus allowing 
further derivatization such as oxidation to alcohols or amines.[26] 
 While a few methods for the synthesis of racemic cyclopropylboronates have existed since 
the mid 1960’s,[27] the synthesis of the optically active variety has only existed since the late 

















Early methods utilized the placement of a chiral 1,2-diol derived auxiliary on boron. 
Hydroboration of acetylenes provided borylated olefins, which could then undergo 
diastereoselective cyclopropanation reactions. Subsequent removal of the chiral auxiliary 
provided enantioenriched cyclopropylboronates (Scheme 15a).[28] More recently, Ito has 
reported an asymmetric copper-catalyzed borylation/1,3-cyclization sequence of allylic 
carbonates (Scheme 15b).[29] However, this reaction was limited to the use of Z-configured 
olefins and was only efficient in the synthesis of trans-cyclopropylboronates. In 2014 Lin and 
Tortosa independently reported copper-catalyzed hydroboration of cyclopropenes in which 
facial differentiation is controlled by the differing sterics of a small and large substituent in the 3 
position of cyclopropene (Scheme 15c).[30] 
However, an additional mode of selectivity which delivers boron to the same face of 
cyclopropane as a large substituent via efficient coordination between a transition metal catalyst 
and a strategically placed directing group was still desired as this selectivity remained 






2.2 Initial Reaction Optimization 
Initial reaction screening was conducted using cyclopropene 26 with catalyst and ligand 
systems which had previously been shown to be efficient in the asymmetric hydroboration of 
olefins.[31] Early combinations of Rh(I) catalyst with Josiphos, Quinap, and BDPP provided 
reactivity, however, in rather disappointing efficiencies (Table 9, entries 1-3). Due to the 
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selectivity shown with the BDPP ligand, a survey of other diphosphine ligands was conducted 
and provided very impressive results. Widely available BINAP provided cyclopropylboronate 27 
in nearly quantitative yield along with extremely high diastereo- and enantioselectivity (Table 
9, entry 8)![32] 
 












With this result in hand, a variety of different cyclopropenes were surveyed to evaluate the 
generality of the developed protocol (Table 10). The reaction proved to be highly efficient both 
with ester 28 and ether 30 as a directing group. Furthermore, the placement of a sterically 
encumbered TMS group and a relatively small methyl group on the opposing face of 
cyclopropenes 29 and 28 provided high degree of diastereo- and enantioselectivity.[32] 
 
Entry Ligand Time, h Yield, %[a] dr[b] er[c] 
1 Josiphos (SL-J008-1) 8 47 1:1 82:18 
2 (R)-Quinap 8 9 17:83 1:1 
3 (S,S)-BDPP 8 43 72:28 83:17 
4 (R,R)-Chiraphos 3 47 98:2 94:6 
5 (S,S)-Me-Duphos 3 82 99:1 94:6 
6 (R)-Phanephos 3 89 99:1 99:1 
7 (R,R)-Norphos 1 86 98:2 99:1 
8 (R)-BINAP 0.3 96 99:1 99:1 
26 27 
[a] NMR yield measured from crude reaction with dibromomethane as standard. 
[b] Determined by GC analysis of crude reaction. [c] Determined by GC analysis 
using CYCLODEX B chiral column. 
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2.3 Directed Catalytic Asymmetric Hydroboration of Cyclopropenylcarboxylates 
The newly developed expedited synthesis of 3,3-disubstituted cyclopropenes via Rh(II)-
catalyzed cyclopropenation of TMS-acetylene followed by desilylation, as discussed in chapter I, 
allowed for a thorough evaluation of the directed catalytic asymmetric hydroboration reaction 
across a wide variety of prochiral substrates 19 possessing an ester as directing group (Table 
11). The reaction was found to be extremely efficient with relatively neutral phenyl-, naphthyl-, 
and tolyl-substituted examples 32a, 32f, and 32g respectively. 
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Additionally, placement of electron-withdrawing halogens at the 3 or 4 position of the aryl 
ring provided high yield, diastereo-, and enantioselectivity. Surprisingly, placement of a halogen 
in the 2 position resulted in a reduced yield and diastereoselectivity. Specifically, the placement 
of fluorine in the 2 position drastically reduced yield and almost completely eroded 
diastereoselectivity, as seen in examples 32c and 32j. 
2.4 Discussion of Proposed Mechanism 
 With the obtained results, a possible operating mechanism is proposed[33], to rationalize the 
outcomes observed in Table 11 (Scheme 17). The process would begin with chiral rhodium(I) 
species 34 coordinating to prochiral cyclopropene 19. This coordination could occur through the 
carbonyl to produce 35 (cycle I). Subsequent oxidative addition of rhodium into the H-B bond of 
pinacolborane could then provide Rh(III) intermediate 36. Diastereo- and enantiodefining 
hydrorhodation of the cyclopropene double bond would result in chiral cyclopropyl rhodium(III) 
complex 37. Reductive elimination to form the C-B bond would return the catalytically active 
species 34 and produce cyclopropylboronate 32 with a cis-configuration of the directing group 
and boron. 
 Alternatively, cycle II may explain the poor diastereoselectivity observed in several examples 
presented in Table 11. The competitive formation of species 38 could occur during substrate 
coordination, possibly due to the proper geometrical orientation between the electron-deficient 
transition metal and electron-rich fluorine. It is also possible this interaction[34] plays a significant 
role in stabilizing complexes formed from substrates possessing fluorine substituents in the 2-
position of the aryl ring. Proceeding through cycle II results in oxidative addition into the B-H 
bond, hydrorhodation of cyclopropene, and reductive elimination to produce 
cyclopropylboronate 33 with a trans-configuration of the directing group and boron. 
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The proposed mechanism in Scheme 17, operating via cationic six coordinate rhodium(III) 
species 36, is further supported by reactions carried out using AgOTf as halide scavenger 
(Scheme 18a) and cationic Rh(NBD)BF4 as the source of rhodium (Scheme 18b). In both 
reactions, essentially the same yield and stereoselectivity was observed as when the reaction is 








2.5 Evaluation of Alternative Directing Groups 
 One important implication of the proposed mechanistic rationale is the possible reversible 
interconversion between species 35 and 38. It was speculated that the equilibrium between the 
two species could be influenced by incorporation of a directing group which would offer stronger 
coordination to the rhodium catalyst. Such substrate modification would shift the reaction 
96% 
dr = >98:2, er = 95:5 
92% 







toward species 35 therefore reducing the feasibility of cycle II and increasing the overall 
diastereoselectivity of the catalytic process. 
 The evaluation of alternative directing groups began by first reducing the ester function of 
cyclopropene 19a according to the protocol developed in chapter I (Scheme 19). The 
hydroxymethyl directing group proved to be incompatible with Rh(I)-catalyzed hydroboration. 
Cyclopropane 39, which may have resulted from protonolysis of its corresponding cyclopropyl 









Alcohol 20a was then further derivatized into four cyclopropenes bearing directing groups 
of varying strength which were subsequently subjected to optimized catalytic hydroboration 
conditions. (Scheme 20). Substrates bearing MOM ether 44, acetate 45, and TBDMS ether 46 
were obtained in essentially equivalent chemical yield while diastereoselectivity seemed to 
decline with increasing steric size of the directing group. Enantioselectivities were disappointing 
in all examples. Carbamate 43 did not offer any reactivity and cyclopropene was recovered after 
prolonged exposure to hydroboration conditions. 
  








We next turned to the possibility of using an amide function to direct rhodium-catalyzed 
hydroboration due to previous reports detailing their use as efficient directors of alkali-metal 
assisted nucleophilic additions to cyclopropenes.[36] However, protocols describing the 
construction of prochiral cyclopropenylcarboxamides with an unsubstituted double bond were 
sparse. One route to such structures involves the 1,2-dehydrobromination of 
80% 84% 95% 97% 
81% 
dr = 98:2 
er = 68:32 
83% 
dr = 96:4 
er = 79:21 
83% 
dr = 92:8 
er = 80:20 
No Reaction 
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bromocyclopropanes[36] 48 (Scheme 21a). However, this method has only been shown to be 
efficient with a methyl group at C-3 of cyclopropane. Another method is the catalytic 
cyclopropenation of terminal acetylenes with carbenoids generated from α-diazoacetamides[37] 
(Scheme 21b). Once again, this method had severe limitations including having only been shown 
to be active toward the synthesis of cyclopropenes 49 possessing a substituted (R3 = aryl, alkyl) 












Returning once again to the expedited Rh(II)-catalyzed cyclopropenation of TMS-acetylene 
with carbenoids generated from α-diazoacetates described in chapter I, we envisioned a more 
practical and direct conversion of cyclopropenecarboxylates 18 into their carboxamide analogs. 
It was quickly found that cyclopropenecarboxylates 18 could be very efficiently hydrolyzed to 
the corresponding desilylated carboxylic acids 50 under basic aqueous conditions without any 





















Fox[38] had previously showed that an HCTU-promoted peptide coupling of substituted 
cyclopropene 51 was viable (Scheme 22a). However, attempts to adapt this protocol with an 
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 Attempts to achieve direct peptide type coupling with alternative carboxylic acid activating 
reagents including DCC, EDC, HBTU, and CDI proved to be rather inefficient. Although conversion 
of the acid into the corresponding activated intermediate seemed to proceed relatively efficiently 
in all cases, the subsequent amine acylation step was rather sluggish and in many cases did not 
reach completion even after three days. This, along with the stoichiometric byproducts produced 
from these coupling reagents, led to significant complications during purification and to 
substantial product loss. 
 Next, coupling reagents which produce only gaseous byproducts were considered. Initial 
reactions performed with thionyl chloride and diethylamine provided mixtures of products along 
with significant decomposition. However, evaluation of more docile oxalyl chloride in the 
presence of catalytic DMF resulted in very efficient conversion of 50a to the acyl chloride 
intermediate 52 (Scheme 23). This intermediate, without isolation or purification, was then 
exposed to diethylamine to provide cyclopropenylcarboxamide 53aa as the sole product 
detectable by TLC and was able to be isolated in 89% yield (Scheme 23). 
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 Substrate 53aa was next subjected to standard directed asymmetric hydroboration 
conditions established for esters. We were pleased to find that the reaction was extremely 
diastereoselective although much slower than the comparable reaction directed by an ester 
function (Table 13, entry 1). Thus, reaction times were extended first to four hours and 
eventually overnight which allowed for complete conversion, 97% yield, and excellent diastereo- 
and enantioselectivity (entries 2, 3). For completeness, a variety of chiral ligands were also 
evaluated with three providing nearly equivalent reactivity (entries 3, 8, 10). However, due to 
our intentions of developing an economical and scalable reaction, we decided to proceed with 






Table 13. Optimization of directed CAHB of cyclopropenylamides. 
 
Entry Ligand Time, h[a] Yield, %[b] dr (54aa:55aa)[c] er[d] 
1 (R)-BINAP 0.5 66 >98:2 ND 
2 (R)-BINAP 4 81 >98:2 ND 
3 (R)-BINAP 18 97 >98:2 96:4 
4 (R)-Tol-BINAP 0.5 89 >98:2 97:3 
5 (R)-DM-BINAP 4 90 >98:2 98:2 
6 (R,R)-NORPHOS 2 96 >98:2 97:3 
7 (S)-PHANEPHOS 1 86 >98:2 98:2 
8 (S)-BINAPINE 0.5 99 >98:2 >99:1 
9 (R)-BINAM 8 81 97:3 34:66 
10 (S,S)-CHIRAPHOS 0.5 99 >98:2 3:97 
11 (S,S)-Me-DUPHOS 2 80 98:2 82:12 
12 (R,R,S,S)-DUANPHOS 18 73 >98:2 81:19 
13 TaniaPhos SL-T001-1 42 27 95:5 ND 











53aa 54aa 55aa 
[a] Time for reaction to reach completion. [b] NMR yield of crude reaction mixtures using 
dibromomethane as standard. [c] Measured by NMR of crude reaction mixture, >98:2 indicates 
absence of minor isomer 55aa. [d] Determined by chiral HPLC analysis. 
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2.6 One-Pot Cyclopropenylamide Synthesis 
With highly promising optimized conditions for amide directed asymmetric catalytic 
hydroboration in hand, the newly developed one-pot synthesis of prochiral 
cyclopropenylcarboxamides was thoroughly evaluated for compatibility and scope. First, the 
array of amines which could be acylated was evaluated (Table 14). As was expected, the reaction 
was very efficient with diallyl- and a variety of secondary benzylamines providing amides 53ac 
and 53ad-53ag in excellent yield. Diisopropylamine provided amide 53ab in much lower yield 
most likely due to its greatly increased steric signature. Diphenylamide, 53ah, proved to be 
incompatible with the acidic work up[39], as complete hydrolysis was observed upon exposure to 
aqueous solution. Secondary cyclic amines including pyrrolidine 53ai, piperidine 53aj, 
morpholine 53ak, and N-ethyl piperazine 53al were efficiently transformed into the 
corresponding amides.  
All primary amines evaluated reacted smoothly to provide secondary amides 53am-53ar. 
Substrates 53aq and 53ar were obtained in good yield and are of particular interest for directed 
addition reactions due to the incorporation of an additional coordination point. Interestingly, 
amides 53as and 53at formed selectively when exposed to aqueous solutions of ethanolamine 
and ammonia respectively. The synthetically useful Weinreb amide 53au could be accessed via 



























 83% 69% 44% 77% 
81% 92% 71% 89% 
85% 90% 95% 83% 
80% 84% 0% 84% 
88% 76% 87% 59% 
50a 53a_ 
53ab 53ac 53ad 53ae 
53ai 53ah 53ag 53af 
53aj 53ak 53al 53am 
53aq 53ap 53ao 53an 
53ar 53as 53at 53au 
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Next, a series of diethylamides possessing the same set of aryl substituents as was evaluated 
in the directed catalytic asymmetric hydroboration of cyclopropenylcarboxylates, were 
synthesized in good yield (Table 15). 
 





















2.7 Directed Catalytic Asymmetric Hydroboration of Cyclopropenylamides with Variation of 
Aryl Substituent  
For direct comparison of amide against ester functions to direct catalytic asymmetric 
hydroboration, the series of carboxamide substrates shown in Table 15 were evaluated under 
optimized hydroboration conditions (Table 16). All amides bearing mono-substituted aromatic 
rings provided cyclopropylboronates in high yields and as a single diastereomer although with 
slightly lower enantioselectivity than was observed with the comparable esters in Table 11. 
Interestingly, the most problematic substrates possessing multiple halogens, and specifically, 2-
fluorinated aromatic rings 54ca and 54ja, showed great increases in diastereoselectivity, as all 
examples were obtained as a single diastereomeric product, exhibiting the superior directing 
ability of amides over the ester function. These very promising results prompted us to fully 
examine the ability of amides to direct Rh(I)-catalyzed hydroboration by screening various 
substitution patterns of the nitrogen atom of the directing group (Table 17). 
Despite the increased steric hindrance of tertiary amides when compared to esters, all 
carboxamide directing groups evaluated proved to be highly diastereoselective as exemplified by 
dibenzylamide 54ad. The excessively large diisopropylamide 54ab exhibited fantastic facial 
selectivity but suffered slight reductions in yield and enantioselectivity. Cyclic amides 54ai and 
54ak provided extremely high stereoselectivity but with a notable loss of yield, possibly due to 
the increased chelation of these directing groups to the rhodium transition metal. Finally, a 
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53a_ 54a_ 55a_ 
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Less sterically demanding secondary amides 54am and 54an showed no reactivity with the 
relatively acidic N-H bond and were converted in high yield and selectivity. 2-furfuryl was a very 
effective directing group, but provided 54ar in rather poor yield. Hydroboration providing 54ao 
included a Rh-catalyzed migration of the double bond of allylamine to provide a 2:1 mixture of E 
and Z configured internal olefins. Substrates 54aq and 54at bearing very strongly chelating 
amides failed to undergo the intended transformation and were recovered from the reaction 
mixture. Additionally, the presence of an alcohol or triple bond proved incompatible, as 54as and 
54ap resulted in only decomposition to a complex mixture of products. 
 The hydroboration reaction proved to be equally efficient upon scale up to 6.5-fold (2.0 
mmol). The preparative scale reaction provided cyclopropylboronate 54aa in 96% yield and 







 Lastly, amide 56 bearing a methyl group on the opposing face of cyclopropene was evaluated 
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2.8 Discussion of Origin and Determination of Absolute Configuration 
 The absolute configuration of the obtained cyclopropylboronates was confirmed by X-ray 
analysis of dibenzyl- product 54ad in which an (S)-configuration is observed at C2 and an (R)-
configuration is observed at C1 of the cyclopropane ring (Figure 5). 
 












The observed enantioselectivity can be rationalized by the two ways cyclopropene could 
coordinate to the chiral transition metal. Coordination of cyclopropene as shown in right handed 
model 58, would be expected to experience significant steric interactions between the aryl 
substituent of cyclopropene with the chiral phosphine ligand (Scheme 26). Therefore, it is 
believed cyclopropene would coordinate as is shown in structure 59, which would then undergo 
diastereo- and enantiodefining hydrorhodation followed by reductive elimination to provide 
products with the configuration observed in tables 11, 16, and 17. 
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2.9 Evaluation of Ortho-Fluoro-Effect 
 The possibility of influencing diastereoselectivity by enhancing the “ortho-fluoro” effect,[34] 
which was observed in cyclopropenylcarboxylates bearing a fluorine in the 2-position of the aryl 
ring, became an interesting possibility. To test this idea, cyclopropenes 60 and 61 possessing 
relatively weakly directing[40] tert-butyldimethylsilyl ether were synthesized by first reducing the 
ester using DIBAL-H followed by exposure of the alcohols to TBDMSCl under basic conditions 
(Scheme 27). Catalytic hydroboration was then conducted with each substrate to provide 


















dr = 71:29, er = 82:18 (81:19) 
79% 




dr = 92:8, er = 80:20 
60 61 42 
19j 19c 19a 
20j 20c 20a 
63 64 46 
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As expected, facial selectivities of ortho-fluorinated substrates 63 and 64 possessing tert-
butyldimethylsilyl ether as a directing group were substantially lower than fluorine lacking 
example 46 (Scheme 27). This observation further supports the presence of a stabilizing ortho-
fluoro effect, as was experienced during hydroboration of cyclopropenylcarboxylates. However, 
sufficient disruption of the directing groups’ ability to deliver the transition metal to only one 
face of cyclopropene was not achieved, as the cis-configured 63 and 64 were still obtained as the 
major products. 
2.10 Evaluation of Alternative Hydroboration Reagents 
The possibility of utilizing other sources of boron was also investigated (Scheme 28). With 
9-BBN the reaction proceeded with and without catalyst present and showed a preference for the 
non-directed diastereomer 67 in both cases (Scheme 28a). Without catalyst loaded in the 
reaction mixture, the products were obtained with a diastereomeric ratio of approximately 
90:10, with each diastereomer remaining completely racemic. However, in the presence of 
catalyst, the diastereoselectivity declines to approximately 70:30, with the non-directed product 
remaining racemic while the directed product showed slight enantioenrichment. This leads us to 
believe that in addition to the direct background hydroboration of cyclopropene by 9-BBN,[43] 
there is an asymmetric catalytic process occurring. Hydroboration conducted with 
catecholborane as the source of boron did not proceed without catalyst present and in the 
presence of catalyst fast and complete consumption of starting material was observed (Scheme 
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 2.11 Conclusion 
 In conclusion, the directed Rh(I)-catalyzed asymmetric hydroboration of cyclopropenes has 
been extensively evaluated across a diverse array of prochiral substrates bearing the ester and 
amide functions as directing groups. The hydroboration of esters was found to be significantly 
more sensitive to the influence of the substituent on the opposing face of cyclopropene, especially 
ortho-fluorine atoms. However, utilization of the much more Lewis basic amide directing group, 
provided sufficient coordination to the transition metal to provide excellent yields and 






2.12.1 Preparation of Cyclopropene Carboxylic Acids 
 
1-(4-fluorophenyl)cycloprop-2-ene-1-carboxylic acid (50b) 
Typical Procedure: A solution of methyl 1-(4-fluorophenyl)-2-
(trimethylsilyl)cycloprop-2-ene-1-carboxylate (18b) (457 mg, 1.73 mmol, 1.0 equiv.) in a 1:1 
mixture of methanol:tetrahydrofuran (20 mL) was stirred at 0 °C. A 1.5 M aqueous solution of 
sodium hydroxide (15 mL) was added dropwise and the mixture was stirred for 18 hours. 
Organic solvents were then removed under vacuum and the remaining aqueous solution was 
added to dichloromethane (20 mL). The mixture was acidified to pH 2 with 1N aqueous HCl. The 
organic phase was separated and the aqueous layer was extracted with dichloromethane (3 X 10 
mL). The combined organic phases were washed with brine, dried with MgSO4, filtered, and 
concentrated. The obtained product is typically pure enough to be used in further amide coupling 
as is, however, if necessary, further purification can be achieved by column chromatography on 
silica gel using a 1:1 hexane:ethyl acetate mobile phase. The titled compound was obtained as 
colorless solid in 96% yield (289 mg, 1.66 mmol). Rf: 0.40; mp: 102.0 – 103.4 °C; 1H NMR (500 
MHz, CDCl3): δ 7.29 – 7.23 (m, 2H), 7.21 (s, 2H), 7.03 – 6.95 (m, 2H); 13C (126 MHz, CDCl3): δ 181.3, 
161.8 (d, J = 245.6 Hz), 136.5 (d, J = 3.2 Hz), 130.1 (+, d, J = 8.2 Hz, 2C), 115.1 (+, d, J = 21.5 Hz, 
2C), 107.2 (+, 2C), 29.7; FTIR (KBr, cm-1): 3155, 3114, 3072, 2972, 2846, 2619, 1693, 1650, 1604, 
1512, 1427, 1317, 1222, 1161, 1108, 983, 933, 813, 752; HRMS (TOF ES): Found 177.0343, 




1-(2,4-difluorophenyl)cycloprop-2-ene-1-carboxylic acid (50c) 
The titled compound was obtained via the typical procedure using methyl 
1-(2,4-difluorophenyl)-2-(trimethylsilyl)cycloprop-2-ene-1-carboxylate 
(18c) (488 mg, 1.73 mmol, 1.0 equiv.) as a pale yellow solid in 86% yield (280 mg, 1.43 mmol). 
mp: 98.7-101.8 °C; 1H NMR (500 MHz, CDCl3): δ 7.02 (s, 2H), 6.88 (td, J = 8.4, 6.4 Hz, 1H), 6.60 – 
6.48 (m, 2H); 13C (126 MHz, CDCl3): δ 180.8, 162.3 (dd, J = 248.3, 11.9 Hz), 161.8 (dd, J = 249.3, 
12.1 Hz), 131.0 (+, dd, J = 9.7, 5.6 Hz), 124.6 (dd, J = 15.8, 3.8 Hz), 111.3 (+, dd, J = 21.3, 3.7 Hz), 
107.5 (+, d, J = 1.6 Hz, 2C), 104.1 (+, d, J = 25.5 Hz), 25.6; FTIR (KBr, cm-1): 3178, 3134, 1693, 1661, 
1614, 1504, 1421, 1269, 1138, 1088, 984, 854, 735, 636, 616; HRMS (TOF ES): Found 219.0223, 
calculated for C10H6F2O2Na (M+Na) 219.0234 (4.8 ppm). 
 
1-(2-chloro-4-fluorophenyl)cycloprop-2-ene-1-carboxylic acid (50d) 
The titled compound was obtained via the typical procedure using methyl 
1-(2-chloro-4-fluorophenyl)-2-(trimethylsilyl)cycloprop-2-ene-1-
carboxylate (18d) (517 mg, 1.73 mmol, 1.0 equiv.) as a colorless solid in 82% yield (303 mg, 1.43 
mmol). mp: 152.4-155.1 °C; 1H NMR (500 MHz, CDCl3): δ 7.30 (s, 2H), 7.18 (dd, J = 8.5, 6.0 Hz, 
1H), 7.09 (dd, J = 8.5, 2.6 Hz, 1H), 6.93 (td, J = 8.3, 2.6 Hz, 1H); 13C (126 MHz, CDCl3): δ 180.0, 
161.8 (d, J = 249.3 Hz), 135.9 (d, J = 10.5 Hz), 135.4 (d, J = 3.7 Hz), 131.3 (+, d, J = 8.7 Hz), 117.0 
(+, d, J = 24.8 Hz), 114.4 (+, d, J = 21.0 Hz), 108.2 (+, 2C), 29.3; FTIR (KBr, cm-1): 3163, 3122, 1693, 
1661, 1597, 1585, 1487, 1301, 1238, 1199, 1045, 982, 887, 856, 756, 634; HRMS (TOF ES): Found 






The titled compound was obtained via the typical procedure using methyl 1-(2-bromo-4-
fluorophenyl)-2-(trimethylsilyl)cycloprop-2-ene-1-carboxylate (18e) (594 mg, 1.73 mmol, 1.0 
equiv.) as colorless solid in 97% yield (430 mg, 1.67 mmol). Rf: 0.53; mp: 140 – 150 °C with 
decomposition; 1H NMR (500 MHz, CDCl3): δ 7.31 (s, 2H), 7.29 – 7.24 (m, 1H), 7.20 – 7.13 (m, 1H), 
7.01 – 6.94 (m, 1H); 13C (126 MHz, CDCl3): δ 180.5, 161.6 (d, J = 250.6 Hz), 137.1 (d, J = 3.7 Hz), 
131.4 (+, d, J = 8.6 Hz), 125.3 (d, J = 9.9 Hz), 120.0 (+, d, J = 24.5 Hz), 114.9 (+, d, J = 21.0 Hz), 
108.4(+, 2C), 31.4; FTIR (KBr, cm-1): 3161, 3118, 2970, 2908, 1693, 1660, 1595, 1485, 1299, 1265, 
1240, 1197, 1037, 981, 854, 754; HRMS (TOF ES): Found 254.9468, calculated for C10H5BrFO2 (M-
H) 254.9457 (4.3 ppm). 
 
1-(naphthalen-2-yl)cycloprop-2-ene-1-carboxylic acid (50f) 
The titled compound was obtained via the typical procedure using 
methyl 1-(naphthalen-2-yl)-2-(trimethylsilyl)cycloprop-2-ene-1-carboxylate (18f) (513 mg, 
1.73 mmol, 1.0 equiv.) as a colorless solid in 91% yield (332 mg, 1.58 mmol). Rf: 0.27; mp: 188-
190 °C (Decomposition); 1H NMR (500 MHz, CDCl3): δ 8.11 – 8.04 (m, 1H), 7.88 – 7.82 (m, 1H), 
7.78 – 7.75 (m, 1H), 7.57 – 7.46 (m, 2H), 7.45 (s, 2H), 7.44 – 7.38 (m, 1H), 7.36 – 7.31 (m, 1H); 13C 
(126 MHz, CDCl3): δ 181.8, 138.1, 133.8, 132.0, 128.9 (+), 128.2 (+), 126.3 (+), 126.0 (+), 125.9 
(+), 125.8 (+), 124.3 (+), 108.8 (+, 2C), 29.1; FTIR (KBr, cm-1): 3161, 3120, 3057, 1691, 1655, 
1410, 1310, 1288, 1263, 1236, 1178, 1121, 955, 775, 733, 660, 640; HRMS (TOF ES): Found 




1-(p-tolyl)cycloprop-2-ene-1-carboxylic acid (50g) 
The titled compound was obtained via the typical procedure using methyl 
1-(p-tolyl)-2-(trimethylsilyl)cycloprop-2-ene-1-carboxylate (18g) (450 mg, 1.73 mmol, 1.0 
equiv.) as colorless solid in 95% yield (286 mg, 1.64 mmol). Rf: 0.47; mp: 105.7 – 106.4 °C; 1H 
NMR (500 MHz, CDCl3): δ 7.21 (s, 2H), 7.20 – 7.16 (m, 2H), 7.14 – 7.09 (m, 2H), 2.32 (s, 3H); 13C 
(126 MHz, CDCl3): δ 181.5, 137.7, 136.6, 129.0 (+, 2C), 128.3 (+, 2C), 107.4 (+, 2C), 30.0, 21.2 (+); 
FTIR (KBr, cm-1): 3155, 3114, 3018, 2920, 1691, 1649, 1514, 1413, 1313, 1290, 1257, 1236, 977, 
954, 941, 929, 867, 813, 740, 628; HRMS (TOF ES): Found 173.0596, calculated for C11H9O2 (M-
H) 173.0603 (4.0 ppm). 
 
1-(2-chlorophenyl)cycloprop-2-ene-1-carboxylic acid (50i) 
The titled compound was obtained via the typical procedure using methyl 1-
(2-chlorophenyl)-2-(trimethylsilyl)cycloprop-2-ene-1-carboxylate (18i) (486 mg, 1.73 mmol, 
1.0 equiv.) as colorless solid in 84% yield (284 mg, 1.46 mmol). Rf: 0.47; mp: 144.9 - 147.3 °C; 1H 
NMR (500 MHz, CDCl3): δ 7.35 – 7.32 (m, 1H), 7.31 (s, 2H), 7.22 – 7.19 (m, 3H); 13C (126 MHz, 
CDCl3): δ 180.7, 139.3, 135.1, 130.3 (+), 129.6 (+), 128.8 (+), 127.2 (+), 108.2 (+, 2C), 29.9; FTIR 
(KBr, cm-1): 3163, 3120, 2972, 1693, 1660, 1473, 1438, 1411, 1294, 1265, 1226, 1056, 981, 945, 
873, 750, 730, 702, 649; HRMS (TOF ES): Found 193.0062, calculated for C10H6ClO2 (M-H) 
193.0056 (3.1 ppm). 
 
1-(2,3-difluorophenyl)cycloprop-2-ene-1-carboxylic acid (50j) 
The titled compound was obtained via the typical procedure using methyl 1-
(2,3-difluorophenyl)-2-(trimethylsilyl)cycloprop-2-ene-1-carboxylate (18j) 
(488 mg, 1.73 mmol, 1.0 equiv.) as colorless solid in 94% yield (319 mg, 1.63 mmol). Rf: 0.47; mp: 
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115.1 – 116.3 °C; 1H NMR (500 MHz, CDCl3): δ 7.27 (s, 2H), 7.10 – 6.97 (m, 2H), 6.95 – 6.88 (m, 
1H); 13C (126 MHz, CDCl3): δ 180.5, 150.6 (dd, J = 248.3, 12.9 Hz), 149.8 (dd, J = 248.2, 12.7 Hz), 
130.9 (d, J = 12.3 Hz), 124.9 (+, t, J = 3.1 Hz), 124.1 (+, dd, J = 6.9, 4.6 Hz), 116.4 (+, d, J = 17.2 Hz), 
107.3 (+, d, J = 1.7 Hz, 2C), 25.8 (t, J = 2.6 Hz); FTIR (KBr, cm-1): 3163, 3122, 2977, 2914, 2837, 
2651, 2540, 1697, 1660, 1589, 1481, 1425, 1313, 1274, 1253, 1220, 1118, 1037, 991, 952, 864, 
810, 742; HRMS (TOF ES): Found 195.0259, calculated for C10H5F2O2 (M-H) 195.0258 (0.5 ppm). 
 
1-(4-bromophenyl)cycloprop-2-ene-1-carboxylic acid (50l) 
The titled compound was obtained via the typical procedure using 
methyl 1-(4-bromophenyl)-2-(trimethylsilyl)cycloprop-2-ene-1-carboxylate (18l) (764 mg, 2.35 
mmol, 1.0 equiv.) as colorless solid in 92% yield (519 mg, 2.17 mmol). Rf: 0.47; mp: 125.7 – 126.5 
°C; 1H NMR (500 MHz, CDCl3): δ 7.46 – 7.39 (m, 2H), 7.19 (s, 2H), 7.19 – 7.14 (m, 2H); 13C (126 
MHz, CDCl3): δ 181.1, 139.7, 131.4 (+, 2C), 130.2 (+, 2C), 120.9, 106.9 (+, 2C), 29.9; FTIR (KBr, cm-
1): 3126, 3110, 3047, 2962, 2881, 1691, 1658, 1485, 1415, 1394, 1307, 1222, 1072, 975, 871, 813, 
761, 692; HRMS (TOF ES): Found 236.9539, calculated for C10H6BrO2 (M-H) 236.9551 (5.1 ppm). 
 
1-(2,4-dichlorophenyl)cycloprop-2-ene-1-carboxylic acid (50m) 
The titled compound was obtained via the typical procedure using 
methyl 1-(2,4-dichlorophenyl)-2-(trimethylsilyl)cycloprop-2-ene-1-carboxylate (18m) (545 mg, 
1.73 mmol, 1.0 equiv.) as colorless solid in 93% yield ( 369 mg, 1.61 mmol). Rf: 0.53; mp: 135.5 – 
137.9 °C; 1H NMR (500 MHz, CDCl3): δ 7.36 (d, J = 2.1 Hz, 1H), 7.29 (s, 2H), 7.19 (dd, J = 8.2, 2.1 
Hz, 1H), 7.13 (d, J = 8.2 Hz, 1H); 13C (126 MHz, CDCl3): δ 180.2, 137.9, 135.9, 133.9, 131.2 (+), 
129.4 (+), 127.5 (+), 108.0 (+, 2C), 29.4; FTIR (KBr, cm-1): 3166, 3114, 2962, 2894, 1697, 1662, 
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1587, 1473, 1419, 1296, 1263, 1224, 1099, 1056, 981, 933, 804, 744, 611; HRMS (TOF ES): Found 
226.9662, calculated for C10H5Cl2O2 (M-H) 226.9667 (2.2 ppm). 
 
1-(3-(trifluoromethyl)phenyl)cycloprop-2-ene-1-carboxylic acid (50n) 
The titled compound was obtained via the typical procedure using methyl 1-
(3-(trifluoromethyl)phenyl)-2-(trimethylsilyl)cycloprop-2-ene-1-
carboxylate (18n) (759 mg, 2.40 mmol, 1.0 equiv.) as colorless solid in 88% yield (483 mg, 2.12 
mmol). Rf: 0.53; mp: 104.3 – 105.5 °C; 1H NMR (500 MHz, CDCl3): δ 7.55 – 7.47 (m, 3H), 7.46 – 
7.39 (m, 1H), 7.24 (s, 2H); 13C (126 MHz, CDCl3): δ 180.8, 141.6, 132.0 (+), 130.6 (q, J = 32.1 Hz), 
128.7 (+), 125.3 (+, d, J = 4.0 Hz), 124.2 (q, J = 273.4 Hz), 123.8 (+, d, J = 3.9 Hz), 106.8 (2C), 30.1; 
FTIR (KBr, cm-1): 3128, 3043, 2979, 2950, 2927, 2837, 1693, 1666, 1427, 1334, 1222, 1166, 1134, 
1074, 987, 933, 806, 750, 705; HRMS (TOF ES): Found 227.0313, calculated for C11H6F3O2 (M-H) 




The titled compound was obtained via the typical procedure using methyl 1-(2-chloro-4,5-
difluorophenyl)-2-(trimethylsilyl)cycloprop-2-ene-1-carboxylate (18o) (546 mg, 1.73 mmol, 1.0 
equiv.) as colorless solid in 84% yield (336 mg, 1.46 mmol). Rf: 0.50; mp: 131.1 – 133.9 °C; 1H 
NMR (500 MHz, CDCl3): δ 7.28 (s, 2H), 7.18 (dd, J = 9.9, 7.2 Hz, 1H), 7.02 (dd, J = 10.3, 8.1 Hz, 1H); 
13C (126 MHz, CDCl3): δ 180.6, 149.5 (dd, J = 251.8, 13.6 Hz), 149.2 (dd, J = 249.6, 12.6 Hz), 137.7 
– 134.6 (m), 129.9 (dd, J = 8.0, 3.5 Hz), 118.8 (+, d, J = 18.1 Hz), 118.6 (+, d, J = 20.2 Hz), 107.8 (+, 
2C), 29.5; FTIR (KBr, cm-1): 3166, 3120, 3072, 2979, 2837, 1697, 1666, 1600, 1496, 1417, 1396, 
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1307, 1280, 1172, 939, 879, 794, 742; HRMS (TOF ES): Found 228.9871, calculated for 
C10H4ClF2O2 (M-H) 228.9868 (1.3 ppm). 
 




Typical Procedure: Part 1: 1-(4-fluorophenyl)cycloprop-2-ene-1-
carboxylic acid (50b) (223 mg, 1.28 mmol, 1.0 equiv.) and dimethylformamide (2 drops) were 
dissolved in freshly distilled and dried dichloromethane (7 mL) and added to a flame dried round 
bottom flask under an inert nitrogen atmosphere. Oxalyl chloride (200 μL, 297 mg, 2.34 mmol, 
1.5 equiv.) was then added slowly dropwise and stirred at room temperature for 2 hours. The 
solution was then evaporated under reduced pressure to provide a pale yellow solid material. 
Part 2: diethylamine (323 μL, 228 mg, 3.12 mmol, 2.0 equiv.) and triethylamine (436 μL, 316 mg, 
3.12 mmol, 2.0 equiv.), and freshly dried dichloromethane (3 mL) were combined in a flame dried 
two neck round bottom flask under an inert nitrogen atmosphere. Recovered material from part 
1 was dissolved in freshly dried dichloromethane (3 mL) and added to the two neck flask slowly 
dropwise. The reaction was then stirred for 18 hours and then partitioned between water and 
dichloromethane. The aqueous phase was then acidified using 1N HCl to a pH of approximately 
2. The organic phase was then extracted with properly acidified water (pH=2, 3 x 10mL). The 
combined acidic aqueous layers were then back extracted once with dichloromethane which was 
combined with other organic layers, washed with brine, dried, filtered, and concentrated. The 
product was then purified by silica gel column chromatography using a 2:1 hexane:ethyl acetate 
mobile phase to provide the titled compound as a colorless solid in 78% yield (232 mg, 0.099 
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mmol). Rf: 0.23; mp: 86.7 – 88.7 °C; 1H NMR (500 MHz, CDCl3): δ 7.25 (s, 2H), 7.12 – 7.05 (m, 2H), 
6.99 – 6.93 (m, 2H), 3.38 (q, J = 7.1 Hz, 2H), 3.30 (q, J = 7.1 Hz, 2H), 1.14 (t, J = 7.1 Hz, 3H), 0.89 (t, 
J = 7.1 Hz, 3H); 13C (126 MHz, CDCl3): δ 173.0, 161.6 (d, J = 244.9 Hz), 139.4 (d, J = 3.1 Hz), 127.6 
(+, d, J = 8.1 Hz, 2C), 115.3 (+, d, J = 21.5 Hz, 2C), 109.9 (+, 2C), 41.9 (-), 39.1 (-), 31.6, 13.8 (+), 
12.7 (+); FTIR (KBr, cm-1): 3070, 2975, 2935, 2875, 1620, 1508, 1460, 1429, 1380, 1363, 1313, 
1276, 1220, 1159, 1120, 1097, 1012, 825, 810; HRMS (TOF ES): Found 256.1121, calculated for 
C14H16FNONa (M+Na) 256.1114 (2.7 ppm). 
 
N,N-diethyl-1-phenylcycloprop-2-ene-1-carboxamide (53aa) 
The titled compound was obtained via typical procedure using 1-
phenylcycloprop-2-ene-1-carboxylic acid (50a) (250 mg, 1.56 mmol, 1.0 equiv.) as a colorless 
solid in 89% yield (300 mg, 1.39 mmol). Rf: 0.16, mp: 84.5-86.0 °C; 1H NMR (500 MHz, CDCl3): δ 
7.33 – 7.10 (m, 7H), 3.40 (q, J = 7.0 Hz, 2H), 3.32 (q, J = 7.1 Hz, 2H), 1.17 (t, J = 7.1 Hz, 3H), 0.90 (t, 
J = 7.1 Hz, 3H); 13C (126 MHz, CDCl3): δ 173.2, 143.5, 128.3 (2C, +), 126.2 (+), 125.9 (2C, +), 109.6 
(2C, +), 41.9 (-), 38.9 (-), 32.0, 13.7 (+), 12.6 (+); FTIR (KBr, cm-1):3078, 2972, 2934, 2872, 1624, 
1491, 1472, 1429, 1379, 1364, 1277, 1221, 1121, 1076, 1018, 999, 839, 764, 739, 700, 638; HRMS 
(TOF ES): Found 215.1311, calculated for C14H17NO (M+) 215.1310 (0.5 ppm). 
 
N,N-diisopropyl-1-phenylcycloprop-2-ene-1-carboxamide (53ab) 
Compound was obtained via typical procedure using diisopropylamine 
(438 μL, 316 mg, 3.12 mmol, 2.0 equiv.). The product was then purified by 
silica gel column chromatography using a 3:1 hexane:ethyl acetate mobile phase to provide the 
titled compound as a very pale yellow solid in 59% yield (224 mg, 0.92 mmol). Rf: 0.26; mp: 66.9-
68.2 °C; 1H NMR (500 MHz, CDCl3): δ 7.24 – 7.19 (m, 2H), 7.18 (s, 2H), 7.14 – 7.07 (m, 3H), 4.23 
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(h, J = 6.7 Hz, 1H), 3.22 (h, J = 6.8 Hz, 1H), 1.40 (d, J = 6.8 Hz, 6H), 0.84 (d, J = 6.7 Hz, 6H); 13C (126 
MHz, CDCl3): δ 173.2, 143.7, 128.3 (+, 2C), 126.3 (+), 126.1 (+, 2C), 110.0 (+, 2C), 49.5 (+), 45.6 
(+), 33.5, 20.5 (+, 2C), 20.4 (+, 2C); FTIR (KBr, cm-1): 3080, 3061, 2999, 2966, 2932, 1643, 1626, 
1614, 1493, 1435, 1369, 1329, 1213, 1161, 1045, 739, 700, 667, 621; HRMS (TOF ES): Found 
244.1701, calculated for C16H22NO (M+H) 244.1701 (0.0 ppm). 
 
N,N-diallyl-1-phenylcycloprop-2-ene-1-carboxamide (53ac) 
Compound was obtained via typical procedure using diallylamine (385 
μL, 363 mg, 3.12 mmol, 2.0 equiv.). The product was then purified by 
silica gel column chromatography using a 3:1 hexane:ethyl acetate mobile phase to provide the 
titled compound as a colorless solid in 87% yield (324 mg, 1.35 mmol). Rf: 0.22; mp: 43.1-44.2 °C; 
1H NMR (500 MHz, CDCl3): δ 7.25 – 7.19 (m, 2H), 7.18 (s, 2H), 7.16 – 7.11 (m, 1H), 7.09 – 7.05 (m, 
2H), 5.74 (ddt, J = 17.1, 10.2, 6.1 Hz, 1H), 5.39 (ddt, J = 17.2, 10.8, 5.4 Hz, 1H), 5.13 – 4.89 (m, 4H), 
3.92 (d, J = 6.1 Hz, 2H), 3.81 (d, J = 5.4 Hz, 2H); 13C (126 MHz, CDCl3): δ 173.9, 143.2, 133.4 (+), 
133.0 (+), 128.5 (+, 2C), 126.5 (+), 126.0 (+, 2C), 117.7 (-), 117.5 (-), 109.6 (+, 2C), 49.5 (-), 46.7 
(-), 31.9; FTIR (KBr, cm-1): 3082, 3022, 2982, 2918, 1645, 1634, 1614, 1493, 1447, 1412, 1285, 
1248, 995, 926, 764, 733, 700; HRMS (TOF ES): Found 240.1387, calculated for C16H18NO (M+H) 
240.1388 (0.4 ppm). 
 
N,N-dibenzyl-1-phenylcycloprop-2-ene-1-carboxamide (53ad) 
Compound was obtained via typical procedure using dibenzylamine 
(600 μL, 616 mg, 3.12 mmol, 2.0 equiv.). The product was then 
purified by silica gel column chromatography using a 3:1 hexane:ethyl acetate mobile phase to 
provide the titled compound as a colorless solid in 76% yield (402 mg, 1.18 mmol). Rf: 0.30; mp: 
114 
 
112.3-113.9 °C; 1H NMR (500 MHz, CDCl3): δ 7.27 – 7.13 (m, 10H), 7.12 – 7.07 (m, 1H), 7.05 (s, 
2H), 7.05 – 7.02 (m, 2H), 6.88 – 6.84 (m, 2H), 4.47 (s, 2H), 4.31 (s, 2H); 13C (126 MHz, CDCl3): δ 
174.6, 143.1, 137.3, 136.9, 128.9 (+, 2C), 128.8 (+, 2C), 128.7 (+, 2C), 128.6 (+, 2C), 127.6 (+), 
127.6 (+), 127.0 (+, 2C), 126.6 (+), 126.1 (+, 2C), 109.8 (+, 2C), 50.2 (-), 47.5 (-), 32.0; FTIR (KBr, 
cm-1): 3084, 3061, 3028, 2924, 2870, 1645, 1634, 1495, 1452, 1418, 1229, 1080, 957, 752, 735, 




Compound was obtained via typical procedure using N-methylbenzylamine (403 μL, 378 mg, 3.12 
mmol, 2.0 equiv.). The product was then purified by silica gel column chromatography using a 
3:1 hexane:ethyl acetate mobile phase to provide the titled compound as a mixture of rotomers 
in a ratio of 1.3:1 as a colorless liquid in 88% yield (362 mg, 1.37 mmol). Rf: 0.15; 1H NMR (500 
MHz, CDCl3): δ [7.36 – 7.11 (m), Σ10H], [7.29, (s) & 7.14 (s), Σ2H], [4.63 (s) & 4.51 (s), Σ2H], [2.92 
(s) & 2.80 (s), Σ3H]; 13C (126 MHz, CDCl3): δ Major Rotomer: 174.0, 143.0, 137.3, 128.6 (+, 2C), 
128.5 (+, 2C), 128.2 (+, 2C), 127.4 (+), 126.3 (+), 125.9 (+, 2C), 109.4 (+, 2C), 50.7 (-), 34.9 (+), 
32.1 . Minor Rotomer: 174.6, 143.1, 136.8, 128.8 (+, 2C), 128.5 (+, 2C), 127.5 (+), 126.7 (+, 2C), 
126.5 (+), 125.9 (+, 2C), 109.4 (+, 2C), 53.6 (-), 33.1 (+), 31.8; FTIR (KBr, cm-1): 3084, 3028, 2920, 
1645, 1614, 1489, 1447, 1398, 1269, 1101, 1003, 959, 739, 698, 652; HRMS (TOF ES): Found 






Compound was obtained via typical procedure using N-
isopropylbenzylamine (522 μL, 466 mg, 3.12 mmol, 2.0 equiv.). The product was then purified by 
silica gel column chromatography using a 3:1 hexane:ethyl acetate mobile phase to provide the 
titled compound as a mixture of rotomers in a ratio of 1.3:1 as a colorless solid in 80% yield (363 
mg, 1.25mmol). Rf: 0.23; mp: 58.7-60.3 °C; 1H NMR (500 MHz, CDCl3): δ [7.33 (s) & 6.83 (s), Σ2H], 
[7.32 – 7.27 (m), Σ5H], [7.25 – 7.17 (m), Σ3H] [7.11 – 7.01 (m), Σ2H], [4.69 (h, J = 6.8 Hz) & 4.48 
(h, J = 6.7 Hz), Σ1H], [4.52 (s) & 4.37 (s), Σ2H], [1.16 (d, J = 6.8 Hz) & 0.92 (d, J = 6.8 Hz), Σ6H]; 13C 
(126 MHz, CDCl3): δ Major Rotomer: 174.4, 143.4, 139.9, 128.5 (+, 2C), 128.4 (+, 2C), 127.5 (+, 
2C), 126.7 (+), 126.5 (+), 126.2 (+, 2C), 110.2 (+, 2C), 49.3 (+), 43.9 (-), 32.4, 21.4 (+, 2C). Minor 
Rotomer: 174.7, 143.4, 139.5, 128.6 (+, 2C), 128.5 (+, 2C), 127.2 (+), 126.6 (+, 2C), 126.4 (+), 125.9 
(+, 2C), 109.3 (+, 2C), 47.7 (-), 47.1 (+), 32.8, 20.3 (+, 2C); FTIR (KBr, cm-1): 3082, 3061, 3026, 
2972, 2932, 1626, 1495, 1437, 1412, 1339, 1178, 1078, 735, 698, 652; HRMS (TOF ES): Found 




Compound was obtained via typical procedure using N-
cyclohexylbenzylamine (591 mg, 3.12 mmol, 2.0 equiv.). The product was then purified by silica 
gel column chromatography using a 3:1 hexane:ethyl acetate mobile phase to provide the titled 
compound as a mixture of rotomers in a ratio of 1.5:1 as a very pale yellow oil in 84% yield (432 
mg, 1.30 mmol). Rf: 0.27; 1H NMR (500 MHz, CDCl3): δ [7.35 (s) & 6.80 (s), Σ2H], [7.32 – 7.27 (m), 
Σ5H], [7.25 – 7.18 (m), Σ3H], [7.09 – 7.00 (m), Σ2H], [4.52 (s) & 4.40 (s), Σ2H], [4.46 – 4.40 (m) & 
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4.07 – 3.97 (m), Σ1H], [1.82 – 1.69 (m) & 1.65 – 1.56 (m) & 1.52 – 1.44 (m) & 1.40 – 1.22 (m) & 
1.08 – 0.84 (m), Σ10H]; 13C (126 MHz, CDCl3): δ Major Rotomer: 174.6, 143.5, 139.9, 128.5 (+, 2C), 
128.3 (+, 2C), 127.5 (+, 2C), 126.7 (+), 126.6 (+), 126.3 (+, 2C), 110.7 (+, 2C), 58.1 (+), 44.9 (-), 
32.6, 32.1 (-, 2C), 26.1 (-, 2C), 25.3 (-). Minor Rotomer: 174.7, 143.5, 139.8, 128.5, 128.5, 127.1, 
126.6, 126.4, 125.9, 109.2, 54.9, 47.9, 32.7, 30.6, 26.0, 25.6; FTIR (KBr, cm-1): 3082, 3060, 3028, 
2930, 2854, 1645, 1625, 1607, 1495, 1447, 1416, 1244, 1078, 1003, 912, 737, 698, 656; HRMS 
(TOF ES): Found 332.2015, calculated for C23H26NO (M+H) 332.2014 (0.2 ppm). 
 
(1-phenylcycloprop-2-en-1-yl)(pyrrolidin-1-yl)methanone (53ai) 
Compound was obtained via typical procedure using pyrrolidine (256 μL, 
222 mg, 3.12 mmol, 2.0 equiv.). The product was then purified by silica gel 
column chromatography using a 2:1 hexane:ethyl acetate mobile phase to provide the titled 
compound as a colorless solid in 84% yield (279 mg, 1.31 mmol). Rf: 0.10; mp: 140.7-143.6 °C; 1H 
NMR (500 MHz, CDCl3): δ 7.25 – 7.20 (m, 2H), 7.20 (s, 2H), 7.15 – 7.10 (m, 1H), 7.09 – 7.05 (m, 
2H), 3.45 (dd, J = 7.2, 6.2 Hz, 2H), 3.15 (dd, J = 6.4 Hz, 2H), 1.79 – 1.67 (m, 4H); 13C (126 MHz, 
CDCl3): δ 172.4, 143.0, 128.5 (+, 2C), 126.3 (+), 126.2 (+, 2C), 109.3 (+, 2C), 46.6 (-), 45.9 (-), 32.9, 
26.1 (-), 24.2 (-); FTIR (KBr, cm-1):3103, 3057, 2968, 2872, 1616, 1447, 1431, 1045, 914, 731, 
681, 669; HRMS (TOF ES): Found 214.1234, calculated for C14H16NO (M+H) 214.1232 (0.9 ppm). 
 
(1-phenylcycloprop-2-en-1-yl)(piperidin-1-yl)methanone (53aj) 
Compound was obtained via typical procedure using piperidine (308 μL, 
266 mg, 3.12 mmol, 2.0 equiv.). The product was then purified by silica gel 
column chromatography using a 2:1 hexane:ethyl acetate mobile phase to provide the titled 
compound as a colorless solid in 83% yield (295 mg, 1.30 mmol). Rf: 0.26; mp: 128.6-132.5 °C; 1H 
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NMR (500 MHz, CDCl3): δ 7.31 – 7.24 (m, 2H), 7.22 (s, 2H), 7.20 – 7.16 (m, 1H), 7.14 – 7.11 (m, 
2H), 3.63 – 3.51 (m, 2H), 3.46 – 3.22 (m, 2H), 1.69 – 1.45 (m, 4H), 1.36 – 1.18 (m, 2H); 13C (126 
MHz, CDCl3): δ 172.3, 143.5, 128.4 (+, 2C), 126.2 (+), 125.9 (+, 2C), 109.2 (+, 2C), 47.0 (-), 42.7 (-
), 31.8, 26.0 (-), 25.5 (-), 24.5 (-); FTIR (KBr, cm-1):3103, 3059, 3016, 2943, 2916, 2851, 1618, 
1439, 1269, 1256, 1122, 1043, 974, 910, 852, 760, 739, 696, 681; HRMS (TOF ES): Found 
228.1386, calculated for C15H18NO (M+H) 228.1388 (0.9 ppm). 
 
morpholino(1-phenylcycloprop-2-en-1-yl)methanone (53ak) 
Compound was obtained via typical procedure using morpholine (270 μL, 
272 mg, 3.12 mmol, 2.0 equiv.). The product was then purified by silica gel 
column chromatography using a 2:1 hexane:ethyl acetate mobile phase to provide the titled 
compound as a colorless solid in 95% yield (340 mg, 1.48 mmol). Rf: 0.13; mp: 115.1-117.6 °C; 1H 
NMR (500 MHz, CDCl3): δ 7.32 – 7.27 (m, 2H), 7.23 (s, 2H), 7.22 – 7.17 (m, 1H), 7.14 – 7.09 (m, 
2H), 3.65 (s, 4H), 3.39 (s, 4H); 13C (126 MHz, CDCl3): δ 172.7, 142.9, 128.6 (+, 2C), 126.6 (+), 125.8 
(+, 2C), 108.9 (+, 2C), 66.8 (-), 66.5 (-), 46.4 (-), 42.1 (-), 31.5; FTIR (KBr, cm-1): 3105, 3063, 2966, 
2916, 2856, 1626, 1429, 1273, 1248, 1115, 980, 766, 737, 702; HRMS (TOF ES): Found 230.1197, 




Titled compound was obtained via typical procedure (part 1). For 
part 2: 1-ethylpiperazine (396 μL, 356 mg, 3.12 mmol, 2.0 equiv.) and triethylamine (436 μL, 316 
mg, 3.12 mmol, 2.0 equiv.), and freshly dried dichloromethane (3.0 mL) were combined in a flame 
dried two neck round bottom flask under an inert nitrogen atmosphere. Recovered material from 
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part 1 was dissolved in freshly dried dichloromethane (3 mL) and added to the two neck flask 
slowly dropwise. The reaction was then stirred for 18 hours and then partitioned between water 
and dichloromethane. The aqueous phase was then acidified using 1N HCl to a pH of 
approximately 2. The organic phase was then extracted with properly acidified water (pH=2, 3 x 
15 mL). The pH of the combined aqueous layers was then adjusted to approximately 9 with 
saturated sodium bicarbonate and extracted with dichloromethane (3 x 15 mL). The combined 
organic phase was then washed with brine, dried, filtered, and concentrated. The product was 
then purified by trimethylamine neutralized silica gel column chromatography using an ethyl 
acetate mobile phase to provide the titled compound as a colorless solid in 90% yield (361 mg, 
1.41 mmol). Rf: 0.17; mp: 51.9-53.7 °C; 1H NMR (500 MHz, CDCl3): δ 7.29 – 7.23 (m, 2H), 7.20 (s, 
2H), 7.19 – 7.14 (m, 1H), 7.11 – 7.07 (m, 2H), 3.70 – 3.61 (m, 2H), 3.45 – 3.37 (m, 2H), 2.44 – 2.36 
(m, 2H), 2.33 (q, J = 7.2 Hz, 2H), 2.19 – 2.08 (m, 2H), 1.01 (t, J = 7.2 Hz, 3H); 13C (126 MHz, CDCl3): 
δ 172.4, 143.1, 128.4 (+, 2C), 126.4 (+), 125.9 (+, 2C), 108.9 (+, 2C), 52.6 (-), 52.4 (-), 52.2 (-), 45.8 
(-), 41.6 (-), 31.6, 11.9 (+); FTIR (KBr, cm-1):3080, 2968, 2931, 2808, 1628, 1437, 1252, 1167, 
1124, 1022, 982, 764, 737, 700, 652; HRMS (TOF ES): Found 257.1648, calculated for C16H21N2O 
(M+H) 257.1654 (2.3 ppm). 
 
N-butyl-1-phenylcycloprop-2-ene-1-carboxamide (53am) 
Compound was obtained via typical procedure using butylamine 
(308 μL, 228 mg, 3.12 mmol, 2.0 equiv.). The product was then purified by silica gel column 
chromatography using a 1:1 hexane:ethyl acetate mobile phase to provide the titled compound 
as a colorless solid in 85% yield (284 mg, 1.32 mmol). Rf: 0.32; mp: 48.2-50.1 °C; 1H NMR (500 
MHz, CDCl3): δ 7.35 – 7.21 (m, 5H), 7.25 (s, 2H), 5.60 (s, 1H), 3.21 (td, J = 7.2, 5.8 Hz, 2H), 1.48 – 
1.31 (m, 2H), 1.31 – 1.15 (m, 2H), 0.86 (t, J = 7.4 Hz, 3H); 13C (126 MHz, CDCl3): δ 174.8, 142.0, 
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128.8 (+, 2C), 128.6 (+, 2C), 127.1 (+), 108.9 (+, 2C), 39.9 (-), 32.6, 31.7 (-), 20.0 (-), 13.8 (+); FTIR 
(KBr, cm-1): 3277, 3082, 2952, 2927, 2858, 1623, 1541, 1431, 1308, 1224, 1143, 1012, 743, 694, 
689; HRMS (TOF ES): Found 216.1396, calculated for C14H18NO (M+H) 216.1388 (3.5 ppm). 
 
N-cycloheptyl-1-phenylcycloprop-2-ene-1-carboxamide (53an) 
Compound was obtained via typical procedure using cycloheptylamine 
(397 μL, 353 mg, 3.12 mmol, 2.0 equiv.). The product was then purified by silica gel column 
chromatography using a 1:1 hexane:ethyl acetate mobile phase to provide the titled compound 
as a colorless solid in 81% yield (321 mg, 1.26 mmol). Rf: 0.42; mp: 118.9-120.8 °C; 1H NMR (500 
MHz, CDCl3): δ 7.35 – 7.22 (m, 5H), 7.25 (s, 2H), 5.52 (d, J = 7.7 Hz, 1H), 4.07 – 3.81 (m, 1H), 1.90 
– 1.76 (m, 2H), 1.62 – 1.37 (m, 8H), 1.38 – 1.27 (m, 2H); 13C (126 MHz, CDCl3): δ 173.6, 142.1, 
128.8 (+, 2C), 128.7 (+, 2C), 127.1 (+), 108.9 (+, 2C), 50.9 (+), 35.0 (-, 2C), 32.7, 27.9 (-, 2C), 24.1 
(-, 2C); FTIR (KBr, cm-1): 3294, 3136, 3084, 2914, 2853, 1614, 1531, 1445, 1319, 1627, 1334, 




Compound was obtained via typical procedure using allylamine (233 μL, 
178 mg, 3.12 mmol, 2.0 equiv.). The product was then purified by silica gel column 
chromatography using a 1:1 hexane:ethyl acetate mobile phase to provide the titled compound 
as a colorless solid in 92% yield (286 mg, 1.44 mmol). Rf: 0.27; mp: 68.0-69.1 °C; 1H NMR (500 
MHz, CDCl3): δ 7.38 – 7.21 (m, 5H), 7.28 (s, 2H), 5.78 (ddt, J = 17.3, 10.6, 5.5 Hz, 1H), 5.68 (s, 1H), 
5.15 – 5.00 (m, 2H), 3.91 – 3.82 (m, 2H); 13C (126 MHz, CDCl3): δ 174.8, 141.8, 134.4 (+), 128.9 (+, 
2C), 128.7 (+, 2C), 127.3 (+), 116.0 (-), 108.9 (+, 2C), 42.5 (-), 32.6; FTIR (KBr, cm-1): 3279, 3080, 
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2927, 1626, 1529, 1425, 1265, 1146, 1013, 986, 916, 741, 694; HRMS (TOF ES): Found 200.1077, 




Compound was obtained via typical procedure using propargylamine (200 μL, 172 mg, 3.12 
mmol, 2.0 equiv.). The product was then purified by silica gel column chromatography using a 
1:1 hexane:ethyl acetate mobile phase to provide the titled compound as a colorless solid in 71% 
yield (219 mg, 1.11 mmol). Rf: 0.33; mp: 123.8-124.7 °C; 1H NMR (500 MHz, CDCl3): δ 7.41 – 7.36 
(m, 2H), 7.34 – 7.28 (m, 3H), 7.31 (s, 2H), 5.78 (s, 1H), 4.07 (dd, J = 5.4, 2.6 Hz, 2H), 2.20 (t, J = 2.6 
Hz, 1H); 13C (126 MHz, CDCl3): δ 174.8, 141.4, 129.1 (+, 2C), 128.8 (+, 2C), 127.5 (+), 108.7 (+, 2C), 
79.8 (+), 71.5, 32.5, 29.9 (-); FTIR (KBr, cm-1): 3319, 3286, 3134, 3090, 1655, 1630, 1524, 1423, 
1360, 1277, 1005, 930, 854, 744, 675, 635; HRMS (TOF ES): Found 198.0922, calculated for 




Compound was obtained via typical procedure (part 1). For part 2: 2-
(aminomethyl)pyridine (322 μL, 337 mg, 3.12 mmol, 2.0 equiv.) and triethylamine (436 μL, 316 
mg, 3.12 mmol, 2.0 equiv.), and freshly dried dichloromethane (3.0 mL) were combined in a flame 
dried two neck round bottom flask under an inert nitrogen atmosphere. Recovered material from 
part 1 was dissolved in freshly dried dichloromethane (3 mL) and added to the two neck flask 
slowly dropwise. The reaction was then stirred for 18 hours and then partitioned between water 
and dichloromethane. The aqueous phase was then acidified using 1N HCl to a pH of 
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approximately 2. The organic phase was then extracted with properly acidified water (pH=2, 3 x 
15 mL). The pH of the combined aqueous layers was then adjusted to approximately 9 with 
saturated sodium bicarbonate and extracted with dichloromethane (3 x 15 mL). The combined 
organic phase was then washed with brine, dried, filtered, and concentrated. The product was 
then purified by trimethylamine neutralized silica gel column chromatography using a 1:3 
hexane:ethyl acetate mobile phase to provide the titled compound as a colorless solid in 89% 
yield (349 mg, 1.39 mmol). Rf: 0.23; mp: 97.7-100.2 °C; 1H NMR (500 MHz, CDCl3): δ 8.53 – 8.40 
(m, 1H), 7.75 – 7.63 (m, 1H), 7.37 – 7.26 (m, 6H), 7.33 (s, 2H), 7.23 – 7.19 (m, 1H), 6.82 (s, 1H), 
4.58 (d, J = 5.4 Hz, 2H); 13C (126 MHz, CDCl3): δ 175.4, 156.7, 148.3 (+), 141.7, 137.7 (+), 128.9 (+, 
2C), 128.8 (+, 2C), 127.3 (+), 122.7 (+), 122.6, 109.1 (+, 2C), 45.0 (-), 32.5; FTIR (KBr, cm-1): 3290, 
3084, 3061, 1660, 1643, 1634, 1514, 1494, 1435, 1296, 1252, 995, 756, 700, 667; HRMS (TOF 




Compound was obtained via typical procedure using furfurylamine (276 μL, 303 mg, 3.12 mmol, 
2.0 equiv.). The product was then purified by silica gel column chromatography using a 1:1 
hexane:ethyl acetate mobile phase to provide the titled compound as a colorless solid in 77% 
yield (286 mg, 1.20 mmol). Rf: 0.33; mp: 51.4-54.1 °C; 1H NMR (500 MHz, CDCl3): δ 7.36 – 7.22 (m, 
6H), 7.27 (s, 2H), 6.28 (dd, J = 3.2, 1.9 Hz, 1H), 6.16 (dd, J = 3.2, 0.9 Hz, 1H), 5.92 (t, J = 5.7 Hz, 1H), 
4.43 (dd, J = 5.6, 0.8 Hz, 2H); 13C (126 MHz, CDCl3): δ 174.8, 151.6, 142.1 (+), 141.6, 128.9 (+, 2C), 
128.7 (+, 2C), 127.3 (+), 110.4 (+), 108.8 (+, 2C), 107.2 (+), 37.2 (-), 32.6; FTIR (KBr, cm-1): 3292, 
3107, 3082, 3057, 1637, 1504, 1445, 1294, 1229, 1148, 1076, 1007, 741, 700, 663; HRMS (TOF 






Compound was obtained via typical procedure using ethanolamine (189 μL, 190 mg, 3.12 mmol, 
2.0 equiv.). The product was then purified by silica gel column chromatography using an ethyl 
acetate mobile phase to provide the titled compound as a colorless oil in 44% yield (138 mg, 0.68 
mmol). Rf: 0.17; 1H NMR (500 MHz, CDCl3): δ 7.17 – 7.05 (m, 5H), 7.08 (s, 2H), 5.92 (s, 1H), 3.44 
(t, J = 5.5 Hz, 2H), 3.18 (td, J = 5.7, 4.4 Hz, 2H), 2.88 (s, 1H); 13C (126 MHz, CDCl3): δ 176.7, 141.5, 
129.0 (+, 2C), 128.8 (+, 2C), 127.4 (+), 108.9 (+, 2C), 62.7 (-), 43.3 (-), 32.5; FTIR (KBr, cm-1): 3340, 
3103, 2934, 2876, 1660, 1643, 1614, 1537, 1518, 1445, 1240, 1072, 991, 764, 700, 665; HRMS 
(TOF ES): Found 204.1030, calculated for C12H14NO2 (M+H) 204.1025 (2.7 ppm). 
 
1-phenylcycloprop-2-ene-1-carboxamide (53at) 
Compound was obtained via typical procedure (part 1). In part 2, the 
recovered acyl chloride from part 1 was dissolved in tetrohydrofuran (3 mL) and added slowly 
dropwise to a solution of approximately 30% aqueous ammonia (5 mL) and stirred overnight. 
The mixture was then concentrated, added to water (10 mL), and then extracted with ethyl 
acetate (3 x 10 mL). Combined organic phases were then washed with brine, dried, filtered, and 
concentrated. The product was then purified by silica gel column chromatography using an ethyl 
acetate mobile phase to provide the titled compound as a colorless solid in 69% yield (171 mg, 
1.07 mmol). Rf: 0.23; mp: 118.2-119.0 °C; 1H NMR (500 MHz, CDCl3): δ 7.32 – 7.16 (m, 5H), 7.22 
(s, 2H), 5.98 (s, 1H), 5.54 (s, 1H); 13C (126 MHz, CDCl3): δ 178.0, 141.7, 129.0 (+, 2C), 128.7 (+, 2C), 
127.4 (+), 108.7 (+, 2C), 32.2 ; FTIR (KBr, cm-1): 3362, 3188, 3111, 1608, 1402, 1261, 1113, 993, 
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Compound was obtained via typical procedure using N,O-dimethylhydroxylamine (228 mg, 2.34 
mmol, 1.50 equiv.). The product was then purified by silica gel column chromatography using a 
1:1 hexane:ethyl acetate mobile phase to provide the titled compound as a colorless solid in 83% 
yield (262 mg, 1.29 mmol). Rf: 0.30; mp: 74.3-75.6 °C; 1H NMR (500 MHz, CDCl3): δ 7.29 (s, 2H), 
7.28 – 7.25 (m, 2H), 7.22 – 7.13 (m, 3H), 3.30 (s (broad), 3H), 3.15 (s, 3H); 13C (126 MHz, CDCl3): 
δ 175.3, 143.2, 128.3 (+, 2C), 126.3 (+, 3C), 109.9 (+, 2C), 60.7 (+), 32.8, 31.7 (+); FTIR (KBr, cm-
1): 3080, 3018, 2972, 2937, 1649, 1624, 1491, 1423, 1387, 1200, 1026, 966, 756, 729, 702, 648; 




Compound was obtained via typical procedure A using 1-(2,4-
difluorophenyl)cycloprop-2-ene-1-carboxylic acid (50c) (163 mg, 0.831 mmol, 1.0 equiv.). The 
product was then purified by silica gel column chromatography using a 1:1 hexane:ethyl acetate 
mobile phase to provide the titled compound as a very light brown solid in 85% yield (178 mg, 
0.708 mmol). Rf: 0.26; mp: 59.7-60.8 °C; 1H NMR (500 MHz, CDCl3): δ 7.34 (s, 2H), 7.16 (td, J = 8.8, 
6.4 Hz, 1H), 6.84 – 6.78 (m, 1H), 6.77 – 6.72 (m, 1H), 3.44 – 3.23 (m, 4H), 1.09 (t, J = 7.1 Hz, 3H), 
0.78 (t, J = 7.1 Hz, 3H); 13C (126 MHz, CDCl3): δ 173.0, 161.7 (dd, J = 248.3, 11.9 Hz), 161.2 (dd, J = 
249.8, 11.8 Hz), 130.4 (+, dd, J = 9.6, 5.5 Hz), 126.8 (dd, J = 12.6, 3.8 Hz), 111.4 (+, dd, J = 21.1, 3.7 
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Hz), 110.3 (+, d, J = 1.9 Hz, 2C), 104.2 (+, t, J = 25.6 Hz), 41.7 (-), 39.6 (-), 27.8, 13.3 (+), 12.5 (+); 
FTIR (KBr, cm-1): 3080, 2976, 2935, 2876, 1625, 1500, 1421, 1267, 1140, 1092, 974, 847, 623; 




Compound was obtained via typical procedure A using 1-(2-chloro-4-
fluorophenyl)cycloprop-2-ene-1-carboxylic acid (50d) (267 mg, 1.26 mmol, 1.0 equiv.). The 
product was then purified by silica gel column chromatography using a 1:1 hexane:ethyl acetate 
mobile phase to provide the titled compound as a colorless solid in 83% yield (277 mg, 1.03 
mmol). Rf: 0.27; mp: 81.1-82.6 °C; 1H NMR (500 MHz, CDCl3): δ 7.28 (s, 2H), 7.25 – 7.19 (m, 1H), 
6.98 (dd, J = 8.5, 2.6 Hz, 1H), 6.88 (ddd, J = 8.7, 7.8, 2.6 Hz, 1H), 3.25 (q, J = 7.1 Hz, 4H), 1.03 (t, J = 
7.2 Hz, 3H), 0.62 (t, J = 7.1 Hz, 3H); 13C (126 MHz, CDCl3): δ 173.1, 161.2 (d, J = 249.5 Hz), 137.2 
(d, J = 3.6 Hz), 134.4 (d, J = 10.1 Hz), 131.7 (+, d, J = 8.7 Hz), 117.2 (+, d, J = 24.3 Hz), 114.4 (+, d, J 
= 21.0 Hz), 110.1 (+, 2C), 41.8 (-), 40.2 (-), 31.5, 13.1 (+), 12.6 (+); FTIR (KBr, cm-1): 3121, 3084, 
2980, 2968, 2934, 1616, 1483, 1385, 1244, 1217, 1194, 1045, 889, 870, 652, 633; HRMS (TOF 




The titled compound was obtained via typical procedure using 1-(2-
bromo-4-fluorophenyl)cycloprop-2-ene-1-carboxylic acid (50e) (263 mg, 1.02 mmol, 1.0 equiv.) 
as a colorless solid in 82% yield (262 mg, 0.84 mmol). Rf: 0.23; mp: 83.5 – 84.1 °C; 1H NMR (500 
MHz, CDCl3): δ 7.33 (s, 2H), 7.28 (dd, J = 8.6, 6.0 Hz, 1H), 7.22 (dd, J = 8.3, 2.6 Hz, 1H), 6.97 (ddd, J 
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= 8.7, 7.8, 2.6 Hz, 1H), 3.29 (q, J = 7.1 Hz, 4H), 1.07 (t, J = 7.1 Hz, 3H), 0.66 (t, J = 7.1 Hz, 3H); 13C 
(126 MHz, CDCl3): δ 173.1, 161.1 (d, J = 250.3 Hz), 138.8 (d, J = 3.6 Hz), 132.1 (+, d, J = 8.4 Hz), 
123.4 (d, J = 9.5 Hz), 120.4 (+, d, J = 24.1 Hz), 115.0 (+, d, J = 21.0 Hz), 110.1 (+, 2C), 41.9 (-), 40.4 
(-), 33.4, 13.1 (+), 12.6 (+); FTIR (KBr, cm-1): 3122, 3082, 2979, 2966, 2943, 1643, 1614, 1579, 
1479, 1384, 1259, 1238, 1191, 1099, 1070, 1037, 865, 649; HRMS (TOF ES): Found 334.0196, 




Compound was obtained via typical procedure A using 1-
(naphthalen-2-yl)cycloprop-2-ene-1-carboxylic acid (50f) (85.0 mg, 0.404 mmol, 1.0 equiv.). The 
product was then purified by silica gel column chromatography using a 1:1 hexane:ethyl acetate 
mobile phase to provide the titled compound as a colorless solid in 92% yield (98.0 mg, 0.370 
mmol). Rf: 0.33; mp: 123.8-125.5 °C; 1H NMR (500 MHz, CDCl3): δ 8.32 – 8.24 (m, 1H), 7.66 – 7.60 
(m, 1H), 7.56 – 7.50 (m, 1H), 7.40 (s, 2H), 7.35 – 7.19 (m, 3H), 7.10 – 7.03 (m, 1H), 3.10 (q, J = 7.1 
Hz, 2H), 3.04 (q, J = 7.1 Hz, 2H), 0.79 (t, J = 7.1 Hz, 3H), 0.13 (t, J = 7.0 Hz, 3H); 13C (126 MHz, 
CDCl3): δ 174.9, 141.0, 133.7, 132.7, 128.5 (+), 127.6 (+), 126.4 (+), 126.0 (+), 125.9 (+), 125.8 (+), 
125.3 (+), 112.0 (+, 2C), 42.3 (+), 40.7 (+), 32.6, 13.0 (+), 12.8 (+); FTIR (KBr, cm-1): 3074, 2974, 
2931, 2872, 1614, 1454, 1427, 1271, 781, 667, 631; HRMS (TOF ES): Found 288.1364, calculated 
for C18H19NONa (M+Na) 288.1364 (0.1 ppm). 
 
N,N-diethyl-1-(p-tolyl)cycloprop-2-ene-1-carboxamide (53ga) 
The titled compound was obtained via typical procedure using 1-(p-
tolyl)cycloprop-2-ene-1-carboxylic acid (50g) (228 mg, 1.31 mmol, 1.0 
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equiv.) as a colorless solid in 86% yield (260 mg, 1.13 mmol). Rf: 0.26; mp: 80.5 – 81.7 °C; 1H NMR 
(500 MHz, CDCl3): δ 7.24 (s, 2H), 7.12 – 7.07 (m, 2H), 7.04 – 6.99 (m, 2H), 3.39 (q, J = 7.1 Hz, 2H), 
3.32 (q, J = 7.1 Hz, 2H), 2.30 (s, 3H), 1.16 (t, J = 7.1 Hz, 3H), 0.91 (t, J = 7.1 Hz, 3H); 13C (126 MHz, 
CDCl3): δ 173.4, 140.6, 135.9, 129.1 (+, 2C), 125.9 (+, 2C), 109.9 (+, 2C), 41.9 (-), 39.0 (-), 31.8, 
21.1 (+), 13.8 (+), 12.7 (+); FTIR (KBr, cm-1): 3105, 3064, 2975, 2935, 2873, 1614, 1510, 1454, 
1440, 1427, 1379, 1344, 1284, 1276, 1218, 1122, 1083, 1041, 810, 740; HRMS (TOF ES): Found 




The titled compound was obtained via typical procedure using 1-(2-
chlorophenyl)cycloprop-2-ene-1-carboxylic acid (50i) (237 mg, 1.22 mmol, 1.0 equiv.) as a very 
viscous colorless oil in 93% yield (285 mg, 1.14 mmol). Rf: 0.26; 1H NMR (500 MHz, CDCl3): δ 7.33 
(s, 2H), 7.30 – 7.25 (m, 2H), 7.21 – 7.10 (m, 2H), 3.29 (q, J = 7.1 Hz, 4H), 1.08 (t, J = 7.1 Hz, 3H), 
0.61 (t, J = 7.1 Hz, 3H); 13C (126 MHz, CDCl3): δ 173.4, 141.1, 133.8, 130.7 (+), 130.2 (+), 128.1 (+), 
127.1 (+), 110.1 (+, 2C), 41.9 (-), 40.2 (-), 32.2, 13.0 (+), 12.6 (+); FTIR (KBr, cm-1): 3083, 2974, 
2933, 2873, 1623, 1471, 1427, 1379, 1361, 1313, 1276, 1265, 1218, 1163, 1056, 1037, 748; HRMS 




The titled compound was obtained via typical procedure using 1-(2,3-
difluorophenyl)cycloprop-2-ene-1-carboxylic acid (50j) (264 mg, 1.35 mmol, 1.0 equiv.) as a 
colorless solid in 85% yield (289 mg, 1.15 mmol). Rf: 0.20; mp: 77.7 – 78.7 °C; 1H NMR (500 MHz, 
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CDCl3): δ 7.33 (s, 2H), 7.06 – 6.87 (m, 3H), 3.45 – 3.20 (m, 4H), 1.10 (t, J = 7.1 Hz, 3H), 0.79 (t, J = 
7.1 Hz, 3H); 13C (126 MHz, CDCl3): δ 172.7, 150.8 (dd, J = 248.6, 13.0 Hz), 149.6 (dd, J = 248.9, 13.1 
Hz), 133.4 (d, J = 9.1 Hz), 124.4 (+, t, J = 3.0 Hz), 124.1 (+, dd, J = 7.1, 4.7 Hz), 115.6 (+, d, J = 17.2 
Hz), 110.2 (+, d, J = 2.1 Hz, 2C), 41.9 (-), 39.7 (-), 28.2 (d, J = 2.7 Hz), 13.4 (+), 12.6 (+); FTIR (KBr, 
cm-1): 3080, 2975, 2935, 2875, 1625, 1589, 1479, 1442, 1427, 1380, 1272, 1253, 1218, 1041, 999, 
873, 838, 784, 744; HRMS (TOF ES): Found 274.1021, calculated for C14H15F2NONa (M+Na) 




The titled compound was obtained via typical procedure using 1-(4-
bromophenyl)cycloprop-2-ene-1-carboxylic acid (50l) (482 mg, 2.02 mmol, 1.0 equiv.) as a pale 
yellow solid in 89% yield (531 mg, 1.80 mmol). Rf: 0.23; mp: 92.9 – 94.4 °C; 1H NMR (500 MHz, 
CDCl3): δ 7.46 – 7.32 (m, 2H), 7.23 (s, 2H), 7.03 – 6.94 (m, 2H), 3.38 (q, J = 7.1 Hz, 2H), 3.29 (q, J = 
6.8 Hz, 2H), 1.15 (t, J = 7.1 Hz, 3H), 0.92 (t, J = 7.1 Hz, 3H); 13C (126 MHz, CDCl3): δ 172.7, 142.8, 
131.5 (+, 2C), 127.8 (+, 2C), 120.2, 109.6 (+, 2C), 41.9 (-), 39.1 (-), 31.7, 13.9 (+), 12.7 (+); FTIR 
(KBr, cm-1): 3078, 2974, 2933, 2873, 1623, 1485, 1460, 1429, 1380, 1313, 1282, 1218, 1118, 
1072, 1006, 813; HRMS (TOF ES): Found 316.0317, calculated for C14H16BrNONa (M+Na) 




The titled compound was obtained via typical procedure using 1-(2,4-
dichlorophenyl)cycloprop-2-ene-1-carboxylic acid (50m) (304 mg, 1.33 mmol, 1.0 equiv.) as a 
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colorless solid in 94% yield (356 mg, 1.25 mmol). Rf: 0.23; mp: 74.7 – 76.4 °C; 1H NMR (500 MHz, 
CDCl3): δ 7.32 (s, 2H), 7.30 (d, J = 2.1 Hz, 1H), 7.23 (d, J = 8.3 Hz, 1H), 7.18 (dd, J = 8.3, 2.1 Hz, 1H), 
3.29 (q, J = 7.1 Hz, 4H), 1.07 (t, J = 7.2 Hz, 3H), 0.70 (t, J = 7.1 Hz, 3H); 13C (126 MHz, CDCl3): δ 
172.9, 139.8, 134.5, 133.1, 131.6 (+), 129.9 (+), 127.5 (+), 110.0 (+, 2C), 41.9 (-), 40.3 (-), 31.7, 
13.2 (+), 12.6 (+); FTIR (KBr, cm-1): 3080, 2975, 2933, 2873, 1614, 1552, 1469, 1442, 1431, 1379, 
1361, 1315, 1280, 1259, 1218, 1164, 1101, 1054, 852, 825, 794; HRMS (TOF ES): Found 




The titled compound was obtained via typical procedure using 1-(3-
(trifluoromethyl)phenyl)cycloprop-2-ene-1-carboxylic acid (50n) (443 mg, 1.94 mmol, 1.0 
equiv.) as a colorless solid in 84% yield (461 mg, 1.63 mmol). Rf: 0.27; mp: 101.9 – 103.2 °C; 1H 
NMR (500 MHz, CDCl3): δ 7.46 – 7.29 (m, 4H), 7.25 (s, 2H), 3.39 (q, J = 7.1 Hz, 2H), 3.29 (q, J = 7.1 
Hz, 2H), 1.15 (t, J = 7.1 Hz, 3H), 0.90 (t, J = 7.1 Hz, 3H); 13C (126 MHz, CDCl3): δ 172.4, 144.8, 130.8 
(q, J = 32.1 Hz), 129.4 (+), 128.9 (+), 124.2 (q, J = 272.4 Hz), 123.2 (+, d, J = 3.8 Hz), 122.7 (+, d, J = 
3.9 Hz), 109.3 (+, 2C), 41.9 (-), 39.0 (-), 31.9, 13.8 (+), 12.6 (+); FTIR (KBr, cm-1): 3107, 3062, 2974, 
2935, 2877, 1614, 1471, 1429, 1330, 1280, 1215, 1170, 1118, 1072, 1041, 906, 798, 694, 678; 




The titled compound was obtained via typical procedure using 1-(2-
chloro-4,5-difluorophenyl)cycloprop-2-ene-1-carboxylic acid (50o) (211 mg, 0.92 mmol, 1.0 
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equiv.) as a colorless solid in 89% yield (233 mg, 0.815 mmol). Rf: 0.32; mp: 92.1 – 93.5 °C; 1H 
NMR (500 MHz, CDCl3): δ 7.32 (s, 2H), 7.17 – 7.05 (m, 2H), 3.47 – 3.15 (m, 4H), 1.07 (t, J = 7.1 Hz, 
3H), 0.74 (t, J = 7.1 Hz, 3H); 13C (126 MHz, CDCl3): δ 172.5, 149.2 (dd, J = 249.9, 12.6 Hz), 148.9 
(dd, J = 251.9, 13.7 Hz), 138.2, 128.4 (dd, J = 7.7, 3.4 Hz), 119.0 (+, d, J = 20.0 Hz), 118.8 (+, d, J = 
18.2 Hz), 110.1 (+, 2C), 41.9 (-), 40.3 (-), 31.7, 13.3 (+), 12.6 (+); FTIR (KBr, cm-1): 3083, 2975, 
2935, 2875, 1631, 1614, 1598, 1494, 1427, 1380, 1299, 1274, 1220, 1164, 1045, 1004, 900, 891, 
790, 665; HRMS (TOF ES): Found 308.0635, calculated for C14H14ClF2NONa (M+Na) 308.0630 (1.6 
ppm). 
 




(1-phenylcycloprop-2-en-1-yl)methanol (20a) (250 mg, 1.71 mmol, 
1.0 equiv.) was dissolved in dry tetrahydrofuran (17 mL) and cooled to 0 °C. Carbonyldiimidazole 
(305 mg, 1.88 mmol, 1.10 equiv.) was added and the reaction was allowed to warm to room 
temperature and stirred for 3 hours. Solvent was evaporated and the crude product was directly 
purified by silica gel column chromatography using 2:1 hexane:ethyl acetate mobile phase. The 
titled compound was obtained colorless solid in 97% yield (398.1 mg, 1.65 mmol). Rf: 0.57; 1H 
NMR (500 MHz, CDCl3) δ 8.13 – 8.04 (m, 1H), 7.40 – 7.36 (m, 1H), 7.34 – 7.28 (m, 4H), 7.24 – 7.18 
(m, 3H), 7.06 – 7.01 (m, 1H), 4.84 (s, 2H); 13C NMR (126 MHz, CDCl3) δ 148.7, 144.4, 137.1 (+), 
130.6 (+), 128.4 (+, 2C), 126.3 (+), 126.1 (+, 2C), 117.1 (+), 111.8 (+, 2C), 75.1 (-), 25.9; FTIR (KBr, 
cm-1): 3132, 3107, 3024, 2954, 1758, 1471, 1398, 1290, 1240, 1172, 1001, 752, 698; HRMS (TOF 






(1-(2,3-difluorophenyl)cycloprop-2-en-1-yl)methanol (20j) (290 mg, 
1.59 mmol, 1.0 equiv.) was dissolved in dichloromethane (10 mL) and cooled to 0 °C. 
Triethylamine (670 μL, 4.78 mmol, 3.0 equiv.) and tert-butyldimethylsilyl chloride (360 mg, 2.39 
mmol, 1.5 equiv.) were then added to the reaction mixture. The reaction was then allowed to 
warm to room temperature and stirred overnight. Saturated aqueous sodium bicarbonate was 
then added and stirred for one hour. Additional dichloromethane was added to the reaction and 
the product was extracted with dichloromethane (3 x 10 mL), dried, filtered, and concentrated. 
The product was then purified by silica gel column chromatography using a hexane:ethyl acetate 
(20:1) mobile phase. The titled compound was obtained as a clear oil in 92% yield (431 mg, 1.45 
mmol). Rf: 0.15; 1H NMR (500 MHz, CDCl3): δ 7.49 (s, 2H), 7.06 – 6.91 (m, 3H), 3.87 (s, 2H), 0.84 
(s, 9H), -0.04 (s, 6H); 13C NMR (126 MHz, CDCl3): δ 150.8 (dd, J = 247.4, 13.4 Hz), 149.9 (dd, J = 
246.5, 12.3 Hz), 135.6 (d, J = 12.7 Hz), 125.2 (+, t, J = 3.6 Hz), 123.8 (+, dd, J = 7.0, 4.6 Hz), 115.9 
(+, 2C), 115.1 (+, d, J = 17.4 Hz), 69.0 (-, d, J = 2.2 Hz), 26.7, 26.0 (+, 3C), 18.5, -5.2 (+, 2C); 19F NMR 
(376 MHz, CDCl3): δ -139.2 (d, J = 21.1 Hz), -143.5 (d, J = 21.2 Hz); FTIR (KBr, cm-1): 2955, 2929, 
2886, 2857, 1478, 1270, 1256, 1117, 1083, 837, 777, 728, 618; HRMS (TOF ES): Found 297.1502, 





(20c) ( 140 mg, 0.768 mmol, 1.0 equiv) was dissolved in dichloromethane (5 mL) and cooled to 
0 °C. Triethylamine (323 μL, 2.31 mmol, 3.0 equiv.) and tert-butyldimethylsilyl chloride (174 mg, 
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1.15 mmol, 1.5 equiv.) were then added to the reaction mixture. The reaction was then allowed 
to warm to room temperature and was stirred overnight. Saturated aqueous sodium bicarbonate 
was then added and stirred for 1 hour. Additional dichloromethane was added to the reaction 
and the product was extracted with dichloromethane (3 x 10 mL), dried, filtered, and 
concentrated. The product was then purified by silica column chromatography using a 
hexane:ethyl acetate (20:1) mobile phase. The titled product was obtained as a clear oil in 90% 
yield (204 mg, 0.690 mmol). Rf: 0.16; 1H NMR (500 MHz, CDCl3): δ 7.54 (s, 2H), 7.20 (td, J = 8.5, 
6.6 Hz, 1H), 6.86 – 6.71 (m, 2H), 3.87 (s, 2H), 0.88 (s, 9H), 0.00 (s, 6H); 13C (126 MHz, CDCl3): δ 
161.7 (dd, J = 247.6, 11.7 Hz), 161.5 (dd, J = 245.4, 11.0 Hz), 131.3 (+, dd, J = 9.5, 7.0 Hz), 128.9 
(dd, J = 16.3, 3.7 Hz), 116.1 (+, d, J = 1.8 Hz, 2C), 110.8 (+, dd, J = 20.7, 3.7 Hz), 103.6 (+, dd, J = 
26.4, 25.0 Hz), 69.1 (-, d, J = 2.0 Hz), 26.2, 25.9 (+, 3C), 18.4, -5.3 (+, 2C); FTIR (KBr, cm-1): 2954, 
2929, 2885, 2856, 1641, 1614, 1596, 1502, 1463, 1421, 1269, 1255, 1135, 1091, 1047, 1004, 977, 





(1-phenylcycloprop-2-en-1-yl)methanol (20a) (250 mg, 1.71 mmol, 1.0 
equiv.) was dissolved in dry dichloromethane and cooled to 0 °C. Triethylamine (716 μL, 5.13 
mmol, 3.0 equiv.) was then added followed by tert-butyldimethylsilyl chloride (387 mg, 2.57 
mmol, 1.5 equiv.). The reaction was allowed to warm to room temperature and then stir for 30 
minutes. Excess saturated aqueous sodium bicarbonate was then added and the mixture was 
stirred for an additional 10 minutes. The reaction was then extracted with dichloromethane, 
dried, filtered, and concentrated. The product was purified by column chromatography using 
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20:1 hexane:ethyl acetate mobile phase. The titled product was obtained as pale yellow oil in 95% 
yield (422 mg, 1.62 mmol). Rf: 0.16; 1H NMR (500 MHz, CDCl3): δ 7.28 – 7.21 (m, 4H), 7.21 (s, 2H), 
7.16 – 7.10 (m, 1H), 4.03 (s, 2H), 0.86 (s, 9H), -0.00 (s, 6H); 13C (126 MHz, CDCl3): δ 129.3, 128.0 
(+, 2C), 126.7 (+, 2C), 125.6 (+), 113.1 (+, 2C), 69.0 (-), 29.2, 26.1 (+, 3C), 18.6, -5.0 (+, 2C); FTIR 
(KBr, cm-1): 3057, 3022, 2953, 2928, 2885, 2854, 1643, 1601, 1493, 1472, 1360, 1256, 1095, 
1051, 1005, 972, 837, 775, 748, 696; HRMS (TOF ES): Found 260.1594, calculated for C16H24OSi 
(M+) 260.1596 (0.8 ppm). 
 




Typical Procedure (Direct Injection): A 1mL reaction vial was loaded 
with [Rh(COD)Cl]2 (7.40 mg, 0.015 mmol, 0.03 equiv.) and (R)-BINAP (19.9 
mg, 0.03 mmol, 0.06 equiv.) in a glove box. Freshly distilled and dried tetrahydrofuran (500 μL) 
was then added to the vial via syringe and the mixture was stirred until homogenous. Pinnacol 
borane (72.6 μL, 0.50 mmol, 1.0 equiv.) followed by methyl 1-phenylcycloprop-2-ene-1-
carboxylate (19a) (87.1 mg, 0.50 mmol, 1.0 equiv.) were then added using a syringe. The reaction 
was then stirred for 30 minutes at room temperature. The product was purified by column 
chromatography using 3:1 hexane:ethyl acetate mobile phase. The titled compound was obtained 
as a pale yellow oil in 99% yield (149 mg, 0.493 mmol). Rf: 0.52; dr: >99:1; er: 99:1; [α]D20 -57.89 
(c = 4.067, CHCl3); 1H NMR (500 MHz, CDCl3): 7.43 – 7.38 (m, 1H), 7.32 – 7.23 (m, 4H), 3.61 (s, 
3H), 1.68 (dd, J = 8.4, 3.5 Hz, 1H), 1.35 (dd, J = 10.2, 3.5 Hz, 1H), 1.30 (s, 6H), 1.29 (s, 6H), 0.76 (dd, 
J = 10.2, 8.4 Hz, 1H); 13C (126 MHz, CDCl3): δ 174.5, 140.4, 130.3 (+, 2C), 128.2 (+, 2C), 127.3 (+), 
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83.7 (2C), 52.5 (+), 34.5, 25.1 (+, 4C), 19.1 (-), 11.9; 19F NMR (376 MHz, CDCl3) δ -115.2 (s, 1F); 
FTIR (KBr, cm-1): 3052, 3026, 2978, 2949, 2932, 1718, 1435, 1410, 1391, 1371, 1313, 1292, 1215, 
1198, 1167, 1144, 1107, 972, 858, 768, 752, 700, 667; HRMS (TOF ES): Found 302.1685, 




Typical Procedure (Dissolved Method): A 1mL reaction vial was loaded 
with [Rh(COD)Cl]2 (3.75 mg, 7.50 μmol, 0.03 equiv.) and (R)-BINAP (10.0 
mg, 0.015 mmol, 0.06 equiv.) in a glove box. Freshly distilled and dried tetrahydrofuran (500 μL) 
was then added to the vial via syringe and the mixture was stirred until homogenous. Pinnacol 
borane (37.0 μL, 0.25 mmol, 1.0 equiv.) followed by methyl 1-(naphthalen-1-yl)cycloprop-2-ene-
1-carboxylate (19f) (56.1 mg, 0.25 mmol, 1.0 equiv.) dissolved in a minimal amount of 
tetrahydrofuran were then added using a syringe. The reaction was then stirred for 30 minutes 
at room temperature. The product was purified by column chromatography using 3:1 
hexane:ethyl acetate mobile phase. The titled compound was obtained as a colorless solid in 99% 
yield (87.2 mg, 0.248 mmol). Rf: 0.52; dr: 97:3; er: 96.5:3.5; [α]D20 -40.63 (c = 2.267, CHCl3); mp: 
122.3 – 124.7 °C; 1H NMR (500 MHz, CDCl3): δ 8.29 (d, J = 8.4 Hz, 1H), 7.89 – 7.81 (m, 1H), 7.81 – 
7.75 (m, 1H), 7.60 – 7.44 (m, 3H), 7.45 – 7.37 (m, 1H), 3.53 (s, 3H), 1.98 – 1.85 (m, 1H), 1.54 – 1.43 
(m, 1H), 1.35 (s, 6H), 1.34 (s, 6H), 0.95 – 0.80 (m, 1H); 13C (126 MHz, CDCl3): δ 174.9, 136.9, 133.7, 
133.3, 128.6 (+), 128.2 (+), 127.9 (+), 126.4 (+), 125.7 (+), 125.3 (+), 125.1 (+), 83.8 (2C), 52.6 
(+), 32.1, 25.2 (+, 2C), 25.1 (+, 2C), 20.2 (-), 13.4; FTIR (KBr, cm-1): 3045, 2976, 2949, 2930, 1717, 
1437, 1414, 1391, 1312, 1288, 1223, 1202, 1165, 1144, 970, 858, 800, 779, 736, 685; HRMS (TOF 






Compound was obtained via typical procedure for direct injection using 
methyl 1-(4-fluorophenyl)cycloprop-2-ene-1-carboxylate (19b) (48.0 mg, 
0.25 mmol, 1.0 equiv.). The product was purified by column chromatography using 3:1 
hexane:ethyl acetate mobile phase. The titled compound was obtained as a pale yellow oil in 80% 
yield (63.8 mg, 0.20 mmol). Rf: 0.52; dr: 98:2; er: 96:4; [α]D20 -40.56 (c = 0.900, CHCl3); 1H NMR 
(500 MHz, CDCl3): δ 7.38 – 7.33 (m, 2H), 6.99 – 6.93 (m, 2H), 3.61 (s, 3H), 1.67 (dd, J = 8.4, 3.5 Hz, 
1H), 1.32 (dd, J = 10.7, 3.9 Hz, 1H), 1.30 (s, 6H), 1.28 (s, 6H), 0.71 (dd, J = 10.2, 8.4 Hz, 1H); 13C 
(126 MHz, CDCl3): δ 174.3, 162.0 (d, J = 245.7 Hz), 136.2 (d, J = 3.2 Hz), 132.0 (+, d, J = 8.1 Hz, 2C), 
115.0 (+, d, J = 21.4 Hz, 2C), 83.7 (2C), 52.6 (+), 33.7, 25.1 (+, 4C), 19.2 (-), 12.1; 19F NMR (376 
MHz, CDCl3) δ -115.2 (s, 1F); FTIR (KBr, cm-1): 3050, 2978, 2951, 2932, 1724, 1605, 1514, 1437, 
1414, 1371, 1315, 1292, 1273, 1221, 1200, 1167, 1144, 1105, 972, 858, 837, 814, 775, 684; HRMS 




Compound was obtained via typical procedure for dissolved method using 
methyl 1-(2,4-difluorophenyl)cycloprop-2-ene-1-carboxylate (19c) (52.5 
mg, 0.25 mmol, 1.0 equiv.). The product was purified by column chromatography using 3:1 
hexane:ethyl acetate mobile phase. The titled compound was obtained as a pale yellow oil in 60% 
yield (50.2 mg, 0.150 mmol). Rf: 0.54; dr: 57:43; er: 90:10 (major), 68:32 (minor); [α]D20 -48.46 (c 
= 0.867, CHCl3); 1H NMR (500 MHz, CDCl3): [7.36 – 7.17 (m), Σ1H], [6.85 – 6.67 (m), Σ2H], [3.60 
135 
 
(s) & 3.60 (s), Σ3H], [1.78 – 1.71 (m), Σ1H], [1.49 (dd, J = 8.23, 3.43 Hz) & 0.74 (dd, J = 10.39, 8.77 
Hz), Σ1H], [1.37 – 1.25 (m) & 1.08 (s) & 0.93 (s), Σ13H]; 13C (126 MHz, CDCl3): δ [173.7 (s), Σ1C], 
[164.0 – 160.9 (m), Σ2C], [132.8 (+, dd, J = 9.72, 5.34 Hz) & 132.3 (+, dd, J = 9.69, 5.10 Hz), Σ1C], 
[123.8 (dd, J = 14.84, 3.80 Hz) & 121.9 (dd, J = 14.69, 3.85 Hz), Σ1C], [111.4 – 108.9 (+, m), Σ1C], 
[105.3 – 102.3 (+, m), Σ1C], [83.7 (s) & 83.4 (s), Σ2C], [52.6 (+, s) & 52.5 (+, s), Σ1C], [28.4 (s) & 
27.9 (s), Σ1C], [25.0 (+, s) & 24.7 (+, s), Σ2C], [24.9 (+, s) & 24.4 (+, s), Σ2C], [19.3 (-, s), Σ1C], [12.5 
(s), Σ1C]; 19F NMR (376 MHz, CDCl3) δ -109.6 (d, J = 8.0 Hz, 1F), -111.6 (d, J = 8.0 Hz, 1F); FTIR 
(KBr, cm-1): 3068, 2980, 2932, 1728, 1616, 1508, 1437, 1410, 1333, 1269, 1213, 1167, 1142, 
1111, 968, 856, 698, 669; HRMS (TOF ES): Found 338.1498, calculated for C17H21BF2O4 (M+) 




Compound was obtained via typical procedure for dissolved method using 
methyl 1-(2-chloro-4-fluorophenyl)cycloprop-2-ene-1-carboxylate (19d) 
(56.7 mg, 0.25 mmol, 1.0 equiv.). The product was purified by column chromatography using 3:1 
hexane:ethyl acetate mobile phase. The titled compound was obtained as a pale yellow oil in 92% 
yield (81.6 mg, 0.230 mmol). Rf: 0.54; dr: 94:6; er: 83:17; [α]D20 -47.75 (c = 2.367, CHCl3); 1H NMR 
(500 MHz, CDCl3): δ 7.34 (dd, J = 8.6, 6.0 Hz, 1H), 7.10 (dd, J = 8.5, 2.7 Hz, 1H), 6.91 (td, J = 8.3, 2.6 
Hz, 1H), 3.60 (s, 3H), 1.83 (dd, J = 8.8, 3.8 Hz, 1H), 1.30 (s, 6H), 1.31 – 1.27 (m, 1H), 1.28 (s, 6H), 
0.79 (dd, J = 10.4, 8.8 Hz, 1H); 13C (126 MHz, CDCl3): δ 173.7, 161.8 (d, J = 249.3 Hz), 137.5 (d, J = 
10.5 Hz), 134.6 (d, J = 3.6 Hz), 132.9 (+, d, J = 8.8 Hz), 116.8 (+, d, J = 24.8 Hz), 113.6 (+, d, J = 21.0 
Hz), 83.8 (2C), 52.6 (+), 32.0, 25.1(+, 2C), 25.0 (+, 2C), 20.5 (-), 13.8; 19F NMR (376 MHz, CDCl3) δ 
-113.1 (s, 1F); FTIR (KBr, cm-1): 3071, 2978, 2951, 2932, 1726, 1602, 1495, 1437, 1410, 1317, 
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1290, 1261, 1219, 1202, 1169, 1144, 1109, 972, 905, 858, 829, 684; HRMS (TOF ES): Found 




Compound was obtained via typical procedure for dissolved method using 
methyl 1-(2-bromo-4-fluorophenyl)cycloprop-2-ene-1-carboxylate (19e) 
(67.8 mg, 0.25 mmol, 1.0 equiv.). The product was purified by column chromatography using 3:1 
hexane:ethyl acetate mobile phase. The titled compound was obtained as a pale yellow oil in 81% 
yield (80.9 mg, 0.208 mmol). Rf: 0.50; dr: 97:3; er: 93.5:6.5; [α]D20 -38.22 (c = 1.667, CHCl3); 1H 
NMR (500 MHz, CDCl3): δ 7.34 (dd, J = 8.6, 5.9 Hz, 1H), 7.29 (dd, J = 8.2, 2.6 Hz, 1H), 6.96 (td, J = 
8.3, 2.7 Hz, 1H), 3.61 (s, 3H), 1.87 (dd, J = 8.8, 3.8 Hz, 1H), 1.30 (s, 6H), 1.31 – 1.28 (m, 1H), 1.28 
(s, 6H), 0.82 (dd, J = 10.5, 8.8 Hz, 1H); 13C (126 MHz, CDCl3): δ 173.6, 161.6 (d, J = 250.3 Hz), 136.2 
(d, J = 3.5 Hz), 133.1 (+, d, J = 8.5 Hz), 127.3 (d, J = 9.6 Hz), 120.0 (+, d, J = 24.4 Hz), 114.2 (+, d, J = 
20.9 Hz), 83.8 (2C), 52.6 (+), 34.0, 25.1 (+, 2C), 25.0 (+, 2C), 21.2 (-), 14.5; 19F NMR (376 MHz, 
CDCl3) δ -113.2 (s, 1F); FTIR (KBr, cm-1): 3067, 2978, 2951, 2932, 1726, 1597, 1583, 1489, 1437, 
1410, 1371, 1315, 1290, 1263, 1217, 1202, 1169, 1144, 1109, 972, 883, 856, 829; HRMS (TOF 




Compound was obtained via typical procedure for direct injection using 
methyl 1-(p-tolyl)cycloprop-2-ene-1-carboxylate (19g) (47.1 mg, 0.25 
mmol, 1.0 equiv.). The product was purified by column chromatography using 3:1 hexane:ethyl 
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acetate mobile phase. The titled compound was obtained as a pale yellow oil in 94% yield (73.8 
mg, 0.233 mmol). Rf: 0.52; dr: >99:1; er: 97.5:2.5; [α]D20 -62.39 (c = 2.300, CHCl3); 1H NMR (500 
MHz, CDCl3): δ 7.33 – 7.27 (m, 2H), 7.12 – 7.07 (m, 2H), 3.61 (s, 3H), 2.33 (s, 3H), 1.65 (dd, J = 8.4, 
3.5 Hz, 1H), 1.32 (dd, J = 10.2, 3.4 Hz, 1H), 1.30 (s, 6H), 1.29 (s, 6H), 0.73 (dd, J = 10.2, 8.4 Hz, 1H); 
13C (126 MHz, CDCl3): δ 174.6, 137.5, 137.0, 130.2 (+, 2C), 128.9 (+, 2C), 83.6 (2C), 52.5 (+), 34.1, 
25.1 (+, 4C), 21.3, 19.2 (-), 12.0; FTIR (KBr, cm-1): 2978, 2949, 2928, 2872, 1718, 1516, 1437, 
1412, 1371, 1313, 1290, 1273, 1213, 1198, 1167, 1144, 1105, 1049, 972, 858, 824, 773, 685; 




Compound was obtained via typical procedure for dissolved method using 
methyl 1-(2-chlorophenyl)cycloprop-2-ene-1-carboxylate (19i) (52.2 mg, 
0.25 mmol, 1.0 equiv.). The product was purified by column chromatography using 3:1 
hexane:ethyl acetate mobile phase. The titled compound was obtained as a colorless solid in 91% 
yield (76.6 mg, 0.228 mmol). Rf: 0.52; dr: 89:11; er: 97:3; [α]D20 -53.50 (c = 1.200, CHCl3); mp: 83.6 
– 84.4 °C; 1H NMR (500 MHz, CDCl3): δ 7.41 – 7.32 (m, 2H), 7.22 – 7.18 (m, 2H), 3.60 (s, 3H), 1.84 
(dd, J = 8.8, 3.8 Hz, 1H), 1.33 – 1.29 (m, 1H), 1.31 (s, 6H), 1.29 (s, 6H), 0.83 (dd, J = 10.4, 8.8 Hz, 
1H); 13C (126 MHz, CDCl3): δ 173.9, 138.5, 136.8, 131.8 (+), 129.4 (+), 128.6 (+), 126.5 (+), 83.7 
(2C), 52.6 (+), 32.7, 25.1 (+, 2C), 25.0 (+, 2C), 20.4 (-), 13.6; FTIR (KBr, cm-1): 3070, 2978, 2949, 
2932, 1724, 1437, 1408, 1315, 1290, 1296, 1215, 1200, 1169, 1144, 1111, 1068, 1041, 972, 858, 






Compound was obtained via typical procedure for direct injection using 
methyl 1-(2,3-difluorophenyl)cycloprop-2-ene-1-carboxylate (19j) (52.5 
mg, 0.25 mmol, 1.0 equiv.). The product was purified by column 
chromatography using 3:1 hexane:ethyl acetate mobile phase. The titled compound was obtained 
as a colorless oil in 55% yield (46.1 mg, 0.138 mmol). Rf: 0.54; dr:54:46; er: 90:10 (major), 88:12 
(minor); [α]D20 -49.17 (c = 0.767, CHCl3); 1H NMR (500 MHz, CDCl3): δ [7.12 – 6.95 (m), Σ3H], [3.69 
& 3.62 (s), Σ3H], [1.80 – 1.73 (m), Σ1H], [1.54 – 1.48 (m) & 0.84 – 0.73 (m), Σ1H], [1.38 – 1.32 (m), 
Σ1H], [1.31 (s) & 1.08 (s), Σ6H], [1.29 (s) & 0.93 (s), Σ6H]; 13C (126 MHz, CDCl3): δ [173.5 (s) & 
173.5 (s), Σ1C], [152.0 – 151.3 (m) & 150.0 – 149.2 (m), Σ2C], [130.2 (d, J = 9.82 Hz) & 128.3 (d, J 
= 11.30 Hz) & 127.0 (+, s) & 126.3 (+, s) & 124.5 – 122.7 (+, m) & 117.5 – 115.6 (+, m) & 107.8 (s), 
Σ4C], [83.8 (s) & 83.5 (s), Σ2C], [52.8 (+, s) & 52.7 (+, s), Σ1C], [28.8 (s) & 28.3 (s), Σ1C], [25.1 (+, 
s) & 24.8 +, (s), Σ2C], [25.0 (+, s) & 24.5 (+, s), Σ2C], [19.6 (-, s) & 19.4 (-, s), Σ1C], [12.6 (s), Σ1C]; 
19F NMR (376 MHz, CDCl3) δ -138.1 (d, J = 21.0 Hz, 1F), -139.8 (d, J = 20.8 Hz, 1F); FTIR (KBr, cm-
1): 2980, 2953, 2932, 1730, 1481, 1448, 1437, 1412, 1335, 1267, 1227, 1198, 1163, 1142, 968, 
858, 787, 742, 719; HRMS (TOF ES): Found 345.1648, calculated for C17H21BF2O4Li (M+Li) 




Compound was obtained via typical procedure for dissolved method using 
methyl 1-(3-bromophenyl)cycloprop-2-ene-1-carboxylate (19k) (63.3 mg, 
0.25 mmol, 1.0 equiv.). The product was purified by column 
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chromatography using 3:1 hexane:ethyl acetate mobile phase. The titled compound was obtained 
as a pale yellow oil in 90% yield (85.9 mg, 0.225 mmol). Rf: 0.53; dr: 85:15; er: 99:1; [α]D20 -35.54 
(c = 1.300, CHCl3); 1H NMR (500 MHz, CDCl3): δ 7.56 – 7.53 (m, 1H), 7.39 – 7.35 (m, 1H), 7.34 – 
7.31 (m, 1H), 7.18 – 7.13 (m, 1H), 3.61 (s, 3H), 1.67 (dd, J = 8.5, 3.6 Hz, 1H), 1.34 (dd, J = 10.3, 3.6 
Hz, 1H), 1.30 (s, 6H), 1.29 (s, 6H), 0.74 (dd, J = 10.3, 8.5 Hz, 1H); 13C (126 MHz, CDCl3): δ 173.9, 
142.6, 133.4 (+), 130.5 (+), 129.7 (+), 129.1 (+), 122.1, 83.8 (2C), 52.7 (+), 34.0, 25.1 (+, 2C), 25.1 
(+, 2C), 19.2 (-), 12.3; FTIR (KBr, cm-1): 3109, 3061, 2978, 2951, 2932, 1724, 1595, 1564, 1477, 
1437, 1408, 1315, 1288, 1215, 1200, 1167, 1144, 1111, 972, 883, 858, 779, 696; HRMS (TOF ES): 




Compound was obtained via typical procedure for dissolved method 
using methyl 1-(4-bromophenyl)cycloprop-2-ene-1-carboxylate (19l) 
(63.3 mg, 0.25 mmol, 1.0 equiv.). The product was purified by column chromatography using 3:1 
hexane:ethyl acetate mobile phase. The titled compound was obtained as a pale yellow oil in 89% 
yield (84.6 mg, 0.222 mmol). Rf: 0.53; dr: 98:2; er: 96.5:3.5; [α]D20 -51.86 (c = 1.167, CHCl3); 1H 
NMR (500 MHz, CDCl3): δ 7.45 – 7.40 (m, 2H), 7.31 – 7.26 (m, 2H), 3.63 (s, 3H), 1.69 (dd, J = 8.5, 
3.6 Hz, 1H), 1.35 – 1.32 (m, 1H), 1.32 (s, 6H), 1.30 (s, 6H), 0.73 (dd, J = 10.3, 8.5 Hz, 1H); 13C (126 
MHz, CDCl3): δ 174.0, 139.5, 132.1 (+, 2C), 131.3 (+, 2C), 121.3, 83.8 (2C), 52.6 (+), 33.8, 25.0 (+, 
4C), 19.2 (-), 12.2; FTIR (KBr, cm-1): 2978, 2932, 1722, 1489, 1435, 1410, 1313, 1288, 1215, 1198, 
1167, 1144, 1101, 1011, 972, 858, 827; HRMS (TOF ES): Found 381.0884, calculated for 






Compound was obtained via typical procedure for dissolved method 
using methyl 1-(2,4-dichlorophenyl)cycloprop-2-ene-1-carboxylate 
(19m) (60.8 mg, 0.25 mmol, 1.0 equiv.). The product was purified by column chromatography 
using 3:1 hexane:ethyl acetate mobile phase. The titled compound was obtained as a colorless 
solid in 83% yield (76.3 mg, 0.206 mmol). Rf: 0.53; dr: 84:16; er:83:17; [α]D20 -54.49 (c = 1.633, 
CHCl3); mp: 129.2 – 130.9 °C; 1H NMR (500 MHz, CDCl3): δ 7.38 – 7.35 (m, 1H), 7.32 – 7.28 (m, 
1H), 7.23 – 7.16 (m, 1H), 3.60 (s, 3H), 1.83 (dd, J = 8.8, 3.8 Hz, 1H), 1.30 (s, 6H), 1.31 – 1.28 (m, 
1H), 1.28 (s, 6H), 0.79 (dd, J = 10.5, 8.8 Hz, 1H); 13C (126 MHz, CDCl3): δ 173.5, 137.5, 137.2, 133.8, 
132.7 (+), 129.3 (+), 126.8 (+), 83.8 (2C), 52.7 (+), 32.1, 25.1 (+, 2C), 25.0 (+, 2C), 20.5 (-), 13.8; 
FTIR (KBr, cm-1): 2978, 2951, 2930, 1726, 1479, 1437, 1410, 1379, 1315, 1288, 1215, 1200, 1169, 
1144, 1103, 970, 858, 827, 806; HRMS (TOF ES): Found 371.0992, calculated for C17H22BCl2O4 




Compound was obtained via typical procedure for dissolved method using 
methyl 1-(3-(trifluoromethyl)phenyl)cycloprop-2-ene-1-carboxylate 
(19n) (60.5 mg, 0.25 mmol, 1.0 equiv.). The product was purified by column 
chromatography using 3:1 hexane:ethyl acetate mobile phase. The titled compound was obtained 
as a pale yellow oil in 75% yield (68.6 mg, 0.185 mmol). Rf: 0.53; dr: 96:4; er: 96:4; [α]D20 -39.08 
(c = 1.333, CHCl3); 1H NMR (500 MHz, CDCl3): δ 7.66 – 7.61 (m, 1H), 7.61 – 7.57 (m, 1H), 7.53 – 
7.47 (m, 1H), 7.44 – 7.37 (m, 1H), 3.62 (s, 3H), 1.73 (dd, J = 8.5, 3.6 Hz, 1H), 1.36 (dd, J = 10.4, 3.6 
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Hz, 1H), 1.31 (s, 6H), 1.29 (s, 6H), 0.77 (dd, J = 10.3, 8.5 Hz, 1H); 13C (126 MHz, CDCl3): δ 173.8, 
141.3, 134.0 (+), 130.5 (q, J = 32.1 Hz), 128.6 (+), 127.0 (+, d, J = 3.8 Hz), 124.2 (+, d, J = 3.9 Hz), 
124.2 (q, J = 272.3 Hz), 83.8 (2C), 52.7 (+), 34.1, 25.1 (+, 4C), 19.2 (-), 12.3; 19F NMR (376 MHz, 
CDCl3) δ -62.4 (s, 3F); FTIR (KBr, cm-1): 3065, 2980, 2953, 2934, 1726, 1437, 1410, 1371, 1340, 
1319, 1308, 1275, 1215, 1200, 1165, 1144, 1128, 1097, 1074, 1057, 972, 858, 800, 704; HRMS 




Compound was obtained via typical procedure for dissolved method 
using methyl 1-(2-chloro-4,5-difluorophenyl)cycloprop-2-ene-1-
carboxylate (19o) (61.2 mg, 0.25 mmol, 1.0 equiv.). The product was purified by column 
chromatography using 3:1 hexane:ethyl acetate mobile phase. The titled compound was obtained 
as a pale yellow oil in 83% yield (77.4 mg, 0.208 mmol). Rf: 0.50; dr: 75:25; er: 93:7; [α]D20 -38.65 
(c = 1.433, CHCl3); 1H NMR (500 MHz, CDCl3): δ 7.24 – 7.12 (m, 2H), 3.61 (s, 3H), 1.84 (dd, J = 8.8, 
3.9 Hz, 1H), 1.30 (s, 6H), 1.31 – 1.28 (m, 1H), 1.28 (s, 6H), 0.77 (dd, J = 10.5, 8.8 Hz, 1H); 13C (126 
MHz, CDCl3): δ 173.1, 149.4 (dd, J = 251.7, 13.5 Hz), 148.6 (dd, J = 248.8, 12.5 Hz), 135.4 (dd, J = 
5.7, 3.9 Hz), 131.5 (dd, J = 7.9, 3.6 Hz), 120.4 (+, d, J = 18.6 Hz), 118.4 (+, d, J = 20.3 Hz), 83.9 (2C), 
52.7 (+), 32.1, 25.1 (+, 2C), 25.0 (+, 2C), 20.6 (-), 14.0; 19F NMR (376 MHz, CDCl3) δ -136.7 (d, J = 
21.2 Hz, 1F), -139.5 (d, J = 21.2 Hz, 1F); FTIR (KBr, cm-1): 3117, 3055, 2980, 2953, 1730, 1603, 
1499, 1437, 1412, 1391, 1321, 1298, 1271, 1250, 1182, 1163, 1144, 1107, 970, 858, 800, 775; 








Compound was obtained via typical procedure for dissolved method 
using N,N-diethyl-1-phenylcycloprop-2-ene-1-carboxamide (53aa) (53.8 
mg, 0.25 mmol, 1.0 equiv.) and allowing reaction to stir overnight. The product was purified by 
column chromatography using 2:1 hexane:ethyl acetate mobile phase. The titled compound was 
obtained as a pale yellow oil in 92% yield (78.5 mg, 0.229 mmol). Rf: 0.37; dr: >98:2; er: 96:4; 
[α]D20 43.24 (c = 1.133, CHCl3); 1H NMR (500 MHz, CDCl3): δ 7.33 – 7.23 (m, 4H), 7.21 – 7.13 (m, 
1H), 3.50 – 3.29 (m, 2H), 3.27 – 3.14 (m, 2H), 1.65 (dd, J = 9.8, 3.9 Hz, 1H), 1.41 (dd, J = 7.5, 3.9 Hz, 
1H), 1.24 (s, 6H), 1.22 (s, 6H), 1.16 (t, J = 7.1 Hz, 3H), 0.71 (t, J = 7.1 Hz, 3H), 0.65 (dd, J = 9.8, 7.5 
Hz, 1H); 13C (126 MHz, CDCl3): δ 175.5, 140.1, 128.7 (+, 2C), 127.7 (+, 2C), 126.8 (+), 81.4 (2C), 
43.1 (-), 42.1 (-), 36.0, 25.2 (+, 2C), 25.1 (+, 2C), 19.5 (-), 18.7, 12.6 (+), 12.6 (+); FTIR (KBr, cm-1): 
3061, 2976, 2935, 2876, 1643, 1634, 1601, 1470, 1454, 1404, 1381, 1325, 1211, 1142, 1115, 953, 





Compound was obtained via typical procedure for dissolved method 
using N,N-diisopropyl-1-phenylcycloprop-2-ene-1-carboxamide (53ab) 
(60.8 mg, 0.25 mmol, 1.0 equiv.) and allowing reaction to stir overnight. The product was purified 
by column chromatography using 2:1 hexane:ethyl acetate mobile phase. The titled compound 
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was obtained as a pale yellow oil in 83% yield (77.2 mg, 0.208 mmol). Rf: 0.30; dr: >98:2; er: 
83:17; [α]D20 52.50 (c = 1.333, CHCl3); 1H NMR (500 MHz, CDCl3): δ 7.25 – 7.22 (m, 4H), 7.18 – 
7.13 (m, 1H), 4.27 – 4.14 (m, 1H), 3.41 – 3.28 (m, 1H), 1.74 (dd, J = 9.9, 4.0 Hz, 1H), 1.43 (d, J = 6.9 
Hz, 3H), 1.42 (d, J = 6.8 Hz, 3H), 1.33 (dd, J = 7.5, 4.0 Hz, 1H), 1.25 (s, 6H), 1.23 (s, 6H), 1.03 (d, J = 
6.7 Hz, 3H), 0.58 (d, J = 6.6 Hz, 3H), 0.50 (dd, J = 9.8, 7.5 Hz, 1H); 13C (126 MHz, CDCl3): δ 176.1, 
140.3, 128.7 (+, 2C), 127.5 (+, 2C), 126.6 (+), 80.9 (2C), 50.9 (+), 47.3 (+), 37.3, 25.3 (+, 2C), 25.2 
(+, 2C), 21.0 (+), 20.7 (+), 20.0 (+), 19.8, 18.5 (+), 18.4 (-); FTIR (KBr, cm-1): 2972, 2932, 1634, 
1591, 1470, 1441, 1404, 1371, 1346, 1290, 1265, 1209, 1146, 1115, 1036, 964, 862, 760, 700; 




Compound was obtained via typical procedure for dissolved 
method using N,N-dibenzyl-1-phenylcycloprop-2-ene-1-
carboxamide (53ad) (85.0 mg, 0.25 mmol, 1.0 equiv.) and allowing reaction to stir overnight. The 
product was purified by column chromatography using 2:1 hexane:ethyl acetate mobile phase. 
The titled compound was obtained as a colorless solid in 98% yield (115 mg, 0.246 mmol). Rf: 
0.48; dr: >98:2; er: 96.5:3.5; [α]D20 9.67 (c = 0.900, CHCl3); mp: 115.9 – 117.6 °C; 1H NMR (500 
MHz, CDCl3): δ 7.38 – 7.14 (m, 13H), 6.87 – 6.77 (m, 2H), 4.46 (s, 4H), 1.75 (dd, J = 9.7, 4.1 Hz, 1H), 
1.59 (dd, J = 7.7, 4.2 Hz, 1H), 1.34 (s, 6H), 1.29 (s, 6H), 0.61 (dd, J = 9.7, 7.7 Hz, 1H); 13C (126 MHz, 
CDCl3): δ 173.4, 140.6, 136.9, 135.8, 128.8 (+, 2C), 128.7 (+, 2C), 128.6 (+, 2C), 128.6 (+, 2C), 127.8 
(+, 2C), 127.6 (+), 127.5 (+), 127.1 (+, 2C), 126.9 (+), 82.9 (2C), 50.2 (-), 47.6 (-), 36.9, 25.2 (+, 2C), 
25.1 (+, 2C), 18.0 (-), 15.6; FTIR (KBr, cm-1): 3060, 3028, 2976, 2928, 1939, 1601, 1495, 1421, 
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1404, 1325, 1290, 1267, 1209, 1192, 1144, 1007, 962, 862, 737, 700; HRMS (TOF ES): Found 




Compound was obtained via typical procedure for dissolved 
method using N-benzyl-N-methyl-1-phenylcycloprop-2-ene-1-
carboxamide (53ae) (66.0 mg, 0.25 mmol, 1.0 equiv.) and allowing reaction to stir overnight. The 
product was purified by column chromatography using 2:1 hexane:ethyl acetate mobile phase. 
The titled compound was obtained as a pale yellow oil in 73% yield (71.1 mg, 0.182 mmol). Rf: 
0.38; dr: >98:2; er: 93.5:6.5; [α]D20 -8.78 (c = 1.833, CHCl3); 1H NMR (500 MHz, CDCl3): δ [7.38 – 
7.12 (m), Σ10H], [4.98 (d, J = 14.5 Hz) & 4.85 (d, J = 15.5 Hz), Σ1H], [4.20 (d, J = 14.6 Hz) & 4.14 
(d, J = 15.5 Hz), Σ1H], [2.83 (s) & 2.75 (s), Σ3H], [1.68 – 1.52 (m), Σ2H], [1.31 (s) & 1.29 (s), Σ6H], 
[1.27 (s) & 1.25 (s), Σ6H], [0.78 – 0.68 (m), Σ1H]; 13C (126 MHz, CDCl3): δ [173.0 & 174.6, Σ1C], 
[140.3 & 140.2, Σ1C], [136.9 & 135.6, Σ1C], [128.7 & 128.6 & 128.5 & 128.3 & 127.6 & 127.4 & 
127.4 & 127.3 & 126.5 & 126.5 & 126.2, (+),Σ10C], [82.8 & 82.3, Σ2C], [51.9 & 53.8, (-), Σ1C], [36.3 
& 36.2, Σ1C], [35.4 & 34.1, (+), Σ1C], [25.1 & 25.2, (+), Σ2C], [24.8 & 24.9, (+), Σ2C], 19.3 (-), 15.2; 
FTIR (KBr, cm-1): 3058, 3026, 2974, 2925, 1641, 1602, 1496, 1481, 1444, 1429, 1400, 1325, 1290, 
1269, 1211, 1143, 1122, 1091, 860, 757, 736; HRMS (TOF ES): Found 414.2235, calculated for 







Compound was obtained via typical procedure for dissolved 
method using N-benzyl-N-isopropyl-1-phenylcycloprop-2-ene-1-carboxamide (53af) (72.8 mg, 
0.25 mmol, 1.0 equiv.) and allowing reaction to stir overnight. The product was purified by 
column chromatography using 2:1 hexane:ethyl acetate mobile phase. The titled compound was 
obtained as a pale yellow oil in 82% yield (86.5 mg, 0.206 mmol). Rf: 0.48; dr: >98:2; er: 91.5:8.5; 
[α]D20 33.14 (c = 1.467, CHCl3); 1H NMR (500 MHz, CDCl3): δ [7.36 – 7.13 (m), Σ10H], [4.62 (d, J = 
15.41 Hz) & 4.58 (d, J = 16.72 Hz), Σ1H], [4.51 – 4.43 (m) & 4.40 (d, J = 15.38 Hz) & 4.15 (d, J = 
16.48 Hz) & 4.20 – 4.10 (m), Σ2H], [1.81 (dd, J = 9.81, 4.14 Hz) & 1.63 (dd, J = 9.80, 4.05 Hz), Σ1H], 
[1.49 (dd, J = 7.80, 4.20), Σ1H], [1.30 (s) & 1.23 (s), Σ6H], [1.27 (s) & 1.20 (s), Σ6H], [1.18 (d, J = 
6.83 Hz) & 0.93 (d, J = 6.69), Σ3H], [1.14, (d, J = 6.82 Hz) & 0.64 (d, J = 6.63 Hz), Σ3H], [0.60 (dd, J 
= 9.81, 7.56 Hz) & 0.55 (dd, J = 9.81, 7.78 Hz), Σ1H]; 13C (126 MHz, CDCl3): δ [174.8 & 176.3, Σ1C], 
[140.4 & 139.9, Σ1C], [139.1 & 136.9, Σ1C], [128.8 & 128.7 & 128.4 & 128.4 & 127.5 & 127.5 & 
127.4 & 127.3 & 127.0 & 126.9 & 126.9 & 126.8, (+), Σ10C], [82.2 & 81.7, 2C], [49.8 & 51.2, (+), 
Σ1C], [45.2 & 50.0, (-), Σ1C], [36.8 & 37.1, Σ1C], [25.1 & 25.2, (+), 2C], [25.0 & 25.1, (+), 2C], 21.6 
(+), [20.0 & 19.8, (+), Σ1C], 17.7 (-), 14.3; FTIR (KBr, cm-1): 3060, 3026, 2974, 2931, 1633, 1434, 
1404, 1369, 1344, 1323, 1292, 1211, 1145, 1116, 858, 732, 698; HRMS (TOF ES): Found 






Compound was obtained via typical procedure for dissolved method 
using (1-phenylcycloprop-2-en-1-yl)(piperidin-1-yl)methanone (53aj) 
(56.8 mg, 0.25 mmol, 1.0 equiv.) and allowing reaction to stir overnight. The product was purified 
by column chromatography using 2:1 hexane:ethyl acetate mobile phase. The titled compound 
was obtained as a colorless solid in 69% yield (61.4 mg, 0.173 mmol). Rf: 0.16; dr: >98:2; er: 
97.5:2.5; [α]D20 7.77 (c = 0.733, CHCl3); mp: 103.3 – 103.9 °C; 1H NMR (500 MHz, CDCl3): δ 7.29 – 
7.21 (m, 4H), 7.20 – 7.11 (m, 1H), 3.74 – 3.63 (m, 1H), 3.51 – 3.40 (m, 1H), 3.40 – 3.31 (m, 1H), 
3.26 – 3.14 (m, 1H), 1.62 (dd, J = 9.8, 4.0 Hz, 1H), 1.58 – 1.50 (m, 4H), 1.47 (dd, J = 7.7, 4.0 Hz, 1H), 
1.25 (s, 6H), 1.24 – 1.20 (m, 6H), 1.19 – 1.08 (m, 2H), 0.71 (dd, J = 9.8, 7.6 Hz, 1H); 13C (126 MHz, 
CDCl3): δ 173.7, 140.4, 128.7 (+, 2C), 126.7 (+, 2C), 126.6 (+), 81.9 (2C), 75.1, 47.7 (-), 45.1 (-), 
35.8, 25.4 (-), 25.2 (-), 25.0 (+, 4C), 24.2 (-), 19.5 (-), 17.8; FTIR (KBr, cm-1): 2974, 2935, 2856, 
1634, 1601, 1468, 1435, 1402, 1371, 1325, 1269, 1209, 1146, 1009, 860, 760, 733, 700; HRMS 




Compound was obtained via typical procedure for dissolved method 
using morpholino(1-phenylcycloprop-2-en-1-yl)methanone (53ak) 
(57.3 mg, 0.25 mmol, 1.0 equiv.) and allowing reaction to stir overnight. The product was purified 
by column chromatography using 2:1 hexane:ethyl acetate mobile phase. The titled compound 
was obtained as a colorless oil in 48% yield (43.2 mg, 0.121 mmol). Rf: 0.18; dr: >98:2; er: 94:6; 
[α]D20 -59.16 (c = 0.833, CHCl3); 1H NMR (500 MHz, CDCl3): δ 7.35 – 7.16 (m, 5H), 3.89 – 3.77 (m, 
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1H), 3.74 – 3.63 (m, 1H), 3.63 – 3.55 (m, 1H), 3.54 – 3.40 (m, 2H), 3.40 – 3.26 (m, 2H), 3.26 – 3.17 
(m, 1H), 1.58 (dd, J = 7.8, 4.0 Hz, 1H), 1.44 (dd, J = 9.9, 4.0 Hz, 1H), 1.27 (s, 6H), 1.24 (s, 6H), 0.81 
(dd, J = 9.9, 7.8 Hz, 1H); 13C (126 MHz, CDCl3): δ 171.5, 140.5, 128.9 (+, 2C), 126.8 (+), 126.0 (+, 
2C), 83.1 (2C), 66.7 (-), 66.2 (-), 46.6 (-), 43.2 (-), 35.6, 25.3 (+, 2C), 24.9 (+, 2C), 19.6 (-), 13.4; 
FTIR (KBr, cm-1): 2976, 2924, 2856, 1634, 1601, 1429, 1404, 1371, 1329, 1300, 1273, 1211, 1144, 
1115, 1022, 860, 760, 735, 700; HRMS (TOF ES): Found 380.2012, calculated for C20H28BNO4Na 




Compound was obtained via typical procedure for dissolved 
method using N-butyl-1-phenylcycloprop-2-ene-1-carboxamide 
(53am) (53.8 mg, 0.25 mmol, 1.0 equiv.) and allowing reaction to stir overnight. The product was 
purified by column chromatography using 2:1 hexane:ethyl acetate mobile phase. The titled 
compound was obtained as a colorless solid in 81% yield (69.3 mg, 0.202 mmol). Rf: 0.41; dr: 
>98:2; er: 91.5:8.5; [α]D20 -30.55 (c = 1.100, CHCl3); mp: 97.8 – 99.0 °C; 1H NMR (500 MHz, CDCl3): 
δ 7.48 – 7.41 (m, 2H), 7.36 – 7.26 (m, 3H), 5.54 – 5.03 (m, 1H), 3.38 – 2.82 (m, 2H), 1.57 (dd, J = 
8.0, 3.1 Hz, 1H), 1.38 – 1.32 (m, 2H), 1.32 (s, 6H), 1.29 (s, 6H), 1.25 (dd, J = 10.2, 3.1 Hz, 1H), 1.23 
– 1.15 (m, 2H), 0.84 (t, J = 7.3 Hz, 3H), 0.64 (dd, J = 10.2, 8.0 Hz, 1H); 13C (126 MHz, CDCl3): δ 174.4, 
140.0, 131.0 (+, 2C), 128.9 (+, 2C), 127.9 (+), 83.0 (2C), 40.2 (-), 35.8, 31.7 (-), 25.3 (+, 2C), 25.1 
(+, 2C), 20.0 (-), 18.8 (-), 13.9 (+), 12.7; FTIR (KBr, cm-1): 3433, 2970, 2929, 2871, 1662, 1647, 
1618, 1517, 1436, 1406, 1299, 1211, 1145, 1114, 972, 860, 702; HRMS (TOF ES): Found 






Compound was obtained via typical procedure for dissolved method 
using N-cycloheptyl-1-phenylcycloprop-2-ene-1-carboxamide 
(53an) (63.8 mg, 0.25 mmol, 1.0 equiv.) and allowing reaction to stir overnight. The product was 
purified by column chromatography using 2:1 hexane:ethyl acetate mobile phase. The titled 
compound was obtained as a viscous pale yellow oil in 94% yield (90.4 mg, 0.236 mmol). Rf: 0.53; 
dr: >98:2; er: 90.5:9.5; [α]D20 -23.84 (c = 1.233, CHCl3); 1H NMR (500 MHz, CDCl3): δ 7.45 – 7.41 
(m, 2H), 7.35 – 7.27 (m, 3H), 5.26 (d, J = 8.1 Hz, 1H), 3.96 – 3.71 (m, 1H), 1.84 – 1.67 (m, 2H), 1.55 
(dd, J = 7.9, 3.0 Hz, 1H), 1.54 – 1.47 (m, 2H), 1.47 – 1.34 (m, 7H), 1.31 (s, 6H), 1.28 (s, 6H), 1.27 – 
1.21 (m, 1H), 1.24 (dd, J = 10.1, 3.0 Hz, 1H), 0.64 (dd, J = 10.2, 7.9 Hz, 1H); 13C (126 MHz, CDCl3): 
δ 173.5, 139.8, 130.9 (+, 2C), 128.8 (+, 2C), 127.9 (+), 82.8 (2C), 51.3 (+), 35.8, 34.8 (-), 34.6 (-), 
28.0 (-), 27.8 (-), 25.3 (+, 2C), 25.0 (+, 2C), 24.2 (-), 24.1 (-), 18.7 (-), 13.0; FTIR (KBr, cm-1): 3425, 
2974, 2927, 2856, 1660, 1650, 1514, 1444, 1404, 1371, 1301, 1211, 1145, 1112, 975, 960, 860, 







Compound was obtained via typical procedure for dissolved method using N-allyl-1-
phenylcycloprop-2-ene-1-carboxamide (53ao) (49.8 mg, 0.25 mmol, 1.0 equiv.) and allowing 
reaction to stir overnight. The product was purified by column chromatography using 2:1 
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hexane:ethyl acetate mobile phase. The titled compound was obtained as a mixture of isomers in 
a 1:2 (E:Z) ratio as a colorless oil in 58% yield (47.3 mg, 0.145 mmol). Rf: 0.57; dr: >98:2 for both 
E and Z isomers; er: 94:6 for both E and Z isomers; [α]D20 -35.73 (c = 0.367, CHCl3); 1H NMR (500 
MHz, CDCl3): Major (Cis Isomer) δ 7.52 – 7.48 (m, 2H), 7.41 – 7.31 (m, 3H), 6.82 (d, J = 10.9 Hz, 
1H), 6.67 – 6.53 (m, 1H), 4.73 – 4.56 (m, 1H), 1.67 (dd, J = 8.3, 3.1 Hz, 1H), 1.32 (s, 6H), 1.30 (s, 
6H), 1.33 – 1.31 (m, 1H), 1.20 (dd, J = 7.0, 1.8 Hz, 3H), 0.72 (dd, J = 10.3, 8.3 Hz, 1H); 13C (126 MHz, 
CDCl3): δ 170.9, 139.7, 131.0 (+, 2C), 129.1 (+, 2C), 128.3 (+), 122.4, 104.7, 83.5 (2C), 35.9, 25.2 
(+, 2C), 25.1 (+, 2C), 19.2 (-), 12.5, 10.3 (+); FTIR (KBr, cm-1): 3429, 2975, 2929, 1681, 1650, 1487, 
1444, 1404, 1371, 1303, 1271, 1213, 1145, 956, 858, 763, 727, 703; HRMS (TOF ES): Found 





Compound was obtained via typical procedure for dissolved 
method using N-(furan-2-ylmethyl)-1-phenylcycloprop-2-ene-1-carboxamide (53ar) (50.0 mg, 
0.21 mmol, 1.0 equiv.) and allowing reaction to stir overnight. The product was purified by 
column chromatography using 2:1 hexane:ethyl acetate mobile phase. The titled compound was 
obtained as a pale yellow oil in 34% yield (26.2 mg, 0.071 mmol). Rf: 0.43; dr: >98:2; er: 93.5:6.5; 
[α]D20 -35.82 (c = 0.567, CHCl3); 1H NMR (500 MHz, CDCl3): δ 7.49 – 7.42 (m, 2H), 7.35 – 7.26 (m, 
4H), 6.26 (dd, J = 3.2, 1.8 Hz, 1H), 6.10 (dd, J = 3.2, 1.0 Hz, 1H), 5.68 – 5.56 (m, 1H), 4.34 (dd, J = 
5.7, 0.8 Hz, 2H), 1.64 (dd, J = 8.2, 3.1 Hz, 1H), 1.32 (s, 6H), 1.30 – 1.26 (m, 1H), 1.29 (s, 6H), 0.66 
(dd, J = 10.2, 8.2 Hz, 1H); 13C (126 MHz, CDCl3): δ 173.8, 151.5, 142.0 (+), 139.9, 131.0 (+, 2C), 
129.0 (+, 2C), 128.0 (+), 110.4 (+), 107.1 (+), 83.3 (2C), 37.4 (-), 35.8, 25.2 (+, 2C), 25.0 (+, 2C), 
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18.8 (-), 12.4; FTIR (KBr, cm-1): 3434, 2975, 2929, 1660, 1650, 1519, 1504, 1446, 1407, 1371, 
1301, 1211, 1145, 1014, 973, 858, 738, 703; HRMS (TOF ES): Found 390.1855, calculated for 




Compound was obtained via typical procedure for dissolved method 
using N-methoxy-N-methyl-1-phenylcycloprop-2-ene-1-carboxamide 
(53au) (50.8 mg, 0.25 mmol, 1.0 equiv.) and allowing reaction to stir overnight. The product was 
purified by column chromatography using 2:1 hexane:ethyl acetate mobile phase. The titled 
compound was obtained as a pale yellow oil in 68% yield (56.2 mg, 0.170 mmol). Rf: 0.40; dr: 
97:3; er: 94.5:5.5; [α]D20 -64.64 (c = 0.733, CHCl3); 1H NMR (500 MHz, CDCl3): δ 7.37 – 7.29 (m, 
2H), 7.30 – 7.23 (m, 2H), 7.21 – 7.14 (m, 1H), 3.12 (s (broad), 6H), 1.58 (dd, J = 7.8, 3.8 Hz, 1H), 
1.26 (s, 6H), 1.26 - 1.25 (m, 1H), 1.25 (s, 6H), 0.84 (dd, J = 9.9, 7.8 Hz, 1H); 13C (126 MHz, CDCl3): 
δ 174.2, 141.0, 128.4 (+, 2C), 127.8 (+), 126.7 (+, 2C), 83.3 (2C), 60.4 (-), 36.0, 33.5 (+), 25.1 (+, 
2C), 24.9 (+, 2C), 18.6, 10.0 (+); FTIR (KBr, cm-1): 2975, 2933, 1666, 1650, 1444, 1407, 1371, 
1328, 1298, 1211, 1164, 1145, 1122, 1004, 975, 860, 763, 700; HRMS (TOF ES): Found 354.1866, 




Compound was obtained via typical procedure for dissolved method 
using N,N-diethyl-1-(4-fluorophenyl)cycloprop-2-ene-1-carboxamide 
(53ba) (58.3 mg, 0.25 mmol, 1.0 equiv.) and allowing reaction to stir overnight. The product was 
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purified by column chromatography using 1:1 hexane:ethyl acetate mobile phase. The titled 
compound was obtained as a pale yellow oil in 88% yield (79.8 mg, 0.220 mmol). Rf: 0.33; dr: 
>98:2; er: 90:10; [α]D20 38.80 (c = 1.533, CHCl3); 1H NMR (500 MHz, CDCl3): δ 7.32 – 7.19 (m, 2H), 
7.00 – 6.86 (m, 2H), 3.44 – 3.30 (m, 2H), 3.22 (q, J = 7.2 Hz, 2H), 1.58 (dd, J = 9.9, 3.9 Hz, 1H), 1.42 
(dd, J = 7.5, 4.0 Hz, 1H), 1.24 (s, 6H), 1.22 (s, 6H), 1.14 (t, J = 7.1 Hz, 3H), 0.72 (t, J = 7.1 Hz, 3H), 
0.60 (dd, J = 9.9, 7.6 Hz, 1H); 13C (126 MHz, CDCl3): δ 174.8, 161.7 (d, J = 245.8 Hz), 136.1 (d, J = 
3.1 Hz), 129.3 (+, dd, J = 8.1, 2.2 Hz, 2C), 115.6 (+, d, J = 21.4 Hz, 2C), 81.6 (2C), 42.9 (-), 41.9 (-), 
35.5, 25.1 (+, 2C), 25.1 (+, 2C), 19.6 (-), 18.1, 12.8 (+), 12.6 (+);19F NMR (376 MHz, CDCl3) δ -
115.50 (s, 1F); FTIR (KBr, cm-1): 3066, 2974, 2935, 2875, 1631, 1602, 1512, 1458, 1431, 1004, 
1380, 1323, 1290, 1272, 1220, 1143, 1116, 952, 860, 835, 821; HRMS (TOF ES): Found 384.2126, 





Compound was obtained via typical procedure for dissolved method 
using 1-(2,4-difluorophenyl)-N,N-diethylcycloprop-2-ene-1-carboxamide (53ca) (62.8 mg, 0.25 
mmol, 1.0 equiv.) and allowing reaction to stir overnight. The product was purified by column 
chromatography using 1:2 hexane:ethyl acetate mobile phase. The titled compound was obtained 
as a pale yellow oil in 96% yield (91.0 mg, 0.240 mmol). Rf: 0.24; dr: >98:2; er: 95.5:4.5; [α]D20 
104.58 (c = 1.900, CHCl3); 1H NMR (500 MHz, CDCl3): δ 7.33 – 7.26 (m, 1H), 6.88 – 6.71 (m, 2H), 
3.56 – 3.40 (m, 1H), 3.35 – 3.24 (m, 2H), 3.22 – 3.09 (m, 1H), 1.70 (dd, J = 10.0, 4.1 Hz, 1H), 1.43 
(dd, J = 7.6, 4.1 Hz, 1H), 1.24 (s, 6H), 1.23 (s, 6H), 1.16 (t, J = 7.1 Hz, 3H), 0.74 (t, J = 7.1 Hz, 3H), 
0.62 (dd, J = 10.0, 7.6 Hz, 1H); 13C (126 MHz, CDCl3): δ 176.2, 162.2 (dd, J = 249.5, 11.8 Hz), 162.0 
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(dd, J = 251.2, 11.9 Hz) 131.1 (+, dd, J = 9.5, 5.0 Hz), 123.5 (dd, J = 13.7, 3.9 Hz), 111.7 (+, dd, J = 
21.2, 3.6 Hz), 104.4 (+, t, J = 25.3 Hz), 80.8 (2C), 43.2 (-), 43.2 (-), 30.3, 25.3 (+, 2C), 25.1 (+, 2C), 
20.3, 19.7 (-), 12.7 (+), 12.5 (+);19F NMR (376 MHz, CDCl3) δ -108.1 (d, J = 7.6 Hz, 1F), -110.6 (d, J 
= 7.4 Hz, 1F); FTIR (KBr, cm-1): 2974, 2937, 1607, 1506, 1462, 1385, 1350, 1271, 1184, 1140, 
1115, 1088, 974, 851, 808, 721, 675; HRMS (TOF ES): Found 402.2032, calculated for 





Compound was obtained via typical procedure for dissolved method 
using 1-(2-chloro-4-fluorophenyl)-N,N-diethylcycloprop-2-ene-1-carboxamide (53da) (67.0 mg, 
0.25 mmol, 1.0 equiv.) and allowing reaction to stir overnight. The product was purified by 
column chromatography using 1:2 hexane:ethyl acetate mobile phase. The titled compound was 
obtained as a colorless solid in 85% yield (84.0 mg, 0.212 mmol). Rf: 0.17; dr: >98:2; er: 97:3; 
[α]D20 139.08 (c = 1.667, CHCl3); mp: 100.0 – 101.6 °C; 1H NMR (500 MHz, CDCl3): δ 7.30 (dd, J = 
8.7, 5.9 Hz, 1H), 7.11 (dd, J = 8.3, 2.7 Hz, 1H), 6.94 (td, J = 8.2, 2.7 Hz, 1H), 3.74 – 3.52 (m, 1H), 3.32 
– 3.08 (m, 2H), 3.09 – 2.96 (m, 1H), 1.75 (dd, J = 10.0, 4.1 Hz, 1H), 1.45 (dd, J = 7.4, 4.0 Hz, 1H), 
1.24 (s, 6H), 1.23 (s, 6H), 1.19 (t, J = 7.1 Hz, 3H), 0.75 (t, J = 7.1 Hz, 3H), 0.62 (dd, J = 9.9, 7.4 Hz, 
1H); 13C (126 MHz, CDCl3): δ 176.7, 161.6 (d, J = 250.5 Hz), 137.9 (d, J = 10.3 Hz), 134.0 (d, J = 3.6 
Hz), 131.1 (+, d, J = 8.7 Hz), 117.3 (+, d, J = 24.6 Hz), 114.4 (+, d, J = 21.0 Hz), 80.3 (2C), 44.2 (-), 
43.9 (-), 34.2, 25.7 (+, 2C), 25.0 (+, 2C), 21.8 (-), 21.1, 12.6 (+), 12.5 (+);19F NMR (376 MHz, CDCl3) 
δ -112.4 (s, 1F); FTIR (KBr, cm-1): 2972, 2937, 1715, 1601, 1495, 1454, 1385, 1346, 1265, 1209, 
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1184, 1159, 1115, 910, 858, 806, 754, 675; HRMS (TOF ES): Found 402.2006, calculated for 





Compound was obtained via typical procedure for dissolved method 
using 1-(2-bromo-4-fluorophenyl)-N,N-diethylcycloprop-2-ene-1-carboxamide (53ea) (78.0 
mg, 0.25 mmol, 1.0 equiv.) and allowing reaction to stir overnight. The product was purified by 
column chromatography using 2:1 hexane:ethyl acetate mobile phase. The titled compound was 
obtained as a pale yellow oil in 98% yield (108 mg, 0.245 mmol). Rf: 0.17; dr: >98:2; er: 95:5; 
[α]D20 105.18 (c = 2.767, CHCl3); 1H NMR (500 MHz, CDCl3): δ 7.33 – 7.28 (m, 2H), 7.01 – 6.95 (m, 
1H), 3.78 – 3.50 (m, 1H), 3.33 – 3.09 (m, 2H), 3.09 – 2.93 (m, 1H), 1.75 (dd, J = 10.0, 4.0 Hz, 1H), 
1.50 (dd, J = 7.4, 4.0 Hz, 1H), 1.23 (s, 6H), 1.23 (s, 6H), 1.20 (t, J = 7.2 Hz, 3H), 0.75 (t, J = 7.1 Hz, 
3H), 0.65 (dd, J = 10.0, 7.4 Hz, 1H); 13C (126 MHz, CDCl3): δ 176.6, 161.5 (d, J = 251.7 Hz), 135.6 
(d, J = 3.6 Hz), 131.6 (+, d, J = 8.5 Hz), 127.7 (d, J = 9.5 Hz), 120.6 (+, d, J = 24.2 Hz), 114.9 (+, d, J = 
21.0 Hz), 80.3 (2C), 44.4 (-), 43.9 (-), 36.1, 25.6 (+, 2C), 25.0 (+, 2C), 22.4, 22.0 (-), 12.6 (+), 12.5 
(+);19F NMR (376 MHz, CDCl3) δ -112.5 (s, 1F); FTIR (KBr, cm-1): 2972, 2935, 1596, 1488, 1461, 
1440, 1382, 1344, 1265, 1209, 1157, 1112, 1099, 1035, 972, 946, 864, 806, 707; HRMS (TOF ES): 






Compound was obtained via typical procedure for dissolved method 
using N,N-diethyl-1-(naphthalen-1-yl)cycloprop-2-ene-1-carboxamide 
(53fa) (66.3 mg, 0.25 mmol, 1.0 equiv.) and allowing reaction to stir overnight. The product was 
purified by column chromatography using 2:1 hexane:ethyl acetate mobile phase. The titled 
compound was obtained as a colorless solid in 88% yield (86.8 mg, 0.221 mmol). Rf: 0.19; dr: 
>98:2; er: 94.5:5.5; [α]D20 151.77 (c = 1.867, CHCl3); mp: 109.8 – 110.5 °C; 1H NMR (500 MHz, 
CDCl3): δ 8.39 (d, J = 8.5 Hz, 1H), 7.81 (d, J = 8.2 Hz, 1H), 7.74 (d, J = 8.1 Hz, 1H), 7.62 – 7.53 (m, 
1H), 7.52 – 7.42 (m, 2H), 7.41 – 7.32 (m, 1H), 3.64 – 3.50 (m, 1H), 3.19 – 3.02 (m, 2H), 2.97 – 2.80 
(m, 1H), 1.95 – 1.81 (m, 1H), 1.59 – 1.50 (m, 1H), 1.31 (s, 6H), 1.27 (s, 6H), 1.08 (t, J = 7.1 Hz, 3H), 
0.78 – 0.63 (m, 1H), 0.37 (t, J = 7.1 Hz, 3H); 13C (126 MHz, CDCl3): δ 177.5, 136.3, 133.8, 133.6, 
128.4 (+), 128.2 (+), 127.1 (+), 126.2 (+), 125.8 (+), 125.6 (+), 125.3 (+), 80.6 (2C), 44.1 (-), 43.6 
(-), 34.3, 25.8 (+, 2C), 25.1 (+, 2C), 20.6 (-), [12.6 & 12.4, (+), Σ3C]; FTIR (KBr, cm-1): 3045, 2972, 
2933, 1595, 1458, 1438, 1380, 1361, 1340, 1282, 1211, 1188, 1114, 972, 902, 802, 781, 736, 703, 





Compound was obtained via typical procedure for dissolved method 
using N,N-diethyl-1-(p-tolyl)cycloprop-2-ene-1-carboxamide (53ga) 
(57.3 mg, 0.25 mmol, 1.0 equiv.) and allowing reaction to stir overnight. The product was purified 
by column chromatography using 2:1 hexane:ethyl acetate mobile phase. The titled compound 
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was obtained as a very viscous pale yellow oil in 92% yield (81.8 mg, 0.229 mmol). Rf: 0.21; dr: 
>98:2; er: 91:9; [α]D20 44.62 (c = 1.300, CHCl3); 1H NMR (500 MHz, CDCl3): δ 7.17 (d, J = 8.2 Hz, 
2H), 7.06 (d, J = 7.7 Hz, 2H), 3.48 – 3.29 (m, 2H), 3.28 – 3.15 (m, 2H), 2.29 (s, 3H), 1.62 (dd, J = 9.8, 
3.9 Hz, 1H), 1.39 (dd, J = 7.4, 3.9 Hz, 1H), 1.25 (s, 6H), 1.23 (s, 6H), 1.16 (t, J = 7.1 Hz, 3H), 0.73 (t, 
J = 7.1 Hz, 3H), 0.62 (dd, J = 9.8, 7.4 Hz, 1H); 13C (126 MHz, CDCl3): δ 175.8, 137.1, 136.5, 129.4 (+, 
2C), 127.8 (+, d, J = 2.0 Hz, 2C), 81.3 (2C), 43.1 (-), 42.2 (-), 35.7, 25.2 (+, 2C), 25.2 (+, 2C), 21.2 (+), 
19.6 (-), 18.9, 12.8 (+), 12.6 (+); FTIR (KBr, cm-1): 2974, 2933, 2873, 1633, 1598, 1515, 1496, 
1427, 1402, 1380, 1371, 1323, 1288, 1271, 1209, 1145, 1114, 952, 860, 808; HRMS (TOF ES): 




Compound was obtained via typical procedure for dissolved method 
using 1-(2-chlorophenyl)-N,N-diethylcycloprop-2-ene-1-carboxamide 
(53ia) (62.4 mg, 0.25 mmol, 1.0 equiv.) and allowing reaction to stir overnight. The product was 
purified by column chromatography using 2:1hexane:ethyl acetate mobile phase. The titled 
compound was obtained as a pale yellow solid in 96% yield (90.6 mg, 0.240 mmol). Rf: 0.17; dr: 
>98:2; er: 87.5:12.5; [α]D20 140.64 (c = 2.233, CHCl3); mp: 140.5 – 142.8 °C; 1H NMR (500 MHz, 
CDCl3): δ 7.38 – 7.28 (m, 2H), 7.23 – 7.15 (m, 2H), 3.72 – 3.59 (m, 1H), 3.31 – 3.08 (m, 2H), 3.09 – 
2.92 (m, 1H), 1.80 (dd, J = 9.9, 4.0 Hz, 1H), 1.43 (dd, J = 7.4, 4.0 Hz, 1H), 1.24 (s, 6H), 1.23 (s, 6H), 
1.19 (t, J = 7.2 Hz, 3H), 0.72 (t, J = 7.1 Hz, 3H), 0.64 (dd, J = 10.0, 7.3 Hz, 1H); 13C (126 MHz, CDCl3): 
δ 177.1, 137.8, 137.1, 130.0 (+, 2C), 128.6 (+), 127.2 (+), 80.1 (2C), 44.2 (-), 43.9 (-), 34.8, 25.7 (+, 
2C), 25.0 (+, 2C), 21.9, 20.9 (-), 12.5 (+), 12.5 (+); FTIR (KBr, cm-1): 2970, 2937, 1600, 1485, 1461, 
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1438, 1382, 1346, 1284, 1245, 1186, 1157, 1114, 1051, 972, 904, 757, 671; HRMS (TOF ES): 




Compound was obtained via typical procedure for dissolved method 
using 1-(2,3-difluorophenyl)-N,N-diethylcycloprop-2-ene-1-
carboxamide (53ja) (63.0 mg, 0.25 mmol, 1.0 equiv.) and allowing 
reaction to stir overnight. The product was purified by column chromatography using 2:1 
hexane:ethyl acetate mobile phase. The titled compound was obtained as a pale yellow solid in 
91% yield (86.1 mg, 0.227 mmol). Rf: 0.24; dr: >98:2; er: 91.5:8.5; [α]D20 103.46 (c = 1.300, CHCl3); 
mp: 99.9 – 101.3 °C; 1H NMR (500 MHz, CDCl3): δ 7.09 – 6.97 (m, 3H), 3.60 – 3.41 (m, 1H), 3.38 – 
3.22 (m, 2H), 3.22 – 3.10 (m, 1H), 1.76 (dd, J = 10.0, 4.2 Hz, 1H), 1.44 (dd, J = 7.6, 4.2 Hz, 1H), 1.24 
(s, 6H), 1.23 (s, 6H), 1.17 (t, J = 7.1 Hz, 3H), 0.76 (t, J = 7.1 Hz, 3H), 0.67 (dd, J = 10.0, 7.6 Hz, 1H); 
13C (126 MHz, CDCl3): δ 175.9, 150.8 (dd, J = 243.7, 6.4 Hz), 150.0 (dd, J = 248.7, 11.5 Hz), 129.8 
(d, J = 10.2 Hz), 124.5 (+, t, J = 2.7 Hz), 124.4 (+, dd, J = 7.1, 4.7 Hz), 116.3 (+, d, J = 17.1 Hz), 80.8 
(2C), 43.3 (-), 43.2 (-), 30.7 (t, J = 2.3 Hz), 25.3 (+, 2C), 25.1 (+, 2C), 20.6, 19.8 (-), 12.6 (+), 12.5 
(+);19F NMR (376 MHz, CDCl3) δ -137.6 (d, J = 20.5 Hz, 1F), -138.4 (d, J = 20.5 Hz, 1F); FTIR (KBr, 
cm-1): 2974, 2937, 1631, 1604, 1479, 1442, 1406, 1382, 1323, 1292, 1263, 1211, 1141, 1114, 968, 
862, 788, 729, 667; HRMS (TOF ES): Found 402.2026, calculated for C20H28BF2NO3Na (M+Na) 






Compound was obtained via typical procedure for dissolved method 
using 1-(4-bromophenyl)-N,N-diethylcycloprop-2-ene-1-
carboxamide (53la) (74.0 mg, 0.25 mmol, 1.0 equiv.) and allowing reaction to stir overnight. The 
product was purified by column chromatography using 2:1 hexane:ethyl acetate mobile phase. 
The titled compound was obtained as a pale yellow oil in 85% yield (89.9 mg, 0.213 mmol). Rf: 
0.17; dr: >98:2; er: 87:13; [α]D20 21.25 (c = 1.600, CHCl3); 1H NMR (500 MHz, CDCl3): δ 7.43 – 7.34 
(m, 2H), 7.19 – 7.09 (m, 2H), 3.46 – 3.30 (m, 2H), 3.30 – 3.14 (m, 2H), 1.59 (dd, J = 9.9, 4.0 Hz, 1H), 
1.44 (dd, J = 7.6, 4.0 Hz, 1H), 1.25 (s, 6H), 1.22 (s, 6H), 1.15 (t, J = 7.1 Hz, 3H), 0.77 (t, J = 7.1 Hz, 
3H), 0.62 (dd, J = 9.9, 7.6 Hz, 1H); 13C (126 MHz, CDCl3): δ 174.2, 139.6, 131.8 (+, 2C), 129.1 (+, 
2C), 120.6, 81.8 (2C), 42.9 (-), 41.8 (-), 35.7, 25.1 (+, 2C), 25.1 (+, 2C), 19.5 (-), 18.1, 12.9 (+), 12.6 
(+); FTIR (KBr, cm-1): 2974, 2933, 2873, 1633, 1600, 1490, 1460, 1427, 1406, 1388, 1323, 1288, 
1267, 1213, 1139, 1116, 1008, 860, 808; HRMS (TOF ES): Found 444.1321, calculated for 





Compound was obtained via typical procedure for dissolved method 
using 1-(2,4-dichlorophenyl)-N,N-diethylcycloprop-2-ene-1-carboxamide (53ma) (76.0 mg, 
0.267 mmol, 1.0 equiv.) and allowing reaction to stir overnight. The product was purified by 
column chromatography using 2:1 hexane:ethyl acetate mobile phase. The titled compound was 
obtained as a pale yellow amorphous solid in 98% yield (108 mg, 0.262 mmol). Rf: 0.14; dr: >98:2; 
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er: 98:2; [α]D20 132.12 (c = 2.433, CHCl3); 1H NMR (500 MHz, CDCl3): δ 7.37 (d, J = 2.2 Hz, 1H), 7.25 
(d, J = 9.2 Hz, 1H), 7.19 (dd, J = 8.3, 2.1 Hz, 1H), 3.71 – 3.58 (m, 1H), 3.26 – 3.09 (m, 2H), 3.09 – 
2.97 (m, 1H), 1.75 (dd, J = 10.0, 4.1 Hz, 1H), 1.46 (dd, J = 7.4, 4.1 Hz, 1H), 1.23 (s, 6H), 1.22 (s, 6H), 
1.18 (t, J = 7.2 Hz, 3H), 0.77 (t, J = 7.1 Hz, 3H), 0.63 (dd, J = 10.0, 7.4 Hz, 1H); 13C (126 MHz, CDCl3): 
δ 176.5, 137.8, 136.6, 133.8, 130.7 (+), 129.7 (+), 127.5 (+), 80.3 (2C), 44.2 (-), 43.9 (-), 34.3, 25.6 
(+, 2C), 25.0 (+, 2C), 21.8, 21.0 (-), 12.6 (+), 12.5 (+); FTIR (KBr, cm-1): 2972, 2935, 1600, 1483, 
1461, 1444, 1380, 1361, 1344, 1280, 1157, 1114, 1107, 972, 904, 867, 815, 777, 659; HRMS (TOF 





Compound was obtained via typical procedure for dissolved method 
using N,N-diethyl-1-(3-(trifluoromethyl)phenyl)cycloprop-2-ene-1-
carboxamide (53na) (71.0 mg, 0.25 mmol, 1.0 equiv.) and allowing reaction to stir overnight. The 
product was purified by column chromatography using 1:1 hexane:ethyl acetate mobile phase. 
The titled compound was obtained as a pale yellow oil in 87% yield (89.6 mg, 0.218 mmol). Rf: 
0.24; dr: >98:2; er: 91.5:8.5; [α]D20 9.55 (c = 1.100, CHCl3); 1H NMR (500 MHz, CDCl3): δ 7.51 – 
7.42 (m, 3H), 7.42 – 7.36 (m, 1H), 3.45 – 3.31 (m, 2H), 3.32 – 3.12 (m, 2H), 1.64 (dd, J = 9.9, 4.2 Hz, 
1H), 1.53 (dd, J = 7.7, 4.1 Hz, 1H), 1.26 (s, 6H), 1.23 (s, 6H), 1.16 (t, J = 7.1 Hz, 3H), 0.73 (t, J = 7.1 
Hz, 3H), 0.72 – 0.67, 1H); 13C (126 MHz, CDCl3): δ 173.4, 141.7, 131.1 (q, J = 32.2 Hz), 130.7 (+), 
129.3 (+), 124.1 (q, J = 272.4 Hz), 123.6 (+, d, J = 2.3 Hz), 123.6 (+, d, J = 2.3 Hz), 82.2 (2C), 42.8 (-
), 41.5 (-), 36.0, 25.1 (+, 2C), 25.0 (+, 2C), 19.6 (-), 17.7, 12.7 (+), 12.6 (+);19F NMR (376 MHz, 
CDCl3) δ -62.6 (s, 3F); FTIR (KBr, cm-1): 2975, 2935, 2877, 1639, 1460, 1427, 1404, 1371, 1332, 
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1274, 1213, 1166, 1126, 1076, 964, 860, 800, 702; HRMS (TOF ES): Found 434.2099, calculated 





Compound was obtained via typical procedure for dissolved method 
using 1-(2-chloro-4,5-difluorophenyl)-N,N-diethylcycloprop-2-ene-1-carboxamide (53oa) (71.0 
mg, 0.25 mmol, 1.0 equiv.) and allowing reaction to stir overnight. The product was purified by 
column chromatography using 2:1 hexane:ethyl acetate mobile phase. The titled compound was 
obtained as a pale yellow oil in 91% yield (94.1 mg, 0.227 mmol). Rf: 0.28; dr: >98:2; er: 97:3; 
[α]D20 121.78 (c = 2.300, CHCl3); 1H NMR (500 MHz, CDCl3): δ 7.20 (dd, J = 9.7, 7.3 Hz, 1H), 7.15 
(dd, J = 10.8, 8.1 Hz, 1H), 3.75 – 3.54 (m, 1H), 3.29 – 3.11 (m, 2H), 3.11 – 2.98 (m, 1H), 1.70 (dd, J 
= 10.1, 4.2 Hz, 1H), 1.47 (dd, J = 7.5, 4.2 Hz, 1H), 1.23 (s, 6H), 1.22 (s, 6H), 1.19 (t, J = 7.2 Hz, 3H), 
0.80 (t, J = 7.1 Hz, 3H), 0.64 (dd, J = 10.1, 7.5 Hz, 1H); 13C (126 MHz, CDCl3): δ 175.8, 149.1 (dd, J = 
253.1, 13.5 Hz), 148.9 (dd, J = 250.0, 12.5 Hz), 134.8 (t, J = 4.7 Hz), 131.8 (dd, J = 7.7, 3.6 Hz), 118.9 
(+, d, J = 20.0 Hz), 118.1 (+, d, J = 18.7 Hz), 80.3 (2C), 44.0 (-), 43.8 (-), 34.2, 25.5 (+, 2C), 24.8 (+, 
2C), 21.9, 21.0 (-), 12.5 (+), 12.4 (+);19F NMR (376 MHz, CDCl3) δ -135.9 (d, J = 21.7 Hz, 1F), -137.7 
(d, J = 21.7 Hz, 1F); FTIR (KBr, cm-1): 2972, 2937, 2879, 1600, 1496, 1463, 1442, 1404, 1382, 
1361, 1340, 1292, 1267, 1238, 1217, 1184, 1114, 792, 707; HRMS (TOF ES): Found 436.1639, 






Compound was obtained via typical procedure for dissolved method using 
N,N-diethyl-1-methylcycloprop-2-ene-1-carboxamide (56) (76.6 mg, 0.50 
mmol, 1.0 equiv.) and allowing reaction to stir overnight. The product was purified by column 
chromatography using 3:1 hexane:ethyl acetate mobile phase. The titled compound was obtained 
as a pale yellow oil in 92% yield (128 mg, 0.46 mmol). Rf: 0.17; dr: >98:2; er: 92:8; [α]D20 +49.51 
(c = 0.80, CHCl3); 1H NMR (500 MHz, CDCl3) δ 3.61 (dq, J = 14.4, 7.2 Hz, 1H), 3.46 (dq, J = 14.3, 7.1 
Hz, 1H), 3.39 – 3.23 (m, 2H), 1.36 (s, 3H), 1.23 – 1.19 (m, 3H), 1.19 (s, 6H), 1.17 (s, 6H), 1.13 (dd, 
J = 7.0, 3.6 Hz, 1H), 1.09 (t, J = 7.1 Hz, 3H), 0.83 (dd, J = 9.4, 3.6 Hz, 1H), 0.18 (dd, J = 9.4, 7.0 Hz, 
1H); 13C NMR (126 MHz, CDCl3) δ 175.0, 82.0, 42.1 (-), 40.9 (-), 27.1, 25.1 (+, 4C), 22.7 (+), 20.1 (-
), 14.1 (+), 13.8 (+, broad), 12.7 (+); FTIR (KBr, cm-1): 2975, 2934, 1635, 1428, 1408, 1324, 1240, 
1146, 1130, 973, 860; HRMS (TOF ES): Found 278.2651, calculated for C17H33BNO (M+H) 




Compound was obtained via typical procedure for dissolved method using 
N,N-diethyl-1-phenylcycloprop-2-ene-1-carboxamide (53aa) (108.0 mg, 
0.50 mmol, 1.0 equiv.) and 9-Borabicyclo[3.3.1]nonane dimer (1.0 mL, 0.5M in THF, 0.50 mmol, 
1.0 equiv.) and allowing reaction to stir overnight. The product was purified by column 
chromatography using 3:1 hexane:ethyl acetate mobile phase. The titled compound was obtained 
as a colorless solid in 53% yield (89.6 mg, 0.266 mmol). Rf: 0.31; dr: 70:30; 1H NMR (500 MHz, 
CDCl3): Major: δ 7.32 – 7.27 (m, 2H), 7.26 – 7.18 (m, 3H), 3.48 (dq, J = 14.2, 7.1 Hz, 1H), 3.35 (dq, 
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J = 14.0, 7.1 Hz, 1H), 3.26 (dq, J = 14.4, 7.2 Hz, 1H), 3.07 (dq, J = 14.2, 7.1 Hz, 1H), 1.99 – 1.88 (m, 
2H), 1.86 – 1.80 (m, 3H), 1.76 – 1.66 (m, 5H), 1.54 (s, 2H), 1.46 – 1.40 (m, 1H), 1.21 (t, J = 7.1 Hz, 
3H), 1.00 – 0.93 (m, 2H), 0.73 (t, J = 7.1 Hz, 3H), 0.69 – 0.64 (m, 1H), 0.50 – 0.42 (m, 1H). Minor: 
δ 7.31 – 7.27 (m, 2H), 7.21 – 7.17 (m, 2H), 7.11 – 7.06 (m, 1H), 3.74 – 3.38 (m, 4H), 1.95 (dd, J = 
8.4, 2.8 Hz, 1H), 1.92 – 1.82 (m, 3H), 1.82 – 1.73 (m, 1H), 1.71 – 1.61 (m, 3H), 1.54 (s, 2H), 1.45 
(dd, J = 8.4, 2.7 Hz, 1H), 1.34 (t, J = 7.2 Hz, 3H), 1.26 – 1.23 (m, 1H), 1.25 (t, J = 7.2 Hz, 3H), 1.22 – 
1.16 (m, 1H), 1.13 – 1.05 (m, 1H), 0.77 – 0.71 (m, 1H), 0.71 – 0.61 (m, 1H), 0.59 – 0.53 (m, 1H); 13C 
NMR (126 MHz, CDCl3): Major: δ 179.8, 140.8, 129.0 (+, 2C), 128.9 (+, 2C), 126.7 (+), 44.4 (-), 43.7 
(-), 36.1, 33.6 (-), 32.7 (-), 32.4 (-), 31.8 (-), 28.0 (+), 27.9 (+), 25.9 (-), 25.5 (-), 18.8 (-), 12.6 (+), 
12.5(+), 12.2 (+). Minor: δ 178.9, 148.3, 129.8 (+, 2C), 127.8 (+, 2C), 124.8 (+), 44.8 (-), 43.0 (-), 
33.0 (-), 32.7 (-), 32.5 (-), 31.0 (-), 27.1, 27.0 (+), 26.9 (+), 25.6 (-), 25.0 (-), 21.5 (-), 14.3 (+), 13.0 
(+), 12.9 (+); FTIR (KBr, cm-1): 2978, 2914, 2869, 2835, 1600, 1488, 1314, 1212, 968, 759, 726, 
700; HRMS (TOF ES): Found 338.2650, calculated for C22H33BNO (M+H) 338.2655 (1.5 ppm). 
 
2.12.6 Miscellaneous Catalytic Asymmetric Hydroboration 
 
 (1-(3,4-difluorophenyl)cyclopropyl)methanol 
Compound was obtained via typical procedure for dissolved method using 
(1-(2,4-difluorophenyl)cycloprop-2-en-1-yl)methanol (###) (45.5 mg, 0.25 mmol, 1.0 equiv.). 
The product was purified by column chromatography using 3:1 hexane:ethyl acetate mobile 
phase. The titled compound was obtained as a pale yellow oil in 49% yield (22.5 mg, 0.122 mmol). 
Rf: 0.22; 1H NMR (500 MHz, CDCl3): δ 7.34 – 7.27 (m, 1H), 6.90 – 6.73 (m, 2H), 3.60 (s, 2H), 1.47 
(s, 1H), 0.92 – 0.76 (m, 4H); 13C (126 MHz, CDCl3): δ 162.6 (dd, J = 249.5, 11.8 Hz), 162.1 (dd, J = 
247.7, 12.0 Hz), 133.2 (+, dd, J = 9.6, 6.0 Hz), 125.6 (dd, J = 14.1, 3.7 Hz), 111.1 (+, dd, J = 20.9, 3.6 
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Hz), 105.5 – 101.5 (+, m), 70.4 (-), 23.6, 10.3 (-, d, J = 1.7 Hz, 2C); FTIR (KBr, cm-1): 3354, 3082, 
3007, 2928, 2872, 1614, 1601, 1506, 1466, 1421, 1267, 1138, 1117, 1084, 1036, 968, 849, 816, 




Compound was obtained via typical procedure for dissolved method 
using (1-((methoxymethoxy)methyl)cycloprop-2-en-1-yl)benzene (40) 
(95.2 mg, 0.50 mmol, 1.0 equiv.), [Rh(COD)Cl]2 (14.8 mg, 0.03 μmol, 0.06 equiv.) and (R)-BINAP 
(37.4.0 mg, 0.06 mmol, 0.12 equiv.), Pinnacol borane (148.0 μL, 1.0 mmol, 2.0 equiv.) and allowing 
reaction to stir overnight. The product was purified by column chromatography using 20:1 
hexane:ethyl acetate mobile phase. The titled compound was obtained as a colorless oil in 81% 
yield (128.2 mg, 0.402 mmol). Rf: 0.31; dr: 98:2; er: 68:32; [α]D20 +10.58 (c = 1.04, CHCl3); 1H NMR 
(500 MHz, CDCl3) δ 7.43 – 7.38 (m, 2H), 7.31 – 7.25 (m, 2H), 7.21 – 7.16 (m, 1H), 4.53 (s, 2H), 3.96 
(d, J = 10.1 Hz, 1H), 3.70 (d, J = 10.1 Hz, 1H), 3.14 (s, 3H), 1.29 (s, 6H), 1.28 (s, 6H), 1.22 (dd, J = 
9.5, 3.8 Hz, 1H), 1.12 (dd, J = 7.3, 3.8 Hz, 1H), 0.47 (dd, J = 9.5, 7.3 Hz, 1H); 13C NMR (126 MHz, 
CDCl3) δ 144.7, 128.9 (+, 2C), 128.1 (+, 2C), 126.3 (+), 96.3 (-), 83.4 (2C), 72.8 (-), 55.1 (+), 32.3, 
25.1 (+, 2C), 24.8 (+, 2C), 17.6 (-), 7.3 (+); FTIR (KBr, cm-1): 2978, 2929, 2882, 1415, 1371, 1323, 
1215, 1147, 1106, 1053, 966, 859, 700; HRMS (TOF ES): Found 337.2322, calculated for 





yl)cyclopropyl)methyl acetate (45) 
Compound was obtained via typical procedure for dissolved method 
using (1-phenylcycloprop-2-en-1-yl)methyl acetate (41) (47.1 mg, 0.25 
mmol, 1.0 equiv.) and allowing the reaction to stir overnight. The product was purified by column 
chromatography using 3:1 hexane:ethyl acetate mobile phase. The titled compound was obtained 
as a pale yellow oil in 83% yield (65.0 mg, 0.206 mmol). Rf: 0.29; dr: 96:4; er: 79:21; [α]D20 -45.65 
(c = 1.233, CHCl3); 1H NMR (500 MHz, CDCl3): δ 7.37 – 7.32 (m, 2H), 7.30 – 7.24 (m, 2H), 7.22 – 
7.17 (m, 1H), 4.51 (d, J = 11.41 Hz, 1H), 4.19 (d, J = 11.4 Hz, 1H), 1.97 (s, 3H), 1.27 (s, 6H), 1.24 (s, 
6H), 1.24 – 1.19 (m, 1H), 1.15 (dd, J = 7.3, 3.9 Hz, 1H), 0.51 (dd, J = 9.6, 7.3 Hz, 1H); 13C (126 MHz, 
CDCl3): δ 171.1, 143.8, 129.0 (+, 2C), 128.2 (+, 2C), 126.7 (+), 83.5 (2C), 70.2 (-), 31.1, 25.1 (+, 2C), 
24.6 (+, 2C), 21.2 (+), 17.9 (-), 7.3; FTIR (KBr, cm-1): 3059, 2978, 2934, 1742, 1732, 1416, 1371, 
1362, 1327, 1248, 1215, 1167, 1144, 1028, 976, 858, 729, 700, 671; HRMS (TOF ES): Found 




Compound was obtained via typical procedure for dissolved method 
using tert-butyldimethyl((1-phenylcycloprop-2-en-1-yl)methoxy)silane 
(42) (65.1 mg, 0.25 mmol, 1.0 equiv.) and allowing reaction to stir overnight. The product was 
purified by column chromatography using 2:1 hexane:ethyl acetate mobile phase. The titled 
compound was obtained as a colorless oil in 60% yield (58.3 mg, 0.150 mmol). Rf: 0.47; dr: 92:8; 
er: 80:20; [α]D20 -4.71 (c = 0.233, CHCl3); 1H NMR (500 MHz, CDCl3): δ 7.41 – 7.35 (m, 2H), 7.26 – 
7.21 (m, 2H), 7.19 – 7.14 (m, 1H), 3.85 (d, J = 10.5 Hz, 1H), 3.74 (d, J = 10.4 Hz, 1H), 1.29 (s, 6H), 
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1.27 (s, 6H), 1.10 – 1.06 (m, 1H), 1.04 (dd, J = 7.1, 3.7 Hz, 1H), 0.77 (s, 9H), 0.39 (dd, J = 9.2, 7.2 Hz, 
1H), -0.25 (s, 3H), -0.27 (s, 3H); 13C (126 MHz, CDCl3): δ 145.0, 130.3 (+, 2C), 127.7 (+, 2C), 126.3 
(+), 83.3 (2C), 68.7 (-), 35.4, 26.1 (+, 3C), 25.2 (+, 2C), 24.8 (+, 2C), 18.5, 16.4 (-), 6.1, -5.5 (+), -5.6 
(+); FTIR (KBr, cm-1): 3059, 2978, 2955, 2928, 2885, 2856, 1472, 1416, 1379, 1321, 1252, 1213, 
1146, 1088, 1076, 837, 773, 700; HRMS (TOF ES): Found 411.2523, calculated for C22H37BO3SiNa 




Compound was obtained via typical procedure for dissolved method using 
tert-butyl((1-(2,3-difluorophenyl)cycloprop-2-en-1-
yl)methoxy)dimethylsilane (60) (148.0 mg, 0.50 mmol, 1.0 equiv.) and 
allowing reaction to stir overnight. The product was purified by column chromatography using 
20:1 hexane:ethyl acetate mobile phase. The titled compound was obtained as a colorless oil in 
72% yield (152.2 mg, 0.358 mmol). Rf: 0.35; dr: 2.5:1; er: Major (d1): 82:18 (Column IB, IPA 0.4%, 
Flow Rate 1.0mL/min) Minor (d2): 73:27 (Column IB, IPA 0.4%, Flow Rate 1.0mL/min); [α]D20 
Major (d1): -30.69 (C = 1.88, CHCl3) Minor (d2): -14.77 (C = 0.88, CHCl3); 19F NMR (376 MHz, 
CDCl3) Major (d1): δ -140.0 (d, J = 20.8 Hz), -141.2 (d, J = 20.5 Hz). Minor (d2): δ -140.3 (d, J = 
21.0 Hz), -140.5 (d, J = 20.8 Hz); 1H NMR (500 MHz, CDCl3): Major (d1): δ 7.16 – 7.07 (m, 1H), 
7.04 – 6.89 (m, 2H), 3.88 (d, J = 10.7 Hz, 1H), 3.71 (d, J = 10.7 Hz, 1H), 1.28 (s, 6H), 1.26 (s, 6H), 
1.11 – 1.09 (m, 1H), 1.09 – 1.07 (m, 1H), 0.75 (s, 9H), 0.35 (t, J = 8.4 Hz, 1H), -0.23 (s, 3H), -0.27 
(s, 3H). Minor (d2): δ 7.10 – 7.04 (m, 1H), 7.04 – 6.91 (m, 2H), 3.86 (d, J = 10.1 Hz, 1H), 3.44 (d, J 
= 10.2 Hz, 1H), 1.16 (dd, J = 9.6, 3.7 Hz, 1H), 1.11 – 1.09 (m, 1H), 1.10 (s, 6H), 0.96 (s, 6H), 0.80 (s, 
9H), 0.48 (dd, J = 9.6, 7.0 Hz, 1H), -0.10 (s, 3H), -0.14 (s, 3H); 13C (126 MHz, CDCl3): Major (d1): 
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δ 150.6 (dd, J = 247.0, 12.8 Hz), 150.2 (dd, J = 248.6, 12.3 Hz), 134.2 (d, J = 10.8 Hz), 128.2 (+, t, J 
= 3.1 Hz), 123.0 (+, dd, J = 7.2, 4.6 Hz), 115.4 (+, d, J = 17.2 Hz), 83.4 (2C), 67.4 (-), 30.4 (d, J = 2.7 
Hz), 26.0 (+, 3C), 25.2 (+, 2C), 24.7 (+, 2C), 18.4, 15.8 (-), 5.6 (+), -5.6 (+), -5.7 (+). Minor (d2): δ 
151.7 (dd, J = 249.5, 13.8 Hz), 151.6 (dd, J = 249.5, 16.4 Hz), 131.6 (d, J = 10.1 Hz), 128.1 (+, t, J = 
3.2 Hz), 123.2 (+, dd, J = 6.6, 4.9 Hz), 115.3 (+, d, J = 16.8 Hz), 83.0 (2C), 68.9 (-), 29.8, 25.9 (+, 3C), 
24.9 (+, 2C), 24.5 (+, 2C), 18.4, 14.4 (-), 4.1 (+), -5.5 (+), -5.5 (+); FTIR (KBr, cm-1): 2978, 2956, 
2929, 2885, 2857, 1372, 1324, 1255, 1213, 1146, 1090, 836, 780, 729; HRMS (TOF ES): Found 





Compound was obtained via typical procedure for dissolved method 
using tert butyl((1-(2,4-difluorophenyl)cycloprop-2-en-1-
yl)methoxy)dimethylsilane (61) (148.0 mg, 0.50 mmol, 1.0 equiv.) and allowing reaction to stir 
overnight. The product was purified by column chromatography using 20:1 hexane:ethyl acetate 
mobile phase. The titled compound was obtained as a clear oil in 79% yield (167.2 mg, 0.394 
mmol). Rf: 0.30; dr: 2:1; er: Major (d1): 82:18 (Column IB, IPA 0.2%, Flow Rate 1.0mL/min) 
Minor (d2): 81:19 (Column IB, IPA 0.4%, Flow Rate 1.0mL/min); [α]D20 Major (d1): -31.08 (C = 
2.04, CHCl3) Minor (d2): -18.89 (C = 1.44, CHCl3); 19F NMR (376 MHz, CDCl3) Major (d1): δ -111.8 
(d, J = 7.4 Hz), -113.0 (d, J = 6.9 Hz). Minor (d2): δ -111.0 (d, J = 7.5 Hz), -113.3 (d, J = 7.3 Hz); 1H 
NMR (500 MHz, CDCl3): Major (d1): δ 7.35 – 7.28 (m, 1H), 6.77 – 6.67 (m, 2H), 3.84 (d, J = 10.6 
Hz, 1H), 3.66 (d, J = 10.6 Hz, 1H), 1.28 (s, 6H), 1.26 (s, 6H), 1.11 – 1.02 (m, 2H), 0.75 (s, 9H), 0.30 
(dd, J = 9.2, 7.4 Hz, 1H), -0.24 (s, 3H), -0.27 (s, 3H). Minor (d2): δ 7.32 – 7.21 (m, 1H), 6.81 – 6.73 
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(m, 1H), 6.74 – 6.64 (m, 1H), 3.83 (d, J = 10.1 Hz, 1H), 3.39 (d, J = 10.1 Hz, 1H), 1.13 (dd, J = 9.5, 
3.7 Hz, 1H), 1.10 (s, 6H), 1.07 (dd, J = 7.1, 3.7 Hz, 1H), 0.96 (s, 6H), 0.79 (s, 9H), 0.43 (dd, J = 9.6, 
7.0 Hz, 1H), -0.11 (s, 3H), -0.15 (s, 3H); 13C NMR (126 MHz, CDCl3): Major (d1): δ 163.0 (dd, J = 
249.5, 12.6 Hz), 162.9 (dd, J = 248.2, 12.5 Hz), 134.4 (+, dd, J = 9.5, 5.9 Hz), 127.7 (dd, J = 13.6, 3.6 
Hz), 110.3 (+, dd, J = 20.8, 3.6 Hz), 103.3 (+, t, J = 25.5 Hz), 83.4 (2C), 67.4 (-), 30.1, 26.0 (+, 3C), 
25.2 (+, 2C), 24.7 (+, 2C), 18.4, 15.9 (-), 5.5 (+), -5.5 (+), -5.7 (+). Minor (d2): δ 162.6 (dd, J = 249.2, 
12.0 Hz), 162.0 (dd, J = 246.5, 12.0 Hz), 134.2 (+, dd, J = 9.8, 6.3 Hz), 125.0 (dd, J = 13.7, 3.6 Hz), 
110.4 (+, dd, J = 20.6, 3.3 Hz), 103.3 (+, t, J = 25.5 Hz), 83.0 (2C), 69.1 (-), 29.4, 25.9 (+, 3C), 24.9 
(+, 2C), 24.6 (+, 2C), 18.4, 14.4 (-), 4.1 (+), -5.5 (+), -5.5 (+); FTIR (KBr, cm-1): 2979, 2952, 2929, 
2887, 2858, 1598, 1504, 1446, 1415, 1371, 1359, 1325, 1257, 1083, 968, 837, 775; HRMS (TOF 




Chapter 3. Directed Copper(I)-Catalyzed Carbomagnesiation of Cyclopropenes 
3.1 Introduction 
 Carbometalation reactions involving the addition of organometallic reagents across the 
double bond of cyclopropene are among the most interesting transformations performed on the 
strained three-membered ring due to the potential of constructing carbon-carbon bonds in a 
stereoselective manner.[41] Direct addition of Grignard,[42] organozinc,[43] and organocopper[43] 
reagents under steric control have been known for more than 30 years. Recently, the catalytic 
delivery of such reagents has been developed. These reactions include copper-catalyzed 
asymmetric addition of organozinc[44] and alkyl Grignard[45] reagents to cyclopropenes in which 
diastereoselectivity is under steric control (Scheme 29). Additionally, the catalytic directed 






Various directing groups including an alcohol,[46] ether,[47] ester,[48] and an oxazolidinone[48] 
auxiliary have been used to successfully direct carbomagnesiation to one face of cyclopropene. 
In 2016, an amide was shown by Marek to direct carbomagnesiation in a ring-opening process 
toward ɣ-ketoamides.[49] However these methods generally require a large excess of 
organometallic reagent, extreme cooling, and suffer from poor diastereoselectivity and functional 
group tolerance. Furthermore, the addition of Grignard reagents in the presence of a carbonyl 
functionality remains a distinct challenge and thus has been limited to more docile organozinc 
reagents.  
Fox[48a] has previously developed a copper-catalyzed addition of organozinc reagents to 1-
phenylcycloprop-2-ene-1-carboxylate. In this protocol, species 19a underwent highly 
diastereoselective carbozincation in the presence of four equivalents of dimethylzinc at 0 °C. A 
subsequent protic quench provided cyclopropane 70 in 82% yield and >95:5 diastereomeric 
ratio (Scheme 30). 
 
Scheme 30  
 
The development of a protocol utilizing more reactive Grignard reagents would have several 
immediate advantages. Organozinc reagents are severely limited in availability with only 
dimethylzinc, diethylzinc, and diphenylzinc being commercially available. In order to utilize more 
exotic organozinc reagents, their in-situ synthesis from corresponding organolithium or Grignard 
82% 





reagents is required. The development of a protocol utilizing more reactive Grignard reagents 
would not only vastly expand structural diversity but would also eliminate an entire labor 
intensive synthetic step. Therefore, we sought to develop a directed stereoselective catalytic 
addition of Grignard reagents to our recently developed cyclopropenylcarboxamide scaffolds for 




3.2 Early Reaction Screening 
Initial attempts to achieve directed catalytic addition of Grignard reagents to cyclopropenes 
were conducted using cyclopropenylcarboxylate 19a. This allowed for the direct benchmarking 
of the envisioned reaction against diastereoselective carbozincation as developed by Fox.[51a] 
Experiments carried out at room temperature and at 0 °C showed that nearly all starting material 
decomposed into a complex mixture of products (Table 18, entries 1, 2). At -60 °C no reaction 
occurred but at -35 °C 72% yield was achieved with a 2:1 diastereomeric ratio (entries 3, 4). 
However, these results were a bit disappointing compared to the reaction with organozinc which 
provided far superior efficiency and diastereoselectivity (Table 18, entry 5). From here, 
attention was given to cyclopropene-3-carboxamides developed in chapter II, due to the general 
nature of amides as being less electrophilic and more lewis basic as well as being less stabilizing 
of anions when compared to esters. Using amides could potentially provide several advantages 
over esters including allowing for elevated reaction temperatures, improved coordination to the 
catalyst, better configurational stability, and a greatly reduced propensity toward ring cleavage. 
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Delightfully, evaluation of diethylamide 53aa under the best conditions for esters provided 71a 
in excellent diastereoselectivity but in only 25% yield (Scheme 32). 
 














3.3 Optimization of Grignard Reagent Addition to Cyclopropenenyamides 
  The high degree of facial selectivity observed in carbomagnesiation of 53aa first prompted 
optimization toward improved chemical yield. Initially, an extension of reaction time to one hour 
was able to provide up to 76% yield (Table 19, entry 2). Any further increase in reaction time 
Entry Temperature, °C Time, h dr[a] Yield[b] 
1 20 1 - Decomposition 
2 0 0.5 - Trace 
3 -60 4 - No Conversion 
4 -35 0.3 2:1 72% 
5 Reaction with Organozinc[48a] 0.3 >95:5 82% 
25% 




[a] Determined by NMR of crude reaction mixture. [b] Isolated yield of purified product. 
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had negligible effect on the reaction. Increasing the amount of Grignard reagent to two 
equivalents further increased yield to 89% (entry 4). Interestingly, a large excess of highly 
reactive methylmagnesium bromide did not have any detrimental effects on reaction efficiency 
(entries 4, 5). It was found that the catalyst loading could be greatly reduced, first to 10 mol% 
and even 5 mol% without any noticeable decline in chemical yield. However, a further decrease 
of catalyst loading below 5 mol% resulted in a sharp decline of yield (entries 6-8). Without 
catalyst the reaction was found to be inoperable and only provided trace evidence of any addition 
products (entry 9). A survey of ethereal solvents showed that yield correlated with the 
coordination ability of the solvent. Dimethoxyethane provided 71a in near quantitative yield as 
essentially a single diastereomer (entry 12). Evaluation of several other fourth row transition 
metals was also conducted (entries 13-19). Marginal reactivity was found with iron(II) (entry 
16) and cobalt(II) (entry 17) while no reactivity was observed with titanium(IV), vanadium(IV), 
manganese(II), or nickel(II) (entries 13 – 15, 18). However, neither iron(II) or cobalt(II) was 
remotely comparable to the efficieny demonstrated with both copper(I) and copper(II) salts 
(entries 12, 19). The trend in copper salt reactivity (CuI>CuCN>CuBr>CuCl) correlated with the 
solubility of these species in DME (entries 12, 20 – 22). The reaction with carboxamide 53aa 
was found to be operable at room temperature but still resulted in considerable formation of over 
addition products (entry 23). Slight cooling to 0 °C using a simple ice water bath was found to be 
the optimal reaction temperature, providing 71a as a single diastereomer in 97% yield (entry 
24). At this temperature the reaction was surprisingly fast and reached full conversion and 96% 
yield in under five minutes (entries 25-27). Finally, the amount of Grignard reagent was able to 
be reduced to as low as 1.35 equivalents while still obtaining the monoaddition product 71a as a 
single diastereomer in near quantitative yields (Table 19, entry 28)! 
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Table 19. Optimization of amide directed catalytic carbomagnesiation. 













1 CuI (20) 1.5 Et2O -35 30 25 >98:2 
2 CuI (20) 1.5 Et2O -35 60 76 >98:2 
3 CuI (20) 1.5 Et2O -35 120 78 >98:2 
4 CuI (20) 2.0 Et2O -35 60 89 >98:2 
5 CuI (20) 3.0 Et2O -35 60 87 >98:2 
6 CuI (10) 2.0 Et2O -35 60 89 >98:2 
7 CuI (5) 2.0 Et2O -35 60 86 >98:2 
8 CuI (2.5) 2.0 Et2O -35 60 63 >98:2 
9 None 2.0 Et2O -35 60 <2 - 
10 CuI (5) 2.0 MTBE -35 60 13 >98:2 
11 CuI (5) 2.0 THF -35 60 90 >98:2 
12 CuI (5) 2.0 DME -35 60 99 >98:2 
13 Ti(Cp)2Cl2 (10) 2.0 DME -35 60 <2 - 
14 V(O)(AcAc)2 (10) 2.0 DME -35 60 <2 - 
15 MnCl2 (10) 2.0 DME -35 60 <2 - 
16 FeBr2 (10) 2.0 DME -35 60 40 >98:2 
17 CoCl2 (10) 2.0 DME -35 60 36 >98:2 
18 NiCl2 (10) 2.0 DME -35 60 <2 - 
19 CuCl2 (10) 2.0 DME -35 60 98 >98:2 
20 CuCN (5) 2.0 DME -35 60 74 >98:2 
21 CuBr (5) 2.0 DME -35 60 64 >98:2 
22 CuCl (5) 2.0 DME -35 60 13 >98:2 
23 CuI (5) 2.0 DME 20 60 58 >98:2 
24 CuI (5) 2.0 DME 0 60 97 >98:2 
25 CuI (5) 2.0 DME 0 30 96 >98:2 
26 CuI (5) 2.0 DME 0 15 94 >98:2 
27 CuI (5) 2.0 DME 0 5 96 >98:2 
28 CuI (5) 1.35 DME 0 5 95 >98:2 
53aa 71a 
[a] NMR yield of crude reaction mixtures with dibromomethane as standard. [b] Determined by 




3.4 Evaluation of Grignard Reagent Scope 
Next, a variety of other Grignard reagents were evaluated using the conditions optimized for 
the delivery of methylmagnesium bromide (Table 20). The reaction proved to be extremely 
diastereoselective and high yielding with methyl 71a, allyl 71b, and (trimethylsilyl)methyl 71c 
Grignard reagents. sp2-Hybridized phenyl and vinyl Grignard reagents were also efficient 
nucleophiles and provided 71d and 71e very efficiently. Even the less nucleophilic sp-
hybridized acetylenic reagent 71f also provided high diastereoselectivity.  
 





dr = >98:2 
94% 
dr = >98:2 
84% 
dr = >98:2 
10% 
dr = >98:2 
97% 
dr = >98:2 
93% 
dr = >98:2 
53aa 71 
71a 71b 71c 
71d 71e 71f 
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Interestingly, when extended alkyl Grignard reagents were used, the reaction became much 
more complex and resulted in a mixture of ring-retentive and ring-opened products 71 and 72 
(Table 21). This intriguing observation does not offer an immediate rationale based on 
traditional steric and electronic factors and invokes consideration of more subtle London 
dispersion effects,[45, 51] the complex and variable aggregate supramolecular structures[52] of 
cuprates in solution, and solvent effects influencing cation Lewis acidity and the Schlenk 
equilibrium. Isopropylmagensium bromide proved to be too sterically demanding and resulted 
in only traces of the ring opened product (R.O.P) 72j. 
 
Table 21. Evaluation of alkyl Grignard reagent scope. 
 
83% 
Pdt ratio 60:40 
dr = >98:2, 98:2 E:Z 
77% 
Pdt ratio 55:45 
dr = >98:2, 98:2 E:Z 
82% 
Pdt ratio 80:20 
dr = >98:2, 98:2 E:Z 
Trace 
Only R.O.P. Observed 





3.5 Optimization and Evaluation of Addition of Alkyl Grignard Reagents 
Optimization of the addition of isobutylmagnesium bromide to cyclopropene 53aa was 
conducted (Table 22). It became immediately apparent that cooling the reaction to -78 °C 
shutdown the reaction while only slight cooling using a brine/ice bath still resulted in 
considerable amounts of ring-opened product 72i (Table 22, entries 1, 2). Conducting the 
reaction at -35 °C and -45 °C for 90 minutes only slightly increased the product ratio. It was found 
that stirring for 60 minutes at -45 °C provided full conversion in addition to suppressing ring 
opening (entry 5). 
 








Subjecting the problematic alkyl Grignard reagents to cyclopropene 53aa at reduced 
temperature with prolonged reaction time allowed for the cyclopropane products 71g, 71h, and 
Entry Temp ( °C) Time (min) Yield (%)[a] Pdt Ratio[b] 
1 -78 60 5 >99:1 
2 -10 15 80 89:11 
3 -35 90 94 88:12 
4 -45 90 91 91:9 
5 -45 60 90 95:5 
53aa 71i 72i 
[a] NMR yield of crude reaction mixtures using dibromomethane as standard. [b] 
Determined by NMR of crude reactions. 
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71i to be obtained as the major product in excellent yield (Table 23). Isopropylmagnesium 
bromide failed to show any reactivity under these altered conditions. 
 














It was also possible to drive this process toward the ring opened product by first conducting 
the reaction at -45 °C for one hour and then allowing the reaction to warm to and stir for one hour 
at room temperature to provide 72g as the E-configured olefin in 77% yield (Scheme 33). 
  
93% 
Pdt ratio 90:10 
dr = >98:2, 98:2 E:Z 
89% 
Pdt ratio 91:9 
dr = >98:2, 98:2 E:Z 
90% 
Pdt ratio 95:5 
dr = >98:2, 98:2 E:Z 
No Reaction 











3.6 Evaluation of Amide Scope 
A wide variety of tertiary cyclopropene-3-carboxamides possessing various substituents on 
nitrogen were evaluated with methyl-, phenyl-, and vinylmagnesium bromide nucleophiles 
(Table 24). Generally, yields and diastereoselectivities were extremely high even with very 
stericly demanding diisopropylamides 73ba and 73be. Cyclic amides were compatible with all 
Grignard reagents, providing cis-configured cyclopropanes 73ia – 73ke in excellent yield and 
extremely high diastereoselectivity. In fact, the reactions were so efficient that the product 
obtained following extraction was of >95% purity and could be considered sufficiently pure for 
subsequent synthetic applications. The only reduction in diastereoselectivity was observed in the 
most sterically demanding combinations such as phenylmagnesium bromide with 



































dr = 13:1 
95% 
dr = >98:2 
94% 
dr = >98:2 
91% 
dr = 20:1 
88% 
dr = >98:2 
90% 
dr = >98:2 
91% 
dr = >98:2 
87% 
dr = >98:2 
84% 
dr = >98:2 
82% 
dr = >98:2 
89% 
dr = >98:2 
86% 
dr = >98:2 
53a_ 
73 
73ie 73id 73ia 

















It was also possible to access cyclopropyl ketones via utilization of the Weinreb amide as a 
directing group (Scheme 34). Upon exposure to methylmagnesium bromide cyclopropene 53u 
underwent efficient chemo- and diastereoselective carbometallation followed by a protic quench 
to provide 73ua in excellent yield. Subsequent introduction of additional Grignard reagent 
combined with slightly elevated temperature allowed for the efficient conversion of the amide 
into the corresponding methyl ketone 74. 
 
Scheme 34  
 
81% 
dr = >98:2 
83% 
dr = >98:2 
80% 
dr = >98:2 
95% 
dr = 9:1 
94% 
dr = >98:2 
92% 
dr = >98:2 
90% 
dr = >98:2 
61% 
dr = >98:2 
73ca 73cd 73ce 





It is important to note that the amide directed copper(I)-catalyzed Grignard reagent addition 
reaction is strictly limited to the use of tertiary amides. All attempts to conduct 
carbomagnesiation involving secondary 53m or primary 53t amides failed to provide any 
reactivity and intact cyclopropene was recovered in both cases (Scheme 35). Most likely, initial 
deprotonation of the acidic N-H bond led to sequestration of the copper catalyst and resulted in 
a complete shutdown of reactivity. This follows with previous observations which require copper 
catalyst to activate the cyclopropene double bond toward addition. Attempts to increase Grignard 
reagent loading to correct for losses due to deprotonation still only returned starting material. 
 









3.7 Carbomagnesiation Followed by Non-Protic Quench 
The possibility of incorporating additional electrophiles across the double bond of 
cyclopropene became of interest. With some optimization, it was found that the reaction could 
be quenched with methanol-d to provide deuterium labeled cis-configured cyclopropanes 75 and 



















Next, this chemistry was extended to feature the variety of compatible electrophiles. It was 
found that quenching with SN2-active alkyl halide electrophiles methyl iodide, allyl bromide, and 
benzyl bromide provided tetrasubstituted cyclopropanes 77a – 77c as single diastereomers in 
high yield (Table 25). Considerably more bulky TMSCl was found to be compatible with the 
reaction with MeMgBr as nucleophile to provide species 77d. Attempts to incorporate this 
electrophile with more sterically encumbered phenyl- or vinylmagnesium bromide failed and the 
protonated compounds 71d or 71e were isolated from these reactions as the sole products. 
Interestingly, electrophilic trapping with freshly distilled propionyl chloride provided a highly 
efficient diastereoselective route to cyclopropyl ketone 77e without any evidence of tertiary 
alcohol formation. Iodine was also successfully utilized as an electrophile to give stereodefined 
cyclopropyl iodide 77f. 
98% (94% D Pdt) 
dr = >98:2 
86% (92% D Pdt) 
























Finally, a set of cyclopropanes exhibiting the vast variability compatible with this 
transformation were synthesized (Table 26). The only decline in diastereoselectivity across all 
examples exhibiting the carbomagnesiation/electrophilic trapping sequence, was observed in 
78ddc possessing excessively sterically demanding dibenzyl amide and phenylmagnesium 
bromide as the nucleophile. Several interesting examples include 78ceb and 78dee which are 
candidates for the formation of interesting ring systems via ring-closing metathesis and a strain-
release driven rearrangement respectively. 
86% 
dr = >98:2 
87% 
dr = >98:2 
82% 
dr = >98:2 
51% 
dr = >98:2 
79% 
dr = >98:2 
72% 
dr = >98:2 
53aa 
77 
77a 77b 77c 
77d 77e 77f 
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dr = >98:2 
87% 
dr = >98:2 
80% 
dr = >98:2 
76% 
dr = >98:2 
81% 
dr = >98:2 
79% 
dr = 15:1 
80% 
dr = >98:2 
52% 
dr = >98:2 
78jda 78kdb 78ide 






3.8 Discussion of Mechanism 
Based on experimental observations, a possible reaction pathway has been devised (Scheme 
37). Initially, copper(I) iodide is converted to the corresponding Gilman-type cuprate 79 during 
a premixing period prior to the introduction of cyclopropene. Upon addition of cyclopropene, the 
cuprate complex is delivered to one face of cyclopropene via coordination with the amide 
function to establish species 80. From here, copper is able to activate the double bond which then 
undergoes an overall carbocupration to provide cyclopropyl cuprate species 81. 
Transmetallation returns the Gilman cuprate 79 to the catalytic cycle and generates a cyclopropyl 
Grignard reagent species 82. Subsequent exposure of the cyclopropyl Grignard reagent to an 
electrophile results in the production of cis-configured cyclopropane 78 as a single diastereomer. 
Alternatively, systems experiencing significant destabilization of species 81 could undergo direct 
decomposition toward the ring-opened product. During this process, the released 
monoorganocuprate would be converted back to Gilman cuprate species 79 following 
transmetallation with another equivalent of Grignard reagent.[53] 
 











3.9 Carbomagnesiation Followed by Diastereoselective Quench with Prochiral 
Electrophiles 
Due to the apparent high conformational and configurational rigidity of the cyclopropyl 
Grignard reagent species 82, the possibility of conducting a diastereoselective addition to 
prochiral electrophiles was considered. By extending the reaction time following introduction of 
an aldehyde, the production of products possessing four contiguous stereocenters was possible 
(Table 27).  
 














dr = 96:4 
60% 
dr = 92:8 
70% 
dr = 87:13 
85% 
dr = >98:2 
88% 
dr = 93:7 
68% 
dr = 84:16 
79% 
dr = >98:2 
79% 
dr = >98:2 
53aa 83 
83da 83aa 83ba 




In a series of reactions with different Grignard reagents all quenched by benzaldehyde, 
diastereoselectivity generally declined with diminishing steric influence of the nucleophilic 
component moving from phenyl substituted 83da to vinyl substituted 83ea. Furthermore, 
diastereoselectivity could be greatly increased when very sterically demanding pivaldehyde was 
used which provided products 83dc, 83cc, and 83ac as a single diastereomer in all combinations 
of Grignard reagents. 
3.10 Determination of Relative Stereochemistry 
The relative stereochemistry of the cyclopropylmethanol products in Table 27 was first 
confirmed by NMR methods using Weinreb amide 53u, which underwent efficient 
carbomagnesiation followed by quenching with pivaldehyde to provide 84 (Scheme 38). 
Exposure of 84 to acidic conditions resulted in the formation of the corresponding fused lactone 
85. NOESY NMR analysis showed very strong methyl/H(green) and tert-butyl/H(black) 












dr = >98:2 
89% 






X-ray analysis of structure 83aa, provided confirmation of the stereochemical outcome of the 
carbomagnesiation/electrophilic trapping sequence (Figure 6). It can clearly be seen that 
carbomagnesiation occurs across the same face of cyclopropene without inversion of the 
intermediate cyclopropylmagensium bromide 82 as the amide, methyl nucleophile, and aldehyde 
electrophile are all located on the same face of cyclopropane. Furthermore, orientation of the 
hydroxyl group toward the amide, as it would be in lactone, places the two phenyl rings on the 
convex face of the molecule as predicted in structure 85. 
 











The highly diastereoselective formation of products 83 was rationalized via conformational 
analysis of proposed complexes 86 - 89 (Scheme 39). Structures 86 and 89 can be considered 
highly unfavorable due to the significant steric interaction expected between R1 of cyclopropane 
and R2 of the aldehyde. Complexes 87 and 88, providing diastereomeric products 90 and 91 
respectively, would be expected to experience relatively similar steric interactions. Therefore, 
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the highly diastereoselective formation of product 91 can likely be attributed to a stabilizing 
chelation-control effect resulting in selective addition of cyclopropylmagnesium bromide to the 














3.11 Carbomagnesiation with Substituted Cyclopropenes 
Finally, the regioselectivity of carbomagnesiation on a substituted double bond of 
cyclopropene was investigated (Table 28). With phenyl substituted cyclopropenes high 
selectivity for vicinally substituted products 94aa – 94ae was observed. However, when a butyl 
substituent was placed on cyclopropene the selectivity becomes more variable. Methyl and vinyl 
nucleophiles provided selectivity toward germinal products 93ba and 93be, while phenyl and 
(trimethylsilyl)methyl selectively formed vicinally substituted products 94bd and 94bc. In all 
cases, yields were high and products were obtained as single diastereomers. 























To probe electronic influences on the carbomagnesiation reaction, a series of phenyl-
substituted cyclopropenes bearing groups of varying electronics in the 4-position were evaluated 
(Table 30). These cyclopropenes were accessed via Sonogashira coupling of the corresponding 
aryl halide with TMS-acetylene followed by desilylation. Cyclopropenation with methyl 
phenyldiazoacetate then provided substituted cyclopropenylcarboxylates 95, which could be 
92% 
Pdt ratio: 91:9 
dr = >98:2 
84% 
Pdt ratio: >98:2 
dr = >98:2 
89% 
Pdt ratio: >98:2 
dr = >98:2 
70% 
Pdt ratio: >98:2 
dr = >98:2 
75% 
Pdt ratio: 75:25 
dr = >98:2 
91% 
Pdt ratio: 70:30 
dr = >98:2 
88% 
Pdt ratio: 81:19 
dr = >98:2 
90% 
Pdt ratio: 88:12 
dr = >98:2 
92 93 94 
94aa 94ae 94ad 94ac 
94bc 94bd 93be 93ba 
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readily hydrolyzed under basic conditions to carboxylic acid species 96. A peptide coupling 
sequence then provided p-substituted aryl cyclopropenes 92a – 92f (Table 29).  
 




















92d 92f 92e 
41% 
94% 53% 96% 
[I] [II] 
[III] [IV] [V] 
[I] Pd(PPh3)4, CuI, NEt3, THF; [II] K2CO3, THF:MeOH (1:1); [III] Rh2(OAc)4, methyl phenyldiazoacetate ; 







Substrates bearing electron withdrawing substituents in the para-position of the phenyl ring 
displayed the highest efficiency and selectivity with 98f being obtained exclusively as the vicinal 
product as a single diastereomer. Evaluation of substrate 98c which possessed an electron-
donating p-methoxy substituent resulted in greatly diminished yield and slightly deteriorated 
regioselectivity. Generally, regioselectivity increased with increasingly electron deficient 
cyclopropenes (Table 30). 
 













The regioselectivity of products 94 and 98 was rationalized by evaluation of the intermediate 
cyclopropylcopper(III) complexes in Figure 7. These structures are believed to form following 
addition of the nucleophilic Gilman cuprate to the electrophilic double bond of cyclopropene 
during a carbocupration sequence. The equilibrium between the two interconverting 
93% 
Pdt ratio: >98:2 
dr = >98:2 
99% 
Pdt ratio: 95:5 
dr = >98:2 
97% 
Pdt ratio: 86:14 
dr = >98:2 
52% 
Pdt ratio: 90:10 
dr = >98:2 
92 97 98 
98f 98e 98d 98c 
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regioisomers is proposed to directly influence the subsequent regiodefining C-C bond forming 
reductive elimination to cyclopropylcuprate species 81.  
With phenyl-substituted cyclopropenes, the combined influence of the more stable anionic 
intermediate, also experiencing minimal steric interactions, led to the highly selective formation 
of vicinally substituted products 94aa–94ae (Figure 7a). Reactions involving butyl-substituted 
cyclopropenes resulted in mixtures of products in all examples due to competing steric and 
electronic influences. These reactions are also highly dependent on the steric signature of the 
cuprate (Figure 7b). In case I, when R2 is a relatively small methyl or vinyl group, steric 
interactions are minimal therefore allowing the reactions to proceed under electronic control via 
the formation of the most stable anionic intermediate to provide geminally substituted products 
93ba and 93be. In case II, when R2 is a more sterically demanding phenyl or 
(trimethylsilyl)methyl group, the reactions are goverened by steric control and provide vicinally 
substituted products 94bd and 94bc. The trend in regioselectivity observed in phenyl-
substituted cyclopropenes in Table 30 can solely be attributed to the electronic influences of the 
substituent in the 4-position of the phenyl ring upon the anionic cyclopropylcopper(III) 
intermediate (Figure 7c). A highly electron-withdrawing p-CF3 substituent provided further 
electronic stabilization to the anion and provided vicinally substituted 98f as the sole product. 
Exchanging the substituent for electron-donating p-methoxy destabilized the anionic 



























More stable anion 




R2 = Me, Vinyl 
Case II 
R2 = Phenyl, MeTMS 
Vinyl 
Unfavorable sterics 
Favorable sterics More stable anion 
Control 
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More stable anion 
Increased product selectivity 
 
Less stable anion 




Lastly, the ability to apply the developed carbomagnesiation/electrophilic trapping reaction 
toward the synthesis of stereodefined cyclopropanes possessing two quaternary stereocenters 
was successfully demonstrated (Scheme 40). Sterically congested penta-substituted 
cyclopropane 99 was obtained in excellent yield and diastereoselectivity. 
 








In conclusion, the directed copper(I)-catalyzed addition of Grignard reagents across the 
strained double bond of cyclopropenes has been developed. The high degree of conformational 
and configurational stability of the intermediate cyclopropyl Grignard reagent has allowed for 
the highly diastereoselective trapping with a variety of electrophiles, including prochiral 
aldehydes providing for the construction of two carbon-carbon bonds and four contiguous 
stereocenters in a single chemical step. Finally the developed methodology was evaluated on 
substituted cyclopropenes and was found to be extremely regio- and diastereoselective with 
electron deficient double bonds and could even be further extended to the synthesis of penta-
substituted cyclopropanes bearing two quaternary stereocenters in a highly efficient and 
diastereoselective manner.   
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[Typical Amide Procedure]: 1-phenyl-2-(p-tolyl)cycloprop-2-ene-
1-carboxylic acid (96d) (250 mg, 1.0 mmol, 1.0 equiv.) and 
dimethylformamide (2 drops) were dissolved in freshly distilled and dried dichloromethane (7 
mL) and added to a flame dried round bottom flask under an inert nitrogen atmosphere. Oxalyl 
chloride (130 μL, 190 mg, 1.5 mmol, 1.5 equiv.) was then added slowly dropwise and stirred at 
room temperature for 2 hours. The solution was then evaporated under reduced pressure to 
provide a pale yellow solid material. Part 2: diethylamine (206 μL, 146 mg, 2.0 mmol, 2.0 equiv.) 
and triethylamine (280 μL, 202 mg, 2.0 mmol, 2.0 equiv.), and freshly dried dichloromethane (6.0 
mL) were combined in a flame dried two neck round bottom flask under an inert nitrogen 
atmosphere. Recovered material from part 1 was dissolved in freshly dried dichloromethane (6.0 
mL) and added to the two neck flask slowly dropwise. The reaction was then stirred for 18 hours 
and then partitioned between water and dichloromethane. The aqueous phase was then acidified 
using 1N HCl to a pH of approximately 2. The organic phase was then extracted with properly 
acidified water (pH = 2, 3 x 10mL). The combined acidic aqueous layers were then back extracted 
once with dichloromethane which was combined with other organic layers, washed with brine, 
dried, filtered, and concentrated. The product was then purified by silica gel column 
chromatography using a 2:1 hexane:ethyl acetate mobile phase to provide the titled compound 
as a colorless solid in 94% yield (288 mg, 0.943 mmol). mp: 123.3 – 125.7 °C; Rf: 0.29; 1H NMR 
(500 MHz, CDCl3) δ 7.69 – 7.59 (m, 2H), 7.32 – 7.23 (m, 4H), 7.22 – 7.12 (m, 3H), 7.03 (s, 1H), 3.53 
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(dq, J = 14.3, 7.1 Hz, 2H), 3.31 (dq, J = 14.0, 7.1 Hz, 2H), 2.33 (s, 3H), 1.19 (t, J = 7.1 Hz, 3H), 0.95 
(t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 173.3, 142.9, 139.9, 130.4 (+, 2C), 129.4 (+, 2C), 
128.4 (+, 2C), 126.2 (+), 126.1 (+, 2C), 123.5, 122.1, 97.8 (+), 42.2 (-), 39.0 (-), 35.4, 21.7 (+), 13.8 
(+), 12.7 (+); FTIR (KBr, cm-1): 3081, 3023, 2972, 2933, 1625, 1457, 1275, 1118, 820, 700; HRMS 
(TOF ES): Found 328.1682, calculated for C21H23NONa (M+Na) 328.1677 (1.5 ppm). 
 
1-phenyl-2-(p-tolyl)cycloprop-2-ene-1-carboxylic acid (96d) 
[Typical Hydrolysis Prodecure]: A solution of methyl 1-phenyl-2-(p-
tolyl)cycloprop-2-ene-1-carboxylate (95d) (300 mg, 1.13 mmol, 1.0 
equiv.) in a 1:1 mixture of methanol:tetrahydrofuran (20 mL) was 
stirred at 0 °C. A 1.5 M aqueous solution of sodium hydroxide (8 mL) was added dropwise and 
the mixture was stirred for 18 hours. Organic solvents were then removed under vacuum and the 
remaining aqueous solution was added to dichloromethane (20 mL). The mixture was acidified 
to pH 2 with 1N aqueous HCl. The organic phase was separated and the aqueous layer was 
extracted with dichloromethane (3 x 10 mL). The combined organic phases were washed with 
brine, dried with MgSO4, filtered, and concentrated. The obtained product is typically pure 
enough to be used in further amide coupling as is, however, if necessary, further purification can 
be achieved by column chromatography on silica gel using a 1:1 hexane:ethyl acetate mobile 
phase. The titled compound was obtained as colorless solid in 92 % yield (261 mg, 1.04 mmol). 
mp: 134.5 – 135.9 °C; Rf: 0.19; 1H NMR (500 MHz, CDCl3) δ 7.56 – 7.51 (m, 2H), 7.45 – 7.39 (m, 
2H), 7.30 – 7.26 (m, 2H), 7.26 – 7.18 (m, 3H), 7.13 (s, 1H), 2.39 (s, 3H); 13C NMR (126 MHz, CDCl3) 
δ 181.3, 140.7, 140.4, 130.1 (+, 2C), 129.8 (+, 2C), 128.5 (+, 2C), 128.1 (+, 2C), 126.7 (+), 122.4, 
116.7, 98.7 (+), 33.2, 21.7 (+); FTIR (KBr, cm-1): 3137, 3025, 1684, 1408, 1224, 1173, 819, 698; 





Compound was obtained via [typical amide procedure] using 1,2-
diphenylcycloprop-2-ene-1-carboxylic acid (96a) (400 mg, 1.69 mmol, 
1.0 equiv.). The product was then purified by silica gel column chromatography using a 1:1 
hexane:ethyl acetate mobile phase to provide the titled compound as a golden oil in 93% yield 
(458 mg, 1.57 mmol). Rf: 0.53; 1H NMR (500 MHz, CDCl3): δ 7.89 – 7.71 (m, 2H), 7.41 – 7.29 (m, 
7H), 7.23 – 7.18 (m, 1H), 7.14 (s, 1H), 3.72 – 3.47 (m, 2H), 3.41 – 3.26 (m, 2H), 1.22 (t, J = 7.1 Hz, 
3H), 0.97 (t, J = 7.1 Hz, 3H); 13C (126 MHz, CDCl3): δ 173.1, 142.6, 130.3 (+, 2C), 129.6 (+), 128.6 
(+, 2C), 128.4 (+, 2C), 126.3, 126.2 (+), 126.0 (+, 2C), 122.3, 98.7 (+), 42.1 (-), 38.9 (-), 35.4, 13.7 
(+), 12.6 (+); FTIR (KBr, cm-1): 3080, 3059, 2974, 2933, 2873, 1682, 1614, 1445, 1427, 1381, 
1277, 1221, 1072, 922, 768, 698, 644; HRMS (TOF ES): Found 292.1699, calculated for C20H22NO 




Compound was obtained via [typical amide procedure] using 2-butyl-
1-phenylcycloprop-2-ene-1-carboxylic acid (96b) (450 mg, 2.08 mmol, 1.0 equiv.). The product 
was then purified by silica gel column chromatography using a 3:1 hexane:ethyl acetate mobile 
phase to provide the titled compound as a very pale yellow oil in 80% yield (434 mg, 1.60 mmol). 
Rf: 0.34; 1H NMR (500 MHz, CDCl3): δ 7.23 – 7.16 (m, 2H), 7.12 – 7.01 (m, 3H), 6.59 (s, 1H), 3.45 
(dq, J = 14.0, 7.1 Hz, 1H), 3.29 (dq, J = 14.3, 7.1 Hz, 1H), 3.16 (dq, J = 14.4, 7.3 Hz, 2H), 2.63 – 2.45 
(m, 2H), 1.59 – 1.42 (m, 2H), 1.35 – 1.18 (m, 2H), 1.09 (t, J = 7.1 Hz, 3H), 0.79 (q, J = 7.1 Hz, 6H); 
13C (126 MHz, CDCl3): δ 174.1, 143.9, 128.3 (+ 2C), 125.9 (+, 2C), 125.8 (+), 124.2, 98.2 (+), 41.9 
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(-), 38.7 (-), 34.2, 29.2 (-), 24.2 (-), 22.4 (-), 13.8 (+), 13.6 (+), 12.7 (+); FTIR (KBr, cm-1):3082, 
3057, 2961, 2932, 2972, 1643, 1634, 1614, 1493, 1445, 1423, 1379, 1275, 1221, 1099, 856, 700; 




Trimethylamine (83 μL, 59.7 mg, 0.590 mmol, 1.5 equiv.) was added 
to 2-(4-methoxyphenyl)-1-phenylcycloprop-2-ene-1-carboxylic 
acid (96c) (105 mg, 0.390 mmol, 1.0 equiv.) dissolved in tetrahydrofuran (5 mL). The solution 
was then cooled to 0 °C. N,N'-Dicyclohexylcarbodiimide (122 mg, 0.590 mmol, 1.5 equiv.), 1-
Hydroxybenzotriazole hydrate (80.0 mg, 0.590 mmol, 1.5 equiv.), and diethylamine (52.0 μL, 37.3 
mg, 0.51 mmol, 1.3 equiv.) were then added sequentially and the reaction was allowed to warm 
to room temperature over approximately 1 hour before being heated to 42 °C and stirred for 24 
hours. Solvent was evaporated and the crude material was directly purified by silica gel column 
chromatography using a 3:1 hexane:ethyl acetate mobile phase to provide the titled product as a 
an amber oil in 41% yield (51.7 mg, 0.161 mmol). Rf: 0.26; 1H NMR (500 MHz, CDCl3) δ 7.70 (d, J 
= 8.7 Hz, 2H), 7.30 – 7.26 (m, 2H), 7.26 – 7.23 (m, 2H), 7.20 – 7.14 (m, 1H), 6.94 (s, 1H), 6.87 (d, J 
= 8.7 Hz, 2H), 3.79 (s, 3H), 3.53 (dq, J = 14.3, 7.1 Hz, 2H), 3.29 (dq, J = 14.0, 7.1 Hz, 2H), 1.19 (t, J = 
7.1 Hz, 3H), 0.95 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 173.4, 160.9, 142.9, 132.1 (+, 2C), 
128.5 (+, 2C), 126.2 (+), 126.1 (+, 2C), 122.0, 119.0, 114.2 (+, 2C), 95.9 (+), 55.5 (+), 42.2 (-), 39.0 
(-), 35.2, 13.9 (+), 12.8 (+); FTIR (KBr, cm-1): 2972, 2934, 1752, 1625, 1505, 1442, 1250, 1177, 







Compound was obtained via [typical amide procedure] using 2-(4-
fluorophenyl)-1-phenylcycloprop-2-ene-1-carboxylic acid (96e) (250 
mg, 1.0 mmol, 1.0 equiv.). The product was then purified by silica gel column chromatography 
using a 2:1 hexane:ethyl acetate mobile phase to provide the titled compound as a pale yellow 
solid in 96% yield (299 mg, 0.966 mmol). mp: 86.6 – 89.1 °C; Rf: 0.29; 1H NMR (500 MHz, CDCl3) 
δ 7.82 – 7.70 (m, 2H), 7.32 – 7.27 (m, 2H), 7.26 – 7.22 (m, 2H), 7.22 – 7.17 (m, 1H), 7.05 (s, 1H), 
7.05 – 6.99 (m, 2H), 3.56 (dq, J = 14.1, 7.1 Hz, 1H), 3.49 (dq, J = 14.3, 7.2 Hz, 1H), 3.36 – 3.22 (m, 
2H), 1.19 (t, J = 7.1 Hz, 3H), 0.95 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 173.2, 163.6 (d, J 
= 250.7 Hz), 142.4, 132.5 (+, d, J = 8.3 Hz, 2C), 128.6 (+, 2C), 126.4 (+), 126.1 (+, 2C), 122.7 (d, J = 
2.9 Hz), 122.0, 115.9 (+, d, J = 21.9 Hz, 2C), 97.7 (+, d, J = 2.7 Hz), 42.2 (-), 39.0 (-), 35.5, 13.8 (+), 
12.7 (+); 19F ; FTIR (KBr, cm-1): 2973, 2934, 1624, 1500, 1428, 1222, 839, 700; HRMS (TOF ES): 




Compound was obtained via [typical amide procedure] using 1-
phenyl-2-(4-(trifluoromethyl)phenyl)cycloprop-2-ene-1-carboxylic 
acid (96f) (230 mg, 0.760 mmol, 1.0 equiv.). The product was then purified by silica gel column 
chromatography using a 40:1 dichloromethane:ethyl acetate mobile phase to provide the titled 
compound as a colorless solid in 53% yield (146.1 mg, 0.406 mmol). mp: 80.0 – 82.4 °C; Rf:0.29; 
1H NMR (500 MHz, CDCl3) δ 7.87 (d, J = 8.0 Hz, 2H), 7.60 (d, J = 8.1 Hz, 2H), 7.35 – 7.15 (m, 6H), 
3.62 – 3.43 (m, 2H), 3.38 – 3.24 (m, 2H), 1.19 (t, J = 7.1 Hz, 3H), 0.95 (t, J = 7.1 Hz, 3H); 13C NMR 
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(126 MHz, CDCl3) δ 172.8, 142.0, 131.3 (q, J = 32.3 Hz), 130.6 (+, 2C), 129.9, 128.7 (+, 2C), 126.7 
(+), 126.1 (+, 2C), 125.7 (q, J = 3.8 Hz, +, 2C), 124.0 (q, J = 272.4 Hz), 122.3, 101.3 (+), 42.2 (-), 39.1 
(-), 35.8, 13.9 (+), 12.7 (+); 19F NMR (376 MHz, CDCl3) δ -62.85 (s, 3F); FTIR (KBr, cm-1): 3082, 
2976, 2936, 1626, 1430, 1323, 1277, 1166, 1124, 1064, 846, 712, 699; HRMS (TOF ES): Found 
382.1385, calculated for C21H20F3NONa (M+Na) 382.1395 (2.6 ppm). 
 
methyl 1-phenyl-2-(p-tolyl)cycloprop-2-ene-1-carboxylate (95d) 
p-tolylacetylene (1.0 g, 8.61 mmol, 1.5 equiv.) and rhodium(II) acetate 
dimer (25.0 mg, 0.115 mmol, 0.02 equiv.) in 7 mL dichloromethane 
were placed in 25 mL 2-neck flask under inert nitrogen atmosphere at 
room temperature. methyl 2-diazo-2-phenylacetate (17a) (1.0 g, 5.74 mmol, 1.0 equiv.) diluted 
in 5 mL DCM was then added via syringe pump over 18 hours and then stirred for an additional 
3 hours. The reaction mixture was then evaporated and purified by silica gel column 
chromatography using 3:1 hexane:ethyl acetate mobile phase. The titled compound was obtained 
as a pale yellow solid in 50% yield (761 mg, 2.88 mmol). mp: 73.1 – 75.9 °C; Rf: 0.26; 1H NMR (500 
MHz, CDCl3) δ 7.57 – 7.53 (m, 2H), 7.44 – 7.40 (m, 2H), 7.33 – 7.28 (m, 2H), 7.27 – 7.20 (m, 3H), 
7.16 (s, 1H), 3.74 (s, 3H), 2.40 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 175.3, 141.2, 140.5, 130.0 (+, 
2C), 129.7 (+, 2C), 128.3 (+, 2C), 128.1 (+, 2C), 126.5 (+), 122.7, 117.1, 99.2 (+), 52.2 (+), 33.5, 21.7 
(+); FTIR (KBr, cm-1): 3025, 2948, 1719, 1504, 1433, 1210, 1020, 820, 699; HRMS (TOF ES): 






1-ethynyl-4-fluorobenzene (1.0 g, 8.32 mmol, 1.5 equiv.) and 
rhodium(II) acetate dimer (25.0 mg, 0.111 mmol, 0.02 equiv.) in 6 mL 
Dichloromethane were placed in 25 mL 2-neck flask under inert nitrogen atmosphere at room 
temperature. methyl 2-diazo-2-phenylacetate (17a) (977 mg, 5.55 mmol, 1.0 equiv.) diluted in 5 
mL DCM was then added via syringe pump over 18 hours and then stirred for an additional 3 
hours. The reaction mixture was then evaporated and purified by silica gel column 
chromatography using 3:1 hexane:ethyl acetate mobile phase. The titled compound was obtained 
as an amorphous solid in 81% yield (1.21 g, 4.51 mmol). Rf: 0.26; 1H NMR (500 MHz, CDCl3) δ 7.66 
– 7.60 (m, 2H), 7.42 – 7.36 (m, 2H), 7.34 – 7.28 (m, 2H), 7.26 – 7.21 (m, 1H), 7.20 (s, 1H), 7.17 – 
7.10 (m, 2H), 3.73 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 174.9, 163.6 (d, J = 251.0 Hz), 140.7, 131.9 
(+, d, J = 9.0 Hz, 2C), 128.2 (+, 2C), 128.1 (+, 2C), 126.6 (+), 121.8 (d, J = 3.5 Hz), 116.5, 116.2 (+, 
d, J = 21.9 Hz, 2C), 99.8 (+, d, J = 2.7 Hz), 52.3 (+), 33.7; 19F NMR (376 MHz, CDCl3) δ -109.1 (s, 1F); 
FTIR (KBr, cm-1): 2951, 1723, 1599, 1503, 1434, 1223, 1014, 840, 699; HRMS (TOF ES): Found 
291.0803, calculated for C17H13FO2Na (M+Na) 291.0797 (2.1 ppm). 
 
1,2-diphenylcycloprop-2-ene-1-carboxylic acid (96a) 
Compound was obtained via [typical hydrolysis procedure] using methyl 
1,2-diphenylcycloprop-2-ene-1-carboxylate (95a) (500 mg, 2.0 mmol, 1.0 
equiv.). The titled compound was obtained as an amorphous glass in 87% yield (411 mg, 1.74 
mmol). 1H NMR (500 MHz, CDCl3): δ 7.66 – 7.60 (m, 2H), 7.47 – 7.38 (m, 5H), 7.30 – 7.26 (m, 2H), 
7.23 – 7.19 (m, 2H); 13C (126 MHz, CDCl3): δ 180.8, 140.0, 130.2 (+), 130.0 (+, 2C), 128.9 (+, 2C), 
128.4 (+, 2C), 128.1 (+, 2C), 126.7 (+), 125.0, 116.9, 99.7 (+), 33.2; FTIR (KBr, cm-1): 3138, 3059, 
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3003, 2887, 2839, 1639, 1682, 1487, 1446, 1414, 1256, 1224, 976, 953, 916, 764, 698; HRMS 




A solution of methyl 2-(4-fluorophenyl)-1-phenylcycloprop-2-ene-1-
carboxylate (95e) (300 mg, 1.12 mmol, 1.0 equiv.) in a 1:1 mixture of 
methanol:tetrahydrofuran (20 mL) was stirred at 0 °C. A 1.5 M aqueous solution of sodium 
hydroxide (8 mL) was added dropwise and the mixture was stirred for 18 hours. Organic solvents 
were then removed under vacuum and the remaining aqueous solution was added to 
dichloromethane (20 mL). The mixture was acidified to pH 2 with 1N aqueous HCl. The organic 
phase was separated and the aqueous layer was extracted with dichloromethane (3 x 10 mL). 
The combined organic phases were washed with brine, dried with MgSO4, filtered, and 
concentrated. The obtained product is typically pure enough to be used in further amide coupling 
as is, however, if necessary, further purification can be achieved by column chromatography on 
silica gel using a 1:1 hexane:ethyl acetate mobile phase. The titled compound was obtained as a 
colorless solid in 90 % yield (257 mg, 1.01 mmol). mp: 138.9 – 140.2 °C; Rf: 0.26; 1H NMR (500 
MHz, CDCl3) δ 7.64 – 7.59 (m, 2H), 7.41 – 7.37 (m, 2H), 7.31 – 7.27 (m, 2H), 7.24 – 7.19 (m, 1H), 
7.18 (s, 1H), 7.15 – 7.09 (m, 2H); 13C NMR (126 MHz, CDCl3) δ 179.8, 163.8 (d, J = 251.6 Hz), 139.9, 
132.1 (+, d, J = 9.0 Hz, 2C), 128.4 (+, 2C), 128.3 (+, 2C), 127.0 (+), 121.5 (d, J = 2.9 Hz), 116.4 (+, d, 
J = 21.9 Hz, 2C), 116.3, 99.4 (+, d, J = 2.9 Hz), 33.3; 19F NMR (376 MHz, CDCl3) δ -108.8 (s, 1F); 
FTIR (KBr, cm-1): 3138, 3025, 1686, 1599, 1502, 1408, 1227, 837, 698; HRMS (TOF ES): Found 








[Typical Procedure A]: Methylmagnesium bromide (135 μL, 3.0 M 
(diethyl ether), 0.405 mmol, 1.35 equiv.) was added dropwise to a flame dried two neck flask 
containing copper iodide (3.0 mg, 15.0 μmol, 5.0 mol%) and freshly dried and distilled 
dimethoxyethane (1.0 mL) under a nitrogen atmosphere at 0 °C. The mixture was stirred for five 
minutes at 0 °C. N,N-diethyl-1-phenylcycloprop-2-ene-1-carboxamide (53aa) (65.0 mg, 0.30 
mmol, 1.0 equiv.) was then added slowly dropwise as a solution in dry dimethoxyethane (1.0 mL). 
After five minutes of stirring at 0 °C, saturated aqueous ammonium chloride (1 mL) was added 
dropwise and the reaction was stirred for another five minutes at 0 °C. The resulting solution was 
then diluted with water and extracted with diethyl ether (3 x 5 mL). Combined organic layers 
were washed with brine, dried, filtered, and evaporated. The product was purified by column 
chromatography using silica and a 3:1 hexane:ethyl acetate mobile phase. The titled compound 
was obtained as a viscous colorless oil in 96% yield (66.4 mg, 0.287 mmol). Rf: 0.45; dr: >99:1; 1H 
NMR (500 MHz, CDCl3) δ 7.31 – 7.11 (m, 5H), 3.69 – 3.46 (m, 2H), 3.18 (dq, J = 13.9, 7.0 Hz, 1H), 
3.07 (dq, J = 14.0, 7.0 Hz, 1H), 1.96 – 1.81 (m, 1H), 1.40 (dd, J = 6.3, 4.6 Hz, 1H), 1.13 (d, J = 6.3 Hz, 
3H), 1.10 (t, J = 7.1 Hz, 3H), 0.85 (dd, J = 8.8, 4.6 Hz, 1H), 0.54 (t, J = 7.1 Hz, 3H); 13C NMR (126 
MHz, CDCl3) δ 170.5, 141.9, 128.7 (+, 2C), 126.2 (+, 3C), 41.4 (-), 39.2 (-), 35.5, 23.6 (-), 18.3 (+), 
14.7 (+), 12.7 (+), 12.5 (+); FTIR (KBr, cm-1): 3059, 3001, 2969, 2933, 2872, 1643, 1600, 1494, 
1444, 1417, 1381, 1363, 1348, 1317, 1298, 1278, 1236, 1220, 1139, 1103, 1091, 761, 736; HRMS 






[Typical Procedure B]: Ethylmagnesium bromide (135 μL, 3.0 M (diethyl 
ether), 0.405 mmol, 1.35 equiv.) was added dropwise to a flame dried two neck flask containing 
copper iodide (3.0 mg, 15.0 μmol, 5.0 mol%) and freshly dried and distilled dimethoxyethane (1.0 
mL) under a nitrogen atmosphere at -45 °C. The mixture was stirred for five minutes at -45 °C. 
N,N-diethyl-1-phenylcycloprop-2-ene-1-carboxamide (53aa) (65.0 mg, 0.30 mmol, 1.0 equiv.) 
was then added slowly dropwise as a solution in dry dimethoxyethane (1.0 mL). The reaction was 
then stirred for 60 minutes at -45 °C. Water was then added very slowly dropwise. After ten 
minutes of stirring, saturated aqueous ammonium chloride (1 mL) was added and the reaction 
was allowed to warm to room temperature. The resulting solution was then diluted with water 
and extracted with diethyl ether (3 x 5 mL). Combined organic layers were washed with brine, 
dried, filtered, and evaporated. The product was purified by column chromatography using silica 
and a 3:1 hexane:ethyl acetate mobile phase. The titled compound was obtained as a viscous 
colorless oil in 83% yield (61.1 mg, 0.249 mmol). Rf: 0.42; dr: >99:1; 1H NMR (500 MHz, CDCl3) δ 
7.36 – 7.13 (m, 5H), 3.67 – 3.47 (m, 2H), 3.17 (dq, J = 13.9, 7.0 Hz, 1H), 3.05 (dq, J = 14.1, 7.0 Hz, 
1H), 1.83 – 1.77 (m, 1H), 1.76 – 1.68 (m, 1H), 1.40 (dd, J = 6.3, 4.6 Hz, 1H), 1.10 (t, J = 7.1 Hz, 3H), 
1.06 (t, J = 7.2 Hz, 3H), 0.99 – 0.93 (m, 1H), 0.84 (dd, J = 8.8, 4.5 Hz, 1H), 0.53 (t, J = 7.1 Hz, 3H); 
13C NMR (126 MHz, CDCl3) δ 170.6, 142.0, 128.7 (+, 2C), 126.3 (+, 2C), 126.2 (+), 41.6 (-), 39.3 (-
), 35.7, 26.1 (+), 23.1 (-), 22.2 (-), 13.8 (+), 12.7 (+), 12.5 (+); FTIR (KBr, cm-1):3059, 3024, 2966, 
2931, 2872, 1643, 1600, 1494, 1444, 1417, 1381, 1361, 1346, 1315, 1298, 1276, 1220, 1139, 
1099, 1068, 771, 754; HRMS (TOF ES): Found 268.1684, calculated for C16H23NONa (M+Na) 






Compound was obtained via [typical procedure A] using allylmagnesium 
bromide (405 μL, 1.0 M (diethyl ether), 0.405 mmol, 1.35 equiv.) and N,N-diethyl-1-
phenylcycloprop-2-ene-1-carboxamide (53aa) (65.0 mg, 0.30 mmol, 1.0 equiv.). The product 
was purified by column chromatography using silica and a 3:1 hexane:ethyl acetate mobile phase. 
The titled compound was obtained as a colorless oil in 94% yield (72.2 mg, 0.280 mmol). Rf: 0.39; 
dr: >99:1; 1H NMR (500 MHz, CDCl3) δ 7.33 – 7.24 (m, 2H), 7.24 – 7.13 (m, 3H), 5.93 (dddd, J = 
17.1, 10.2, 6.9, 5.9 Hz, 1H), 5.13 (dd, J = 17.2, 1.7 Hz, 1H), 5.03 (dd, J = 10.3, 1.7 Hz, 1H), 3.69 – 3.49 
(m, 2H), 3.18 (dq, J = 14.0, 7.1 Hz, 1H), 3.04 (dq, J = 14.1, 7.0 Hz, 1H), 2.46 – 2.32 (m, 1H), 1.96 – 
1.84 (m, 1H), 1.84 – 1.72 (m, 1H), 1.48 (dd, J = 6.3, 4.7 Hz, 1H), 1.11 (t, J = 7.1 Hz, 3H), 0.92 (dd, J 
= 8.8, 4.7 Hz, 1H), 0.52 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 170.3, 141.7, 137.2 (+), 
128.7 (+, 2C), 126.4 (+, 2C), 126.4 (+), 115.4 (-), 41.8 (-), 39.4 (-), 35.4, 34.0 (-), 23.5 (+), 22.1 (-), 
12.6 (+), 12.6 (+); FTIR (KBr, cm-1): 3076, 3063, 2976, 2933, 2874, 1643, 1633, 1494, 1442, 1427, 
1381, 1363, 1346, 1317, 1296, 1278, 1238, 1220, 1139, 1101, 1078, 1031, 995, 912, 761; HRMS 




Compound was obtained via [Typical Procedure A] using 
(trimethylsilyl)methylmagnesium chloride (1.86 mL, 1.3 M (tetrahydrofuran), 2.42 mmol, 1.30 
equiv.), copper iodide (18.0 mg, 0.093 mmol, 0.05 equiv.), N,N-diethyl-1-phenylcycloprop-2-ene-
1-carboxamide (53aa) (400.0 mg, 1.86 mmol, 1.0 equiv.), and quenched with excess water. The 
product was purified by column chromatography using silica and a 2:1 hexane:diethyl ether 
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mobile phase. The titled compound was obtained as colorless oil in 84% yield (475 mg, 1.56 
mmol). Rf: 0.34; dr: >99:1; 1H NMR (500 MHz, CDCl3) δ 7.29 – 7.26 (m, 1H), 7.25 (s, 1H), 7.21 – 
7.14 (m, 3H), 3.65 – 3.48 (m, 2H), 3.24 (dq, J = 13.9, 7.0 Hz, 1H), 3.08 (dq, J = 14.1, 7.0 Hz, 1H), 
1.82 (dddd, J = 12.3, 8.9, 6.3, 2.6 Hz, 1H), 1.38 (dd, J = 6.4, 4.6 Hz, 1H), 1.12 (t, J = 7.1 Hz, 3H), 0.93 
(dd, J = 14.3, 2.6 Hz, 1H), 0.90 (dd, J = 8.8, 4.7 Hz, 1H), 0.56 (t, J = 7.1 Hz, 3H), 0.15 (dd, J = 14.3, 
12.3 Hz, 1H), 0.08 (s, 9H); 13C NMR (126 MHz, CDCl3) δ 172.1, 143.5, 130.0 (+, 2C), 127.6 (+, 2C), 
127.5 (+), 42.8 (-), 40.6 (-), 36.8, 25.4 (-), 21.5 (+), 18.0 (-), 14.1 (+), 14.0 (+), 0.0 (+, 3C); FTIR 
(KBr, cm-1): 2953, 2874, 1634, 1496, 1457, 1442, 1425, 1379, 1273, 1247, 861, 844, 785, 699; 




Compound was obtained via [typical procedure A] using 
phenylmagnesium bromide (135 μL, 3.0 M (diethyl ether), 0.405 mmol, 
1.35 equiv.) and N,N-diethyl-1-phenylcycloprop-2-ene-1-carboxamide (53aa) (65.0 mg, 0.30 
mmol, 1.0 equiv.). The product was purified by column chromatography using silica and a 6:1 
hexane:ethyl acetate mobile phase. The titled compound was obtained as a viscous colorless oil 
in 93% yield (82.2 mg, 0.280 mmol). Rf: 0.32; dr: >99:1; 1H NMR (500 MHz, CDCl3) δ 7.37 – 7.14 
(m, 10H), 3.41 (dq, J = 14.1, 7.1 Hz, 1H), 3.31 (dq, J = 14.2, 7.2 Hz, 1H), 3.10 (dd, J = 9.1, 6.9 Hz, 
1H), 2.81 (dq, J = 14.0, 7.0 Hz, 1H), 2.52 (dq, J = 14.1, 7.0 Hz, 1H), 2.33 (dd, J = 6.9, 5.4 Hz, 1H), 1.27 
(dd, J = 9.1, 5.4 Hz, 1H), 0.66 (t, J = 7.1 Hz, 3H), 0.26 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) 
δ 168.6, 141.3, 137.2, 128.8 (+, 2C), 128.2 (+, 2C), 127.4 (+, 2C), 126.6 (+), 126.5 (+), 126.1 (+, 2C), 
41.0 (-), 40.4, 38.7 (-), 29.3 (+), 22.5 (-), 12.1 (+), 11.8 (+); FTIR (KBr, cm-1): 3294, 3242, 3201, 
3086, 3061, 3026, 3009, 2976, 2935, 2874, 1633, 1606, 1589, 1494, 1444, 1429, 1381, 1361, 
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1317, 1274, 1236, 1220, 1138, 771, 754, 732; HRMS (TOF ES): Found 316.1678, calculated for 




Compound was obtained via [typical procedure A] using vinylmagnesium 
bromide (405 μL, 1.0 M (tetrahydrofuran), 0.405 mmol, 1.35 equiv.) and N,N-diethyl-1-
phenylcycloprop-2-ene-1-carboxamide (53aa) (65.0 mg, 0.30 mmol, 1.0 equiv.). The product 
was purified by column chromatography using silica and a 3:1 hexane:ethyl acetate mobile phase. 
The titled compound was obtained as a viscous colorless oil in 97% yield (70.8 mg, 0.291 mmol). 
Rf: 0.39; dr: >99:1; 1H NMR (500 MHz, CDCl3) δ 7.34 – 7.17 (m, 5H), 5.46 – 5.35 (m, 1H), 5.28 (dd, 
J = 17.0, 1.7 Hz, 1H), 5.05 (dd, J = 10.1, 1.7 Hz, 1H), 3.57 – 3.49 (m, 1H), 3.49 – 3.40 (m, 1H), 3.17 
(dq, J = 14.0, 7.0 Hz, 1H), 3.01 (dq, J = 14.2, 7.0 Hz, 1H), 2.60 – 2.51 (m, 1H), 1.80 (dd, J = 6.2, 4.9 
Hz, 1H), 1.13 – 1.05 (m, 4H), 0.55 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 169.7, 140.9, 
136.7 (+), 128.8 (+, 2C), 126.6 (+), 126.0 (+, 2C), 115.8 (-), 41.3 (-), 39.3 (-), 37.2, 28.3 (+), 23.4 (-
), 12.7 (+), 12.4 (+); FTIR (KBr, cm-1): 3082, 3059, 3003, 2974, 2935, 2874, 1643, 1624, 1494, 
1460, 1427, 1381, 1363, 1346, 1315, 1294, 1276, 1220, 1136, 1101, 1078, 1068, 1030, 989, 949, 





Methylmagnesium bromide (150 μL, 3.0 M (diethyl ether), 0.450 mmol, 
1.50 equiv.) was added slowly dropwise to a flame dried two neck flask 
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containing phenylacetylene (53.0 μL, 0.480 mmol, 1.60 equiv.) and dry dimethoxyethane (1 mL) 
under a nitrogen atmosphere. The reaction was then stirred and heated at 55 °C for one hour. 
The solution was then cooled to room temperature and cannulated dropwise into another flame 
dried two neck flask containing copper iodide (3.0 mg, 15.0 μmol, 5 mol%) and dry 
dimethoxyethane (1 mL) under a nitrogen atmosphere at 0 °C. After 5 minutes of stirring, N,N-
diethyl-1-phenylcycloprop-2-ene-1-carboxamide (53aa) (65.0 mg, 0.30 mmol, 1.0 equiv.) as a 
solution in dry dimethoxyethane (1 mL) was added dropwise and the reaction was stirred for 60 
minutes at 0 °C. Saturated aqueous ammonium chloride (1 mL) was then added dropwise. The 
resulting solution was diluted with water and extracted with diethyl ether (3 x 5 mL). The 
combined organic layers were washed with brine, dried, filtered, and evaporated. The product 
was purified by column chromatography using silica and a 3:1 hexane:ethyl acetate mobile phase. 
The titled compound was obtained as a viscous light yellow oil in 19% yield (18.8 mg, 0.06 mmol). 
Rf: 0.35; dr: >99:1; 1H NMR (500 MHz, CDCl3) δ 7.31 – 7.15 (m, 10H), 3.66 – 3.57 (m, 1H), 3.57 – 
3.49 (m, 1H), 3.20 – 3.04 (m, 2H), 2.62 (dd, J = 9.0, 6.2 Hz, 1H), 2.03 (dd, J = 6.2, 4.6 Hz, 1H), 1.13 
(dd, J = 9.0, 4.5 Hz, 1H), 0.99 (t, J = 7.1 Hz, 3H), 0.56 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) 
δ 168.8, 139.6, 131.7 (+, 2C), 128.9 (+, 2C), 128.3 (+, 2C), 128.0 (+), 127.1 (+), 126.3 (+, 2C), 123.4, 
88.0, 79.6, 41.7 (+), 39.6 (+), 38.3, 25.0 (+), 13.8 (-), 12.8 (-), 12.6 (-); FTIR (KBr, cm-1): 3059, 2968, 
2926, 2852, 1645, 1635, 1558, 1539, 1506, 1456, 1429, 1219, 1134, 1068, 1026, 945, 910, 842, 




Compound was obtained via [typical procedure B] using 
isobutylmagnesium bromide (405 μL, 1.0 M (tetrahydrofuran), 0.405 
209 
 
mmol, 1.35 equiv.) and N,N-diethyl-1-phenylcycloprop-2-ene-1-carboxamide (53aa) (65.0 mg, 
0.30 mmol, 1.0 equiv.). The product was purified by column chromatography using silica and a 
6:1 hexane:ethyl acetate mobile phase. The titled compound was obtained as a viscous colorless 
oil in 90% yield (74.2 mg, 0.271 mmol). Rf: 0.26; dr: >99:1; 1H NMR (500 MHz, CDCl3) δ 7.35 – 
7.11 (m, 5H), 3.63 – 3.49 (m, 2H), 3.18 (dq, J = 13.9, 7.0 Hz, 1H), 3.04 (dq, J = 14.1, 7.0 Hz, 1H), 
1.89 – 1.81 (m, 1H), 1.79 – 1.69 (m, 1H), 1.63 – 1.53 (m, 1H), 1.45 (dd, J = 6.4, 4.5 Hz, 1H), 1.10 (t, 
J = 7.1 Hz, 3H), 0.97 (d, J = 5.5 Hz, 3H), 0.96 (d, J = 6.1 Hz, 3H), 0.88 (dd, J = 8.8, 4.5 Hz, 1H), 0.84 – 
0.77 (m, 1H), 0.52 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 170.6, 142.1, 128.7 (+, 2C), 126.4 
(+, 2C), 126.3 (+), 41.6 (-), 39.3 (-), 38.5 (-), 34.7, 28.6 (+), 23.0 (-), 22.9 (+), 22.7 (+), 22.6 (+), 12.6 
(+), 12.5 (+); FTIR (KBr, cm-1): 3059, 2955, 2933, 2870, 1643, 1633, 1600, 1494, 1442, 1427, 
1381, 1365, 1346, 1317, 1294, 1276, 1242, 1220, 1139, 1101, 1068, 1031, 759, 742; HRMS (TOF 




Compound was obtained via [typical procedure A] using 
Methylmagnesium bromide (135 μL, 3.0 M (diethyl ether), 0.405 mmol, 1.35 equiv.) and N,N-
diisopropyl-1-phenylcycloprop-2-ene-1-carboxamide (53ab) (73.0 mg, 0.30 mmol, 1.0 equiv.). 
The product was purified by column chromatography using silica and a 6:1 hexane:ethyl acetate 
mobile phase. The titled compound was obtained as a viscous colorless oil in 94% yield (73.2 mg, 
0.282 mmol). Rf: 0.35; dr: >99:1; 1H NMR (500 MHz, CDCl3) δ 7.31 – 7.13 (m, 5H), 4.25 (hept, J = 
6.6 Hz, 1H), 3.22 (hept, J = 6.8 Hz, 1H), 2.00 – 1.84 (m, 1H), 1.43 (d, J = 6.8 Hz, 3H), 1.41 (d, J = 7.0 
Hz, 3H), 1.39 (dd, J = 6.25, 4.57 Hz, 1H), 1.20 (d, J = 6.3 Hz, 3H), 1.08 (d, J = 6.7 Hz, 3H), 0.77 (dd, J 
= 8.9, 4.5 Hz, 1H), 0.36 (d, J = 6.6 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 170.1, 142.2, 128.6 (+, 2C), 
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126.6 (+, 2C), 126.2 (+), 48.9 (+), 45.9 (+), 37.2, 22.8 (-), 21.8 (+), 21.1 (+), 19.7 (+), 19.2 (+), 18.0 
(+), 15.1 (+); FTIR (KBr, cm-1): 3059, 2999, 2962, 2931, 2872, 1633, 1600, 1494, 1435, 1369, 
1336, 1238, 1211, 1157, 1134, 1091, 1039, 734; HRMS (TOF ES): Found 282.1844, calculated for 




Compound was obtained via [typical procedure A] using 
phenylmagnesium bromide (135 μL, 3.0 M (diethyl ether), 0.405 mmol, 
1.35 equiv.) and N,N-diisopropyl-1-phenylcycloprop-2-ene-1-carboxamide (53ab) (73.0 mg, 
0.30 mmol, 1.0 equiv.). The product was purified by column chromatography using silica and a 
6:1 hexane:ethyl acetate mobile phase. The titled compound was obtained as a colorless solid in 
91% yield (87.8 mg, 0.273 mmol). mp: 132.8-135.5 °C; Rf: 0.42; dr: 20:1; 1H NMR (500 MHz, 
CDCl3) δ 7.50 – 7.15 (m, 10H), 4.03 – 3.88 (m, 1H), 3.11 (dd, J = 9.3, 6.9 Hz, 1H), 3.01 – 2.89 (m, 
1H), 2.24 (dd, J = 6.9, 5.3 Hz, 1H), 1.34 (d, J = 6.7 Hz, 3H), 1.23 (dd, J = 9.2, 5.3 Hz, 1H), 1.18 (d, J = 
6.8 Hz, 3H), 0.21 (d, J = 6.6 Hz, 3H), 0.06 (d, J = 6.6 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 168.4, 
141.3, 138.2, 128.7 (+, 2C), 128.4 (+, 2C), 127.4 (+, 2C), 126.7 (+, 2C), 126.7 (+), 126.5 (+), 48.8 
(+), 45.9 (+), 42.2, 28.5 (+), 23.2 (-), 20.3 (+), 20.2 (+), 19.5 (+), 19.1 (+); FTIR (KBr, cm-1): 3059, 
3028, 3007, 2960, 2931, 1620, 1496, 1469, 1444, 1369, 1342, 1209, 1157, 1134, 1122, 1078, 
1057, 1037, 1022, 800, 773, 758, 734, 704; HRMS (TOF ES): Found 322.2172, calculated for 






Compound was obtained via [typical procedure A] using vinylmagnesium 
bromide (405 μL, 1.0 M (tetrahydrofuran), 0.405 mmol, 1.35 equiv.) and N,N-diisopropyl-1-
phenylcycloprop-2-ene-1-carboxamide (53ab) (73.0 mg, 0.30 mmol, 1.0 equiv.). The product 
was purified by column chromatography using silica and a 3:1 hexane:ethyl acetate mobile phase. 
The titled compound was obtained as a viscous colorless oil in 88% yield (71.8 mg, 0.265 mmol). 
Rf: 0.55; dr: >99:1; 1H NMR (500 MHz, CDCl3) δ 7.43 – 7.11 (m, 5H), 5.54 – 5.38 (m, 1H), 5.31 (dd, 
J = 17.0, 1.7 Hz, 1H), 5.08 (dd, J = 10.1, 1.7 Hz, 1H), 4.16 (hept, J = 6.6 Hz, 1H), 3.20 (hept, J = 6.8 
Hz, 1H), 2.74 – 2.44 (m, 1H), 1.78 (dd, J = 6.1, 4.8 Hz, 1H), 1.41 (d, J = 6.8 Hz, 3H), 1.41 (d, J = 6.8 
Hz, 3H), 1.02 (d, J = 6.5 Hz, 3H), 1.02 – 0.98 (m, 1H), 0.35 (d, J = 6.6 Hz, 3H); 13C NMR (126 MHz, 
CDCl3) δ 169.3, 140.9, 137.3 (+), 128.7 (+, 2C), 126.6 (+), 126.4 (+, 2C), 115.5 (-), 49.0 (+), 45.9 
(+), 38.8, 27.7 (+), 23.0 (-), 21.8 (+), 20.9 (+), 19.6 (+), 19.2 (+); FTIR (KBr, cm-1): 3082, 3061, 
3001, 2964, 2931, 2874, 1633, 1600, 1494, 1471, 1437, 1369, 1338, 1215, 1157, 1132, 1037, 989, 





Compound was obtained via [typical procedure A] using 
Methylmagnesium bromide (135 μL, 3.0 M (diethyl ether), 0.405 mmol, 1.35 equiv.) and N,N-
diallyl-1-phenylcycloprop-2-ene-1-carboxamide (53ac) (72.0 mg, 0.30 mmol, 1.0 equiv.). The 
product was purified by column chromatography using silica and a 6:1 hexane:ethyl acetate 
mobile phase. The titled compound was obtained as a viscous colorless oil in 94% yield (71.6 mg, 
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0.280 mmol). Rf: 0.29; dr: >99:1; 1H NMR (500 MHz, CDCl3) δ 7.34 – 7.14 (m, 5H), 5.83 – 5.65 (m, 
1H), 5.22 – 5.05 (m, 2H), 4.97 – 4.88 (m, 3H), 4.35 – 4.24 (m, 1H), 4.21 – 4.11 (m, 1H), 3.72 – 3.53 
(m, 2H), 1.94 – 1.86 (m, 1H), 1.43 (dd, J = 6.3, 4.6 Hz, 1H), 1.17 (d, J = 6.3 Hz, 3H), 0.91 (dd, J = 8.8, 
4.7 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 170.9, 141.6, 133.1 (+), 128.8 (+, 3C), 126.4 (+), 126.4 
(+, 2C), 118.5 (-), 117.8 (-), 49.5 (-), 46.7 (-), 35.4, 23.4 (-), 18.7 (+), 15.0 (+); FTIR (KBr, cm-1): 
3078, 3005, 2980, 2958, 2928, 1643, 1633, 1600, 1496, 1454, 1435, 1410, 1332, 1300, 1280, 
1263, 1209, 1193, 1138, 1112, 1095, 993, 923, 759, 731; HRMS (TOF ES): Found 278.1536, 




Compound was obtained via [typical procedure A] using 
phenylmagnesium bromide (135 μL, 3.0 M (diethyl ether), 0.405 mmol, 
1.35 equiv.) and N,N-diallyl-1-phenylcycloprop-2-ene-1-carboxamide (53ac) (72.0 mg, 0.30 
mmol, 1.0 equiv.). The product was purified by column chromatography using silica and a 6:1 
hexane:ethyl acetate mobile phase. The titled compound was obtained as a colorless solid in 95% 
yield (90.6 mg, 0.285 mmol). mp: 111.5-113.9 °C; Rf: 0.32; dr: 9:1; 1H NMR (500 MHz, CDCl3) δ 
7.56 – 7.15 (m, 10H), 5.20 – 5.09 (m, 1H), 4.85 (d, J = 10.2 Hz, 1H), 4.78 (d, J = 10.1 Hz, 1H), 4.74 
(d, J = 17.1 Hz, 1H), 4.64 (d, J = 17.2 Hz, 1H), 4.50 – 4.36 (m, 1H), 4.12 – 4.02 (m, 1H), 3.99 – 3.87 
(m, 1H), 3.37 – 3.29 (m, 1H), 3.14 (dd, J = 9.1, 6.9 Hz, 1H), 3.12 – 3.06 (m, 1H), 2.38 (dd, J = 6.9, 5.5 
Hz, 1H), 1.30 (dd, J = 9.1, 5.5 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 169.0, 141.0, 136.9, 132.8 (+), 
132.6 (+), 128.9 (+, 2C), 128.4 (+, 2C), 127.6 (+, 2C), 126.9 (+), 126.7 (+), 126.4 (+, 2C), 118.5 (-), 
117.3 (-), 49.4 (-), 46.2 (-), 40.4, 29.2 (+), 22.2 (-); FTIR (KBr, cm-1): 3084, 3063, 3028, 3010, 2910, 
1643, 1622, 1600, 1494, 1454, 1442, 1435, 1411, 1300, 1284, 1269, 1215, 1180, 1076, 1031, 991, 
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922, 902, 765, 734; HRMS (TOF ES): Found 340.1675, calculated for C22H23NONa (M+Na) 




Compound was obtained via [typical procedure A] using 
vinylmagnesium bromide (405 μL, 1.0 M (tetrahydrofuran), 0.405 mmol, 1.35 equiv.) and N,N-
diallyl-1-phenylcycloprop-2-ene-1-carboxamide (53ac) (72.0 mg, 0.30 mmol, 1.0 equiv.). The 
product was purified by column chromatography using silica and a 3:1 hexane:ethyl acetate 
mobile phase. The titled compound was obtained as a viscous light yellow oil in 80% yield (63.8 
mg, 0.239 mmol). Rf: 0.45; dr: >99:1; 1H NMR (500 MHz, CDCl3) δ 7.40 – 7.10 (m, 5H), 5.87 – 5.60 
(m, 1H), 5.57 – 5.37 (m, 1H), 5.37 – 5.27 (m, 1H), 5.22 – 5.02 (m, 3H), 5.00 – 4.82 (m, 3H), 4.30 – 
4.15 (m, 1H), 4.12 – 3.93 (m, 1H), 3.77 – 3.45 (m, 2H), 2.70 – 2.41 (m, 1H), 1.83 (dd, J = 6.2, 5.0 Hz, 
1H), 1.14 (dd, J = 8.7, 5.0 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 170.2, 140.5, 136.6 (+), 133.2 (+), 
132.9 (+), 128.9 (+, 2C), 126.8 (+), 126.2 (+, 2C), 118.6 (-), 117.7 (-), 116.2 (-), 49.6 (-), 46.6 (-), 
37.2, 28.4 (+), 23.2 (-); FTIR (KBr, cm-1): 3080, 3063, 3007, 2982, 1643, 1633, 1600, 1496, 1435, 
1411, 1332, 1296, 1261, 1205, 1136, 1111, 1031, 993, 923, 758, 731, 700; HRMS (TOF ES): Found 




Compound was obtained via [typical procedure A] using 
Methylmagnesium bromide (135 μL, 3.0 M (diethyl ether), 0.405 
mmol, 1.35 equiv.) and N,N-dibenzyl-1-phenylcycloprop-2-ene-1-carboxamide (53ad) (102 mg, 
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0.30 mmol, 1.0 equiv.). The product was purified by column chromatography using silica and a 
6:1 hexane:ethyl acetate mobile phase. The titled compound was obtained as a colorless solid in 
95% yield (101 mg, 0.285 mmol). mp: 113.7-115.1 °C; Rf: 0.26; dr: >99:1; 1H NMR (500 MHz, 
CDCl3) δ 7.35 – 7.10 (m, 13H), 6.70 – 6.54 (m, 2H), 4.91 (d, J = 14.4 Hz, 1H), 4.80 (d, J = 15.6 Hz, 
1H), 4.24 (d, J = 15.6 Hz, 1H), 4.01 (d, J = 14.4 Hz, 1H), 1.96 – 1.81 (m, 1H), 1.44 (dd, J = 6.3, 4.6 Hz, 
1H), 1.25 (d, J = 6.3 Hz, 3H), 1.02 (dd, J = 8.8, 4.6 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 171.9, 141.4, 
137.4, 136.0, 129.0 (+, 2C), 128.8 (+, 2C), 128.5 (+, 2C), 128.4 (+, 2C), 127.6 (+, 2C), 127.4 (+), 
127.4 (+), 127.2 (+, 2C), 126.6 (+), 49.9 (-), 47.1 (-), 35.6, 22.5 (-), 19.3 (+), 15.6 (+); FTIR (KBr, 
cm-1): 3061, 3028, 3003, 2956, 2928, 2868, 2359, 2341, 1633, 1600, 1494, 1450, 1417, 1361, 
1317, 1296, 1193, 1078, 1028, 989, 752, 732; HRMS (TOF ES): Found 378.1842, calculated for 




Compound was obtained via [typical procedure A] using 
phenylmagnesium bromide (135 μL, 3.0 M (diethyl ether), 0.405 
mmol, 1.35 equiv.) and N,N-dibenzyl-1-phenylcycloprop-2-ene-1-carboxamide (53ad) (102 mg, 
0.30 mmol, 1.0 equiv.). The product was purified by column chromatography using silica and a 
6:1 hexane:ethyl acetate mobile phase. The titled compound was obtained as a viscous light 
yellow oil in 93% yield (117 mg, 0.280 mmol). Rf: 0.30; dr: 13:1; 1H NMR (500 MHz, CDCl3) δ 7.50 
– 7.41 (m, 2H), 7.36 – 6.93 (m, 14H), 6.69 – 6.56 (m, 2H), 6.19 – 6.05 (m, 2H), 4.58 (d, J = 14.7 Hz, 
1H), 4.57 (d, J = 15.36 Hz, 1H), 3.88 (d, J = 14.8 Hz, 1H), 3.76 (d, J = 15.4 Hz, 1H), 3.20 (dd, J = 9.2, 
7.0 Hz, 1H), 2.46 (dd, J = 7.0, 5.3 Hz, 1H), 1.34 (dd, J = 9.2, 5.3 Hz, 1H); 13C NMR (126 MHz, CDCl3) 
δ 170.2, 141.1, 137.1, 136.5, 135.4, 129.0 (+, 2C), 128.8 (+, 2C), 128.5 (+, 2C), 128.2 (+, 2C), 128.2 
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(+, 2C), 127.8 (+, 2C), 127.8 (+, 2C), 127.5 (+, 2C), 127.2 (+), 127.1 (+), 126.9 (+), 126.8 (+), 50.0 
(-), 46.9 (-), 40.9, 29.0 (+), 21.3 (-); FTIR (KBr, cm-1): 3086, 3061, 3028, 3009, 1643, 1604, 1591, 
1583, 1494, 1454, 1417, 1361, 1313, 1294, 1267, 1209, 1182, 1078, 1030, 1012, 945, 779, 731; 




Compound was obtained via [typical procedure A] using 
vinylmagnesium bromide (405 μL, 1.0 M (tetrahydrofuran), 0.405 
mmol, 1.35 equiv.) and N,N-dibenzyl-1-phenylcycloprop-2-ene-1-carboxamide (53ad) (102 mg, 
0.30 mmol, 1.0 equiv.). The product was purified by column chromatography using silica and a 
3:1 hexane:ethyl acetate mobile phase. The titled compound was obtained as a viscous colorless 
oil in 84% yield (92.4 mg, 0.251 mmol). Rf: 0.52; dr: >99:1; 1H NMR (500 MHz, CDCl3) δ 7.46 – 
7.02 (m, 13H), 6.71 – 6.44 (m, 2H), 5.64 – 5.47 (m, 1H), 5.30 (d, J = 17.0 Hz, 1H), 5.03 (d, J = 10.2 
Hz, 1H), 4.87 (d, J = 14.5 Hz, 1H), 4.72 (d, J = 15.6 Hz, 1H), 4.15 (d, J = 15.6 Hz, 1H), 3.96 (d, J = 14.5 
Hz, 1H), 2.64 – 2.42 (m, 1H), 1.85 (dd, J = 6.2, 4.9 Hz, 1H), 1.22 (dd, J = 8.7, 4.9 Hz, 1H); 13C NMR 
(126 MHz, CDCl3) δ 171.1, 140.3, 137.2, 136.7 (+), 135.8, 129.0 (+, 2C), 129.0 (+, 2C), 128.4 (+, 
2C), 128.4 (+, 2C), 127.9 (+, 2C), 127.4 (+), 127.4 (+), 127.1 (+, 2C), 127.0 (+), 116.3 (-), 50.0 (-), 
47.1 (-), 37.4, 28.5 (+), 22.2 (-); FTIR (KBr, cm-1): 3084, 3061, 3028, 3005, 2822, 1643, 1633, 1600, 
1494, 1448, 1417, 1361, 1315, 1267, 1190, 1078, 1030, 1010, 976, 947, 906, 750, 736, 700; HRMS 






Compound was obtained via [typical procedure A] using 
Methylmagnesium bromide (135 μL, 3.0 M (diethyl ether), 0.405 mmol, 1.35 equiv.) and (1-
phenylcycloprop-2-en-1-yl)(pyrrolidin-1-yl)methanone (53ai) (64.0 mg, 0.30 mmol, 1.0 equiv.). 
The product was purified by column chromatography using silica and a 3:1 hexane:ethyl acetate 
mobile phase. The titled compound was obtained as a viscous colorless oil in 91% yield (62.8 mg, 
0.274 mmol). Rf: 0.16; dr: >99:1; 1H NMR (500 MHz, CDCl3) δ 7.30 – 7.14 (m, 5H), 3.57 – 3.48 (m, 
2H), 3.41 – 3.32 (m, 1H), 2.91 – 2.79 (m, 1H), 1.91 – 1.79 (m, 2H), 1.79 – 1.64 (m, 3H), 1.44 (dd, J 
= 6.3, 4.6 Hz, 1H), 1.14 (d, J = 6.2 Hz, 3H), 0.89 (dd, J = 8.7, 4.6 Hz, 1H); 13C NMR (126 MHz, CDCl3) 
δ 169.6, 141.3, 128.7 (+, 2C), 126.2 (+, 2C), 126.2 (+), 47.1 (-), 46.3 (-), 36.6, 26.4 (-), 24.2 (-), 23.4 
(-), 18.7 (+), 14.8 (+); FTIR (KBr, cm-1): 3057, 2999, 2996, 2953, 2929, 2874, 1633, 1600, 1579, 
1494, 1717, 1367, 1342, 1192, 1168, 1095, 1033, 912, 756, 734, 725, 700; HRMS (TOF ES): Found 




Compound was obtained via [typical procedure A] using 
phenylmagnesium bromide (135 μL, 3.0 M (diethyl ether), 0.405 mmol, 
1.35 equiv.) and (1-phenylcycloprop-2-en-1-yl)(pyrrolidin-1-yl)methanone (53ai) (64.0 mg, 
0.30 mmol, 1.0 equiv.). The product was purified by column chromatography using silica and a 
3:1 hexane:ethyl acetate mobile phase. The titled compound was obtained as a colorless solid in 
87% yield (76.2 mg, 0.262 mmol). mp: 111.1-112.7 °C; Rf: 0.16; dr: >99:1; 1H NMR (500 MHz, 
CDCl3) δ 7.40 – 7.16 (m, 10H), 3.38 – 3.24 (m, 1H), 3.10 – 2.93 (m, 3H), 2.71 – 2.57 (m, 1H), 2.33 
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(dd, J = 6.9, 5.5 Hz, 1H), 1.57 – 1.31 (m, 3H), 1.35 (dd, J = 9.1, 5.6 Hz, 1H), 0.96 – 0.75 (m, 1H); 13C 
NMR (126 MHz, CDCl3) δ 167.7, 140.4, 137.5, 128.8 (+, 2C), 128.2 (+, 2C), 127.0 (+, 2C), 126.6 (+), 
126.5 (+), 126.2 (+, 2C), 46.5 (-), 45.9 (-), 41.6, 29.9 (+), 25.6 (-), 23.8 (-), 22.7 (-); FTIR (KBr, cm-
1): 3057, 3028, 2970, 2874, 1626, 1579, 1496, 1448, 1427, 1340, 1190, 1168, 1122, 1078, 1031, 
914, 873, 775, 763, 732; HRMS (TOF ES): Found 314.1523, calculated for C20H21NONa (M+Na) 




Compound was obtained via [typical procedure A] using phenylmagnesium 
bromide (135 μL, 3.0 M (diethyl ether), 0.405 mmol, 1.35 equiv.) and (1-phenylcycloprop-2-en-
1-yl)(pyrrolidin-1-yl)methanone (53ai) (64.0 mg, 0.30 mmol, 1.0 equiv.). The product was 
purified by column chromatography using silica and a 3:1 hexane:ethyl acetate mobile phase. The 
titled compound was obtained as a viscous colorless oil in 82% yield (59.2 mg, 0.245 mmol). Rf: 
0.16; dr: >99:1; 1H NMR (500 MHz, CDCl3) δ 7.33 – 7.27 (m, 2H), 7.23 – 7.17 (m, 3H), 5.51 – 5.35 
(m, 1H), 5.30 (dd, J = 17.0, 1.8 Hz, 1H), 5.06 (dd, J = 10.0, 1.8 Hz, 1H), 3.61 – 3.43 (m, 2H), 3.45 – 
3.31 (m, 1H), 2.90 – 2.71 (m, 1H), 2.55 – 2.39 (m, 1H), 1.86 – 1.77 (m, 1H), 1.83 (dd, J = 6.2, 5.0 Hz, 
1H), 1.77 – 1.59 (m, 3H), 1.12 (dd, J = 8.7, 4.9 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 168.9, 140.1, 
136.9 (+), 128.8 (+, 2C), 126.5 (+), 126.1 (+, 2C), 115.9 (-), 46.7 (-), 46.4 (-), 38.4, 28.6 (+), 26.3 (-
), 24.2 (-), 23.3 (-); FTIR (KBr, cm-1): 3080, 3057, 3022, 3001, 2970, 2874, 1633, 1600, 1579, 1494, 
1423, 1340, 1190, 1168, 1114, 1031, 993, 941, 910, 758, 727, 700; HRMS (TOF ES): Found 






Compound was obtained via [typical procedure A] using 
Methylmagnesium bromide (135 μL, 3.0 M (diethyl ether), 0.405 mmol, 1.35 equiv.) and (1-
phenylcycloprop-2-en-1-yl)(piperidin-1-yl)methanone (53aj) (68.0 mg, 0.30 mmol, 1.0 equiv.). 
The product was purified by column chromatography using silica and a 6:1 hexane:ethyl acetate 
mobile phase. The titled compound was obtained as a viscous colorless oil in 90% yield (65.6 mg, 
0.270 mmol). Rf: 0.16; dr: >99:1; 1H NMR (500 MHz, CDCl3) δ 7.33 – 7.11 (m, 5H), 3.82 – 3.71 (m, 
1H), 3.49 – 3.35 (m, 2H), 3.31 – 3.20 (m, 1H), 1.92 – 1.81 (m, 1H), 1.59 – 1.44 (m, 4H), 1.38 (dd, J 
= 6.3, 4.7 Hz, 1H), 1.31 – 1.20 (m, 1H), 1.17 (d, J = 6.3 Hz, 3H), 1.09 – 0.96 (m, 1H), 0.91 (dd, J = 
8.8, 4.7 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 169.6, 141.9, 128.7 (+, 2C), 126.1 (+), 125.7 (+, 2C), 
46.7 (-), 43.2 (-), 35.3, 25.8 (-), 25.7 (-), 24.6 (-), 24.0 (-), 19.4 (+), 15.3 (+); FTIR (KBr, cm-1): 3059, 
3001, 2935, 2854, 1633, 1600, 1496, 1465, 1433, 1294, 1271, 1259, 1211, 1138, 1128, 1022, 
1003, 852, 754, 732, 700; HRMS (TOF ES): Found 266.1520, calculated for C16H21NONa (M+Na) 




Compound was obtained via [typical procedure A] using 
phenylmagnesium bromide (135 μL, 3.0 M (diethyl ether), 0.405 mmol, 
1.35 equiv.) and (1-phenylcycloprop-2-en-1-yl)(piperidin-1-yl)methanone (53aj) (68.0 mg, 0.30 
mmol, 1.0 equiv.). The product was purified by column chromatography using silica and a 3:1 
hexane:ethyl acetate mobile phase. The titled compound was obtained as a colorless solid in 89% 
yield (81.8 mg, 0.268 mmol). mp: 120.6-121.9 °C; Rf: 0.29; dr: >99:1; 1H NMR (500 MHz, CDCl3) δ 
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7.41 – 7.16 (m, 10H), 3.54 – 3.43 (m, 1H), 3.35 – 3.20 (m, 1H), 3.01 (dd, J = 9.2, 7.0 Hz, 1H), 2.98 – 
2.91 (m, 1H), 2.88 – 2.81 (m, 1H), 2.26 (dd, J = 7.0, 5.6 Hz, 1H), 1.39 (dd, J = 9.2, 5.6 Hz, 1H), 1.38 
– 1.30 (m, 1H), 1.27 – 1.18 (m, 2H), 1.16 – 1.05 (m, 1H), 0.90 – 0.80 (m, 1H), 0.33 – 0.20 (m, 1H); 
13C NMR (126 MHz, CDCl3) δ 167.7, 141.1, 137.8, 128.7 (+, 2C), 128.2 (+, 2C), 127.0 (+, 2C), 126.5 
(+), 126.4 (+), 125.4 (+, 2C), 46.4 (-), 42.8 (-), 40.0, 30.9 (+), 25.0 (-), 25.0 (-), 24.1 (-), 23.6 (-); 
FTIR (KBr, cm-1): 3057, 3028, 3005, 2935, 2854, 1631, 1496, 1437, 1292, 1271, 1247, 1217, 1136, 
1124, 1078, 1031, 1012, 974, 852, 773, 761, 731; HRMS (TOF ES): Found 328.1682, calculated 




Compound was obtained via [typical procedure A] using vinylmagnesium 
bromide (405 μL, 1.0 M (tetrahydrofuran), 0.405 mmol, 1.35 equiv.) and (1-phenylcycloprop-2-
en-1-yl)(piperidin-1-yl)methanone (53aj) (68.0 mg, 0.30 mmol, 1.0 equiv.). The product was 
purified by column chromatography using silica and a 3:1 hexane:ethyl acetate mobile phase. The 
titled compound was obtained as a viscous colorless oil in 86% yield (66.0 mg, 0.258 mmol). Rf: 
0.29; dr: >99:1; 1H NMR (500 MHz, CDCl3) δ 7.33 – 7.27 (m, 2H), 7.23 – 7.16 (m, 3H), 5.49 – 5.39 
(m, 1H), 5.29 (dd, J = 17.0, 1.6 Hz, 1H), 5.07 (dd, J = 10.2, 1.7 Hz, 1H), 3.75 – 3.66 (m, 1H), 3.52 – 
3.43 (m, 1H), 3.34 – 3.25 (m, 1H), 3.25 – 3.18 (m, 1H), 2.59 – 2.48 (m, 1H), 1.78 (dd, J = 6.2, 5.0 Hz, 
1H), 1.55 – 1.44 (m, 4H), 1.32 – 1.23 (m, 1H), 1.15 (dd, J = 8.7, 5.0 Hz, 1H), 1.06 – 0.94 (m, 1H); 13C 
NMR (126 MHz, CDCl3) δ 168.9, 140.9, 137.1 (+), 128.8 (+, 2C), 126.5 (+), 125.5 (+, 2C), 115.8 (-), 
46.7 (-), 43.3 (-), 37.1, 29.4 (+), 25.8 (-), 25.7 (-), 24.5 (-), 23.8 (-); FTIR (KBr, cm-1): 3080, 3059, 
3003, 2935, 2854, 1643, 1626, 1496, 1435, 1369, 1352, 1271, 1257, 1207, 1136, 1126, 1103, 
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1031, 1010, 983, 952, 902, 852, 758, 742; HRMS (TOF ES): Found 278.1529, calculated for 




Compound was obtained via [typical procedure A] using 
Methylmagnesium bromide (135 μL, 3.0 M (diethyl ether), 0.405 mmol, 1.35 equiv.) and 
morpholino(1-phenylcycloprop-2-en-1-yl)methanone (53ak) (69.0 mg, 0.30 mmol, 1.0 equiv.). 
The product was purified by column chromatography using silica and a 3:1 hexane:ethyl acetate 
mobile phase. The titled compound was obtained as a viscous colorless oil in 92% yield (67.6 mg, 
0.276 mmol). Rf: 0.19; dr: >99:1; 1H NMR (500 MHz, CDCl3) δ 7.34 – 7.11 (m, 5H), 3.74 – 3.66 (m, 
2H), 3.66 – 3.59 (m, 2H), 3.45 – 3.31 (m, 3H), 3.27 – 3.19 (m, 1H), 1.95 – 1.81 (m, 1H), 1.40 (dd, J 
= 6.4, 4.7 Hz, 1H), 1.19 (d, J = 6.2 Hz, 3H), 0.95 (dd, J = 8.8, 4.7 Hz, 1H); 13C NMR (126 MHz, CDCl3) 
δ 169.9, 141.4, 128.9 (+, 2C), 126.4 (+), 125.5 (+, 2C), 66.9 (-), 66.6 (-), 46.3 (-), 42.7 (-), 35.0, 23.9 
(-), 19.3 (+), 15.3 (+); FTIR (KBr, cm-1): 3062, 2999, 2960, 2920, 2899, 2854, 1639, 1496, 1456, 
1427, 1390, 1359, 1301, 1273, 1209, 1114, 1095, 1068, 1030, 1008, 945, 912, 848, 756, 732, 700; 




Compound was obtained via [typical procedure A] using 
phenylmagnesium bromide (135 μL, 3.0 M (diethyl ether), 0.405 mmol, 
1.35 equiv.) and morpholino(1-phenylcycloprop-2-en-1-yl)methanone (53ak) (69.0 mg, 0.30 
mmol, 1.0 equiv.). The product was purified by column chromatography using silica and a 3:1 
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hexane:ethyl acetate mobile phase. The titled compound was obtained as a colorless solid in 81% 
yield (74.8 mg, 0.243 mmol). mp: 138.0-139.9 °C; Rf: 0.26; dr: >99:1; 1H NMR (500 MHz, CDCl3) δ 
7.41 – 7.12 (m, 10H), 3.83 – 3.65 (m, 1H), 3.59 – 3.43 (m, 1H), 3.21 – 3.14 (m, 1H), 3.12 – 3.05 (m, 
1H), 3.05 – 2.97 (m, 3H), 2.95 – 2.87 (m, 1H), 2.29 (dd, J = 7.0, 5.7 Hz, 1H), 2.15 – 2.08 (m, 1H), 
1.42 (dd, J = 9.2, 5.7 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 168.0, 140.6, 137.5, 129.0 (+, 2C), 128.6 
(+, 2C), 127.1 (+, 2C), 127.0 (+), 126.8 (+), 125.4 ( +, 2C), 66.3 (-), 66.0 (-), 46.0 (-), 42.3 (-), 39.8, 
31.0 (+), 23.3 (-); FTIR (KBr, cm-1): 3057, 3028, 3003, 2962, 2922, 2897, 2854, 1639, 1599, 1496, 
1458, 1431, 1359, 1301, 1274, 1215, 1190, 1112, 1068, 1031, 977, 898, 850, 773, 731; HRMS 




Compound was obtained via [typical procedure A] using vinylmagnesium 
bromide (405 μL, 1.0 M (tetrahydrofuran), 0.405 mmol, 1.35 equiv.) and morpholino(1-
phenylcycloprop-2-en-1-yl)methanone (53ak) (69.0 mg, 0.30 mmol, 1.0 equiv.). The product 
was purified by column chromatography using silica and a 3:1 hexane:ethyl acetate mobile phase. 
The titled compound was obtained as a viscous colorless oil in 83% yield (63.8 mg, 0.248 mmol). 
Rf: 0.16; dr: >99:1; 1H NMR (500 MHz, CDCl3) δ 7.36 – 7.28 (m, 2H), 7.25 – 7.20 (m, 1H), 7.18 – 
7.14 (m, 2H), 5.51 – 5.38 (m, 1H), 5.30 (dd, J = 17.0, 1.6 Hz, 1H), 5.12 (dd, J = 10.1, 1.6 Hz, 1H), 
3.80 – 3.70 (m, 1H), 3.69 – 3.53 (m, 3H), 3.44 – 3.32 (m, 2H), 3.30 – 3.18 (m, 2H), 2.60 – 2.47 (m, 
1H), 1.80 (dd, J = 6.2, 5.1 Hz, 1H), 1.18 (dd, J = 8.7, 5.1 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 169.2, 
140.2, 136.8 (+), 129.0 (+, 2C), 126.8 (+), 125.3 (+, 2C), 116.3 (-), 66.8 (-), 66.7 (-), 46.3 (-), 42.6 
(-), 36.6, 29.3 (+), 23.7 (-); FTIR (KBr, cm-1): 3082, 3059, 3001, 2962, 2920, 2899, 2856, 1651, 
1643, 1600, 1496, 1456, 1429, 1359, 1301, 1274, 1195, 1114, 1068, 1031, 985, 943, 908, 850, 
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Compound was obtained via [typical procedure A] using 
Methylmagnesium bromide (135 μL, 3.0 M (diethyl ether), 0.405 mmol, 1.35 equiv.) and N-
methoxy-N-methyl-1-phenylcycloprop-2-ene-1-carboxamide (53au) (61.0 mg, 0.30 mmol, 1.0 
equiv.). The product was purified by column chromatography using silica and a 3:1 hexane:ethyl 
acetate mobile phase. The titled compound was obtained as a viscous light yellow oil in 90% yield 
(59.2 mg, 0.270 mmol). Rf: 0.39; dr: >99:1; 1H NMR (500 MHz, CDCl3) δ 7.34 – 7.14 (m, 5H), 3.12 
(s, 3H), 3.05 (s (broad), 3H), 1.96 – 1.84 (m, 1H), 1.43 (dd, J = 6.4, 4.6 Hz, 1H), 1.16 (d, J = 6.3 Hz, 
3H), 0.85 (s (broad), 1H); 13C NMR (126 MHz, CDCl3) δ 141.6, 128.5 (+, 2C), 127.5, 126.5 (+, 3C), 
60.2, 35.7 (+), 33.3 (+), 22.0 (-), 18.4 (+), 14.5 (+); FTIR (KBr, cm-1): 3059, 3001, 2962, 2931, 2874, 
1660, 1651, 1600, 1496, 1442, 1410, 1365, 1172, 1122, 1101, 1074, 993, 908, 761; HRMS (TOF 




Compound was obtained via [typical procedure A] using 
vinylmagnesium bromide (1.15 mL, 1.0 M (tetrahydrofuran), 1.14 
mmol, 1.30 equiv.) and N-(2-iodobenzyl)-N-methyl-1-phenylcycloprop-2-ene-1-carboxamide 
(53av) (340.0 mg, 0.873 mmol, 1.0 equiv.). The product was purified by column chromatography 
using silica and a 6:1 hexane:ethyl acetate mobile phase. The titled compound was obtained as a 
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pale yellow oil in 89% yield (322 mg, 0.772 mmol). Rf: 0.26; dr: > 98:2; 1H NMR (500 MHz, CDCl3) 
: Mix of Rotomers: δ [7.80 (d, J = 7.9 Hz) & 7.66 (d, J = 7.8 Hz), Σ1H], [7.39 – 7.30 (m) & 7.29 – 7.19 
(m) & 7.15 – 7.11 (m) & 7.06 – 7.00 (m) & 6.97 – 6.90 (m) & 6.79 – 6.74 (m), Σ8H], [5.63 – 5.48 
(m), Σ1H], [5.42 (dd, J = 17.0, 1.7 Hz) & 5.35 (dd, J = 17.0, 1.5 Hz), Σ1H], [5.17 (dd, J = 10.0, 1.7 Hz) 
& 5.13 (dd, J = 10.2, 1.5 Hz), Σ1H], [4.91 (d, J = 17.4 Hz) & 4.70 (d, J = 15.6 Hz), Σ1H], [4.63 (d, J = 
15.6 Hz) & 4.09 (d, J = 17.4 Hz), Σ1H], [2.90 (s) & 2.73 (s), Σ3H], [2.63 – 2.57 (m) & 2.57 – 2.50 
(m), Σ1H], [1.86 (dd, J = 6.3, 5.1 Hz) & 1.80 (dd, J = 6.2, 4.9 Hz), Σ1H], [1.19 (dd, J = 8.7, 5.0 Hz) & 
1.15 (dd, J = 8.7, 4.9 Hz), Σ1H]; 13C NMR (126 MHz, CDCl3) : Mix of Rotomers: δ [171.6 & 170.9, 
Σ1C], [140.1 & 139.6 (+) & 139.4 & 139.3 & 139.0 (+) & 137.9 & 136.7 (+) & 136.5 (+) & 129.0 (+) 
& 128.9 (+) & 128.6 (+) & 128.4 (+) & 128.3 (+) & 128.2 (+) & 128.0 (+) & 127.4 (+) & 126.8 (+) 
& 126.7 (+) & 126.6 (+) & 126.0 (+), Σ12C], [116.6 (-) & 116.5 (-), Σ1C], [99.1 & 97.5, Σ1C], [58.7 
(-) & 56.1 (-), Σ1C], [37.6 & 37.2, Σ1C], [35.4 (+) & 34.5 (+), Σ1C], [28.9 (+) & 27.9 (+), Σ1C], [23.2 
(-) & 21.8 (-), Σ1C]; FTIR (KBr, cm-1): 3058, 3003, 2921, 1642, 1437, 1396, 1045, 907, 750; HRMS 
(TOF ES): Found 418.0680, calculated for C20H21INO (M+H) 418.0668 (2.9 ppm). 
 




[Typical Procedure C]: Methylmagnesium bromide (135 μL, 3.0 M 
(diethyl ether), 0.405 mmol, 1.35 equiv.) was added dropwise to a flame dried two neck flask 
containing copper iodide (3.0 mg, 15.0 μmol, 5.0 mol%) and freshly dried and distilled 
dimethoxyethane (1.0 mL) under a nitrogen atmosphere at 0 °C. The mixture was stirred for five 
minutes at 0 °C. N,N-diethyl-1-phenylcycloprop-2-ene-1-carboxamide (53aa) (65.0 mg, 0.30 
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mmol, 1.0 equiv.) was then added slowly dropwise as a solution in dry dimethoxyethane (1.0 mL). 
After five minutes of stirring at 0 °C, methanol-d4 (19.0 μL, 16.5 mg, 0.45 mmol, 1.50 equiv.) was 
added dropwise and stirred for fifteen minutes at 0 °C. The reaction was then allowed to warm 
to room temperature over 15 minutes before saturated aqueous ammonium chloride (1 mL) was 
added. The resulting solution was then diluted with water and extracted with diethyl ether (3 x 
5 mL). Combined organic layers were washed with brine, dried, filtered, and evaporated. The 
product was purified by column chromatography using silica and a 3:1 hexane:ethyl acetate 
mobile phase. The titled compound was obtained as a viscous colorless oil in 98% yield (68.4 mg, 
0.294 mmol). Rf: 0.32; dr: >99:1; 1H NMR (500 MHz, CDCl3) δ 7.32 – 7.23 (m, 2H), 7.22 – 7.12 (m, 
3H), 3.63 – 3.51 (m, 2H), 3.18 (dq, J = 14.0, 7.0 Hz, 1H), 3.07 (dq, J = 14.1, 7.0 Hz, 1H), 1.88 (dq, J = 
8.8, 6.3 Hz, 1H), 1.13 (d, J = 6.3 Hz, 3H), 1.11 (t, J = 7.1 Hz, 3H), 0.84 (d, J = 8.7 Hz, 1H), 0.55 (t, J = 
7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 170.5, 142.0, 128.7 (+, 2C), 126.2 (+, 3C), 41.4 (-), 39.3 
(-), 35.4, 23.3 (+, t, J = 24.5 Hz), 18.2 (+), 14.7 (+), 12.7 (+), 12.6 (+); FTIR (KBr, cm-1): 3028, 3003, 
2968, 2933, 2872, 1633, 1496, 1471, 1456, 1425, 1379, 1363, 1319, 1294, 1276, 1220, 1151, 
1128, 1101, 1080, 1066, 868, 759, 732, 700; HRMS (TOF ES): Found 255.1586, calculated for 




[Typical Procedure D]: Phenylmagnesium bromide (130 μL, 3.0 M 
(tetrahydrofuran), 0.39 mmol, 1.30 equiv.) was added dropwise to a flame 
dried two neck flask containing copper iodide (3.0 mg, 15.0 μmol, 5.0 mol%) and freshly dried 
and distilled dimethoxyethane (1.0 mL) under a nitrogen atmosphere at 0 °C. The mixture was 
stirred for five minutes at 0 °C. N,N-diethyl-1-phenylcycloprop-2-ene-1-carboxamide (53aa) 
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(65.0 mg, 0.30 mmol, 1.0 equiv.) was then added slowly dropwise as a solution in dry 
dimethoxyethane (1.0 mL). After fifteen minutes of stirring at 0 °C, freshly distilled benzaldehyde 
(48.0 mg, 46.0 μL, 0.45 mmol, 1.5 equiv.) was added dropwise and stirred for thirty minutes at 0 
°C. The reaction was then allowed to warm to room temperature over 15 minutes before 
saturated aqueous ammonium chloride (1 mL) was added. The resulting solution was then 
diluted with water and extracted with diethyl ether (3 x 5 mL). Combined organic layers were 
washed with brine, dried, filtered, and evaporated. The product was purified by column 
chromatography using silica and a 2:1 hexane:ethyl acetate mobile phase. The titled compound 
was obtained as colorless solid in 80% yield (96.4 mg, 0.241 mmol). mp: 181.3 – 182.4 °C; Rf: 
0.31; dr: 96:4; 1H NMR (500 MHz, CDCl3) δ 7.38 – 7.33 (m, 2H), 7.30 – 7.25 (m, 5H), 7.24 – 7.15 
(m, 3H), 7.09 – 7.03 (m, 3H), 6.94 – 6.89 (m, 2H), 5.14 (d, J = 10.4 Hz, 1H), 3.51 (dq, J = 14.1, 7.1 
Hz, 1H), 3.29 (dq, J = 14.3, 7.2 Hz, 1H), 3.19 (dq, J = 14.1, 7.1 Hz, 1H), 3.13 (d, J = 10.1 Hz, 1H), 2.68 
(dq, J = 14.2, 7.1 Hz, 1H), 1.64 (t, J = 10.3 Hz, 1H), 1.19 (s, 1H, broad), 1.11 (t, J = 7.1 Hz, 3H), 0.26 
(t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 170.3, 143.4, 141.2, 136.1, 128.9 (+, 2C), 128.8 (+, 
2C), 128.3 (+, 2C), 128.0 (+, 2C), 127.0 (+), 126.8 (+), 126.8 (+), 126.3 (+, 2C), 125.6 (+, 2C), 68.5 
(+), 44.1 (+), 41.9 (-), 40.6, 39.3 (-), 32.4 (+), 11.9 (+), 11.9 (+); FTIR (KBr, cm-1): 3355. 3060, 3029, 
2976, 2935, 1605, 1497, 1429, 1381, 1278, 1195, 1151, 741; HRMS (TOF ES): Found 422.2098, 




Compound was obtained via [typical procedure C] using vinylmagnesium 
bromide (405 μL, 1.0 M (tetrahydrofuran), 0.405 mmol, 1.35 equiv.), N,N-diethyl-1-
phenylcycloprop-2-ene-1-carboxamide (53aa) (65.0 mg, 0.30 mmol, 1.0 equiv.), and methanol-
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d4 (19.0 μL, 16.5 mg, 0.45 mmol, 1.50 equiv.). The product was purified by column 
chromatography using silica and a 3:1 hexane:ethyl acetate mobile phase. The titled compound 
was obtained as a viscous colorless oil in 86% yield (63.2 mg, 0.259 mmol). Rf: 0.35; dr: >99:1; 1H 
NMR (500 MHz, CDCl3) δ 7.32 – 7.27 (m, 2H), 7.24 – 7.17 (m, 3H), 5.41 (ddd, J = 17.0, 10.1, 9.0 Hz, 
1H), 5.28 (dd, J = 17.0, 1.7 Hz, 1H), 5.05 (dd, J = 10.1, 1.8 Hz, 1H), 3.61 – 3.38 (m, 2H), 3.17 (dq, J = 
13.9, 7.0 Hz, 1H), 3.01 (dq, J = 14.2, 7.1 Hz, 1H), 2.55 (dd, J = 8.9 Hz, 1H), 1.09 (t, J = 7.1 Hz, 3H), 
1.08 (d, J = 8.9 Hz, 1H), 0.55 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 169.7, 140.9, 136.7 
(+), 128.8 (+, 2C), 126.6 (+), 126.0 (+, 2C), 115.8 (-), 41.3 (-), 39.3 (-), 37.2, 28.2 (+), 23.1 (+, t, J = 
25.2 Hz), 12.7 (+), 12.4 (+); FTIR (KBr, cm-1): 3082, 3059, 2974, 2935, 2874, 1633, 1496, 1456, 
1444, 1427, 1381, 1361, 1315, 1276, 1219, 1128, 991, 902, 756, 700; HRMS (TOF ES): Found 




Compound was obtained via [typical procedure C] using 
Methylmagnesium bromide (135 μL, 3.0 M (diethyl ether), 0.405 mmol, 1.35 equiv.), N,N-diethyl-
1-phenylcycloprop-2-ene-1-carboxamide (53aa) (65.0 mg, 0.30 mmol, 1.0 equiv.), and methyl 
iodide (28.0 μL, 64.0 mg, 0.45 mmol, 1.50 equiv.). The product was purified by column 
chromatography using silica and a 3:1 hexane:ethyl acetate mobile phase. The titled compound 
was obtained as a viscous colorless oil in 86% yield (63.2 mg, 0.258 mmol). Rf: 0.32; dr: >99:1; 1H 
NMR (500 MHz, CDCl3) δ 7.28 – 7.23 (m, 2H), 7.21 – 7.12 (m, 3H), 3.37 (q, J = 7.2 Hz, 2H), 3.32 (q, 
J = 7.1 Hz, 2H), 1.47 (s, 2H), 1.21 (d, J = 6.4 Hz, 6H), 1.11 (d, J = 7.1 Hz, 3H), 0.59 (t, J = 7.1 Hz, 3H); 
13C NMR (126 MHz, CDCl3) δ 169.5, 143.0, 128.6 (+, 2C), 126.0 (+), 125.7 (+, 2C), 41.4 (-), 38.4 (-
), 35.9, 25.1 (+, 2C), 13.0 (+), 12.6 (+), 10.0 (+, 2C); FTIR (KBr, cm-1): 3057, 3003, 2970, 2931, 
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2872, 1633, 1496, 1458, 1444, 1423, 1379, 1363, 1346, 1319, 1298, 1278, 1238, 1220, 1155, 
1116, 1093, 1078, 756, 732; HRMS (TOF ES): Found 268.1669, calculated for C16H23NONa (M+Na) 




Compound was obtained via [typical procedure C] using 
Methylmagnesium bromide (135 μL, 3.0 M (diethyl ether), 0.405 mmol, 1.35 equiv.), N,N-diethyl-
1-phenylcycloprop-2-ene-1-carboxamide (53aa) (65.0 mg, 0.30 mmol, 1.0 equiv.), and allyl 
bromide (39.0 μL, 55.0 mg, 0.45 mmol, 1.50 equiv.). The product was purified by column 
chromatography using silica and a 6:1 hexane:ethyl acetate mobile phase. The titled compound 
was obtained as a viscous colorless oil in 87% yield (70.6 mg, 0.260 mmol). Rf: 0.38; dr: >99:1; 1H 
NMR (500 MHz, CDCl3) δ 7.29 – 7.14 (m, 5H), 6.09 – 5.85 (m, 1H), 5.09 (dd, J = 17.2, 1.9 Hz, 1H), 
4.99 (dd, J = 10.2, 2.0 Hz, 1H), 3.55 – 3.36 (m, 2H), 3.34 – 3.16 (m, 2H), 2.74 – 2.55 (m, 1H), 2.26 – 
2.09 (m, 1H), 1.82 – 1.68 (m, 1H), 1.36 – 1.25 (m, 1H), 1.21 (d, J = 6.5 Hz, 3H), 1.11 (t, J = 7.1 Hz, 
3H), 0.56 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 169.4, 142.7, 138.4 (+), 128.7 (+, 2C), 
126.1 (+), 125.9 (+, 2C), 114.6 (-), 41.5 (-), 38.6 (-), 36.1, 31.2 (+), 29.8 (-), 22.9 (+), 12.9 (+), 12.6 
(+), 9.9 (+); FTIR (KBr, cm-1): 3061, 3003, 2972, 2933, 2874, 1633, 1600, 1496, 1458, 1423, 1379, 
1363, 1346, 1319, 1298, 1278, 1240, 1220, 1155, 1120, 1101, 1078, 995, 908, 817; HRMS (TOF 






Compound was obtained via [typical procedure C] using 
Methylmagnesium bromide (135 μL, 3.0 M (diethyl ether), 0.405 mmol, 
1.35 equiv.), N,N-diethyl-1-phenylcycloprop-2-ene-1-carboxamide (53aa) (65.0 mg, 0.30 mmol, 
1.0 equiv.), and benzyl bromide (54.0 μL, 77.0 mg, 0.45 mmol, 1.50 equiv.). The product was 
purified by column chromatography using silica and a 6:1 hexane:ethyl acetate mobile phase. The 
titled compound was obtained as a colorless solid in 82% yield (78.8 mg, 0.245 mmol). mp: 86.0-
86.9 °C; Rf: 0.29; dr: >99:1; 1H NMR (500 MHz, CDCl3) δ 7.44 – 7.08 (m, 10H), 3.54 (dq, J = 14.8, 
7.5 Hz, 1H), 3.47 (dq, J = 14.2, 7.1 Hz, 1H), 3.41 (dd, J = 15.6, 4.5 Hz, 1H), 3.32 – 3.17 (m, 2H), 2.76 
(dd, J = 15.6, 9.9 Hz, 1H), 1.88 (dq, J = 9.5, 6.5 Hz, 1H), 1.52 – 1.43 (m, 1H), 1.27 (d, J = 6.5 Hz, 3H), 
1.15 (t, J = 7.1 Hz, 3H), 0.57 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 169.5, 142.6, 142.3, 
128.7 (+, 2C), 128.6 (+, 2C), 128.4 (+, 2C), 126.2 (+), 125.8 (+, 3C), 41.5 (-), 38.6 (-), 36.3, 33.6 (+), 
31.3 (-), 22.6 (+), 12.9 (+), 12.7 (+), 10.2 (+); FTIR (KBr, cm-1): 3082, 3059, 3024, 2970, 2933, 
2874, 1633, 1600, 1494, 1454, 1423, 1379, 1363, 1346, 1319, 1298, 1278, 1240, 1220, 1153, 
1112, 1103, 1078, 1030, 947, 864; HRMS (TOF ES): Found 344.1995, calculated for C22H27NONa 




Compound was obtained via [typical procedure C] using 
Methylmagnesium bromide (135 μL, 3.0 M (diethyl ether), 0.405 mmol, 1.35 equiv.), N,N-diethyl-
1-phenylcycloprop-2-ene-1-carboxamide (53aa) (65.0 mg, 0.30 mmol, 1.0 equiv.), and 
chlorotrimethylsilane (57.0 μL, 49.0 mg, 0.45 mmol, 1.50 equiv.). The product was purified by 
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column chromatography using silica and a 6:1 hexane:ethyl acetate mobile phase. The titled 
compound was obtained as a colorless solid in 72% yield (65.4 mg, 0.215 mmol). mp: 94.9-96.3 
°C; Rf: 0.48; dr: >99:1; 1H NMR (500 MHz, CDCl3) δ 7.30 – 7.13 (m, 5H), 3.70 – 3.50 (m, 2H), 3.17 
– 2.92 (m, 2H), 2.19 (dq, J = 10.6, 6.4 Hz, 1H), 1.17 (d, J = 6.5 Hz, 3H), 1.09 (t, J = 7.0 Hz, 3H), 0.48 
(t, J = 7.1 Hz, 3H), 0.15 (s, 9H), -0.00 (d, J = 10.6 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 170.1, 144.0, 
128.7 (+, 2C), 126.1 (+, 2C), 126.0 (+), 41.5 (-), 40.0, 39.2 (-), 26.1 (+), 21.9 (+), 13.6 (+), 12.8 (+), 
12.7 (+), 1.3 (+, 3C); FTIR (KBr, cm-1): 3053, 3007, 2970, 2945, 2895, 2874, 1627, 1599, 1462, 
1444, 1427, 1373, 1261, 1240, 1155, 1101, 1053, 1022, 952, 858, 837, 802, 742, 702; HRMS (TOF 




Compound was obtained via [typical procedure C] using 
Methylmagnesium bromide (135 μL, 3.0 M (diethyl ether), 0.405 mmol, 1.35 equiv.), N,N-diethyl-
1-phenylcycloprop-2-ene-1-carboxamide (53aa) (65.0 mg, 0.30 mmol, 1.0 equiv.), and propionyl 
chloride (40.0 μL, 42.0 mg, 0.45 mmol, 1.50 equiv.). The product was purified by column 
chromatography using silica and a 3:1 hexane:ethyl acetate mobile phase. The titled compound 
was obtained as a viscous colorless oil in 79% yield (68.0 mg, 0.237 mmol). Rf: 0.23; dr: >99:1; 1H 
NMR (500 MHz, CDCl3) δ 7.34 – 7.29 (m, 4H), 7.26 – 7.21 (m, 1H), 3.41 (dq, J = 14.1, 7.1 Hz, 1H), 
3.31 – 3.22 (m, 2H), 3.18 (dq, J = 14.1, 7.2 Hz, 1H), 2.79 (dq, J = 17.4, 7.4 Hz, 1H), 2.57 (dq, J = 17.3, 
7.3 Hz, 1H), 2.29 (d, J = 9.0 Hz, 1H), 2.03 (dq, J = 8.9, 6.6 Hz, 1H), 1.49 (d, J = 6.6 Hz, 3H), 1.12 (t, J 
= 7.3 Hz, 3H), 1.10 (t, J = 7.1 Hz, 1H), 0.57 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 207.5, 
167.3, 140.9, 129.0 (+, 2C), 127.1 (+), 126.4 (+, 2C), 43.7, 41.5 (-), 38.9 (-), 38.8 (-), 37.7 (+), 28.1 
(+), 12.9 (+), 12.5 (+), 10.4 (+), 8.2 (+); FTIR (KBr, cm-1): 3059, 2974, 2935, 2875, 1703, 1639, 
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1633, 1494, 1462, 1444, 1427, 1381, 1361, 1317, 1298, 1278, 1219, 1155, 1122, 1105, 1082, 
1066, 1041, 904, 850, 833, 759, 700; HRMS (TOF ES): Found 310.1800, calculated for 




Compound was obtained via [typical procedure C] using 
Methylmagnesium bromide (135 μL, 3.0 M (diethyl ether), 0.405 mmol, 1.35 equiv.), N,N-diethyl-
1-phenylcycloprop-2-ene-1-carboxamide (53aa) (65.0 mg, 0.30 mmol, 1.0 equiv.), and a 
saturated solution of diiodine in dry dimethoxyethane which was added until the coloration 
persisted. The product was purified by column chromatography using silica and a 3:1 
hexane:ethyl acetate mobile phase. The titled compound was obtained as a viscous colorless oil 
in 63% yield (68.2 mg, 0.190 mmol). Rf: 0.45; dr: >99:1; 1H NMR (500 MHz, CDCl3) δ 7.41 – 7.19 
(m, 5H), 3.56 – 3.46 (m, 1H), 3.50 (d, J = 6.9 Hz, 1H), 3.43 – 3.33 (m, 1H), 3.33 – 3.23 (m, 2H), 1.45 
– 1.35 (m, 4H), 1.16 (t, J = 7.1 Hz, 3H), 0.58 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 167.3, 
140.4, 129.0 (+, 2C), 127.0 (+), 126.0 (+, 2C), 42.0 (-), 39.0 (-), 36.1, 26.5 (+), 18.1 (+), 12.6 (+), 
12.6 (+), 7.2 (+); FTIR (KBr, cm-1): 3057, 2970, 2931, 2872, 1633, 1599, 1496, 1444, 1425, 1379, 
1315, 1296, 1278, 1263, 1234, 1219, 1149, 1122, 1103, 1080, 1066, 821, 761, 732; HRMS (TOF 




Compound was obtained via [typical procedure C] using vinylmagnesium 
bromide (405 μL, 1.0 M (tetrahydrofuran), 0.405 mmol, 1.35 equiv.), N,N-diethyl-1-
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phenylcycloprop-2-ene-1-carboxamide (53aa) (65.0 mg, 0.30 mmol, 1.0 equiv.), and a saturated 
solution of diiodine in dry dimethoxyethane which was added until coloration persisted. The 
product was purified by column chromatography using silica and a 3:1 hexane:ethyl acetate 
mobile phase. The titled compound was obtained as a viscous light yellow oil in 51% yield (56.0 
mg, 0.152 mmol). Rf: 0.52; dr: >99:1; 1H NMR (500 MHz, CDCl3) δ 7.39 – 7.19 (m, 5H), 5.89 – 5.68 
(m, 1H), 5.37 – 5.21 (m, 2H), 3.56 (d, J = 8.4 Hz, 1H), 3.52 – 3.41 (m, 1H), 3.36 – 3.24 (m, 2H), 3.21 
(dq, J = 14.3, 7.1 Hz, 1H), 2.19 – 1.94 (m, 1H), 1.13 (t, J = 7.1 Hz, 3H), 0.54 (t, J = 7.1 Hz, 3H); 13C 
NMR (126 MHz, CDCl3) δ 166.7, 139.4, 138.7 (+), 129.1 (+, 2C), 127.4 (+), 126.0 (+, 2C), 117.5 (-), 
42.0 (-), 39.2 (-), 38.8, 35.2 (+), 12.6 (+), 12.5 (+), 4.0 (+); FTIR (KBr, cm-1): 3080, 3057, 3020, 
2972, 2933, 2872, 1631, 1494, 1471, 1458, 1429, 1379, 1313, 1296, 1278, 1257, 1219, 1141, 
1101, 1078, 979, 964, 904, 761, 700; HRMS (TOF ES): Found 369.0601, calculated for C16H20INO 




Compound was obtained via [typical procedure C] using vinylmagnesium 
bromide (405 μL, 1.0 M (tetrahydrofuran), 0.405 mmol, 1.35 equiv.), N,N-diisopropyl-1-
phenylcycloprop-2-ene-1-carboxamide (53ab) (73.0 mg, 0.30 mmol, 1.0 equiv.), and methyl 
iodide (28.0 μL, 64.0 mg, 0.45 mmol, 1.50 equiv.). The product was purified by column 
chromatography using silica and a 3:1 hexane:ethyl acetate mobile phase. The titled compound 
was obtained as a yellow solid in 81% yield (69.4 mg, 0.243 mmol). mp: 94.4-96.0 °C; Rf: 0.61; dr: 
>99:1; 1H NMR (500 MHz, CDCl3) δ 7.30 – 7.27 (m, 4H), 7.22 – 7.15 (m, 1H), 5.95 – 5.74 (m, 1H), 
5.22 (d, J = 17.0 Hz, 1H), 5.13 (dd, J = 10.2, 1.9 Hz, 1H), 4.14 (hept, J = 6.6 Hz, 1H), 3.19 (hept, J = 
6.8 Hz, 1H), 2.08 (s (broad), 1H), 1.76 (s (broad), 1H), 1.42 (t, J = 6.5 Hz, 6H), 1.33 (d, J = 6.6 Hz, 
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3H), 0.78 (s (broad), 3H), 0.64 (s (broad), 3H); 13C NMR (126 MHz, CDCl3) δ 168.3, 142.0, 135.1 
(+), 128.7 (+, 2C), 126.4 (+), 126.2 (+, 2C), 115.8 (-, broad), 48.9 (+), 45.8 (+), 40.8 (broad), 35.0 
(+, broad), 26.2 (+, broad), 20.8 (+), 20.6 (+), 20.4 (+), 20.1 (+), 11.4 (+); FTIR (KBr, cm-1): 3080, 
3059, 3001, 2962, 2929, 2872, 1633, 1494, 1435, 1369, 1336, 1211, 1155, 1118, 1039, 987, 900, 




Compound was obtained via [typical procedure C] using 
vinylmagnesium bromide (405 μL, 1.0 M (tetrahydrofuran), 0.405 mmol, 1.35 equiv.), N,N-diallyl-
1-phenylcycloprop-2-ene-1-carboxamide (53ac) (72.0 mg, 0.30 mmol, 1.0 equiv.), and allyl 
bromide (39.0 μL, 55.0 mg, 0.45 mmol, 1.50 equiv.). The product was purified by column 
chromatography using silica and a 6:1 hexane:ethyl acetate mobile phase. The titled compound 
was obtained as a viscous colorless oil in 76% yield (70.2 mg, 0.228 mmol). Rf: 0.45; dr: >99:1; 1H 
NMR (500 MHz, CDCl3) δ 7.42 – 7.15 (m, 5H), 6.09 – 5.88 (m, 1H), 5.82 – 5.63 (m, 2H), 5.34 (dd, J 
= 16.9, 1.7 Hz, 1H), 5.18 (dd, J = 10.3, 1.8 Hz, 1H), 5.13 (dd, J = 10.2, 1.4 Hz, 1H), 5.09 (dd, J = 17.2, 
1.6 Hz, 2H), 5.00 (dd, J = 10.3, 1.9 Hz, 1H), 4.94 – 4.90 (m, 3H), 4.11 – 3.97 (m, 1H), 3.94 – 3.66 (m, 
3H), 2.81 – 2.65 (m, 1H), 2.48 – 2.35 (m, 1H), 2.33 – 2.18 (m, 1H), 1.61 – 1.50 (m, 1H); 13C NMR 
(126 MHz, CDCl3) δ 169.0, 141.2, 137.4 (+), 133.7 (+), 133.4 (+), 132.9 (+), 128.9 (+, 2C), 126.7 
(+), 126.0 (+, 2C), 118.7 (-), 117.8 (-), 117.2 (-), 115.3 (-), 50.0 (-), 46.0 (-), 38.8, 33.3 (+), 32.9 (+), 
30.6 (-); FTIR (KBr, cm-1): 3078, 3003, 2980, 2920, 1643, 1631, 1600, 1496, 1450, 1435, 1410, 
1330, 1298, 1282, 1269, 1205, 1192, 1128, 993, 922, 910, 759, 734; HRMS (TOF ES): Found 






Compound was obtained via [typical procedure C] using 
phenylmagnesium bromide (135 μL, 3.0 M (diethyl ether), 0.405 
mmol, 1.35 equiv.), N,N-dibenzyl-1-phenylcycloprop-2-ene-1-carboxamide (53ad) (102 mg, 0.30 
mmol, 1.0 equiv.), and benzyl bromide (54.0 μL, 77.0 mg, 0.45 mmol, 1.50 equiv.). The product 
was purified by column chromatography using silica and a 9:1 hexane:ethyl acetate mobile phase. 
The titled compound was obtained as a colorless solid in 79% yield (120 mg, 0.236 mmol). mp: 
143.5-146.1 °C; Rf: 0.38; dr: 15:1; 1H NMR (500 MHz, CDCl3) δ 7.58 – 7.47 (m, 2H), 7.40 – 6.87 (m, 
21H), 6.28 – 6.12 (m, 2H), 4.95 (d, J = 14.0 Hz, 1H), 4.73 (d, J = 15.6 Hz, 1H), 3.80 (dd, J = 15.2, 4.9 
Hz, 1H), 3.78 (d, J = 14.0 Hz, 1H), 3.68 (d, J = 15.6 Hz, 1H), 3.20 (d, J = 9.9 Hz, 1H), 2.99 (dd, J = 
15.2, 9.0 Hz, 1H), 1.67 (ddd, J = 9.9, 9.0, 4.9 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 170.0, 142.2, 
142.1, 136.6, 136.6, 135.6, 130.0 (+, 2C), 129.1 (+, 2C), 128.8 (+, 2C), 128.7 (+, 2C), 128.5 (+, 2C), 
128.3 (+, 2C), 128.3 (+, 2C), 128.2 (+, 2C), 127.9 (+, 2C), 127.5 (+), 127.3 (+, 2C), 127.2 (+), 127.0 
(+), 126.3 (+), 125.7 (+), 50.3 (-), 46.8 (-), 39.3, 36.8 (+), 32.3 (+), 30.5 (-); FTIR (KBr, cm-1): 3084, 
3061, 3028, 2929, 2914, 2862, 1952, 1880, 1809, 1643, 1633, 1600, 1494, 1454, 1417, 1361, 
1329, 1265, 1209, 1078, 1030, 1003, 958, 943, 916, 842, 823, 767, 732, 700; HRMS (TOF ES): 




Compound was obtained via [typical procedure C] using 
vinylmagnesium bromide (405 μL, 1.0 M (tetrahydrofuran), 0.405 
mmol, 1.35 equiv.), N,N-dibenzyl-1-phenylcycloprop-2-ene-1-carboxamide (53ad) (102 mg, 0.30 
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mmol, 1.0 equiv.), and propionyl chloride (40.0 μL, 42.0 mg, 0.45 mmol, 1.50 equiv.). The product 
was purified by column chromatography using silica and a 9:1 hexane:ethyl acetate mobile phase. 
The titled compound was obtained as a viscous colorless oil in 52% yield (66.1 mg, 0.156 mmol). 
Rf: 0.19; dr: >99:1; 1H NMR (500 MHz, CDCl3) δ 7.50 – 7.41 (m, 2H), 7.34 – 7.20 (m, 6H), 7.17 – 
7.03 (m, 5H), 6.57 – 6.46 (m, 1H), 6.48 – 6.44 (m, 2H), 5.32 (dd, J = 17.2, 1.8 Hz, 1H), 5.13 (dd, J = 
10.3, 1.8 Hz, 1H), 4.82 (d, J = 14.6 Hz, 1H), 4.52 (d, J = 15.5 Hz, 1H), 4.14 (d, J = 15.5 Hz, 1H), 3.95 
(d, J = 14.6 Hz, 1H), 2.92 – 2.80 (m, 1H), 2.78 – 2.70 (m, 1H), 2.70 – 2.57 (m, 2H), 1.18 (t, J = 7.3 
Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 206.8, 167.8, 139.6, 136.8, 135.6, 132.8 (+), 129.2 (+, 2C), 
129.0 (+, 2C), 128.4 (+, 2C), 128.4 (+, 2C), 127.9 (+, 2C), 127.8 (+), 127.5 (+, 2C), 127.4 (+), 127.4 
(+), 117.6 (-), 50.2 (-), 46.7 (-), 45.7, 39.3 (+), 38.9 (-), 37.6 (+), 8.2 (+); FTIR (KBr, cm-1): 3061, 
3028, 3003, 2978, 2935, 1707, 1643, 1633, 1602, 1494, 1450, 1417, 1361, 1329, 1315, 1267, 
1234, 1193, 1178, 1122, 1080, 1039, 1030, 989, 945, 908, 806, 734, 700; HRMS (TOF ES): Found 




Compound was obtained via [typical procedure C] using phenylmagnesium 
bromide (135 μL, 3.0 M (diethyl ether), 0.405 mmol, 1.35 equiv.), (1-
phenylcycloprop-2-en-1-yl)(pyrrolidin-1-yl)methanone (53ai) (64.0 mg, 0.30 mmol, 1.0 equiv.), 
and propionyl chloride (40.0 μL, 42.0 mg, 0.45 mmol, 1.50 equiv.). The product was purified by 
column chromatography using silica and a 3:1 hexane:ethyl acetate mobile phase. The titled 
compound was obtained as a colorless solid in 80% yield (83.1 mg, 0.239 mmol). mp: 112.1-114.2 
°C; Rf: 0.18; dr: >99:1; 1H NMR (500 MHz, CDCl3) δ 7.54 – 7.14 (m, 10H), 3.41 – 3.26 (m, 2H), 3.12 
(d, J = 9.3 Hz, 1H), 3.12 – 3.05 (m, 1H), 2.85 – 2.74 (m, 1H), 2.68 – 2.53 (m, 2H), 2.36 (d, J = 9.3 Hz, 
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1H), 1.58 – 1.49 (m, 2H), 1.48 – 1.39 (m, 1H), 1.16 (t, J = 7.3 Hz, 3H), 1.06 – 0.95 (m, 1H); 13C NMR 
(126 MHz, CDCl3) δ 205.7, 166.4, 140.1, 134.1, 129.8 (+, 2C), 129.1 (+, 2C), 127.6 (+, 2C), 127.4 
(+), 126.8 (+), 126.6 (+, 2C), 46.9 (-), 46.3, 46.2 (-), 40.8 (+), 38.4 (-), 35.4 (+), 25.7 (-), 23.9 (-), 8.3 
(+); FTIR (KBr, cm-1): 3057, 3028, 2974, 2947, 2875, 1712, 1631, 1579, 1496, 1448, 1431, 1373, 
1340, 1265, 1251, 1224, 1190, 1168, 1128, 1095, 1080, 1033, 962, 914, 869, 842, 771, 732, 700; 




Compound was obtained via [typical procedure C] using vinylmagnesium 
bromide (405 μL, 1.0 M (tetrahydrofuran), 0.405 mmol, 1.35 equiv.), (1-
phenylcycloprop-2-en-1-yl)(pyrrolidin-1-yl)methanone (53ai) (64.0 mg, 0.30 mmol, 1.0 equiv.), 
and benzyl bromide (54.0 μL, 77.0 mg, 0.45 mmol, 1.50 equiv.). The product was purified by 
column chromatography using silica and a 3:1 hexane:ethyl acetate mobile phase. The titled 
compound was obtained as a viscous colorless oil in 79% yield (78.2 mg, 0.236 mmol). Rf: 0.26; 
dr: >99:1; 1H NMR (500 MHz, CDCl3) δ 7.38 – 7.14 (m, 10H), 5.98 – 5.70 (m, 1H), 5.37 (dd, J = 17.0, 
1.8 Hz, 1H), 5.20 (dd, J = 10.3, 1.8 Hz, 1H), 3.62 – 3.48 (m, 2H), 3.45 (dd, J = 15.3, 5.2 Hz, 1H), 3.35 
– 3.23 (m, 1H), 2.96 – 2.85 (m, 2H), 2.50 (dd, J = 10.2, 9.2 Hz, 1H), 1.85 – 1.71 (m, 2H), 1.71 – 1.61 
(m, 3H); 13C NMR (126 MHz, CDCl3) δ 168.2, 141.9, 140.9, 133.9 (+), 128.9 (+, 2C), 128.8 (+, 2C), 
128.4 (+, 2C), 126.5 (+), 125.9 (+), 125.6 (+, 2C), 117.4 (-), 46.8 (-), 46.1 (-), 40.0, 36.1 (+), 33.1 
(+), 32.1 (-), 26.3 (-), 24.1 (-); FTIR (KBr, cm-1): 3082, 3059, 3024, 2972, 2874, 1633, 1600, 1494, 
1450, 1419, 1340, 1249, 1222, 1190, 1170, 1124, 1112, 1080, 1031, 983, 910, 758, 736; HRMS 






Compound was obtained via [typical procedure C] using 
phenylmagnesium bromide (135 μL, 3.0 M (diethyl ether), 0.405 mmol, 
1.35 equiv.), N,N-diethyl-1-phenylcycloprop-2-ene-1-carboxamide (53aj) (65.0 mg, 0.30 mmol, 
1.0 equiv.), and methyl iodide (28.0 μL, 64.0 mg, 0.45 mmol, 1.50 equiv.). The product was 
purified by column chromatography using silica and a 3:1 hexane:ethyl acetate mobile phase. The 
titled compound was obtained as a colorless solid in 87% yield (83.4 mg, 0.261 mmol). mp: 121.1-
125.4 °C; Rf: 0.42; dr: >99:1; 1H NMR (500 MHz, CDCl3) δ 7.36 – 7.32 (m, 4H), 7.30 – 7.27 (m, 4H), 
7.24 – 7.19 (m, 2H), 3.58 – 3.46 (m, 2H), 3.11 – 2.98 (m, 1H), 2.89 (d, J = 10.0 Hz, 1H), 2.87 – 2.82 
(m, 1H), 1.68 (dq, J = 9.9, 6.7 Hz, 1H), 1.48 (d, J = 6.8 Hz, 3H), 1.44 – 1.34 (m, 2H), 1.34 – 1.23 (m, 
2H), 0.87 – 0.73 (m, 1H), 0.51 – 0.39 (m, 1H); 13C NMR (126 MHz, CDCl3) δ 167.8, 142.5, 136.9, 
129.4 (+, 2C), 128.8 (+, 2C), 127.9 (+, 2C), 126.4 (+), 126.2 (+), 125.6 (+, 2C), 46.7 (-), 42.3 (-), 
38.3, 34.8 (+), 30.3 (+), 25.1 (-), 24.8 (-), 24.3 (-), 10.0 (+); FTIR (KBr, cm-1): 3057, 3026, 2935, 
2854, 1631, 1496, 1435, 1384, 1367, 1352, 1294, 1276, 1251, 1219, 1199, 1126, 1060, 1031, 
1001, 852, 763, 744, 727, 700; HRMS (TOF ES): Found 342.1845, calculated for C22H25NONa 




Compound was obtained via [typical procedure C] using 
phenylmagnesium bromide (135 μL, 3.0 M (diethyl ether), 0.405 mmol, 1.35 equiv.), 
morpholino(1-phenylcycloprop-2-en-1-yl)methanone (53ak) (69.0 mg, 0.30 mmol, 1.0 equiv.), 
and allyl bromide (39.0 μL, 55.0 mg, 0.45 mmol, 1.50 equiv.). The product was purified by column 
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chromatography using silica and a 3:1 hexane:ethyl acetate mobile phase. The titled compound 
was obtained as a colorless solid in 87% yield (91.2 mg, 0.262 mmol). mp: 102.4-103.5 °C; Rf: 
0.29; dr: >99:1; 1H NMR (500 MHz, CDCl3) δ 7.45 – 7.18 (m, 10H), 5.95 – 5.69 (m, 1H), 4.96 (dd, J 
= 17.2, 1.9 Hz, 1H), 4.88 (dd, J = 10.2, 1.9 Hz, 1H), 3.80 – 3.66 (m, 1H), 3.58 – 3.49 (m, 1H), 3.48 – 
3.33 (m, 2H), 3.10 – 2.87 (m, 4H), 3.03 (d, J = 9.9 Hz, 1H), 2.60 – 2.46 (m, 1H), 2.44 – 2.31 (m, 1H), 
1.59 – 1.39 (m, 1H); 13C NMR (126 MHz, CDCl3) δ 167.8, 141.5, 137.6 (+), 136.4, 128.9 ( +, 2C), 
128.7 (+, 2C), 128.2 (+, 2C), 126.7 (+), 126.6 (+), 125.5 (+, 2C), 114.9 (-), 66.0 (-), 65.4 (-), 46.1 (-
), 41.7 (-), 38.4, 35.9 (+), 33.3 (+), 28.7 (-); FTIR (KBr, cm-1): 3059, 3028, 3001, 2970, 2920, 2899, 
2856, 1639, 1600, 1498, 1456, 1427, 1359, 1300, 1273, 1222, 1192, 1114, 1070, 1030, 999, 968, 





Compound was obtained via [Typical Procedure D] using methylmagnesium 
bromide (130 μL, 3.0 M (tetrahydrofuran), 0.40 mmol, 1.30 equiv.), N,N-
diethyl-1-phenylcycloprop-2-ene-1-carboxamide (53aa) (65.0 mg, 0.30 mmol, 1.0 equiv.), and a 
freshly distilled benzaldehyde (48.0 mg, 46.0 μL, 0.45 mmol, 1.5 equiv.). The product was purified 
by column chromatography using silica and a 2:1 hexane:diethyl ether mobile phase. The titled 
compound was obtained as colorless solid in 60% yield (60.9 mg, 0.180 mmol). mp: 140.9-143.6 
°C; Rf: 0.31; dr: 92:8; 1H NMR (500 MHz, CDCl3) δ 7.48 – 7.42 (m, 2H), 7.35 – 7.27 (m, 4H), 7.26 – 
7.16 (m, 4H), 5.81 (s, 1H), 4.78 (d, J = 10.3 Hz, 1H), 3.72 – 3.59 (m, 2H), 3.27 – 3.12 (m, 2H), 2.12 
(dq, J = 9.6, 6.6 Hz, 1H), 1.42 (dd, J = 10.4, 9.6 Hz, 1H), 1.34 (d, J = 6.6 Hz, 3H), 1.18 (t, J = 7.1 Hz, 
3H), 0.60 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 170.7, 143.8, 141.4, 128.9 (+, 2C), 128.5 
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(+, 2C), 127.3 (+), 126.7 (+), 126.3 (+, 2C), 126.2 (+, 2C), 70.8 (+), 42.2 (+), 41.9 (-), 39.2 (-), 38.6, 
20.7 (+), 12.8 (+), 12.6 (+), 10.6 (+); FTIR (KBr, cm-1): 3358, 2972, 2935, 2875, 1608, 1495, 1422, 
1380, 1347, 1318, 1252, 1155, 699; HRMS (TOF ES): Found 360.1949, calculated for C22H27NO2Na 




Compound was obtained via [typical procedure D] using methylmagnesium 
bromide (130.0 μL, 3.0 M (tetrahydrofuran), 0.390 mmol, 1.30 equiv.), N,N-diethyl-1-
phenylcycloprop-2-ene-1-carboxamide (53aa) (65.0 mg, 0.30 mmol, 1.0 equiv.), and freshly 
distilled pivaldehyde (38.8 mg, 48.9 μL, 0.450 mmol, 1.50 equiv.). The product was purified by 
column chromatography using silica and a 2:1 hexane:diethyl ether mobile phase. The titled 
compound was obtained as colorless solid in 79% yield (75.1 mg, 0.237 mmol). mp: 138.1 – 139.4 
°C; Rf: 0.36; dr: >98:2; 1H NMR (500 MHz, CDCl3) δ 7.34 – 7.29 (m, 2H), 7.27 – 7.19 (m, 3H), 5.79 
(d, J = 2.3 Hz, 1H), 3.73 – 3.60 (m, 2H), 3.41 (dd, J = 10.5, 2.3 Hz, 1H), 3.18 – 3.06 (m, 2H), 2.10 (dq, 
J = 9.6, 6.6 Hz, 1H), 1.21 (d, J = 6.6 Hz, 3H), 1.20 – 1.16 (m, 1H), 1.15 (t, J = 7.1 Hz, 3H), 0.99 (s, 9H), 
0.52 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 171.0, 142.1, 128.9 (+, 2C), 126.5 (+), 126.2 
(+, 2C), 74.8 (+), 41.8 (-), 39.1 (-), 38.0 (+), 36.9, 35.0, 26.3 (+, 3C), 21.3 (+), 12.5 (+), 12.4 (+), 11.1 
(+); FTIR (KBr, cm-1): 3348, 3027, 2968, 2873, 1604, 1460, 1429, 1063, 1007, 702; HRMS (TOF 







Compound was obtained via [typical procedure D] using (trimethylsilyl)methylmagnesium 
chloride (450 μL, 1.3 M (tetrahydrofuran), 0.60 mmol, 1.30 equiv.), N,N-diethyl-1-
phenylcycloprop-2-ene-1-carboxamide (53aa) (98.0 mg, 0.45 mmol, 1.0 equiv.), and freshly 
distilled pivaldehyde (59.0 mg, 75.0 μL, 0.68 mmol, 1.50 equiv.). The product was purified by 
column chromatography using silica and a 2:1 hexane:diethyl ether mobile phase. The titled 
compound was obtained as colorless oil in 79% yield (138 mg, 0.354 mmol). Rf: 0.45; dr: > 99:1; 
1H NMR (500 MHz, CDCl3) δ 7.32 – 7.27 (m, 2H), 7.24 – 7.16 (m, 3H), 3.61 (dq, J = 14.0, 7.1 Hz, 
1H), 3.57 – 3.48 (m, 1H), 3.48 (d, J = 10.0 Hz, 1H), 3.14 (dq, J = 14.0, 7.0 Hz, 1H), 2.97 (dq, J = 14.0, 
7.0 Hz, 1H), 2.02 – 1.92 (m, 1H), 1.14 – 1.09 (m, 1H), 1.12 (t, J = 7.1 Hz, 3H), 0.96 (s, 9H), 0.88 (dd, 
J = 15.7, 5.2 Hz, 1H), 0.43 (t, J = 7.1 Hz, 3H), 0.43 – 0.38 (m, 1H), 0.12 (s, 9H); 13C NMR (126 MHz, 
CDCl3) δ 171.2, 142.4, 129.0 (+, 2C), 126.5 (+), 126.4 (+, 2C), 74.6 (+), 42.0 (-), 39.3 (-), 38.6 (+), 
38.5, 35.5, 26.5 (+, 3C), 20.9 (+), 12.5 (+), 12.3 (+), 10.2 (-), -1.1 (+, 3C); FTIR (KBr, cm-1): 3365, 
2951, 2901, 1614, 1479, 1462, 1445, 1249, 1184, 1064, 846, 698; HRMS (TOF ES): Found 




Compound was obtained via [Typical Procedure D] using phenylmagnesium 
bromide (130 μL, 3.0 M (tetrahydrofuran), 0.40 mmol, 1.30 equiv.), N,N-
diethyl-1-phenylcycloprop-2-ene-1-carboxamide (53aa) (65.0 mg, 0.30 
mmol, 1.0 equiv.), and a 4-fluorobenzaldehyde (58.0 mg, 50.0 μL, 0.45 mmol, 1.50 equiv.). The 
product was purified by column chromatography using silica and a 2:1 hexane:diethyl ether 
mobile phase. The titled compound was obtained as colorless oil in 88% yield (110 mg, 0.263 
mmol). Rf: 0.31; dr: 93:7; 1H NMR (400 MHz, CDCl3) δ 7.46 – 7.39 (m, 2H), 7.38 – 7.33 (m, 4H), 
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7.31 – 7.22 (m, 4H), 6.96 – 6.88 (m, 2H), 6.85 – 6.77 (m, 2H), 5.98 (s, 1H), 5.16 (d, J = 10.4 Hz, 1H), 
3.58 (dq, J = 14.1, 7.2 Hz, 1H), 3.36 (dq, J = 14.4, 7.1 Hz, 1H), 3.30 – 3.21 (m, 1H), 3.19 (d, J = 10.0 
Hz, 1H), 2.75 (dq, J = 14.1, 7.0 Hz, 1H), 1.65 (t, J = 10.2 Hz, 1H), 1.18 (t, J = 7.1 Hz, 3H), 0.33 (t, J = 
7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 170.2, 161.8 (d, J = 244.3 Hz), 141.0, 139.1 (d, J = 3.5 Hz), 
136.0, 128.9 (d, J = 24.4 Hz, +, 2C), 128.4 (+, 2C), 127.2 (d, J = 8.1 Hz, +, 2C), 127.1 (+, 2C), 126.9 
(+, 2C), 126.3 (+, 2C), 114.8 (+), 114.7 (+), 68.1 (+), 43.9 (+), 41.9 (-), 40.6, 39.4 (-), 32.2 (+), 11.9 
(+), 11.8 (+); 19F NMR (376 MHz, CDCl3) δ -116.3 (s, 1F); FTIR (KBr, cm-1): 3354, 2976, 2924, 1606, 
1509, 1458, 1381, 1314, 1154, 1033, 767, 700; HRMS (TOF ES): Found 440.1987, calculated for 




Compound was obtained via [Typical Procedure D] using phenylmagnesium 
bromide (130 μL, 3.0 M (tetrahydrofuran), 0.40 mmol, 1.30 equiv.), N,N-diethyl-1-
phenylcycloprop-2-ene-1-carboxamide (53aa) (65.0 mg, 0.30 mmol, 1.0 equiv.), and freshly 
distilled pivaldehyde (39.0 mg, 50.0 μL, 0.45 mmol, 1.50 equiv.). The product was purified by 
column chromatography using silica and a 2:1 hexane:diethyl ether mobile phase. The titled 
compound was obtained as colorless solid in 83% yield (94.2 mg, 0.248 mmol). A 4X times scale 
(1.2 mmol) resulted in 85% yield. (388 mg, 1.02 mmol). mp: 196.9 – 198.0 °C; Rf: 0.38; dr: >99:1; 
1H NMR (500 MHz, CDCl3) δ 7.43 – 7.39 (m, 2H), 7.37 – 7.31 (m, 2H), 7.29 – 7.19 (m, 6H), 3.85 (d, 
J = 10.7 Hz, 1H), 3.52 (dq, J = 14.1, 7.2 Hz, 1H), 3.25 (dq, J = 14.3, 7.2 Hz, 1H), 3.19 – 3.10 (m, 1H), 
3.13 (d, J = 9.9 Hz, 1H), 2.61 (dq, J = 14.2, 7.1 Hz, 1H), 1.65 (s, 1H), 1.53 (t, J = 10.4 Hz, 1H), 1.10 (t, 
J = 7.1 Hz, 3H), 0.73 (s, 9H), 0.25 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 170.5, 141.9, 
137.1, 129.1 (+, 2C), 129.0 (+, 2C), 128.2 (+, 2C), 126.9 (+), 126.5 (+), 126.5 (+, 2C), 72.7 (+), 41.8 
241 
 
(-), 39.3 (-), 39.1 (+), 39.0, 35.3, 33.5 (+), 26.2 (+, 3C), 12.0 (+), 11.9 (+); FTIR (KBr, cm-1): 3363, 
2964, 2648, 1595, 1463, 1442, 1433, 1007, 765, 699; HRMS (TOF ES): Found 402.2411, calculated 





Compound was obtained via [typical procedure D] using methylmagnesium bromide (260 μL, 3.0 
M (tetrahydrofuran), 0.780 mmol, 1.30 equiv.), N-methoxy-N-methyl-1-phenylcycloprop-2-ene-
1-carboxamide (53au) (122.0 mg, 0.60 mmol, 1.0 equiv.), and freshly distilled pivaldehyde (77.6 
mg, 98.0 μL, 0.90 mmol, 1.50 equiv.). The product was purified by column chromatography using 
silica and a 2:1 hexane:diethyl ether mobile phase. The titled compound was obtained as colorless 
oil in 82% yield (151 mg, 0.494 mmol). Rf: 0.30; dr: >98:2; 1H NMR (500 MHz, CDCl3): 1H NMR 
(500 MHz, C6D6) δ 7.25 – 7.19 (m, 2H), 7.10 – 7.03 (m, 2H), 7.01 – 6.95 (m, 1H), 5.36 (s, 1H), 3.61 
(d, J = 10.4 Hz, 1H), 2.77 (s, 3H), 2.75 (s, 3H), 1.93 – 1.81 (m, 1H), 1.30 (t, J = 9.9 Hz, 1H), 1.15 (d, 
J = 6.7 Hz, 3H), 1.11 (s, 9H); 13C NMR (126 MHz, C6D6) δ 172.8, 142.7, 128.8 (+, 2C), 127.5 (+), 
126.6 (+, 2C), 74.9 (+), 59.9 (+), 38.0 (+), 37.7, 35.4, 33.0 (+), 26.6 (+, 3C), 22.2 (+), 10.9 (+); FTIR 
(KBr, cm-1): 3416, 3061, 2953, 2905, 1631, 1460, 1380, 1178, 1007, 699, 611; HRMS (TOF ES): 








Compound was obtained via [typical procedure A] using 
vinylmagnesium bromide (390 μL, 1.0 M (tetrahydrofuran), 0.390 mmol, 1.30 equiv.) and 2-
butyl-N,N-diethyl-1-phenylcycloprop-2-ene-1-carboxamide (53aa) (82.0 mg, 0.30 mmol, 1.0 
equiv.). The product was purified by column chromatography using silica and a 6:1 hexane:ethyl 
acetate mobile phase. The titled compound was obtained as a colorless oil in 88% yield (78.7 mg, 
0.263 mmol). Rf: 0.30; Rs: 81:19 (Geminal Product Major); dr: >98:2; 1H NMR (500 MHz, CDCl3) δ 
7.49 – 7.43 (m, 2H), 7.32 – 7.27 (m, 2H), 7.24 – 7.19 (m, 1H), 5.94 (dd, J = 17.2, 10.5 Hz, 1H), 5.05 
(dd, J = 10.5, 1.4 Hz, 1H), 4.98 (dd, J = 17.2, 1.4 Hz, 1H), 3.56 (dq, J = 14.2, 7.1 Hz, 1H), 3.36 (dq, J 
= 14.2, 7.1 Hz, 1H), 3.27 (dq, J = 14.1, 7.1 Hz, 1H), 3.17 (dq, J = 13.9, 7.1 Hz, 1H), 1.62 (d, J = 5.3 Hz, 
1H), 1.61 – 1.51 (m, 1H), 1.36 (d, J = 5.2 Hz, 1H), 1.34 – 1.28 (m, 1H), 1.24 – 1.02 (m, 3H), 0.97 (t, 
J = 7.1 Hz, 3H), 0.83 (t, J = 7.1 Hz, 3H), 0.81 – 0.76 (m, 1H), 0.74 (t, J = 7.3 Hz, 3H); 13C NMR (126 
MHz, CDCl3) δ 170.1, 141.1 (+), 137.8, 129.7 (+, 2C), 128.4 (+, 2C), 126.9 (+), 113.1 (-), 42.3, 41.6 
(-), 39.2 (-), 35.4, 32.8 (-), 29.0 (-), 22.8 (-), 21.7 (-), 14.1 (+), 13.7 (+), 12.6 (+); FTIR (KBr, cm-1): 
3052, 2958, 2932, 2871, 1633, 1458, 1424, 1275, 1100, 902, 701; HRMS (TOF ES): Found 




Rf: 0.40; dr: >98:2; 1H NMR (500 MHz, CDCl3) δ 7.32 – 7.26 (m, 4H), 7.24 
– 7.19 (m, 1H), 5.47 – 5.35 (m, 1H), 5.26 (dd, J = 17.0, 1.8 Hz, 1H), 5.01 (dd, J = 10.1, 1.8 Hz, 1H), 
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3.61 – 3.44 (m, 2H), 3.06 (dq, J = 13.8, 7.0 Hz, 1H), 2.89 (dq, J = 14.1, 7.0 Hz, 1H), 2.26 (dd, J = 9.2, 
6.0 Hz, 1H), 2.05 – 1.88 (m, 1H), 1.35 – 1.07 (m, 6H), 1.04 (t, J = 7.1 Hz, 3H), 0.75 (t, J = 7.2 Hz, 3H), 
0.34 (t, J = 7.0 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 170.5, 137.6, 137.0 (+), 128.6 (+, 2C), 128.4 
(+, 2C), 126.7 (+), 115.2 (-), 42.7, 41.1 (-), 39.6 (-), 32.4 (+), 31.5 (+), 31.0 (-), 28.2 (-), 22.4 (-), 




Compound was obtained via [typical procedure A] using 
(trimethylsilyl)methylmagnesium chloride (300 μL, 1.3 M 
(tetrahydrofuran), 0.390 mmol, 1.3 equiv.) and N,N-diethyl-1,2-diphenylcycloprop-2-ene-1-
carboxamide (53aa) (88.0 mg, 0.30 mmol, 1.0 equiv.). The product was purified by column 
chromatography using silica and a 6:1 hexane:ethyl acetate mobile phase. The titled compound 
was obtained as a colorless solid in 70% yield (79.4 mg, 0.209 mmol). mp: 186.8 – 187.4 °C; Rf: 
0.30; Rs: >98:2; dr: >98:2; 1H NMR (500 MHz, CDCl3) δ 7.07 (d, J = 4.3 Hz, 4H), 7.04 – 6.90 (m, 6H), 
3.71 (dq, J = 14.3, 7.1 Hz, 1H), 3.54 (dq, J = 13.9, 7.1 Hz, 1H), 3.18 (dq, J = 13.9, 7.0 Hz, 1H), 3.05 
(dq, J = 14.0, 7.0 Hz, 1H), 2.98 (d, J = 6.8 Hz, 1H), 2.35 (ddd, J = 12.3, 6.8, 2.7 Hz, 1H), 1.12 (t, J = 7.1 
Hz, 3H), 1.05 (dd, J = 14.4, 2.7 Hz, 1H), 0.41 – 0.35 (m, 1H), 0.38 (t, J = 7.1 Hz, 3H), 0.09 (s, 9H); 13C 
NMR (126 MHz, CDCl3) δ 170.5, 137.5, 137.3, 128.9 (+, 2C), 128.5 (+, 2C), 128.1 (+, 2C), 127.6 (+, 
2C), 126.3 (+), 125.6 (+), 45.0, 41.5 (-), 39.8 (-), 37.1 (+), 22.7 (+), 16.4 (-), 12.7 (+), 12.5 (+), -1.2 
(+, 3C); FTIR (KBr, cm-1): 3056, 2956, 2902, 1622, 1443, 1426, 1250, 858, 832, 696; HRMS (TOF 






Compound was obtained via [typical procedure A] using 
phenylmagnesium bromide (130.0 μL, 3.0 M (diethyl ether), 0.390 mmol, 
1.30 equiv.) and N,N-diethyl-1,2-diphenylcycloprop-2-ene-1-carboxamide (53aa) (88.0 mg, 0.30 
mmol, 1.0 equiv.). The product was purified by column chromatography using silica and a 6:1 
hexane:ethyl acetate mobile phase. The titled compound was obtained as a colorless solid in 89% 
yield (99.2 mg, 0.268 mmol). mp: 174.3 – 175.6 °C; Rf: 0.27; Rs: >98:2; dr: >98:2; 1H NMR (500 
MHz, CDCl3) δ 7.41 – 7.36 (m, 2H), 7.33 – 7.29 (m, 2H), 7.26 – 7.20 (m, 3H), 7.17 – 7.12 (m, 2H), 
7.11 – 7.03 (m, 5H), 7.02 – 6.97 (m, 1H), 3.90 (d, J = 7.3 Hz, 1H), 3.55 (d, J = 7.3 Hz, 1H), 3.51 – 3.31 
(m, 2H), 2.77 (dq, J = 13.9, 7.0 Hz, 1H), 2.48 (dq, J = 14.1, 7.0 Hz, 1H), 0.69 (t, J = 7.1 Hz, 3H), 0.17 
(t, J = 7.0 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 168.7, 136.9, 136.8, 136.6, 128.8 (+, 2C), 128.6 (+, 
2C), 128.4 (+, 2C), 128.3 (+, 2C), 127.8 (+, 2C), 127.7 (+, 2C), 126.8 (+), 126.7 (+), 126.1 (+), 48.6, 
41.0 (-), 39.2 (-), 35.2 (+), 32.5 (+), 12.0 (+), 11.8 (+); FTIR (KBr, cm-1): 3046, 3029, 2974, 2934, 
1624, 1446, 1277, 1078, 774, 750, 697; HRMS (TOF ES): Found 392.1982, calculated for 




Compound was obtained via [typical procedure A] using vinylmagnesium 
bromide (390.0 μL, 1.0 M (tetrahydrofuran), 0.390 mmol, 1.30 equiv.) and 
N,N-diethyl-1,2-diphenylcycloprop-2-ene-1-carboxamide (53aa) (88.0 mg, 0.30 mmol, 1.0 
equiv.). The product was purified by column chromatography using silica and a 6:1 hexane:ethyl 
acetate mobile phase. The titled compound was obtained as a colorless solid in 84% yield (80.4 
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mg, 0.252 mmol). mp: 101.3 – 101.9 °C; Rf: 0.30; Rs: >98:2; dr: >98:2; 1H NMR (500 MHz, CDCl3) 
δ 7.16 – 7.09 (m, 4H), 7.06 – 7.00 (m, 3H), 7.00 – 6.94 (m, 3H), 5.59 (ddd, J = 17.0, 10.1, 9.0 Hz, 
1H), 5.43 (dd, J = 17.0, 1.5 Hz, 1H), 5.15 (dd, J = 10.2, 1.5 Hz, 1H), 3.63 – 3.50 (m, 2H), 3.37 (d, J = 
6.5 Hz, 1H), 3.12 (dq, J = 13.9, 7.0 Hz, 1H), 3.03 (dd, J = 8.9, 6.5 Hz, 1H), 3.01 – 2.94 (m, 1H), 1.09 
(t, J = 7.1 Hz, 3H), 0.41 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 169.7, 136.6, 136.2, 135.9 
(+), 128.6 (+, 2C), 128.6 (+, 2C), 128.3 (+, 2C), 127.7 (+, 2C), 126.7 (+), 126.0 (+), 116.4 (-), 45.6, 
41.3 (-), 39.7 (-), 36.3 (+), 31.5 (+), 12.5 (+), 12.4 (+); FTIR (KBr, cm-1): 3059, 3027, 2976, 2934, 
1630, 1445, 1428, 1276, 1134, 908, 753, 697; HRMS (TOF ES): Found 342.1820, calculated for 




Compound was obtained via [typical procedure A] using 
(trimethylsilyl)methylmagnesium chloride (300 μL, 1.3 M (tetrahydrofuran), 0.390 mmol, 1.3 
equiv.) and 2-butyl-N,N-diethyl-1-phenylcycloprop-2-ene-1-carboxamide (53aa) (82.0 mg, 0.30 
mmol, 1.0 equiv.). The product was purified by column chromatography using silica and a 6:1 
hexane:ethyl acetate mobile phase. The titled compound was obtained as a pale yellow oil in 75% 
yield (80.7 mg, 0.224 mmol). Rf: 0.46; Rs: 75:25 (Vicinal Product Major); dr: >98:2; 1H NMR (500 
MHz, CDCl3) δ 7.28 – 7.15 (m, 5H), 3.62 (dq, J = 14.4, 7.1 Hz, 1H), 3.49 (dq, J = 13.8, 7.0 Hz, 1H), 
3.13 (dq, J = 13.9, 7.0 Hz, 1H), 2.94 (dq, J = 14.0, 7.0 Hz, 1H), 1.64 – 1.48 (m, 2H), 1.31 – 1.10 (m, 
4H), 1.07 (t, J = 7.1 Hz, 3H), 1.05 – 0.97 (m, 1H), 0.87 – 0.76 (m, 2H), 0.69 (t, J = 7.0 Hz, 3H), 0.31 
(t, J = 7.0 Hz, 3H), 0.17 (dd, J = 14.4, 11.9 Hz, 1H), 0.08 (s, 9H); 13C NMR (126 MHz, CDCl3) δ 171.5, 
138.8, 128.9 (+, 2C), 128.2 (+, 2C), 126.3 (+), 41.4 (-), 41.3, 39.6 (-), 31.6 (+), 31.0 (-), 28.7 (-), 23.6 
(+), 22.6 (-), 16.3 (-), 14.0 (+), 12.6 (+), 12.3 (+), -1.2 (+, 3C); FTIR (KBr, cm-1): 3057, 2955, 2932, 
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2872, 1633, 1457, 1423, 1271, 1247, 860, 838, 758, 701; HRMS (TOF ES): Found 382.2552, 




Compound was obtained via [typical procedure A] using 
phenylmagnesium bromide (130.0 μL, 3.0 M (diethyl ether), 0.390 
mmol, 1.30 equiv.) and 2-butyl-N,N-diethyl-1-phenylcycloprop-2-ene-1-carboxamide (53aa) 
(82.0 mg, 0.30 mmol, 1.0 equiv.). The product was purified by column chromatography using 
silica and a 6:1 hexane:ethyl acetate mobile phase. The titled compound was obtained as a 
colorless oil in 91% yield (95.1 mg, 0.272 mmol). Rf: 0.40; Rs: 70:30 (Vicinal Product Major); dr: 
>98:2; 1H NMR (500 MHz, CDCl3) δ 7.45 – 7.39 (m, 2H), 7.39 – 7.32 (m, 2H), 7.29 – 7.26 (m, 3H), 
7.26 – 7.23 (m, 2H), 7.21 – 7.17 (m, 1H), 3.49 – 3.25 (m, 2H), 2.79 (d, J = 6.8 Hz, 1H), 2.73 (dq, J = 
14.0, 7.1 Hz, 1H), 2.54 – 2.46 (m, 1H), 2.40 (dq, J = 14.0, 7.0 Hz, 1H), 1.41 – 1.14 (m, 5H), 0.94 – 
0.81 (m, 1H), 0.77 (t, J = 7.3 Hz, 3H), 0.65 (t, J = 7.1 Hz, 3H), 0.13 (t, J = 7.1 Hz, 3H); 13C NMR (126 
MHz, CDCl3) δ 169.5, 137.9, 137.9, 128.7 (+, 2C), 128.5 (+, 2C), 128.2 (+, 2C), 127.5 (+, 2C), 126.8 
(+), 126.3 (+), 45.9, 40.8 (-), 39.1 (-), 33.6 (+), 31.0 (-), 30.2 (+), 28.7 (-), 22.5 (-), 14.1 (+), 11.9 
(+), 11.7 (+); FTIR (KBr, cm-1): 3058, 3023, 2957, 2932, 2870, 1631, 1445, 1379, 1274, 1080, 700; 




Rf: 0.26; dr: >98:2; 1H NMR (500 MHz, CDCl3) δ 7.62 – 7.53 (m, 2H), 7.41 
– 7.37 (m, 2H), 7.36 – 7.31 (m, 2H), 7.30 – 7.26 (m, 2H), 7.25 – 7.21 (m, 
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1H), 7.19 – 7.14 (m, 1H), 3.73 (dq, J = 14.2, 7.1 Hz, 1H), 3.11 – 2.90 (m, 2H), 2.79 (dq, J = 13.8, 7.0 
Hz, 1H), 2.32 (d, J = 5.3 Hz, 1H), 2.30 – 2.21 (m, 1H), 1.30 (d, J = 5.3 Hz, 1H), 1.20 – 1.03 (m, 4H), 
1.02 – 0.93 (m, 1H), 0.71 (t, J = 7.0 Hz, 3H), 0.65 (t, J = 7.0 Hz, 3H), 0.46 (t, J = 7.1 Hz, 3H); 13C NMR 
(126 MHz, CDCl3) δ 169.4, 140.1, 139.1, 130.4 (+, 2C), 128.9 (+, 2C), 128.4 (+, 2C), 127.8 (+, 2C), 
126.8 (+), 126.2 (+), 42.9, 41.7 (-), 39.3 (-), 37.5, 36.8 (-), 29.4 (-), 22.8 (-), 22.6 (-), 14.2 (+), 13.4 




Compound was obtained via [typical 
procedure A] using methylmagnesium bromide (130.0 μL, 3.0 M (tetrahydrofuran), 0.390 mmol, 
1.30 equiv.) and 2-butyl-N,N-diethyl-1-phenylcycloprop-2-ene-1-carboxamide (53aa) (82.0 mg, 
0.30 mmol, 1.0 equiv.). The product was purified by column chromatography using silica and a 
6:1 hexane:ethyl acetate mobile phase. The titled compound was obtained as a colorless oil in 
90% yield (77.3 mg, 0.269 mmol). Rf: 0.29; Rs: 88:12 (Geminal Product Major); dr: >98:2; 1H NMR 
(500 MHz, CDCl3) Mix of Regioisomers: δ [7.48 – 7.39 (m), Σ2H], [7.30 – 7.23 (m), Σ2H], [7.21 – 
7.15 (m), Σ1H], [3.68 – 3.49 (m) & 3.44 – 3.28 (m) & 3.18 (dq, J = 14.0, 7.1 Hz) & 3.07 (dq, J = 13.9, 
7.0 Hz) & 2.96 (dq, J = 14.0, 7.0 Hz), Σ4H], [1.62 – 1.54 (m) & 1.36 – 0.97 (m), Σ8H], [1.29 (d, J = 
5.0 Hz) & 1.22 (s), Σ3H], [1.01 (t, J = 7.1 Hz), Σ3H], [0.83 (t, J = 7.1 Hz) & 0.75 (t, J = 7.1 Hz), Σ3H], 
[0.71 (t, J = 7.4 Hz) & 0.33 (t, J = 7.0 Hz), Σ3H]; 13C NMR (126 MHz, CDCl3) Mix of Regioisomers: δ 
[171.0 & 170.8], [138.6 & 138.3], [129.4 (+) & 129.3 (+), Σ2C], [128.1 (+) & 128.0 (+), Σ2C], [126.4 
(+) & 126.2 (+)], [41.4 (-) & 41.0 (-)], [40.8 & 39.8], [39.4 (-) & 39.1 (-)], [35.2 (-) & 31.2 (+) & 31.1 
(-) & 28.5 (-) & 28.4 & 28.3 (-) & 24.0 (-) & 22.8 (-) & 22.3 (-) & 22.0 (+) & 21.9 (+) & 14.2 (+) & 
14.0 (+) & 13.9 (+) & 13.5 (+) & 12.5 (+) & 12.4 (+) & 12.2 (+), Σ9C]; FTIR (KBr, cm-1): 3047, 2958, 
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2932, 2871, 1632, 1457, 1421, 1269, 1105, 729, 701; HRMS (TOF ES): Found 310.2143, calculated 




Compound was obtained via [typical procedure 
A] using methylmagnesium bromide (130.0 μL, 3.0 M (tetrahydrofuran), 
0.390 mmol, 1.30 equiv.) and N,N-diethyl-1,2-diphenylcycloprop-2-ene-1-carboxamide (53aa) 
(88.0 mg, 0.30 mmol, 1.0 equiv.). The product was purified by column chromatography using 
silica and a 6:1 hexane:ethyl acetate mobile phase. The titled compound was obtained as a 
colorless amorphous solid in 92% yield (85.3 mg, 0.277 mmol). Rf: 0.26; Rs: 91:9 (Vicinal Product 
Major); dr: >98:21H NMR (500 MHz, CDCl3): Mix of regioisomers: δ [7.11 – 7.07 (m), Σ4H], [7.03 
– 6.98 (m), Σ3H], [6.98 – 6.92 (m), Σ3H], [3.70 (dq, J = 14.3, 7.1 Hz) & 3.58 (dq, J = 13.9, 7.1 Hz) & 
3.41 – 3.34 (m) & 3.13 (dq, J = 13.5, 7.0 Hz) & 3.07 (dq, J = 14.2, 7.2 Hz), Σ4H], [3.01 (d, J = 6.7 Hz) 
& 2.08 (d, J = 5.4 Hz), Σ1H], [2.40 (dt, J = 6.3 Hz) & 1.50 (d, J = 5.4 Hz), Σ1H], [1.61 (s) & 1.31 (d, J 
= 6.2 Hz), Σ3H], [1.11 (t, J = 7.1 Hz), Σ3H], [0.84 (t, J = 7.1 Hz) & 0.40 (t, J = 7.0 Hz, 1H), Σ3H]; 13C 
NMR (126 MHz, CDCl3) δ 170.3, 137.6, 137.1, 128.9 (+, 2C), 128.6 (+, 2C), 128.1 (+, 2C), 127.6 (+, 
2C), 126.4 (+), 125.7 (+), 44.7, 41.4 (-), 39.7 (-), 36.6 (+), 21.3 (+), 14.4 (+), 12.6 (+), 12.5 (+); FTIR 
(KBr, cm-1): 3041, 2967, 1629, 1458, 1425, 1276, 1140, 697; HRMS (TOF ES): Found 330.1840, 






Compound was obtained via [typical procedure A] using 
methylmagnesium bromide (130 μL, 3.0 M (tetrahydrofuran), 0.390 mmol, 
1.30 equiv.) and N,N-diethyl-2-(4-methoxyphenyl)-1-phenylcycloprop-2-
ene-1-carboxamide (53aa) (96.5 mg, 0.30 mmol, 1.0 equiv.). The product was purified by column 
chromatography using silica and a 3:1 hexane:ethyl acetate mobile phase. The titled compound 
was obtained as a mixture of regioisomers as a colorless oil in 52% yield (52.2 mg, 0.155 mmol). 
Rf: 0.23; Pdt ratio: 90:10; dr: >98:2; 1H NMR (500 MHz, CDCl3) δ 7.12 – 7.06 (m, 4H), 7.05 – 6.98 
(m, 1H), 6.86 (d, J = 8.6 Hz, 2H), 6.56 (d, J = 8.6 Hz, 2H), 3.73 – 3.66 (m, 1H), 3.65 (s, 3H), 3.58 (dq, 
J = 14.0, 7.1 Hz, 1H), 3.13 (dq, J = 14.0, 7.0 Hz, 1H), 3.04 (dq, J = 14.0, 6.9 Hz, 1H), 2.94 (d, J = 6.6 
Hz, 1H), 2.40 – 2.25 (m, 1H), 1.29 (d, J = 6.2 Hz, 3H), 1.11 (t, J = 7.0 Hz, 3H), 0.40 (t, J = 7.0 Hz, 3H); 
13C NMR (126 MHz, CDCl3) δ 170.4, 157.6, 137.3, 129.7, 129.5 (+, 2C), 128.8 (+, 2C), 128.2 (+, 2C), 
126.3 (+), 113.1 (+, 2C), 55.2 (+), 44.4, 41.4 (-), 39.7 (-), 35.9 (+), 21.4 (+), 14.4 (+), 12.6 (+), 12.5 
(+); FTIR (KBr, cm-1): 3057, 2965, 2934, 2871, 1628, 1515, 1426, 1277, 1247, 1036, 821, 756, 





Compound was obtained via [typical procedure A] using 
methylmagnesium bromide (130 μL, 3.0 M (tetrahydrofuran), 0.390 mmol, 1.30 equiv.) and N,N-
diethyl-1-phenyl-2-(p-tolyl)cycloprop-2-ene-1-carboxamide (53aa) (92.0 mg, 0.30 mmol, 1.0 
equiv.). The product was purified by column chromatography using silica and a 6:1 hexane:ethyl 
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acetate mobile phase. The titled compound was obtained as a mixture of regioisomers as a 
colorless solid in 97 % yield (93.5 mg, 0.291 mmol). mp: 115.7 – 118.3 °C; Rf: 0.26; Pdt ratio: 
86:14; dr: >98:2; 1H NMR (500 MHz, CDCl3): δ [7.13 – 7.07 (m, Σ4H)], [7.05 – 6.99 (m, Σ1H)], [6.87 
– 6.79 (m, Σ4H)], [3.70 (dq, J = 14.3, 7.1 Hz) & 3.58 (dq, J = 14.0, 7.1 Hz) & 3.42 – 3.33 (m) & 3.12 
(dq, J = 14.0, 7.0 Hz) & 3.05 (dq, J = 14.0, 7.0 Hz), Σ4H], [2.96 (d, J = 6.7 Hz) & 2.39 – 2.32 (m) & 
2.02 (d, J = 5.7 Hz), Σ2H], [2.21 (s) & 2.14 (s), Σ3H], [1.58 (s) & 1.30 (d, J = 6.2 Hz), Σ3H], [1.11 (t, 
J = 7.1 Hz), Σ3H], [0.82 (t, J = 7.0 Hz) & 0.40 (t, J = 7.0 Hz), Σ3H]; 13C NMR (126 MHz, CDCl3) δ 
[170.6 & 170.3, Σ1C], [139.2 & 138.1 & 137.2 & 135.5 & 135.0 & 134.4, Σ3C], [128.9 (+) & 128.7 
(+) & 128.6 (+) & 128.4 (+) & 128.4 (+) & 128.3 (+) & 128.1 (+) & 127.8 (+), Σ8C], [126.3 (+) & 
126.0 (+), Σ1C], [57.1 & 44.6, Σ1C], [41.6 (-) & 41.3 (-) & 39.7 (-) & 39.3 (-), Σ2C], [36.3 (+) & 26.8, 
Σ1C], [24.1 (-) & 21.4 (+), Σ1C], [21.1 (+) & 21.0 (+), Σ1C], [14.5 (+) & 14.4 (+), Σ1C], [12.5 (+) & 
12.5 (+) & 12.5 (+) & 12.5 (+), Σ2C]; FTIR (KBr, cm-1): 3062, 2968, 2932, 2871, 1632, 1457, 1425, 
1276, 1219, 1140, 811, 700; HRMS (TOF ES): Found 344.1989, calculated for C22H27NONa (M+Na) 





Compound was obtained via [typical procedure A] using 
methylmagnesium bromide (130 μL, 3.0 M (tetrahydrofuran), 0.390 mmol, 1.30 equiv.) and N,N-
diethyl-2-(4-fluorophenyl)-1-phenylcycloprop-2-ene-1-carboxamide (53aa) (93.0 mg, 0.30 
mmol, 1.0 equiv.). The product was purified by column chromatography using silica and a 6:1 
hexane:ethyl acetate mobile phase. The titled compound was obtained as a mixture of 
regioisomers as a colorless oil in 99% yield (97.0 mg, 0.298 mmol). Rf: 0.16; Pdt Ratio: 95:5; dr: 
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>98:2; 1H NMR (500 MHz, CDCl3) mixture of regioisomers: δ [7.13 – 7.04 (m), Σ4H], [7.04 – 6.99 
(m), Σ1H], [6.92 – 6.86 (m), Σ2H], [6.79 – 6.73 (m) & 6.71 – 6.65 (m), Σ2H], [3.67 (dq, J = 14.4, 7.1 
Hz) & 3.58 (dq, J = 13.8, 7.1 Hz) & 3.12 (dq, J = 13.9, 7.0 Hz) & 3.04 (dq, J = 14.0, 7.0 Hz), Σ4H], 
[2.97 (d, J = 6.6 Hz) & 2.38 – 2.31 (m) & 2.07 (d, J = 5.5 Hz) & 1.45 (d, J = 5.3 Hz), Σ2H], [1.58 (s) & 
1.30 (d, J = 6.2 Hz), Σ3H], [1.11 (t, J = 7.1 Hz), Σ3H], [0.84 (t, J = 7.1 Hz) & 0.39 (t, J = 7.0 Hz), Σ3H]; 
13C NMR (126 MHz, CDCl3) major regioisomer: δ 170.1, 161.1 (d, J = 243.9 Hz), 136.9, 133.3 (d, J 
= 2.8 Hz), 129.9 (+, d, J = 8.1 Hz, 2C), 128.7 (+), 128.2 (+, 2C), 126.5 (+, 2C), 114.4 (+, d, J = 21.5 
Hz, 2C), 44.5, 41.4 (-), 39.7 (-), 35.8 (+), 21.4 (+), 14.3 (+), 12.5 (+), 12.5 (+);19F NMR (376 MHz, 
CDCl3) δ -117.6 (s, 1F); FTIR (KBr, cm-1): 2969, 2934, 2872, 1629, 1512, 1426, 1216, 822, 761, 




Compound was obtained via [typical procedure A] using 
methylmagnesium bromide (130 μL, 3.0 M (tetrahydrofuran), 0.390 mmol, 
1.30 equiv.) and N,N-diethyl-1-phenyl-2-(4-(trifluoromethyl)phenyl)cycloprop-2-ene-1-
carboxamide (53aa) (108 mg, 0.30 mmol, 1.0 equiv.). The product was purified by column 
chromatography using silica and a 3:1 hexane:ethyl acetate mobile phase. The titled compound 
was obtained as a colorless solid in 93% yield (104.3 mg, 0.278 mmol). mp: 93.9 – 94.8 °C; Rf: 
0.29; Pdt ratio: >98:2; dr: >98:2; 1H NMR (500 MHz, CDCl3) δ 7.25 (d, J = 8.3 Hz, 2H), 7.14 – 7.06 
(m, 4H), 7.06 – 7.01 (m, 1H), 7.02 (d, J = 8.3 Hz, 2H), 3.68 (dq, J = 14.3, 7.1 Hz, 1H), 3.58 (dq, J = 
14.1, 7.1 Hz, 1H), 3.17 – 3.01 (m, 2H), 3.05 (d, J = 6.6 Hz, 1H), 2.47 – 2.38 (m, 1H), 1.32 (d, J = 6.2 
Hz, 3H), 1.11 (t, J = 7.0 Hz, 3H), 0.40 (t, J = 7.0 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 169.6, 141.9, 
136.3, 128.7 (+), 128.5 (+, 2C), 128.3 (+, 2C), 127.7 (q, J = 32.0 Hz), 126.7 (+, 2C), 124.4 (q, J = 3.7 
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Hz, +, 2C), 124.3 (q, J = 271.7 Hz), 45.3, 41.3 (-), 39.7 (-), 36.1 (+), 21.7 (+), 14.1 (+), 12.4 (+), 12.4 
(+); 19F NMR (376 MHz, CDCl3) δ -62.34 (s, 3F); FTIR (KBr, cm-1): 2972, 2936, 1630, 1326, 1164, 
1121, 1068, 1017, 860, 728, 701; HRMS (TOF ES): Found 398.1719, calculated for C22H24F3NONa 




Methylmagnesium bromide (130 μL, 3.0 M (diethyl ether), 0.390 mmol, 
1.35 equiv.) was added dropwise to a flame dried two neck flask containing copper iodide (3.0 
mg, 15.0 μmol, 5.0 mol%) and freshly dried and distilled tetrahydrofuran (4 mL) under a nitrogen 
atmosphere at 0 °C. The mixture was stirred for five minutes at 0 °C. N,N-diethyl-1,2-
diphenylcycloprop-2-ene-1-carboxamide (53aa) (88.0 mg, 0.30 mmol, 1.0 equiv.) was then 
added slowly dropwise as a solution in dry tetrahydrofuran (2 mL). After 20 minutes of stirring 
at 0 °C, iodomethane (28 μL, 64.0 mg, 0.45 mmol, 1.50 equiv.) was added dropwise and stirred 
for 30 minutes at 0 °C. The reaction was then allowed to warm to room temperature over 15 
minutes before saturated aqueous ammonium chloride (1 mL) was added. The resulting solution 
was then diluted with water and extracted with diethyl ether (3 x 5 mL). Combined organic layers 
were washed with brine, dried, filtered, and evaporated. The product was purified by column 
chromatography using silica and a 3:1 hexane:ethyl acetate mobile phase. The titled compound 
was obtained as a colorless solid in 91 % yield (87.5 mg, 0.272 mmol). mp: 150.3 – 151.2 °C; Rf: 
0.26; dr: >98:2; 1H NMR (500 MHz, CDCl3) δ 7.08 – 6.97 (m, 8H), 6.96 – 6.90 (m, 2H), 3.67 – 3.51 
(m, 2H), 3.21 – 3.03 (m, 2H), 2.39 (q, J = 6.5 Hz, 1H), 1.61 (s, 3H), 1.36 (d, J = 6.5 Hz, 3H), 1.12 (t, J 
= 7.1 Hz, 3H), 0.44 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 169.5, 144.9, 138.7, 129.4 (+, 
2C), 127.9 (+, 2C), 127.8 (+), 127.7 (+, 2C), 125.9 (+, 2C), 125.5 (+), 42.4, 41.6 (-), 38.7 (-), 38.2, 
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23.5 (+), 21.5 (+), 12.7 (+), 12.7 (+), 10.5 (+); FTIR (KBr, cm-1): 3059, 2969, 1624, 1444, 1422, 
1267, 1066, 694; HRMS (TOF ES): Found 344.1996, calculated for C22H27NONa (M+Na) 344.1990 
(1.7 ppm). 
 
3.13.5 Miscellaneous  
 
 (E)-N,N-diethyl-2-phenylhex-3-enamide (72g) 
Ethylmagnesium bromide (135 μL, 3.0 M (diethyl ether), 0.405 mmol, 1.35 
equiv.) was added dropwise to a flame dried two neck flask containing 
copper iodide (3.0 mg, 15.0 μmol, 5.0 mol%) and freshly dried and distilled 
dimethoxyethane (1.0 mL) under a nitrogen atmosphere at 0 °C. The mixture was stirred for five 
minutes at 0 °C. N,N-diethyl-1-phenylcycloprop-2-ene-1-carboxamide (53aa) (65.0 mg, 0.30 
mmol, 1.0 equiv.) was then added slowly dropwise as a solution in dry dimethoxyethane (1.0 mL). 
The reaction was then stirred for 60 minutes at room temperature. Saturated aqueous 
ammonium chloride (1 mL) was added slowly dropwise. The resulting solution was then diluted 
with water and extracted with diethyl ether (3 x 5 mL). Combined organic layers were washed 
with brine, dried, filtered, and evaporated. The product was purified by column chromatography 
using silica and a 6:1 hexane:ethyl acetate mobile phase. The titled compound was obtained as a 
viscous colorless oil in 77% yield (56.4 mg, 0.230 mmol). Rf: 0.26; 1H NMR (500 MHz, CDCl3) δ 
7.37 – 7.19 (m, 5H), 5.87 (dd, J = 15.4, 8.0 Hz, 1H), 5.51 (dt, J = 15.4, 6.3 Hz, 1H), 4.38 (d, J = 8.0 
Hz, 1H), 3.55 – 3.44 (m, 1H), 3.38 – 3.14 (m, 3H), 2.11 – 1.99 (m, 2H), 1.11 (t, J = 7.1 Hz, 6H), 1.07 
(t, J = 7.1 Hz, 3H), 0.97 (t, J = 7.5 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 171.7, 140.2, 133.6 (+), 
129.0 (+), 128.8 (+, 2C), 128.0 (+, 2C), 126.9 (+), 52.5 (+), 41.9 (-), 40.4 (-), 25.6 (-), 14.6 (+), 13.6 
(+), 13.0 (+); FTIR (KBr, cm-1): 3059, 3026, 2966, 2931, 2872, 1639, 1600, 1492, 1479, 1454, 
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1427, 1379, 1361, 1311, 1276, 1253, 1219, 1138, 1095, 1072, 966, 783, 752; HRMS (TOF ES): 
Found 246.1852, calculated for C16H24NO (M+H) 246.1858 (2.4 ppm). 
 
1-((1S*,2R*)-2-methyl-1-phenylcyclopropyl)ethan-1-one (74) 
Methylmagnesium bromide (130 μL, 3.0 M (diethyl ether), 0.40 mmol, 2.0 
equiv.) was added dropwise to (1S*,2R*)-N-methoxy-N,2-dimethyl-1-
phenylcyclopropane-1-carboxamide (53au) (44.0 mg, 0.20 mmol, 1.0 equiv.) dissolved in dry 
dimethoxyethane in a flame dried two neck flask under a nitrogen atmosphere. The reaction was 
then stirred at 40 °C for 18 hours. After cooling to room temperature, saturated aqueous 
ammonium chloride (1 mL) was added dropwise. The resulting solution was diluted with water 
and extracted with diethyl ether (3 x 5 mL). Combined organic layers were dried, filtered, and 
evaporated. The product was purified by column chromatography using silica and a 6:1 
hexane:ethyl acetate mobile phase. The titled compound was obtained as a viscous colorless oil 
in 61% yield (21.2 mg, 0.122 mmol). Rf: 0.32; 1H NMR (500 MHz, CDCl3) δ 7.34 – 7.16 (m, 5H), 
1.90 (s, 3H), 1.70 (ddq, J = 8.7, 7.2, 6.2 Hz, 1H), 1.58 (dd, J = 7.1, 4.0 Hz, 1H), 1.12 (d, J = 6.2 Hz, 
3H), 1.01 (dd, J = 8.7, 4.0 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 206.9, 142.6, 130.5 (+, 2C), 128.8 
(+, 2C), 127.4 (+), 43.3, 30.8 (+), 25.5 (+), 22.0 (-), 12.3 (+); FTIR (KBr, cm-1): 3022, 3001, 2955, 
2928, 2874, 1691, 1600, 1492, 1456, 1444, 1435, 1361, 1280, 1165, 1132, 1097, 1074, 1024, 979, 








phenylcyclopropane-1-carboxamide (53au) (61.0 mg, 0.20 mmol, 1.0 equiv.) dissolved in 
benzene ( 5 mL) and stirred for 10 minutes. The reaction was then warmed to 50 °C and stirred 
for one hour. After cooling to room temperature, potassium carbonate (35 mg, 0.25 mmol, 1.2 
equiv.) was added and stirred for 15 minutes. The reaction was then filtered through a silica plug 
using ethyl acetate, evaporated, and further purified by silica gel column chromatography using 
6:1 hexane:ethyl acetate mobile phase. The titled compound was obtained as colorless oil in 89% 
yield (43.4 mg, 0.177 mmol). Rf: 0.37; 1H NMR (500 MHz, CDCl3) δ 7.39 – 7.32 (m, 2H), 7.30 – 7.23 
(m, 2H), 7.22 – 7.17 (m, 1H), 3.86 (s, 1H), 2.32 (d, J = 8.2 Hz, 1H), 1.76 (dq, J = 8.2, 6.5 Hz, 1H), 1.21 
(d, J = 6.5 Hz, 3H), 0.98 (s, 9H); 13C NMR (126 MHz, CDCl3) δ 174.5, 135.5, 128.7 (+, 2C), 127.8 (+, 
2C), 127.5 (+), 83.4 (+), 37.5, 34.6, 31.5 (+), 25.2 (+, 3C), 25.0 (+), 8.4 (+); FTIR (KBr, cm-1): 3060, 
2962, 2907, 2873, 1759, 1500, 1335, 1112, 994, 908, 754, 697; HRMS (TOF ES): Found 267.1358, 




Chapter 4. Review of Nucleophilic Additions to Cyclopropenes 
4.1 Introduction 
The expansive chemistry of the smallest cyclic olefin, cyclopropene, has been detailed in 
several recent reviews.[54-61] These reviews have detailed the use of cyclopropenes’ large amount 
of strain energy (approximately 55 kcal/mol) to facilitate a variety of Lewis acid promoted, 
radical, and organometallic reactions. However, the use of cyclopropene as the electrophilic 
component of a variety of newly developed nucleophilic addition reactions has not been 
comprehensively compiled. Thus, this review will highlight nucleophilic addition reactions to 
cyclopropenes published since 2005 and will only focus on reactions involving a non-concerted 
addition mechanism. 
The stability of cyclopropenes varies dramatically depending on both the location of and 
identity of substituents located on the 3-membered ring (Figure 8). Cyclopropenes possessing 
electron-withdrawing substituents at C-1 or C-2 are considered highly unstable due to their high 
reactivity as Michael acceptors. Replacement of the hydrogens at C-3 provides significant 
stabilization by eliminating the possibility of the ene-reaction. Large substituents at C-1 or C-2 
provide stabilization via steric shielding of the strained double bond. A combination of stabilizing 
substituents at multiple locations of the ring can result in cyclopropenes which are shelf stable 
from several days to many months. 
 




R = Alkyl, aryl, alkynyl 
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4.2 Nucleophilic Additions to In-Situ Generated Cyclopropenes 
Two of the most common methods for the generation of cyclopropenes involve a base-
assisted 1,2-dehydrohalogenation of cyclopropyl halides 100 (Scheme 41a, Path A)[62, 63] and 
the 1,2-dehalogenation of dihalogenated cyclopropanes 101 using organolithium reagents 
(Scheme 41a, Path B).[64] Following the elimination event, the highly unstable cyclopropene 
intermediate 102 can be intercepted by a nucleophile prior to decomposition to provide 
cyclopropyl anion 103. Exposure of this species to a suitable electrophile allows for the 
production of products 104. This type of mechanism involving a stepwise elimination/addition 
sequence can be considered an overall formal nucleophilic substitution performed on 
cyclopropyl halides. This type of mechanism is in sharp contrast to cyclopropanes of type 105 in 
which similar formal substitution products are obtained via an E1-mechanism involving a 























4.2.1 Nucleophilic Additions of Oxygen Nucleophiles 
Cyclopropyl ethers can be obtained by exposure of cyclopropyl bromide to alcohols or 
phenols in the presence of a suitable base. This strategy found application during the synthesis 
of CRF1 receptor antagonist 107 in which alcohol 108 underwent nucleophilic addition to 
cyclopropyl bromide in the presence of sodium hydride in DMF (Scheme 42a).[65] Additionally, 
phenol 109 was shown to be a suitable nucleophile in the reaction with cyclopropyl bromide to 
provide cyclopropyl ether 110 which was then converted to adrenergic receptor antagonist 111 
(Scheme 42b).[66] Furthermore, the addition of phenoxide nucleophiles to cyclopropenes was 
used during the synthesis of antitumor and angioinhibitor 112 (Scheme 43a),[67] plasmodium 




































 Even though cyclopropene intermediates were not identified during these transformations, 
it can be postulated that an elimination/addition sequence is the operating mechanism due to the 
difficulty of performing direct nucleophilic displacement on cyclopropane due to the unique near 
sp2 hybridization of the carbon – bromine bond. The symmetric nature of the proposed 
cyclopropene intermediates in schemes 2, 3, and 4, negates a discussion of stereoselectivity. 
 Shavrin reported the first attempts to conduct stereoselective nucleophilic additions to 






achiral cyclopropene 116, which then underwent nucleophilic addition of various alkoxides to 
provide mixtures of products 117 with rather poor diastereoselectivity (Scheme 45a).[70] 
Similarily, alkynylcyclopropane 118 proceeding via achiral cyclopropene intermediate 119 
failed to produce meaningful diastereoselectivity by producing cyclopropane 120 as a mixture of 
diastereomers (Scheme 45b).[70] Rather poor diastereoselectivity was also observed in the 























Yield: 35 - 80%; cis:trans 1:2 - 1:10 
Yield: 55 - 65%; cis:trans 1.4:1 - 1.6:1 
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Wiberg first reported a highly diastereoselective nucleophilic addition to cyclopropenes 
using bromocyclopropane 123 in 1957.[71] Exposure of 123 to potassium tert-butoxide produced 
cyclopropene intermediate 124 which then underwent conjugate addition of tert-butanol across 
the double bond. The incorporation of an ester function allowed for efficient epimerization of the 
alpha-center to selectively form the thermodynamically favored trans-configured product 125 


















Yield: 45%; cis:trans 2:1 
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Much more recently, Rubin showed that this reaction only proceeds using very weak t-
butoxide nucleophiles with substrates which form highly electrophilic conjugated cyclopropenes. 
Attempts to achieve the transformation with non-conjugated ester 126 only led to decomposition 
(Scheme 47b).[72] Attempts to increase reactivity by using more nucleophilic secondary or 
primary nucleophiles in the reaction with 123 also only resulted in decomposition. 
Replacement of the ester function with a less electrophilic carboxamide in substrate 127 
allowed for the development of a general diastereoselective formal nucleophilic substitution of 
bromocyclopropanes with oxygen based nucleophiles under thermodynamic control (Scheme 
48a). The use of potassium hydroxide instead of potassium tert-butoxide with carboxamides 128 
allowed for the incorporation of phenoxides along with secondary and primary alkoxide 
nucleophiles into cyclopropanes 129 (Scheme 48b).[73,74] It was reported that the addition of less 
nucleophilic alcohols and most phenols in the presence of KOH resulted in deteriorated 
diastereoselectivities which, was attributed to the reduced propensity of product to undergo 
epimerization. As a solution to this problem, recovered crude material could be subjected to t-












Yield: 44 - 93%; dr: 6:1 - 25:1 
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A second mode of diastereoselectivity was also demonstrated using bromocyclopropanes 
130 which, after 1,2-dehydrobromination provides 3,3-disubstituted non-conjugated 
cyclopropene 131. Subsequent nucleophilic addition of tert-butoxide occurs with facial 
selectivity as determined by the differing steric signature of the substituents in the 3-position 
(Scheme 49a).[72,73] Additionally primary and secondary alkoxides were shown to outcompete 
tert-butoxide as the nucleophile and add selectively to cyclopropene to generate cyclopropyl 
ethers 132 (Scheme 49b).[72,73] Utilization of cyclopropylcarboxamide 133 resulted in another 
mode of diastereoselectivity. In this system, the alkoxide nucleophile was delivered via efficient 




















Yield: 85 - 93%; dr: >25:1 
Yield: 75 - 93%; dr: 14:1 - 25:1 
Yield: 75 - 95%; dr: 10:1 - 25:1 
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Interetingly, cis-configured cyclopropylesters 135 could be accessed via use of carboxylate 
salts 136 (Scheme 50).[72] 1,2-dehydrobromination of salts 136 provided cyclopropene 
intermediate 137 which then underwent carboxylate directed addition of various alkoxides to 
provide alkoxycyclopropane salt 138. Subsequent exposure of this species to SN2-active 
electrophiles resulted in efficient alkylation of the carboxylate and cyclopropylesters 135. 
 








Both steric and thermodynamic modes of stereocontrol were combined during the formal 
nucleophilic substitution of cyclopropyl bromide 139 (Scheme 51a).[75] In this process, 1,2-
dehydrobromination occurs to provide tri-substituted conjugated cyclopropene intermediate 
140. Next, conjugate nucleophilic addition occurs with facial differentiation being determined by 
the steric signature of the substituents at C-3 to provide cyclopropyl enolate 141. This species 
can then undergo efficient epimerization of the amide alpha-carbon to establish the 
thermodynamically favored product 142. The ability to access optically active cyclopropyl 
bromides[76] 143 via recrystallization of the corresponding carboxylic acid with chincona 

























In the attempted synthesis of methylenecyclopropane 145, Zefirov proposed the elimination 
of phenol from chlorocyclopropane 146 as the first step leading to the observed product 147 
(Scheme 52).[77] Following the elimination of phenol, the resulting chlorocyclopropene 148 
could then undergo nucleophilic addition of tert-butoxide to furnish cyclopropyl ether 149. The 
subsequent elimination of HCl would then provide the observed product 147. The formal 
nucleophilic substitution mechanism proposed by Zefirov is debatable due to an alternative 
plausible mechanism which would avoid the formation of a cyclopropene intermediate. Initial 




Yield: 63 - 92%; dr: >30:1 
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which could then undergo an SN1 reaction via the formation of the stabilized allylic cationic 










Gong has recently reported the addition of phenoxide nucleophiles to cyclopropenes followed 
by intramolecular quenching with carbon electrophiles (Scheme 53).[78] Highly reactive β-keto-
ester 151 was found to undergo highly efficient 1,2-dehydrochlorination to provide conjugated 
cyclopropene 152 in the presence of cesium carbonate. This species then underwent nucleophilic 
addition of the conjugate base of salicylic aldehyde 153 to provide cyclopropyl enolate 154. A 
subsequent intramolecular aldol reaction resulted in tetrahydrocyclopropa[b]chromenes 155 in 
good yield with moderate diastereoselectivity (Scheme 53, Path A). Additionally, the use of 
salicylic imines 156 resulted in the production of similar products 157 via an intramolecular 


















This type of nucleophilic addition/electrophilic trapping was also extended to include [2+3]-
cycloadditions of nitrones 158 to provide isoxazolidines 159 in good yield and moderate 
diastereoselectivities (Scheme 54).[80] Exposure of products 159 to zinc in acetic acid allowed 
for the reductive cleavage of the N-O bond and subsequent rearrangement to pyrrolines 160 and 
pyrroles 161. 
 




















Yield: 75 - 92%; dr: 1.2:1 - 5.8:1 
Yield: 56 - 96%; dr: 0.84:1 - 20:1 
Yield: 37 - 92%; dr: 1.4:1 - 15:1 
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4.2.2 Addition of Sulfur Nucleophiles 
Thiols and thiophenolates are more reactive nucleophiles and stronger acids than their 
oxygen based analogs discussed in section 4.2.1. The increased reactivity has two repercussions 
including generally reduced stereoselectivity and requiring additional base loading to achieve 
proper effective basicity. Shavrin demonstrated that sulfur nucleophiles, just as oxygen 
nucleophiles in scheme 45, underwent conjugate addition to in-situ generated cyclopropene 116 
but without diastereoselectivity (Scheme 55a).[81] The reduced basicity of thiolates was 
demonstrated by exposure of cyclopropane 115 to sodium thiolate in DMSO which failed to 
undergo intended 1,2-dehydrohalogenation to form cyclopropene intermediate 116 (Scheme 
55b).[81] Instead, a mixture of E- and Z-configured olefin products 162 were obtained which were 
believed to result from  the initial addition of thiolate to the triple bond to provide allene 


















Yield: 56 - 67%; dr: 1.4:1 - 1.7:1 
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Rubin has reported that thiolates and thiophenolates are efficient nucleophiles for conjugate 
addition to cyclopropenes generated from cyclopropyl bromide 128 (Scheme 56).[72] These 
nucleophiles exhibited similarly poor diastereoselectivity in crude products 164 as was observed 
during addition of phenols in scheme 48. This observation was attributed to the decreased 
propensity for efficient epimerization in systems possessing relatively acidic nucleophilic 
components. As was previously shown during the addition of phenols, the diastereomeric ratio 
could greatly be improved by subjecting the crude mixture of cis- and trans-configured 164 to 








4.2.3 Addition of Nitrogen Nucleophiles 
Competition experiments revealing the reactivity of nitrogen nucleophiles against alkoxides 
and thiolates were conducted by Rubin (Scheme 57).[72,82] Both reactions conducted between 
cyclopropyl bromide 128 and bifunctional pronucleophiles led to exclusive production of 
products 165 and 166. The high selectivity for oxygen- or sulfur- nucleophilic attack was 
rationalized by the particular deprotonation of the far more acidic alcohol or thiol under weakly 
basic reaction conditions.[70] 
  
128 164 trans-164 


















The relative poor nucleophilicity of nitrogen nucleophiles has been overcome by either 
utilizing a stronger base capable of efficiently deprotonating secondary amines or by 
incorporation of an electron-withdrawing group thus activating the N-H bond toward 
deprotonation by weaker bases. 
Taylor attempted to conduct the addition of ammonia to in-situ generated cyclopropene 167 
using potassium hexamethyldisilazide as base (Scheme 58).[83] This process was unsuccessful as 
methoxycyclopropane 168 was the only observed product in very poor yield. Rubin has also 
reported the failure of amide bases to undergo conjugate addition to cyclopropene 169.[82] It was 
proposed that instead of acting as a nucleophile the amide base deprotonates cyclopropene 169 




Yield: 80 - 90%; dr: 7:1 - 15:1 
271 
 
































Yield: 33 - 71%; dr: 2.5:1 - >98:2 
Yield: 37 - 48%; dr: 2.5:1 - 5:1 
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The strategy of utilizing nitrogen pronucleophiles with enhanced acidity was utilized by 
Rubin during the formal nucleophilic substitution of cyclopropyl bromide 130 with N-
methylacetamide under steric control (Scheme 61a).[82] Likewise, carboxamide and sulfonamide 
pronucleophiles were found to undergo addition to conjugated cyclopropenes formed from 
cyclopropanes 128 under thermodynamic control (Scheme 61b and 61c).[82] Azoles and anilines, 
which possess similar acidity as carboxamides, were also reported to undergo this 
transformation to provide N-substituted cyclopropanes 171 and 172 (Scheme 62).[82] It is also 
possible to add nitrogen nucleophiles in the form of pyrroles and indoles to cyclopropenes under 




















Yield: 85%;  
dr: 13:1 
Yield: 31 - 94%;  
dr: >25:1 
Yield: 67 - 95%;  
dr: 9:1 - 25:1 
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It is important to note nucleophilic additions reported by Rubin were strictly limited to 
secondary nitrogen nucleophiles. All attempts to incorporate primary nitrogen nucleophiles 
resulted in the nucleophile-catalyzed ring-opening process to provide aldehyde 173 (Scheme 
64).[82] Initially the primary nitrogen nucleophile undergoes typical nucleophilic addition to 
cyclopropene to establish species 174. The presence of an additional acidic N-H bond allowed for 
a second deprotonation to generate amide 175 which was followed by strain-release driven ring-
171 
172 
Yield: 50 - 84%;  
dr: >25:1 
Yield: 50 - 84%;  
dr: >25:1 
Yield: 41 - 85%;  
dr: 3:1-19:1 




opening to form imine 176. Subsequent exposure to aqueous conditions resulted in hydrolysis of 
the imine and formation of linear aldehyde 173 as the sole product 
 








Gong has also demonstrated a nucleophilic addition/electrophilic trapping sequence using 
nitrogen nucleophiles similar to the chemistry previously shown with phenoxide nucleophiles 
(Scheme 65a).[88] N-acylhydrazones were shown to undergo efficient addition to cyclopropenes 
generated from cyclopropyl chloride 151 to provide intermediate 177 which could react in an 
intramolecular mannich reaction yielding pyrazolidines 178. The heating of products 178 under 
proper conditions resulted in ring opening and subsequent elimination of benzamide to provide 
pyrrole derivatives 179 (Scheme 65b).[88] Additionally, the addition of secondary amides to 




























Gvozdev reported the addition of primary diamines to alkynylcyclopropane 115 followed by 







Yield: 58 - 90%; dr: 1.3:1 - 2.6:1 








4.2.4 Addition of Carbon Nucleophiles 
While the number of reports detailing the addition of carbon based nucleophiles to in-situ 
generated cyclopropenes is far fewer than what has been reported for additions to pre-generated 
cyclopropenes(see section 4.3.6), both organometallic reagents and enolates have been shown 
to display this type of reactivity. Marek reported tri-functionalization of cyclopropanes 182 via 
initial direct addition of allylmagnesium bromide to cyclopropenyl lithium species 183 to 
generate 184. Subsequent exposure to two equivalents of an electrophilic component provided 
tetra-substituted cyclopropanes (Scheme 68a).[92] Further development of this chemistry 
allowed for the diastereoselective incorporation of two non-identical electrophiles via the 
placement of a hydroxymethyl substituent at C-3 of 185. (Scheme 68b).[92] In species 186, the 
first equivalent of an electrophilic quench is added in a trans-configuration to the directing group 
due to the stabilizing coordination between the alkoxide and metal cation. 
Gong has reported the nucleophilic addition of carbon based enolate nucleophiles to 
cyclopropanes 151 using 1,3-diketone pro-nucleophiles to provide cyclopropanes 187 which, 



































Yield: 53 - 81% 
Yield: 55 - 93% 
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4.2.5 Addition of Halogen Nucleophiles 
Very recently, a single example demonstrating the ability of halogen nucleophiles to add to 
cyclopropenes has been reported. Gong demonstrated that fluoride underwent nucleophilic 
addition to cyclopropene 152 to provide fluorinated cyclopropane 189 (Scheme 70).[95] The 
rather surprising formation of cyclopropene under such weakly basic conditions was confirmed 
via [4+2]-cycloaddition reaction with anthracene. 
 





4.3 Additions to Pre-Generated Cyclopropenes 
Stable cyclopropenes which can be isolated in pure form offer more general reactivity and 
less restrictive reaction conditions that those generated in-situ. However, the requirement of 
isolable cyclopropenes to resist decomposition limits the substitution pattern around the ring to 
those which possess proper stabilization (Figure 8). Thus, additions to pre-generated 
cyclopropenes often require harsher conditions to achieve the desired reactivity which may 
cause complications with stereoselectivity. Despite these concerns, reactions involving the 
addition of hydride, oxygen, sulfur, nitrogen, phosphorus, and carbon nucleophiles to pre-
generated cyclopropenes have been reported. 
4.3.1 Addition of Hydride Nucleophiles 
The reduction of cyclopropenes to cyclopropanes using hydride sources such as lithium 
aluminum hydride has been known for over 50 years.[96-98] However, not until recently has the 
152 
189 
Yield: 71 - 85%; dr: 1.2:1 - 2.6:1 
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stereoselective addition of such nucleophiles been observed. Marek has shown that cyclopropene 
190 underwent diastereoselective reduction via efficient coordination between the incoming 
nucleophilic species and the alkoxide directing group (Scheme 71).[100] Organic hydride sources 
can also be used to reduce cyclopropene as was demonstrated by the reduction of conjugated 
cyclopropene 191 with Hantzsch ester 192 to provide cyclopropane 193 with moderate 
diastereoselectivity (Scheme 72).[101] Hydride nucleophiles delivered in a catalytic fashion is also 
known. Marek reported the production of methylene cyclopropane 194 via catalytic SN2’ addition 
of hydride to cyclopropene 195 (Scheme 73).[102] 
 



















Yield: 50 - 86%; dr: 4:1 - 50:1 
Yield: 61 - 95%; dr: 54:46 - 85:15 
Yield: 40 - 87%; dr: 85:15 - 93:7 
280 
 
4.3.2 Addition of Oxygen Nucleophiles 
The addition of oxygen nucleophiles to cyclopropenes often occurs under conditions 
facilitating efficient 1,2-dehydrobromination and therefore is more commonly conducted with 
in-situ generated cyclopropenes (See section 4.2.1). However, pre-generated cyclopropenes 
offer the advantage of being less prone to decomposition and therefore provide a possibility for 
the addition of very weak nucleophiles which require harsher conditions and longer reaction 
times to achieve acceptable yield. Sharpless epoxidation was used for the kinetic resolution of 
racemic cyclopropene 196 (Scheme 74).[103,104] In this system, one enantiomer of 196 underwent 
epoxidation to species 197, which subsequently decomposed to products 198 and 199 while the 
other enantiomer of 196 failed to react and remained intact. Recently, Rubin has reported the 
addition of primary alkoxides to pre-generated cyclopropenes. In this instance 200 underwent 
dimerization to generate 8-membered 1,5-dioxocanes 201 in a highly diastereoselective manner 
(Scheme 75).[107] A [3,3]-sigmatropic rearrangement has been reported with pre-generated 
cyclopropene 202 (Scheme 76).[104,108] 
 










Yield: 40 - 47%; 
ee: 95 - 99% 
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4.3.3 Addition of Sulfur Nucleophiles 
Zhang demonstrated that sulfur nucleophiles are compatible in nucleophilic additions to pre-
generated cyclopropenes. He showed that optically active cyclopropene 203, obtained from 
asymmetric cyclopropenation of phenylacetylene, undergoes highly regioselective formation of 
cyclopropane 204 with complete conservation of optical purity (Scheme 77).[109] 
 




4.3.4 Addition of Nitrogen Nucleophiles 
Despite the relatively high nucleophilicity of amine nucleophiles, very few examples of their 
nucleophilic addition to cyclopropenes have been reported. This has been attributed to their 
decreased acidity which, in reactions with in-situ generated cyclopropenes resulted in their out-




Yield: 55 - 83%; dr: 88:12 - 99:1 
Yield: 60 - 92%; dr: 2:1 - 99:1 
Yield: 54 - 98% 
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pre-generated cyclopropenes this obstacle could be overcome (Scheme 78).[110] Exposure of 
cyclopropene 133 to secondary amines at elevated temperatures generated push-pull 
aminocyclopropane 205. Following ring-opening, zwitterionic species 206 could be efficiently 
reduced to provide GABA derivatives 207. Additionally, Hyland reported a [3,3]-sigmatropic 
rearrangement of cyclopropene intermediates 208 (Scheme 79).[111] 
  













4.3.5 Addition of Phosphorus Nucleophiles 
The direct nucleophilic addition of phosphorous nucleophiles to cyclopropenes remains 
largely unknown, although it was proposed to occur catalytically by Gevorgyan in the 
development of the Morita-Baylis-Hillman reaction of cyclopropenes (Scheme 80).[113] It was 





Yield: 65 - 76% 
Yield: 47 - 99% 
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cyclopropene 209 would lead to stabilized zwitterionic intermediate 210. Introduction of an 
aldehyde to the reaction resulted in formation of species 211 which, then underwent a 1,3-Brook 
rearrangement to reform cyclopropene 212 and expel triphenylphosphine. 
  







Marek has reported the [2,3]-sigmatropic rearrangement of cyclopropene intermediates 213 
(Scheme 81).[108] This reactivity is similar to sigmatropic rearrangements reported in the 
addition of oxygen (Scheme 76) and nitrogen (Scheme 79) nucleophiles. 
 





Nearly simultaneously, Rubin reported the synthesis of cyclopropene phosphonates 214 
(Scheme 82).[114] Interestingly, this reaction was found to occur only in the presence of the Lewis 







Yield: 50 - 86% 
Yield: 85 - 93%; dr: ~4:1 
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4.3.6 Addition of Carbon Nucleophiles 
The direct addition of organometallic reagents to cyclopropenes has been known for more 
than 50 years and was detailed by Fox in a 2005 review.[115] Recently, the catalytic delivery of 
organometallic carbon nucleophiles has begun to receive considerable attention. Reports on the 
direct and catalytic addition of organometallic reagents to pre-generated cyclopropenes dating 
to post-2005  are detailed in this section.  
Marek First described the copper-mediated delivery of Grignard reagents to pre-generated 
cyclopropenes 207 to provide difunctionalized cyclopropane products 215 in which 
diastereoselectivity was determined by efficient coordination with the hydroxymethyl directing 
group (Scheme 83a).[119] Interestingly, he reported that facial selectivity was dependent on the 
identity of the organocopper species and utilization of stoichiometric Gilman cuprate resulted in 
opposite diastereoselectivity (Scheme 83b).[119]  
  
214 













A highly diastereo- and enantioselective direct addition of Grignard reagents to cyclopropene 
216 has been reported which uses (S)-N-methylprolinol to provide cyclopropane 217 in high 
enantiomeric ratios (Scheme 84).[123] Fox reported a similar diastereoselective direct addition of 
Grignard reagents to cyclopropenes 218 (Scheme 85a).[124] The use of 5-6 equivalents of 
Grignard reagent to achieve this transformation was justified via proposition of intermediate 219 
in which two equivalents of RMgBr were required to properly activate the double bond toward 
nucleophilic addition. One equivalent was proposed to coordinate to the alkoxide directing group 
and act as the nucleophile in the reaction while the second equivalent would act as a Lewis acid 
and activate the leaving group. Recently, the catalytic delivery of Grignard reagents to 1-
hydroxymethylcyclopropene 207 has been described by Marek. Interestingly, the catalytic 
transformation proceeded by an SN2’-type mechanism to provide methylene cyclopropanes 220, 




Yield: 70 - 92%; dr: 75:25 - 95:5 
Yield: 75 - 87%; dr: 90:10 - 99:1 
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Catalytic allylic transposition of cyclopropenes 221 has also been achieved. Interestingly, it 
was found that different facial selectivities could be achieved by using different catalysts. The 
reaction proceeded under directed control by use of a copper catalyst to provide cis-configured 
methylene cyclopropane 222 (Scheme 86a),[125] and under steric control to trans-configured 







Yield: 55 - 81%; ee: 91 - 96% 
Yield: 62 - 87%; dr: 75:25 - 95:5 
Yield: 66 - 88%;  












Recently catalytic carbomagnesiation and carbozincation reaction of 3,3-disubstituted 
cyclopropenes have also been developed. Endo first described the copper-catalyzed 
carbomagnesiation and carbocupration of symmetric cyclopropene 224 using a hydrazine-
carboxamide ligand (Scheme 87a).[126] Further attempts to achieve facial selectivity under steric 















Yield: 48 - 91%;  
dr: 66:33 - 95:5 
Yield: 52 - 73%;  
dr: 80:20 - 95:5 
Yield: 63 - 98% 




A major development was reported by Marek when he reported the copper-catalyzed 
asymmetric carbozincation of cyclopropenes 225. In this reaction the steric influence of the 
substituents at C-3 of 225 resulted in good facial selectivity while efficient enantioselectivity was 
established by a chiral SEGPHOS ligand (Scheme 88a).[127] In 2017, this work was extended to 
include asymmetric carbomagnesiation using (R,S)-Josiphos ligand (Scheme 88b).[128] 
 










The directed catalytic asymmetric addition of organometallic reagents to 3-substituted 
cyclopropenes remains unknown, most probably due to the susceptibility of intermediate 
cyclopropane structures bearing electron-withdrawing directing groups to undergo ring-
opening. Furthermore, the exposure of carbonyl-based directing groups to excess organometallic 
reagents often requires extreme cooling to prevent unwanted decomposition. 
Fox conducted investigations concerning the catalytic carbozincation of cyclopropene 226 
utilizing an ester functionality at C-3 as an efficient directing group (Scheme 89).[121] In this 
process organozinc reagents were prepared prior to introduction to the carbozincation reaction 
225 
Yield: 47 - 97%; dr: 78:22 - 98:2; er: >91:9 
Yield: 52 - 94%; dr: >98:2; er: >94:6 
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by exposure of various aryl halides first to isopropylmagnesium bromide and then zinc(II) 
chloride in 1,4-dioxane. It was found that reactions carried out in diethyl ether resulted in 
reduced facial selectivity which, was postulated to be due to the presence of Lewis acidic 
magnesium salts. Incorporation of 1,4-dioxane as a co-solvent eliminated this problem and 
diastereoselectivities improved in all examples. 
 







 Oxazolidinone auxillaries have also been shown to be highly efficient directing groups 
for the copper mediated carbozincation of cyclopropene 227 providing cis-configured tri-
substituted cyclopropanes 228 with a high degree of diastereoselectivity (Scheme 90a).[120] 
Additionally, carbozincation of cyclopropene 229 bearing chiral oxazolidinone auxillary allowed 
for the production of products 230 possessing three contiguous stereocenters (Scheme 90b). 
[123] 
Marek has described the copper-catalyzed addition of Grignard reagents to optically active 
cyclopropenes 231 to form intermediate 232 which underwent facile oxidation under aerobic 
conditions. Subsequent ring-opening then produced enantioenriched aldehydes 233 (Scheme 
91a).[129] Interestingly, the use of stoichiometric cyanocuprate nucleophiles was able to provide 
the opposite configuration of 233 (Scheme 91b).[129] 
226 

























A similar example showcased the highly variable stability of optically active cyclopropenes 
234 possessing ester and ether directing groups (Scheme 92).[130] Substrates bearing an 







Yield: 56 - 76%; dr: >95:5 
Yield: 65 - 82%; dr: >95:5 
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235. The presence of a methoxymethyl directing group at C-3 of 234 proved to be stabilized 
toward ring-opening and provided cyclopropanols 236. 
 








The Stetter reaction of cyclopropene 225 has been reported by Glorius which, was proposed 
to proceed via nucleophilic addition of Breslow intermediate 237 to cyclopropene 225 under 
steric control (Scheme 93a).[133] Subsequent formation of an aldehyde would return species 238 
to the catalytic cycle and provide cyclopropane 239. An asymmetric version of this chemistry has 
also been developed using chiral catalyst 240 (Scheme 93b).[135] 
Meyer and Cossy have reported a diastereoselective Ireland-Claisen rearrangement of 
cyclopropenes 241 (Scheme 94).[138] It was proposed that exposure of 241 to basic conditions 
resulted in the formation of silyl enol ether intermediate 242. Next, a strain-release driven [3,3]-





Yield: 63 - 90%;  
dr: >98:2 






























Yield: 52 - 96%;  
dr: 1.6:1 - 95:5 
Yield: 50 - 93%;  











The nucleophilic addition of heteroatom and carbon based nucleophiles has seen 
considerable development within the past decade. The use of strategically designed cyclopropene 
substrates and asymmetric catalysts has allowed for the development of a variety of highly 
diastereo- and enantioselective reactions under steric, thermodynamic, and directed control. The 
stereoselective construction of highly variable cyclopropane scaffolds offer interesting 
possibilities for biologically active small molecules. The tunable reactivity of many cyclopropane 
intermediates toward highly diastereoselective ring opening provide the possibility of using 
stereoselective nucleophilic additions to cyclopropenes as a vehicle for the synthesis of other 









A-1) Xray Data for [21g] 












































Table 31. Crystal data and structure refinement for 21g. 
 Identification code q32c 
 Empirical formula C22H24O2 
 Formula weight 320.41 
 Temperature 100(2) K 
 Wavelength 1.54178 Å 
 Crystal system Monoclinic 
 Space group C2/c 
 Unit cell dimensions a = 19.9651(7) Å α= 90° 
  b = 6.1398(2) Å β= 116.9270(10)° 
  c = 15.2881(6) Å γ = 90° 
 Volume 1670.87(10) Å3 
 Z 4 
 Density (calculated) 1.274 g/cm3 
 Absorption coefficient 0.623 mm-1 
 F(000) 688 
 Crystal size 0.30 x 0.08 x 0.04 mm3 
 Theta range for data collection 4.97 to 69.35° 
 Index ranges -22<=h<=23, -7<=k<=6, -18<=l<=16 
 Reflections collected 7532 
 Independent reflections 1507 [R(int) = 0.0163] 
 Completeness to theta = 66.00° 98.4 % 
 Absorption correction Multi-scan 
 Max and min transmission 1.000 and 0.873 
 Refinement method Full-matrix least-squares on F2 
 Data/restraints/parameters 1507 / 0 / 157 
 Goodness-of-fit on F2 1.054 
 Final R indices [I>2sigma(I)] R1 = 0.0347, wR2 = 0.0941 
 R indices (all data) R1 = 0.0349, wR2 = 0.0944 





Table 32. Atomic coordinates (x 104) and equivalent isotropic displacement parameters (Å2 x 
103) for 21g. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
 
  X Y Z U(eq) 
 
 O 4600(1) -2172(1) 5110(1) 16(1)  
 C(1) 4414(1) -1542(2) 4114(1) 16(1) 
 C(2) 4079(1) 713(2) 3894(1) 15(1) 
 C(3) 4630(1) 2599(2) 4321(1) 16(1) 
 C(4) 4316(1) 2121(2) 3255(1) 19(1) 
 C(5) 3307(1) 1001(2) 3818(1) 15(1) 
 C(6) 2910(1) 2956(2) 3487(1) 18(1) 
 C(7) 2204(1) 3230(2) 3443(1) 19(1) 
 C(8) 1861(1) 1569(2) 3715(1) 19(1) 
 C(9) 2253(1) -382(2) 4038(1) 19(1) 
 C(10) 2963(1) -662(2) 4093(1) 17(1) 





Table 33. Bond lengths [Å] and angles [°] for 21g. 
 O-C(3)#1 1.4053(13) C(3)#1-O-C(1) 112.89(8) 
 O-C(1) 1.4477(13)  O-C(1)-C(2)  110.89(9) 
 C(1)-C(2) 1.5076(15)  O-C(1)-H(1A)  108.4(8) 
 C(1)-H(1A) 0.991(13)  C(2)-C(1)-H(1A)  110.9(7) 
 C(1)-H(1B) 0.977(14)  O-C(1)-H(1B)  109.4(7) 
 C(2)-C(5) 1.5020(14)  C(2)-C(1)-H(1B)  110.7(8) 
 C(2)-C(3) 1.5258(15)  H(1A)-C(1)-H(1B)  106.4(11) 
 C(2)-C(4) 1.5325(15)  C(5)-C(2)-C(1)  117.50(9) 
 C(3)-O#1 1.4053(13)  C(5)-C(2)-C(3)  117.38(9) 
 C(3)-C(4) 1.4866(15)  C(1)-C(2)-C(3)  116.12(9) 
 C(3)-H(3) 0.965(15)  C(5)-C(2)-C(4)  119.12(9) 
 C(4)-H(4A) 0.974(15)  C(1)-C(2)-C(4)  115.20(9) 
 C(4)-H(4B) 0.946(15)  C(3)-C(2)-C(4)  58.17(7) 
 C(5)-C(10) 1.3978(16)  O#1-C(3)-C(4)  116.16(10) 
 C(5)-C(6) 1.4004(16)  O#1-C(3)-C(2)  119.86(9) 
 C(6)-C(7) 1.3907(16)  C(4)-C(3)-C(2)  61.14(7) 
 C(6)-H(6) 0.964(15)  O#1-C(3)-H(3)  114.8(8) 
 C(7)-C(8) 1.3922(18)  C(4)-C(3)-H(3)  119.1(8) 
 C(7)-H(7) 0.942(16)  C(2)-C(3)-H(3)  115.5(8) 
 C(8)-C(9) 1.3930(17)  C(3)-C(4)-C(2)  60.69(7) 
 C(8)-C(11) 1.5088(15)  C(3)-C(4)-H(4A)  118.6(8) 
 C(9)-C(10) 1.3928(16)  C(2)-C(4)-H(4A)  118.5(9) 
 C(9)-H(9) 0.965(15)  C(3)-C(4)-H(4B)  114.7(8) 
 C(10)-H(10) 0.975(15)  C(2)-C(4)-H(4B)  114.5(8) 
 C(11)-H(11A) 0.96(2)  H(4A)-C(4)-H(4B)  117.6(12) 
 C(11)-H(11C) 0.97(2)  C(10)-C(5)-C(2)  121.10(10) 
 C(11)-H(11B) 0.96(2)  C(10)-C(5)-C(6)  117.41(10) 
 C(6)-C(5)-C(2) 121.48(10)  C(7)-C(6)-H(6)  118.7(8) 
 C(7)-C(6)-C(5) 121.10(11)  C(5)-C(6)-H(6)  120.2(8) 
 C(6)-C(7)-C(8) 121.44(11)  C(9)-C(10)-C(5)  121.11(10) 
 C(6)-C(7)-H(7) 119.2(9)  C(9)-C(10)-H(10)  119.9(8) 
 C(8)-C(7)-H(7)  119.4(9)  C(5)-C(10)-H(10)  119.0(8) 
 C(7)-C(8)-C(9) 117.56(10)  C(8)-C(11)-H(11A)  112.4(12) 
 C(7)-C(8)-C(11) 121.10(11)  C(8)-C(11)-H(11B)  110.8(12) 
 C(9)-C(8)-C(11) 121.33(11)  H(11A)-C(11)-H(11B)  106.6(17) 
 C(10)-C(9)-C(8) 121.37(11)  C(8)-C(11)-H(11C)  111.0(12) 
 C(10)-C(9)-H(9) 119.1(8)  H(11A)-C(11)-H(11C)  104.5(17) 
 C(8)-C(9)-H(9) 119.5(8)  H(11B)-C(11)-H(11C)  111.3(17) 
 




Table 34. Anisotropic displacement parameters (Å2 x 103) for 21g. The anisotropic 
displacement factor exponent takes the form: -2p2[h2a*2U11+…+2hka*b*U12] 
 
  U11 U22 U33 U23 U13 U12 
  
 O 12(1) 17(1) 18(1)  3(1)  5(1)  1(1) 
 C 14(1) 15(1) 17(1)  -1(1)  6(1)  0(1) 
 C 13(1) 16(1) 15(1)  0(1)  5(1)  0(1) 
 C 12(1) 14(1) 20(1)  2(1)  5(1)  1(1) 
 C 15(1) 21(1) 20(1)  4(1)  8(1)  1(1) 
 C 13(1) 18(1) 13(1)  -2(1)  4(1)  0(1) 
 C 17(1) 17(1) 18(1)  1(1)  6(1)  0(1) 
 C 17(1) 20(1) 18(1)  0(1)  4(1)  5(1) 
 C 14(1) 26(1) 13(1)  -4(1)  4(1)  1(1) 
 C 16(1) 23(1) 16(1)  0(1)  7(1) -2(1) 
 C 16(1) 17(1) 16(1)  0(1)  5(1)  1(1) 
 C 16(1) 35(1) 22(1)  -2(1)  8(1)  3(1) 
  
Table 35. Hydrogen coordinates (x 104) and isotropic displacement parameters (Å2 x 103) for 
21g. 
 
  X Y Z U(eq) 
 
 H(1A)  4058(7)  -2630(20)  3662(10)  14(3) 
 H(1B)  4864(7)  -1610(20)  4016(9)  16(3) 
 H(3)  4444(7)  3840(20)  4531(10)  17(3) 
 H(4A)  3951(8)  3130(20)  2791(10)  22(3) 
 H(4B)  4656(8)  1440(20)  3067(10)  19(3) 
 H(6)  3122(8)  4140(20)  3278(10)  21(3) 
 H(7)  1951(8)  4570(30)  3220(10)  23(3) 
 H(9)  2028(8)  -1570(20)  4227(10)  21(3) 
 H(10)  3228(8)  -2040(20)  4327(10)  21(3) 
 H(11A)  956(11)  690(40)  3960(15)  61(6) 
 H(11B)  714(12)  1970(30)  2994(15)  58(6) 




Table 36. Torsional angles [°] for 21g. 
 
 C(3)#1-O-C(1)-C(2) -119.27(9) 
 O-C(1)-C(2)-C(5)  -69.90(11) 
 O-C(1)-C(2)-C(3)  76.48(11) 
 O-C(1)-C(2)-C(4)  141.74(9) 
 C(5)-C(2)-C(3)-O#1  145.81(10) 
 C(1)-C(2)-C(3)-O#1  -0.62(14) 
 C(4)-C(2)-C(3)-O#1  -105.32(11) 
 C(5)-C(2)-C(3)-C(4)  -108.87(11) 
 C(1)-C(2)-C(3)-C(4)  104.70(11) 
 O#1-C(3)-C(4)-C(2)  111.26(11) 
 C(5)-C(2)-C(4)-C(3)  105.89(11) 
 C(1)-C(2)-C(4)-C(3)  -106.29(10) 
 C(1)-C(2)-C(5)-C(10)  10.09(15) 
 C(3)-C(2)-C(5)-C(10)  -135.87(11) 
 C(4)-C(2)-C(5)-C(10)  157.18(10)  
 C(1)-C(2)-C(5)-C(6)  -171.26(10)  
 C(3)-C(2)-C(5)-C(6)  42.79(14)  
 C(4)-C(2)-C(5)-C(6)  -24.17(15)  
 C(10)-C(5)-C(6)-C(7)  0.39(16)  
 C(2)-C(5)-C(6)-C(7)  -178.31(10)  
 C(5)-C(6)-C(7)-C(8)  -0.61(17)  
 C(6)-C(7)-C(8)-C(9)  0.20(17)  
 C(6)-C(7)-C(8)-C(11)  179.94(10)  
 C(7)-C(8)-C(9)-C(10)  0.41(16)  
 C(11)-C(8)-C(9)-C(10)  -179.32(10)  
 C(8)-C(9)-C(10)-C(5)  -0.63(17)  
 C(6)-C(5)-C(10)-C(9)  0.22(16)  
 C(2)-C(5)-C(10)-C(9)  178.92(9) 
 




A-2) Xray Data for [54ad] 








































Table 37. Crystal data and structure refinement for 54ad. 
 
 Empirical formula C30H34BNO3 
 Formula weight 467.39 
 Temperature/K 100.02(10) 
 Crystal system orthorhombic 
 Space group P212121 
 a/Å 6.45257(14) 
 b/Å 15.3580(3) 
 c/Å 25.9426(4) 
 α/° 90  
 β/° 90 
 γ/° 90 
 Volume/Å3 2570.87(8) 
 Z 4 
 ρcalcg/cm3 1.208 
 μ/mm-1 0.598 
 F(000) 1000.0 
 Crystal size/mm3 0.325 × 0.111 × 0.066 
 Radiation CuKα (λ = 1.54184) 
 2Θ range for data collection/° 6.688 to 148.374 
 Index ranges -7 ≤ h ≤ 7, -17 ≤ k ≤ 19, -29 ≤ l ≤ 31 
 Reflections collected 23574 
 Independent reflections 5164 [Rint = 0.0515, Rsigma = 0.0389] 
 Data/restraints/parameters 5164/0/320 
 Goodness-of-fit on F2 1.066 
 Final R indexes [I>=2σ (I)] R1 = 0.0364, wR2 = 0.0871 
 Final R indexes [all data] R1 = 0.0389, wR2 = 0.0892 
 Largest diff. peak/hole / e Å-3 0.18/-0.17 




Table 38. Atomic coordinates (x 104) and equivalent isotropic displacement parameters (Å2 x 
103) for 54ad. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
 
 Atom X Y Z U(eq) 
 O2 5411(2) 5526.2(9) 2491.3(5) 20.1(3) 
 O1 2247(2) 6201.1(9) 2465.3(5) 21.3(3) 
 O3 3344(3) 6102.9(9) 3617.0(6) 23.2(3) 
 N1 202(3) 5999.0(11) 4002.3(6) 18.7(4) 
 C4 1722(3) 5698.9(12) 3690.6(7) 17.9(4) 
 C25 -827(4) 7562.0(13) 4034.4(8) 24.0(4) 
 C15 691(4) 2771.3(14) 4273.0(8) 23.8(5) 
 C23 -4301(4) 5572.3(14) 4811.0(8) 23.0(4) 
 C14 2621(4) 2707.4(14) 4502.0(8) 26.6(5) 
 C12 3726(4) 3980.2(14) 4038.2(8) 22.5(4) 
 C11 1787(4) 4060.3(13) 3809.3(7) 18.6(4) 
 C18 -2355(3) 5363.6(13) 4616.5(8) 19.5(4) 
 C16 262(4) 3450.1(13) 3930.5(8) 20.6(4) 
 C24 476(4) 6841.5(13) 4265.9(8) 21.6(4) 
 C19 -950(4) 4922.1(13) 4930.4(8) 23.5(4) 
 C17 -1831(3) 5593.9(13) 4061.9(8) 19.9(4) 
 C20 -1515(4) 4681.2(14) 5427.5(9) 28.0(5) 
 C1 2344(3) 4706.3(13) 2902.5(7) 19.2(4) 
 C13 4150(4) 3313.4(15) 4384.6(8) 27.3(5) 
 C21 -3467(4) 4882.6(15) 5615.6(8) 28.8(5) 
 C2 1434(3) 4804.4(12) 3442.2(7) 17.1(4) 
 C26 -2797(4) 7738.6(15) 4221.0(10) 32.0(5) 
 C6 5818(3) 6401.9(13) 2294.1(8) 19.6(4) 
 C22 -4863(4) 5331.6(15) 5309.7(8) 27.9(5) 
 C7 6798(4) 6920.1(14) 2731.0(9) 27.3(5) 
 C9 7316(4) 6320.7(17) 1848.2(9) 28.7(5) 
 B1 3377(4) 5499.1(15) 2632.5(8) 18.9(5) 
 C5 3607(4) 6728.0(14) 2142.4(8) 22.6(4) 
 C8 3152(4) 7673.7(14) 2258.7(10) 32.1(5) 
 C10 3029(4) 6526.7(16) 1582.6(8) 29.1(5) 
 C30 -59(5) 8052.1(15) 3623.1(9) 32.0(6) 
 C27 -4014(5) 8383.1(17) 3997.8(13) 45.1(7) 
 C28 -3252(6) 8863.0(16) 3588.6(12) 48.8(8) 
 C29 -1279(6) 8702.3(16) 3405.7(10) 43.6(8) 




Table 39. Anisotropic Displacement Parameters (Å2×103) for 54ad. The Anisotropic 
displacement factor exponent takes the form: -2π2[h2a*2U11+2hka*b*U12+…]. 
 
 Atom U11 U22 U33 U23 U13 U12 
 O2 18.7(8) 17.4(7) 24.1(7) 1.6(5) 0.5(6) 1.5(6) 
 O1 17.6(8) 19.7(7) 26.6(7) 6.7(5) 2.4(6) 0.7(6) 
 O3 19.2(8) 21.3(7) 29.0(7) -1.4(6) 1.5(6) -3.4(6) 
 N1 16.6(9) 15.9(8) 23.7(8) -2.7(7) 0.2(6) -1.6(7) 
 C4 18.8(11) 16.5(9) 18.4(9) 2.3(7) -3.7(7) 0.6(8) 
 C25 30.3(13) 16.0(9) 25.8(10) -4.8(8) -5.0(9) -1.2(9) 
 C15 32.4(14) 17.7(9) 21.3(9) 0.8(8) 3.2(8) -4.6(9) 
 C23 23.0(12) 21.3(10) 24.8(10) -1.2(8) -0.1(8) 2.4(9) 
 C14 40.3(15) 17.4(9) 22.2(10) 4.1(8) 0.3(9) 3.5(9) 
 C12 21.2(12) 20.0(9) 26.3(10) 2.7(8) -1.2(8) -1.7(8) 
 C11 22.5(11) 13.8(8) 19.6(9) -1.5(7) 0.8(8) 0.8(8) 
 C18 21.8(11) 14.8(9) 21.8(9) -2.2(7) -0.9(7) -1.6(8) 
 C16 23.2(12) 17.0(9) 21.5(10) -0.3(7) -0.1(8) -0.8(8) 
 C24 24.1(12) 17.5(9) 23.2(9) -4.3(8) -2.1(8) -1.0(8) 
 C19 21.6(12) 20.4(10) 28.6(10) -2.6(8) -1.6(8) 3.0(8) 
 C17 16.3(11) 19.9(9) 23.5(9) -2.0(8) 0.0(8) 1.4(8) 
 C20 36.7(14) 21.6(10) 25.6(10) 0.9(8) -4.9(9) 3.6(10) 
 C1 22.3(11) 15.4(9) 19.8(9) -0.7(7) -0.3(7) 0.7(8) 
 C13 27.0(13) 27.3(11) 27.7(10) 4.4(8) -3.9(9) 4.4(10) 
 C21 39.2(15) 24.4(11) 22.9(10) 2.1(8) 3.8(9) 0.3(10) 
 C2 15.5(10) 15.0(9) 20.9(9) 0.5(7) 1.4(7) 0.2(8) 
 C26 30.8(15) 20.0(10) 45.3(13) -7.5(9) -2.3(10) 0.2(9) 
 C6 16.5(11) 18.6(9) 23.8(9) 3.6(8) 1.0(8) -0.8(8) 
 C22 27.2(13) 27.8(11) 28.9(11) -1.1(9) 6.7(9) 3.0(10) 
 C7 24.2(12) 22.8(10) 34.8(11) 0.0(9) -4.5(9) -2.5(9) 
 C9 17.4(12) 40.3(13) 28.4(11) 6.2(9) 3.7(8) 1.3(10) 
 B1 20.5(12) 18.4(11) 17.8(10) -1.3(8) 0.7(8) 1.5(9) 
 C5 17.8(12) 22.8(10) 27.1(10) 8.3(8) 2.8(8) 0.3(8) 
 C8 25.3(13) 22.4(11) 48.4(14) 7.3(10) 3.5(10) 4.0(10) 
 C10 21.9(13) 38.0(12) 27.3(11) 10.5(9) -3.4(9) -2.7(10) 
 C30 47.9(17) 23.2(11) 24.8(10) -3.8(9) -5.7(10) -3.5(10) 
 C27 35.3(17) 23.7(12) 76(2) -15.3(13) -15.6(14) 5.4(11) 
 C28 63(2) 21.4(12) 61.5(18) -8.8(12) -36.5(16) 10.5(13) 
 C29 76(2) 22.7(11) 32.4(13) -0.1(10) -20.1(13) -3.6(13) 




Table 40. Bond lengths [Å] for 54ad. 
 
 Atom-Atom Length/Å Atom-Atom Length/Å 
 O2-C6 1.463(2)  C11-C2 1.505(3) 
 O2-B1 1.363(3)  C18-C19 1.395(3) 
 O1-B1 1.372(3)  C18-C17 1.520(3) 
 O1-C5 1.458(2)  C19-C20 1.390(3) 
 O3-C4 1.231(3)  C20-C21 1.386(4) 
 N1-C4 1.352(3)  C1-C2 1.526(3) 
 N1-C24 1.474(3)  C1-B1 1.555(3) 
 N1-C17 1.460(3)  C1-C3 1.523(3) 
 C4-C2 1.529(3)  C21-C22 1.385(3) 
 C25-C24 1.514(3)  C2-C3 1.501(3) 
 C25-C26 1.387(4)  C26-C27 1.390(4) 
 C25-C30 1.397(3)  C6-C7 1.522(3) 
 C15-C14 1.383(3)  C6-C9 1.512(3) 
 C15-C16 1.397(3)  C6-C5 1.563(3) 
 C23-C18 1.391(3)  C5-C8 1.512(3) 
 C23-C22 1.394(3)  C5-C10 1.531(3) 
 C14-C13 1.390(3)  C30-C29 1.391(4) 
 C12-C11 1.390(3)  C27-C28 1.383(5) 
 C12-C13 1.390(3)  C28-C29 1.381(5) 





Table 41. Bond angles for 54ad. 
 
 Atom-Atom-Atom Angle/° Atom-Atom-Atom Angle/° 
 B1-O2-C6 107.16(16)  C22-C21-C20 120.1(2) 
 B1-O1-C5 107.33(16)  C11-C2-C4 113.41(16) 
 C4-N1-C24 119.33(18)  C11-C2-C1 116.58(17) 
 C4-N1-C17 124.74(17)  C1-C2-C4 115.39(16) 
 C17-N1-C24 115.62(17)  C3-C2-C4 120.03(17) 
 O3-C4-N1 122.51(18)  C3-C2-C11 120.50(17) 
 O3-C4-C2 119.39(19)  C3-C2-C1 60.40(13) 
 N1-C4-C2 118.05(18)  C25-C26-C27 120.8(3) 
 C26-C25-C24 120.9(2)  O2-C6-C7 107.15(16) 
 C26-C25-C30 119.1(2)  O2-C6-C9 107.85(17) 
 C30-C25-C24 120.0(2)  O2-C6-C5 102.63(16) 
 C14-C15-C16 120.3(2)  C7-C6-C5 113.52(18) 
 C18-C23-C22 120.7(2)  C9-C6-C7 110.33(19) 
 C15-C14-C13 119.8(2)  C9-C6-C5 114.65(17) 
 C13-C12-C11 121.3(2)  C21-C22-C23 119.7(2) 
 C12-C11-C16 118.62(19)  O2-B1-O1 113.75(18) 
 C12-C11-C2 118.27(19)  O2-B1-C1 123.89(19) 
 C16-C11-C2 123.1(2)  O1-B1-C1 122.0(2) 
 C23-C18-C19 119.2(2)  O1-C5-C6 103.11(15) 
 C23-C18-C17 119.39(19)  O1-C5-C8 107.55(18) 
 C19-C18-C17 121.4(2)  O1-C5-C10 106.65(18) 
 C11-C16-C15 120.3(2)  C8-C5-C6 115.8(2) 
 N1-C24-C25 113.02(17)  C8-C5-C10 109.64(19) 
 C20-C19-C18 120.0(2)  C10-C5-C6 113.36(18) 
 N1-C17-C18 113.54(17)  C29-C30-C25 119.7(3) 
 C21-C20-C19 120.4(2)  C28-C27-C26 119.9(3) 
 C2-C1-B1 120.07(17)  C29-C28-C27 119.8(3) 
 C3-C1-C2 58.98(13)  C28-C29-C30 120.7(3) 
 C3-C1-B1 119.67(18)  C2-C3-C1 60.62(13) 






Table 42. Hydrogen Atom Coordinates (Å×104) and Isotropic Displacement Parameters 
(Å2×103) for 54ad. 
 
 Atom x y z U(eq) 
 H15 -347 2352 4349 29 
 H23 -5258 5882 4602 28 
 H14 2900 2251 4739 32 
 H12 4780 4389 3956 27 
 H16 -1075 3496 3780 25 
 H24A 1954 7011 4249 26 
 H24B 103 6773 4634 26 
 H19 394 4786 4804 28 
 H17A -1878 5057 3851 24 
 H17B -2901 5996 3928 24 
 H20 -557 4377 5639 34 
 H1 2980 4127 2825 23 
 H13 5479 3272 4540 33 
 H21 -3847 4713 5955 35 
 H26 -3321 7415 4505 38 
 H22 -6198 5475 5439 34 
 H7A 5858 6927 3028 41 
 H7B 7054 7518 2616 41 
 H7C 8113 6649 2831 41 
 H9A 8650 6103 1975 43 
 H9B 7513 6893 1688 43 
 H9C 6754 5914 1593 43 
 H8A 1683 7793 2195 48 
 H8B 4003 8045 2036 48 
 H8C 3476 7796 2621 48 
 H10A 3228 5904 1516 44 
 H10B 3915 6866 1351 44 
 H10C 1575 6681 1523 44 
 H30 1291 7942 3492 38 
 H27 -5368 8494 4126 54 
 H28 -4083 9302 3434 59 
 H29 -749 9039 3128 52 
 H3A -786 5217 2876 24 





A-3) Xray Data for [83aa] 
Figure 13. ORTEP drawing of 83aa showing 50% probability amplitude displacement 
ellipsoids. 




Table 43. Crystal data and structure refinement for 83aa. 
 Empirical formula C22H27NO2 
 Formula weight 337.44 
 Temperature/K 150.00(10) 
 Crystal system monoclinic 
 Space group P21/n 
 a/Å 14.9999(2) 
 b/Å 7.56312(8) 
 c/Å 17.9960(3) 
 α/° 90 
 β/° 113.2748(18) 
 γ/° 90 
 Volume/Å3 1875.43(5) 
 Z 4 
 ρcalcg/cm3 1.195 
 μ/mm -1 0.592 
 F(000) 728.0 
 Crystal size/mm3 0.451 × 0.301 × 0.252 
 Radiation CuKα (λ = 1.54184) 
 2Θ range for data collection/° 9.848 to 152.316 
 Index ranges -18 ≤ h ≤ 18, -9 ≤ k ≤ 7, -22 ≤ l ≤ 22 
 Reflections collected 13759 
 Independent reflections 3897 [Rint = 0.0184, Rsigma = 0.0147] 
 Data/restraints/parameters 3897/0/244 
 Goodness-of-fit on F2 1.021 
 Final R indexes [I>=2σ (I)] R1 = 0.0366, wR2 = 0.0902 
 Final R indexes [all data] R1 = 0.0399, wR2 = 0.0942 






Table 44. Atomic coordinates (x 104) and equivalent isotropic displacement parameters (Å2 x 
103) for 83aa. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
 
 Atom x y z U(eq) 
  
 O001 3924.3(5) 3541.7(10) 7284.8(4) 26.52(17) 
 O002 5048.6(5) 945.7(10) 6936.0(4) 26.57(17) 
 N003 3176.9(7) 6101.5(12) 6742.8(5) 26.0(2) 
 C004 3649.0(7) 4105.9(13) 5892.9(5) 18.4(2) 
 C005 6289.3(7) 2164.5(13) 6564.7(6) 20.8(2) 
 C006 4551.9(7) 3165.0(13) 5897.1(6) 19.2(2) 
 C007 5356.0(7) 2538.6(13) 6671.6(6) 20.4(2) 
 C008 3600.7(7) 4562.5(13) 6697.2(6) 20.1(2) 
 C009 2683.8(7) 3524.3(13) 5266.6(6) 20.0(2) 
 C00A 4385.7(7) 5083.5(13) 5655.0(6) 20.8(2) 
 C00B 6321.8(8) 967.3(14) 5987.4(6) 26.2(2) 
 C00C 7140.6(7) 3022.4(14) 7055.5(6) 24.2(2) 
 C00D 2095.3(8) 2418.6(15) 5499.1(6) 26.1(2) 
 C00E 2351.2(8) 4052.1(15) 4463.0(6) 28.0(2) 
 C00F 5016.4(8) 6525.0(15) 6184.2(7) 28.1(2) 
 C00G 8008.1(7) 2699.7(15) 6967.9(7) 28.0(2) 
 C00H 8026.8(8) 1522.3(16) 6388.2(7) 30.6(2) 
 C00I 7185.5(8) 652.1(16) 5897.3(7) 31.0(2) 
 C00J 1191.5(8) 1884.5(16) 4941.1(7) 32.3(2) 
 C00K 870.6(8) 2411.7(17) 4140.9(7) 34.0(3) 
 C00L 3182.0(9) 6659.1(16) 7527.3(7) 33.1(3) 
 C00M 1453.5(9) 3488.5(17) 3904.3(7) 34.3(3) 
 C00N 2709.3(9) 7309.9(15) 6061.7(7) 31.8(3) 
 C00O 1608.5(10) 7218(2) 5738.5(9) 46.0(3) 
 C00P 4124(7) 7692(14) 8044(6) 52.3(15) 




Table 45. Anisotropic Displacement Parameters (Å2×103) for 83aa. The Anisotropic 
displacement factor exponent takes the form: -2π2[h2a*2U11+2hka*b*U12+…]. 
 Atom U11 U22 U33 U23 U13 U12 
 
 O001 28.4(4) 33.9(4) 18.7(3) 4.8(3) 10.8(3) 5.3(3) 
 O002 25.8(4) 27.6(4) 25.5(4) 6.0(3) 9.3(3) 1.9(3) 
 N003 31.2(5) 26.6(4) 24.5(4) -0.6(3) 15.6(4) 4.0(4) 
 C004 19.2(4) 20.0(4) 15.9(4) 0.8(3) 6.8(4) 1.6(3) 
 C005 20.2(5) 21.2(5) 18.6(4) 1.9(4) 5.2(4) 3.3(4) 
 C006 18.5(4) 22.4(5) 16.6(4) -1.1(3) 6.7(4) 1.5(4) 
 C007 20.5(5) 21.9(5) 17.0(4) -0.1(3) 5.4(4) 1.5(4) 
 C008 18.0(4) 24.7(5) 18.2(4) -0.6(4) 7.7(3) -1.4(4) 
 C009 19.4(4) 20.6(5) 18.7(4) 0.0(4) 6.1(4) 3.3(4) 
 C00A 20.7(4) 24.0(5) 18.9(4) 2.0(4) 9.0(4) 1.0(4) 
 C00B 23.4(5) 26.3(5) 25.5(5) -4.3(4) 6.1(4) 1.5(4) 
 C00C 23.7(5) 24.1(5) 20.8(5) 0.3(4) 4.3(4) 1.7(4) 
 C00D 24.4(5) 29.6(5) 24.8(5) 0.8(4) 10.3(4) -0.6(4) 
 C00E 27.5(5) 31.6(6) 21.0(5) 4.4(4) 5.4(4) 1.0(4) 
 C00F 26.7(5) 26.0(5) 32.8(6) -1.7(4) 13.0(4) -4.6(4) 
 C00G 19.9(5) 28.4(5) 30.5(5) 5.9(4) 4.3(4) 0.2(4) 
 C00H 24.5(5) 32.4(6) 37.2(6) 7.7(5) 14.7(5) 7.0(4) 
 C00I 32.4(6) 30.8(6) 31.8(6) -2.5(4) 14.9(5) 7.2(4) 
 C00J 23.9(5) 35.2(6) 37.7(6) -4.4(5) 12.1(5) -5.0(4) 
 C00K 20.7(5) 38.1(6) 34.3(6) -8.5(5) 1.4(4) 0.8(4) 
 C00L 41.7(6) 34.4(6) 32.9(6) -6.5(5) 25.2(5) 0.4(5) 
 C00M 30.9(6) 40.4(7) 22.3(5) 1.0(5) 0.5(4) 2.9(5) 
 C00N 38.9(6) 25.4(5) 36.3(6) 5.2(4) 20.4(5) 9.5(5) 
 C00O 38.8(7) 47.0(8) 54.6(8) 11.7(6) 20.9(6) 18.6(6) 
 C00P 48(3) 83(3) 28(3) -21(2) 17(2) -29(2) 




Table 46. Bond lengths [Å] for 83aa. 
 
 Atom-Atom Length/Å  Atom-Atom Length/Å 
 
 O001-C008 1.2427(12)  C009-C00D 1.3947(14) 
 O002-C007 1.4366(12)  C009-C00E 1.3891(14) 
 N003-C008 1.3442(14)  C00A-C00F 1.5095(14) 
 N003-C00L 1.4707(13)  C00B-C00I 1.3883(15) 
 N003-C00N 1.4663(14)  C00C-C00G 1.3928(15) 
 C004-C006 1.5273(13)  C00D-C00J 1.3905(15) 
 C004-C008 1.5175(12)  C00E-C00M 1.3913(16) 
 C004-C009 1.5067(13)  C00G-C00H 1.3803(17) 
 C004-C00A 1.5248(13)  C00H-C00I 1.3875(17) 
 C005-C007 1.5132(13)  C00J-C00K 1.3843(18) 
 C005-C00B 1.3934(14)  C00K-C00M 1.3796(18) 
 C005-C00C 1.3930(14)  C00L-C00P 1.560(9) 
 C006-C007 1.5144(13)  C00L-C00Q 1.417(18) 
 C006-C00A 1.5071(14)  C00N-C00O 1.5201(18) 
 
Table 47. Bond angles for 83aa. 
 
 Atom-Atom-Atom Angle/˚  Atom-Atom-Atom Angle/˚ 
  
 C008-N003-C00L 118.92(9)  N003-C008-C004 117.21(8) 
 C008-N003-C00N 124.77(9)  C00D-C009-C004 119.06(9) 
 C00N-N003-C00L 116.30(9)  C00E-C009-C004 122.58(9) 
 C008-C004-C006 118.54(8)  C00E-C009-C00D 118.36(9) 
 C008-C004-C00A 118.07(8)  C006-C00A-C004 60.49(6) 
 C009-C004-C006 117.11(8)  C006-C00A-C00F 121.48(9) 
 C009-C004-C008 112.71(8)  C00F-C00A-C004 121.07(8) 
 C009-C004-C00A 121.36(8)  C00I-C00B-C005 120.52(10) 
 C00A-C004-C006 59.18(6)  C00G-C00C-C005 120.66(10) 
 C00B-C005-C007 121.54(9)  C00J-C00D-C009 120.64(10) 
 C00C-C005-C007 119.64(9)  C009-C00E-C00M 120.75(11) 
 C00C-C005-C00B 118.82(9)  C00H-C00G-C00C 119.84(10) 
 C007-C006-C004 122.17(8)  C00G-C00H-C00I 120.14(10) 
 C00A-C006-C004 60.33(6)  C00H-C00I-C00B 120.01(10) 
 C00A-C006-C007 123.22(8)  C00K-C00J-C00D 120.43(11) 
 O002-C007-C005 108.63(8)  C00M-C00K-C00J 119.26(10) 
 O002-C007-C006 108.91(8)  N003-C00L-C00P 112.1(3) 
 C005-C007-C006 112.45(8)  C00Q-C00L-N003 109.9(6) 
 O001-C008-N003 121.42(9)  C00K-C00M-C00E 120.55(11) 





Table 48. Hydrogen Atom Coordinates (Å×104) and Isotropic Displacement Parameters 
(Å2×103) for 83aa. 
 
 Atom x y z U(eq) 
 
 H006 4419.76 2357.96 5439.72 23 
 H007 5478.95 3449.46 7087.84 24 
 H00A 4173.16 5296.18 5073.06 25 
 H00B 5760.57 374.65 5659.92 31 
 H00C 7129.56 3818.55 7445.66 29 
 H00D 2309.46 2034.92 6032.38 31 
 H00E 2732.82 4790.46 4296.51 34 
 H00F 4687.83 7639.95 6034.76 42 
 H00G 5618.02 6575.67 6114.14 42 
 H00H 5144.46 6276.03 6740.17 42 
 H00I 8573.32 3276.11 7299.12 34 
 H00J 8604.65 1311.76 6326.54 37 
 H00K 7200.08 -142.45 5507.86 37 
 H00L 800.1 1168.44 5106.57 39 
 H00M 268.78 2044.07 3767.08 41 
 H00N 3127.79 5623.64 7824.83 40 
 H00O 2622.43 7405.04 7436.25 40 
 H00P 2544.25 7092.74 7454.68 40 
 H00Q 3334.78 5656.37 7892.71 40 
 H00R 1244.65 3840.68 3366.94 41 
 H00S 2917.53 7017.24 5630.29 38 
 H00T 2916.7 8509.83 6234.86 38 
 H00U 1333.77 8026.85 5294.96 69 
 H00V 1397.81 7529.94 6160.35 69 
 H00W 1398.64 6037.61 5556.05 69 
 H00X 4672.54 6914.37 8191.11 78 
 H00Y 4070.1 8133.24 8525.3 78 
 H 4207.97 8663.89 7735.26 78 
 H00Z 4501.75 7607.87 7896.78 80 
 HA 3920.98 8294.26 8396.8 80 
 HB 3691.88 9043.38 7528.27 80 






















HK - HC 
HK – HF 
HI/J – HA/B 
HI/J – HD 
HI/J – HE 
HI/J – HG/H 
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A-10) Chiral HPLC Data 
Chiral HPLC analysis was conducted with either a Rainin Dynamax SD-200 equipped with a 
250mm x 4.6mm Chiracel OD-H column and Rainin Dynamax Absorbance detector UV-C set at 
254nm or Agilent Technologies 1220 Infinity system equipped with either Diacel Chirapak IC, 
Diacel Chirapak IE, or Diacel Chirapak IB. Columns are Identified as follows: 
Column 1: Chiracel OD-H (Eluent flow rate 0.5 mL/min) 
Column 2: Diacel Chirapak IC (Eluent flow rate 1.0 mL/min) 
Column 3: Diacel Chirapak IE (Eluent flow rate 1.0 mL/min) 
Column 4: Diacel Chirapak IB (Eluent flow rate 1.0 mL/min) 
All analytical methods were optimized using racemic hydroboration products obtained via 
the same procedure as described in the experimental for asymmetric hydroboration except with 
racemic BINAP ligand used instead of asymmetric ligand. Crude reaction mixtures were filtered 
through a short column of silica gel and analyzed without further purification. 
 
Compound Column Eluent (Hexane/IPA) Rt of Enantiomers (min) 
32a 1  (99.5/0.5) 10.65; 12.89 
32b 1  (99.5/0.5) 12.11; 16.88  
32c 2  (95/5) 4.27; 4.61[a]  
5.95; 6.33[b]  
32d 1  (99.5/0.5) 11.39; 14.61  
32e 1  (99.5/0.5) 12.03; 16.11  
32f 1  (99.9/0.1) 36.30; 43.17  
32g 1  (99.5/0.5) 11.12; 15.68  
32i 1  (99.5/0.5) 12.38; 18.97  
32j 2  (95/5) 4.12; 4.34[a]  
5.02; 5.35[b]  
32k 1  (99.5/0.5) 11.76; 14.89  
32l 1  (99.5/0.5) 11.74; 15.68  
32m 1  (99.5/0.5) 11.12; 14.42  
32n 1  (99.5/0.5) 9.84; 13.04  
32o 2  (95/5) 3.92; 4.23  
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44 2  (97:3) 4.38; 4.85  
45 2  (97:3) 5.26; 5.79  
46 4  (99.6/0.4) 3.48; 4.13  
54aa 2  (80/20) 5.75; 8.62  
54ab 2  (80/20) 5.58; 6.09  
54ad 2  (80/20) 5.36; 7.58  
54ae 2  (80/20) 6.03; 7.81  
54af 2  (80/20) 5.68; 6.43  
54ai 2  (80/20) 6.86; 8.98  
54ak 2  (80/20) 8.33; 9.74  
54am 2  (80/20) 4.60; 5.27  
54an 2  (90/10) 6.27; 7.94  
54ao 2  (97.5/2.5) 8.08; 10.20[a]  
8.74; 11.27[b]  
54ar 2  (90/10) 6.69; 7.65  
54au 2  (95/5) 15.32; 16.84  
54fa 2  (80/20) 6.17; 8.55 
54ga 2  (80/20) 6.64; 11.13 
54ba 2  (80/20) 5.04; 8.32 
54la 2  (80/20) 5.06; 9.01  
54na 2  (80/20) 4.28; 10.62  
54ia 2  (80/20) 5.75; 8.62  
54ja 2  (80/20) 5.65; 11.88  
54ca 2  (80/20) 5.31; 7.80  
54da 2  (80/20) 5.89; 10.66  
54oa 3  (90/10) 11.22; 8.72  
54ma 2  (80/20) 5.70; 14.02  
54ea 2  (80/20) 5.79; 13.35  
57 2  (80/20) 7.96; 16.29  
63 (cis) 4  (99.6/0.4) 3.50; 3.62  
63 (trans) 4  (99.6/0.4) 3.54; 3.70  
64 (cis) 4  (99.8/0.2) 4.40; 6.19  
64 (trans) 4  (99.6/0.4) 3.13; 3.61  
66 2  (97:3) 3.77; 3.98  
67 4  (99/1) 4.13; 4.38  
 
  
[a] Major diastereomer. [b] Minor diastereomer. 
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